data_2a00_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a00 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.003 0.43 . . . . 6.1 110.12 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.94 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.95 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.469 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.82 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 355' ' ' LEU . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.53 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.478 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 1.28 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.44 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.526 ' CB ' HG22 ' A' ' 416' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 2.3 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.37 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.79 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 2.53 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.537 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.475 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.76 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 1.21 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 1.62 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.569 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 1.39 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 440' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 1.34 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 1.29 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.604 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 2.22 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.24 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.83 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 339' ' ' LEU . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.66 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 4.28 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.84 110.112 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 351' ' ' SER . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.314 0.578 . . . . 3.25 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.56 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 4.07 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB2' ' HG3' ' A' ' 318' ' ' GLN . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.79 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.522 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 2.19 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.8 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 350' ' ' ARG . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.99 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 322' ' ' PHE . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.83 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.604 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 1.07 109.743 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.187 0.518 . . . . 4.66 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 3.11 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.64 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.93 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.46 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.7 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.76 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.499 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.82 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.514 ' N ' HG11 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.39 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.89 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.577 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.66 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 5.26 111.268 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.542 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 6.59 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.91 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.79 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.92 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.98 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.62 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.53 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.09 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.88 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.13 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.86 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.476 ' ND2' ' HE1' ' A' ' 392' ' ' MET . 3.0 m120 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.26 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.86 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.85 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.51 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 3.03 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.476 ' HE1' ' ND2' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.45 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 2.27 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.577 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 3.45 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 2.2 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.82 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 382' ' ' ARG . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.62 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 1.19 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.59 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 1.28 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.556 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 1.37 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 3.13 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 3.14 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.504 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 3.05 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 1.43 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.16 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.61 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.28 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 2.34 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.95 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 4.15 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.51 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 2.25 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.87 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 325' ' ' ALA . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 1.43 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.81 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.97 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 3.09 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 1.4 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.05 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.89 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.65 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.66 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.75 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 3.33 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.21 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.6 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.9 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.533 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.53 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 445' ' ' LEU . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.98 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.515 HG13 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 1.15 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.461 HG22 ' HG3' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.73 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.556 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 1.32 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.505 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.42 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.82 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 4.21 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.471 ' HA ' HG13 ' A' ' 434' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.73 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 2.29 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.38 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 420' ' ' VAL . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 1.3 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.494 ' CD1' HD23 ' A' ' 333' ' ' LEU . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.75 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.468 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 1.33 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.7 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.79 109.511 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.477 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.105 0.479 . . . . 6.1 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.523 ' HB3' ' CD2' ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.94 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.522 ' CA ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.95 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.466 ' HG2' HD13 ' A' ' 323' ' ' ILE . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.82 110.881 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.53 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.523 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 1.28 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.44 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.555 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 2.3 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.37 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.79 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 324' ' ' PRO . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 2.53 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.465 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.76 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 1.21 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.527 ' CD1' HD12 ' A' ' 440' ' ' LEU . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 1.62 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 1.39 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.482 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 1.34 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 1.29 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 2.22 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.24 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.83 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.66 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.524 ' HB2' ' CA ' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 4.28 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.7 p30 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.84 110.161 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' A' ' 351' ' ' SER . 98.2 mt-10 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.387 0.613 . . . . 3.25 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.453 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.56 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 4.07 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.477 ' HB2' ' CB ' ' A' ' 318' ' ' GLN . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.79 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.485 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 2.19 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.8 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 350' ' ' ARG . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.99 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.83 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.546 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 1.07 109.388 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.369 0.604 . . . . 4.66 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 3.11 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.64 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.93 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.46 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.525 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.7 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.76 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.495 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.82 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.39 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.89 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.528 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.66 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 5.26 111.207 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.522 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 6.59 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.91 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.79 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.92 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.98 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 381' ' ' SER . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.62 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.09 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.88 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.13 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.86 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.26 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.525 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.86 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.85 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.51 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 3.03 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.45 109.09 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.546 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 2.27 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 3.45 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.461 ' HG3' HG21 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 2.2 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.82 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.479 ' OG ' ' HB1' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.62 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 1.19 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.59 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 1.28 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.557 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 1.37 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 3.13 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 3.14 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.576 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.7 t-80 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 3.05 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.516 HG11 ' CA ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 1.43 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.16 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.61 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.1 m120 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.28 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.516 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 2.34 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.467 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.95 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.523 ' CZ ' HG12 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 4.15 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.51 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 2.25 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.87 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 1.43 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.81 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 26.6 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.97 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 3.09 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 1.4 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.05 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.89 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.65 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.66 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.75 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 3.33 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.21 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.6 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.9 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 428' ' ' ALA . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.53 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.52 HD11 ' CD2' ' A' ' 445' ' ' LEU . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.98 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.523 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 1.15 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.461 HG21 ' HG3' ' A' ' 395' ' ' LYS . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.73 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.557 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 1.32 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.42 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.82 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.509 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 4.21 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.514 ' CG1' HG13 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.73 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.527 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 2.29 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.38 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 420' ' ' VAL . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 1.3 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.532 HD12 ' CB ' ' A' ' 322' ' ' PHE . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.75 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.526 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 1.33 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.521 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.7 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.79 110.022 172.602 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 351' ' ' SER . 25.5 mt-30 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.234 -0.654 . . . . 6.1 109.234 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.519 ' N ' ' HG ' ' A' ' 445' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.94 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.52 ' CA ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.95 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.82 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.53 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.5 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 1.28 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.44 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 2.3 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.37 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.79 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 2.53 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.465 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.531 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.76 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 1.21 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 440' ' ' LEU . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.62 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 1.39 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.458 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 1.34 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 1.29 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.562 ' CG ' ' HB2' ' A' ' 356' ' ' ALA . 0.9 OUTLIER -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 2.22 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.24 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.83 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 339' ' ' LEU . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.66 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 4.28 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.84 110.126 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 351' ' ' SER . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.445 0.641 . . . . 3.25 110.081 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.56 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 4.07 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.79 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.52 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 2.19 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.8 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.99 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.52 HD12 ' CA ' ' A' ' 320' ' ' SER . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.83 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 1.07 109.478 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.401 0.619 . . . . 4.66 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 3.11 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.64 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.93 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.46 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.516 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.7 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.76 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.82 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.39 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.89 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.569 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.66 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 5.26 111.355 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 6.59 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.91 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.79 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.92 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.98 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 381' ' ' SER . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.62 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.551 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.09 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.88 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.427 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.13 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.86 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.8 m120 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.26 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.86 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.51 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 3.03 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.45 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 2.27 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.571 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 3.45 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.48 ' NZ ' ' CD1' ' A' ' 352' ' ' ILE . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 2.2 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.49 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.82 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.62 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.58 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 1.19 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.59 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 1.28 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.572 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 1.37 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 3.13 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 3.14 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.571 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 3.05 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.516 HG12 ' CA ' ' A' ' 410' ' ' GLY . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 1.43 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.16 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.61 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.28 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.516 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 2.34 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.95 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 4.15 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.51 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 2.25 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.531 ' N ' ' CG2' ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.87 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 1.43 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.81 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.97 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 3.09 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.58 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.4 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.05 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.89 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.65 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.66 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.75 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 422' ' ' GLN . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 3.33 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.21 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.6 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.9 108.985 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.53 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 445' ' ' LEU . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.98 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.516 ' CG1' HG12 ' A' ' 439' ' ' VAL . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 1.15 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.73 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.572 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 1.32 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.42 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.82 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 4.21 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 432' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.73 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 2.29 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.38 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 1.3 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.469 ' CD1' ' CB ' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.75 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 1.33 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.7 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.8 tttt . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.79 109.604 174.21 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.473 ' HB2' ' OG ' ' A' ' 351' ' ' SER . 14.3 pt20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.903 0.383 . . . . 6.1 110.149 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.94 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.469 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.95 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.82 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.53 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.501 ' C ' ' CD2' ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 1.28 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.44 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 416' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 2.3 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.37 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.79 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 2.53 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.76 110.51 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 1.21 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 1.62 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 1.39 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.467 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 1.34 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.507 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 1.29 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.611 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 2.22 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.24 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.83 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 339' ' ' LEU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.66 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 4.28 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.84 110.107 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.276 0.56 . . . . 3.25 110.142 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.56 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 4.07 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 318' ' ' GLN . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.79 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.469 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 2.19 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 338' ' ' GLN . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.8 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 350' ' ' ARG . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.99 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.83 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.611 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 1.07 109.58 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.528 ' CZ ' HD23 ' A' ' 339' ' ' LEU . 10.8 ptp180 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.46 0.647 . . . . 4.66 110.317 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 3.11 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 374' ' ' PHE . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.64 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.93 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.46 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.523 ' CD1' HD12 ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.7 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.76 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.528 ' CB ' HG11 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.82 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.39 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.89 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.519 ' N ' ' HB2' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.66 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 5.26 111.119 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 6.59 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.91 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.79 110.528 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.92 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.98 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 381' ' ' SER . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.62 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.522 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.09 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.88 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.433 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.13 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.86 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 3.3 m120 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.26 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.86 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.85 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.51 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 3.03 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.45 109.317 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 2.27 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.514 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 3.45 110.069 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.561 ' CG ' ' CD1' ' A' ' 431' ' ' LEU . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 2.2 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.82 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.62 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 1.19 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.59 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' OG ' ' A' ' 397' ' ' SER . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 1.28 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 1.37 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 3.13 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 3.14 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.514 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 55.5 t-80 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 3.05 110.722 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.511 HG13 ' CA ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 1.43 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.16 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.61 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.28 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 2.34 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.95 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 4.15 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.51 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 2.25 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.87 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 412' ' ' PHE . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 1.43 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.81 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 9.2 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.97 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.519 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 3.09 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.531 ' O ' ' CG ' ' A' ' 430' ' ' PRO . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 1.4 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.05 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.89 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 444' ' ' ALA . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.65 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.66 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.75 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 3.33 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.21 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.6 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.9 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.53 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.561 ' CD1' ' CG ' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.98 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.512 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 1.15 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.517 HG22 ' CG ' ' A' ' 395' ' ' LYS . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.73 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 1.32 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.525 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.42 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.82 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 4.21 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.73 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 2.29 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.525 ' HA3' ' CD1' ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.38 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.529 HG12 ' CG2' ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 1.3 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 431' ' ' LEU . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.75 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 1.33 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.7 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.79 109.382 170.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.153 0.501 . . . . 6.1 110.384 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.94 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.95 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.82 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 334' ' ' ALA . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.53 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.509 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 1.28 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.531 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.44 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 2.3 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.462 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.37 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.79 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 2.53 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.413 ' N ' HG11 ' A' ' 328' ' ' VAL . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.531 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.76 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 1.21 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 1.62 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 1.39 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 1.34 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.501 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 1.29 110.099 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.597 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 2.22 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.24 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.83 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.66 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 4.28 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.84 110.007 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.275 0.56 . . . . 3.25 110.136 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.56 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 4.07 109.444 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.79 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 2.19 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.8 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.99 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.55 HD21 ' CE1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.83 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.597 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.07 109.634 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.518 ' HD3' ' CD1' ' A' ' 370' ' ' LEU . 25.3 ttm180 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.663 0.744 . . . . 4.66 109.997 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.482 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 3.11 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.64 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.93 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.482 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.46 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.7 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.76 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.82 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.39 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.89 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.516 HG22 ' CA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.66 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 5.26 111.331 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.535 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 6.59 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.91 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.79 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.92 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.98 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.62 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.09 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.88 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.425 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.13 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.86 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.456 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.26 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.86 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.85 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.51 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 3.03 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.45 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.542 HG13 ' CD1' ' A' ' 339' ' ' LEU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 2.27 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.517 ' NH2' ' HE2' ' A' ' 383' ' ' MET . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 3.45 110.419 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 396' ' ' GLY . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 2.2 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 395' ' ' LYS . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.82 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.486 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.62 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.528 ' CG2' HG11 ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 1.19 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.59 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 1.28 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 1.37 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 3.13 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 3.14 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.454 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 85.7 t60 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 3.05 110.58 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.5 HG13 ' CA ' ' A' ' 410' ' ' GLY . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 1.43 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.16 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.61 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.28 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.5 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 2.34 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.403 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.95 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.608 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 4.15 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.51 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 2.25 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.87 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.608 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 1.43 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.81 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.97 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 3.09 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 1.4 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.05 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.89 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.65 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.66 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.75 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 3.33 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.21 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.6 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.9 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.492 ' HB2' HG11 ' A' ' 420' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.53 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.523 HD11 ' CD2' ' A' ' 445' ' ' LEU . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.98 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 420' ' ' VAL . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 1.15 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.73 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 1.32 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.42 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.82 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.495 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 4.21 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.515 HG11 ' CG1' ' A' ' 432' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.73 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 2.29 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.38 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.525 HG12 ' CG2' ' A' ' 420' ' ' VAL . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 1.3 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 322' ' ' PHE . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.75 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 1.33 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD2' HD11 ' A' ' 431' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.7 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.79 109.162 169.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.837 -0.431 . . . . 6.1 109.837 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.486 ' N ' ' HG ' ' A' ' 445' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.94 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.434 ' C ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.95 110.564 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.468 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.82 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.574 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.53 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.543 ' N ' ' CD2' ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 1.28 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.44 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 416' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 2.3 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.37 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.79 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 2.53 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.76 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.21 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 323' ' ' ILE . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 1.62 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 1.39 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.478 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 1.34 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.457 ' HB1' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 1.29 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 356' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 2.22 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.566 ' N ' ' CD1' ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.24 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.83 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 365' ' ' ARG . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.66 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 4.28 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.84 110.309 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.56 . . . . 3.25 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.456 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.56 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 4.07 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.525 ' OG ' ' CB ' ' A' ' 318' ' ' GLN . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.79 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.483 ' O ' ' CG ' ' A' ' 338' ' ' GLN . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.19 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.456 HG22 ' OG ' ' A' ' 341' ' ' SER . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.8 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 350' ' ' ARG . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.99 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.482 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.83 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 1.07 109.561 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 342' ' ' LEU . 82.6 mtp180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.171 0.51 . . . . 4.66 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 3.11 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.642 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.64 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.93 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.46 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.7 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 29.7 m170 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.76 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.82 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.39 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.89 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.66 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 5.26 111.162 -175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.572 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 6.59 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.91 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.79 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.92 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.98 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.62 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.535 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.09 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.572 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.88 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.461 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.13 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.86 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.414 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 7.9 m120 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.26 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.86 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.85 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.51 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.531 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 3.03 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.45 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 2.27 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.563 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 3.45 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 431' ' ' LEU . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 2.2 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.467 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.82 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.62 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 1.19 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.59 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.535 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 1.28 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 434' ' ' VAL . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 1.37 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 3.13 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 3.14 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.563 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 57.7 t-80 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 3.05 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 1.43 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.16 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.61 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.28 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.489 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 2.34 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.95 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 4.15 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.51 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 2.25 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.87 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.519 HG23 ' CB ' ' A' ' 325' ' ' ALA . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 1.43 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.81 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.97 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.538 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 3.09 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 1.4 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.05 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.89 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.65 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.66 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.75 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 3.33 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.21 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.6 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.9 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.521 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.53 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.455 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.98 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 420' ' ' VAL . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 1.15 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.73 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 1.32 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.471 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.42 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.82 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 4.21 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.73 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 336' ' ' ALA . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 2.29 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.38 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 420' ' ' VAL . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 1.3 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 333' ' ' LEU . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.75 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 423' ' ' VAL . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 1.33 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.7 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.79 109.772 174.374 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.544 -0.539 . . . . 6.1 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.94 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.95 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.467 ' HG2' HD12 ' A' ' 323' ' ' ILE . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.82 110.739 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.53 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.526 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 1.28 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.44 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 2.3 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.37 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.79 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 2.53 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.537 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.76 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 1.21 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 1.62 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 1.39 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.479 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 1.34 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.513 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 1.29 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.606 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.535 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 2.22 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.24 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.83 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.66 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.529 ' HB3' ' CA ' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 4.28 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.84 110.12 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.311 0.577 . . . . 3.25 110.067 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.56 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 4.07 109.653 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' GLN . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.79 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.528 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 2.19 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.8 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.99 110.491 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.53 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.83 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.606 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 1.07 109.606 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' A' ' 339' ' ' LEU . 58.5 mtp85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.671 0.748 . . . . 4.66 110.563 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 3.11 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.64 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.93 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.46 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.54 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.7 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.76 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.517 ' HB3' ' CG1' ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.82 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.39 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.593 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.89 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.491 HG22 ' CA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.66 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 5.26 111.27 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.523 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 6.59 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.91 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.79 110.472 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.92 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.98 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.62 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.52 ' HE2' ' NH2' ' A' ' 394' ' ' ARG . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.09 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.88 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.13 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.86 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 3.2 m120 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.26 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.86 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.51 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 3.03 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.45 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 2.27 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.52 ' NH2' ' HE2' ' A' ' 383' ' ' MET . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 3.45 110.393 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 396' ' ' GLY . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 2.2 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 395' ' ' LYS . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.82 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.62 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 1.19 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.59 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 1.28 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 1.37 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 3.13 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 3.14 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.7 t60 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 3.05 110.56 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.492 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 1.43 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.16 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.61 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.28 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.492 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 2.34 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.407 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.95 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.46 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 4.15 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.51 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 2.25 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.87 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.43 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.81 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.97 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 3.09 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.4 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.05 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 25.5 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.89 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.65 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.66 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.75 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 3.33 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.21 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.6 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.9 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.53 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.455 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.98 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 420' ' ' VAL . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 1.15 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.465 HG21 ' HG2' ' A' ' 395' ' ' LYS . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.73 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 1.32 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.535 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.42 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.82 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 4.21 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.73 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 2.29 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.38 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.526 HG11 ' CG2' ' A' ' 420' ' ' VAL . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 1.3 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.528 HD13 ' CB ' ' A' ' 322' ' ' PHE . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.75 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.526 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 1.33 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.7 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.79 109.89 174.507 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.881 -0.414 . . . . 6.1 109.881 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.94 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.454 ' O ' HD11 ' A' ' 355' ' ' LEU . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.95 110.543 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.473 ' HG3' HD11 ' A' ' 323' ' ' ILE . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.82 110.641 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.53 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.481 ' O ' HD23 ' A' ' 333' ' ' LEU . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 1.28 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.536 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.44 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 2.3 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.37 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.79 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 2.53 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.445 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.536 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.76 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 1.21 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 322' ' ' PHE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 1.62 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 1.39 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 1.34 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.492 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 1.29 110.087 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.6 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 2.22 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.24 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.83 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.66 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.53 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 4.28 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.2 p30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.84 110.062 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.371 0.605 . . . . 3.25 110.117 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.56 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 4.07 109.498 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 318' ' ' GLN . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.79 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 319' ' ' ALA . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 2.19 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.8 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.99 110.342 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.83 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 1.07 109.663 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.518 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 88.5 mtt180 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.258 0.552 . . . . 4.66 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.458 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 3.11 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.64 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.93 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.46 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.7 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.76 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.511 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.82 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.39 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.89 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 386' ' ' ILE . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.66 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 5.26 111.172 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 6.59 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.91 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.79 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.92 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.98 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.62 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.529 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.09 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.512 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.88 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.429 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.13 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.86 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 3.4 m120 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.26 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.86 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.85 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.51 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 3.03 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.45 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.547 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 2.27 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' HG21 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 3.45 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.453 ' HG2' HG21 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 2.2 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.472 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.82 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.487 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.62 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.524 ' CG2' HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 1.19 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.59 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.529 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 1.28 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 1.37 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 3.13 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 3.14 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 3.05 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.474 HG12 ' CA ' ' A' ' 410' ' ' GLY . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 1.43 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.16 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.61 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.28 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.474 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 2.34 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.95 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 4.15 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.51 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 2.25 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.87 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 1.43 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.81 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.97 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 3.09 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 1.4 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.05 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.89 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.65 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.66 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.75 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 3.33 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.21 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.6 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.9 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.53 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.53 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.524 HD12 ' CD2' ' A' ' 445' ' ' LEU . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.98 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 1.15 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.73 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 1.32 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.42 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.516 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.82 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 4.21 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.524 HG13 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.73 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 2.29 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.38 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 420' ' ' VAL . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 1.3 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 445' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.75 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 423' ' ' VAL . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 1.33 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.7 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.79 109.279 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.154 0.502 . . . . 6.1 110.314 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.94 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.431 ' C ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.95 110.413 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.82 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.53 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.492 ' C ' ' CD2' ' A' ' 333' ' ' LEU . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 1.28 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.535 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.44 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.531 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 2.3 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.37 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.79 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 2.53 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.76 109.645 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 1.21 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.528 HD11 ' CD1' ' A' ' 440' ' ' LEU . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 1.62 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 1.39 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.523 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 1.34 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.441 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 1.29 109.987 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.599 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 2.22 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.24 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.83 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 339' ' ' LEU . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.66 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 4.28 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.527 ' HB2' ' CB ' ' A' ' 377' ' ' PHE . 8.2 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.84 110.287 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.455 ' O ' ' OG ' ' A' ' 351' ' ' SER . 75.3 mm-40 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.361 0.6 . . . . 3.25 110.104 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 353' ' ' VAL . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.56 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 4.07 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' A' ' 318' ' ' GLN . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.79 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 2.19 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.8 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 350' ' ' ARG . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.99 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.527 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.83 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.599 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 1.07 109.565 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.685 0.755 . . . . 4.66 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 3.11 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.64 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.93 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.46 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.7 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.76 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.491 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.82 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.432 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.39 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.89 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.66 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 5.26 111.371 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.528 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 6.59 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.91 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.79 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.92 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.98 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 381' ' ' SER . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.62 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.519 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.09 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.528 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.88 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.13 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.86 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.421 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 3.7 m120 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.26 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.86 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.85 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.51 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 3.03 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.45 109.236 167.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 2.27 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 3.45 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 2.2 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.82 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.483 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.62 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 1.19 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.59 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 1.28 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 1.37 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 3.13 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 3.14 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.549 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 3.05 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.52 HG13 ' CA ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 1.43 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.16 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.61 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.28 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.52 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 2.34 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.95 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.577 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 4.15 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.51 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.543 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 2.25 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.543 ' N ' ' CG2' ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.87 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.531 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 1.43 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.81 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.97 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 3.09 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 398' ' ' VAL . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 1.4 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.05 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.89 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.65 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.66 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.75 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 3.33 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.21 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.6 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.9 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.525 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.53 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.98 108.32 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 401' ' ' ILE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 1.15 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.73 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 1.32 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.42 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.82 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 4.21 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.464 ' HA ' HG13 ' A' ' 434' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.73 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 333' ' ' LEU . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 2.29 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.38 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 420' ' ' VAL . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 1.3 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 ' CB ' ' A' ' 322' ' ' PHE . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.75 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 1.33 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.7 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.79 109.717 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.043 0.449 . . . . 6.1 110.438 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.94 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.95 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.82 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.53 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.472 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 1.28 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.44 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 2.3 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.463 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.37 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.79 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 2.53 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.53 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.76 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 1.21 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 440' ' ' LEU . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 1.62 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 1.39 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 1.34 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.506 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 1.29 109.967 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.601 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 2.22 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.24 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.531 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.83 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 339' ' ' LEU . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.66 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 4.28 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.84 110.151 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.353 0.597 . . . . 3.25 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.434 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.56 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 4.07 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.79 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 319' ' ' ALA . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 2.19 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.531 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.8 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.99 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.83 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.601 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 1.07 109.864 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 4.66 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.463 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 3.11 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.64 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.93 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.46 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.7 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.76 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.82 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.39 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.89 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.571 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.66 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 5.26 111.332 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.531 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 6.59 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.91 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.79 110.458 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.92 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.98 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.62 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.09 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.88 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.434 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.13 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.86 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.26 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.535 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.86 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.85 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.51 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 3.03 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.45 109.174 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 2.27 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.571 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 3.45 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 396' ' ' GLY . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 2.2 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.82 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.62 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.529 HG22 ' CG1' ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 1.19 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.59 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.549 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 1.28 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.563 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 1.37 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 3.13 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 3.14 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.542 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 3.05 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.526 HG13 ' CA ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 1.43 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.16 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.61 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.28 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.526 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 2.34 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.95 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 4.15 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.51 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 2.25 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.87 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.58 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 1.43 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.81 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.97 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 3.09 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.529 ' CG1' HG22 ' A' ' 398' ' ' VAL . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 1.4 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.05 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.89 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.65 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.66 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.75 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 3.33 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.21 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.6 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.9 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.5 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.53 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 445' ' ' LEU . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.98 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 1.15 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.73 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.563 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 1.32 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.46 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.42 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.485 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.82 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 4.21 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.517 ' CG1' HG13 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.73 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 2.29 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.38 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 420' ' ' VAL . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 1.3 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.516 HD12 ' CB ' ' A' ' 322' ' ' PHE . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.75 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.515 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 1.33 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.7 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.79 109.635 172.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 14.9 mt-30 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.436 -0.579 . . . . 6.1 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' ' CG1' ' A' ' 352' ' ' ILE . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.94 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.95 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.458 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.82 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.53 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 333' ' ' LEU . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 1.28 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.44 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 2.3 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.37 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.79 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 2.53 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.76 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 1.21 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 1.62 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 1.39 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.484 ' O ' HD22 ' A' ' 339' ' ' LEU . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 1.34 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.458 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 1.29 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.558 ' HG2' ' CB ' ' A' ' 356' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 2.22 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.24 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.83 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.66 109.894 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 4.28 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.84 110.155 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.437 0.637 . . . . 3.25 110.114 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.56 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 4.07 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.79 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 2.19 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.466 HG23 ' OG ' ' A' ' 341' ' ' SER . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.8 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 350' ' ' ARG . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.99 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.516 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.83 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.558 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 1.07 109.357 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.52 ' CZ ' HD23 ' A' ' 339' ' ' LEU . 58.8 mtm180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.175 0.512 . . . . 4.66 110.362 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.458 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 3.11 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.64 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.93 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.46 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CD1' HD12 ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.7 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.76 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.492 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.82 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.39 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.89 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.431 ' HB ' ' C ' ' A' ' 385' ' ' GLY . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.66 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 5.26 111.181 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 6.59 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.91 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.79 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.92 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.98 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 381' ' ' SER . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.62 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.533 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.09 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.88 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.431 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.13 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.86 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 2.9 m120 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.26 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.527 HD12 ' CD1' ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.86 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.85 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 29.7 t30 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.51 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 3.03 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.458 ' O ' HD11 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.45 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 2.27 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 3.45 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.466 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.2 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.487 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.82 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.62 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.19 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.59 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 1.28 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.589 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 1.37 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 3.13 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.538 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 3.14 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 3.05 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.52 HG12 ' CA ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 1.43 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.16 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.61 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.482 ' CB ' ' CB ' ' A' ' 437' ' ' SER . 18.3 m120 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.28 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.52 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 2.34 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.95 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 4.15 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.51 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 2.25 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.87 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 1.43 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.81 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.97 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.532 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 3.09 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 1.4 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.05 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.89 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.65 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.66 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.75 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 3.33 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.21 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.6 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.9 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.53 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.98 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 401' ' ' ILE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 1.15 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.466 HG22 ' HG3' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.73 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 1.32 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.42 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.482 ' CB ' ' CB ' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.82 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 4.21 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.73 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 2.29 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.38 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 420' ' ' VAL . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 1.3 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.526 HD11 ' CB ' ' A' ' 322' ' ' PHE . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.75 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.497 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 1.33 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.7 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.79 109.869 176.446 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.094 0.473 . . . . 6.1 110.279 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.564 ' CB ' ' CD2' ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.94 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.459 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.95 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.82 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.534 ' CB ' HD13 ' A' ' 443' ' ' ILE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.53 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.53 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 1.28 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.531 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.44 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.544 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 2.3 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.37 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.79 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 2.53 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.76 110.706 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 1.21 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 323' ' ' ILE . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 1.62 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 1.39 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 1.34 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 338' ' ' GLN . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 1.29 109.443 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.624 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.532 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 2.22 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.24 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.83 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.66 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 4.28 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.2 p30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.84 110.007 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.325 0.583 . . . . 3.25 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.56 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 4.07 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.79 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.55 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 2.19 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.8 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.99 110.481 170.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.83 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.57 ' CB ' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 1.07 109.369 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.409 ' HD2' ' HB3' ' A' ' 339' ' ' LEU . 95.3 mtt-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.373 0.606 . . . . 4.66 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 3.11 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.64 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.93 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.46 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.53 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.7 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.76 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.513 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.82 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.39 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.89 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.501 HG22 ' CA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.66 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 5.26 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.49 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 6.59 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.91 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.79 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.92 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.98 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.62 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.534 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.09 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.88 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.13 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.86 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 2.8 m120 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.26 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.53 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.86 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.85 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.51 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 3.03 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.45 109.111 167.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 2.27 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 3.45 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.508 ' CG ' HG23 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 2.2 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.82 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.62 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 1.19 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.59 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 1.28 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 1.37 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 3.13 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 3.14 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 3.05 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.507 HG13 ' CA ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 1.43 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.16 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.61 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 97.7 m-20 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.28 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.507 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 2.34 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.95 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 4.15 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.51 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 2.25 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.87 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.43 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.81 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.473 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.97 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 3.09 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 1.4 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.05 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.89 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 444' ' ' ALA . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.65 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.66 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.75 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 3.33 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.21 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.6 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.9 108.916 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.53 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 445' ' ' LEU . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.98 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 420' ' ' VAL . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 1.15 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.508 HG23 ' CG ' ' A' ' 395' ' ' LYS . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.73 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 1.32 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.525 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.42 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.82 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 4.21 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.73 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.527 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 2.29 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.38 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG1' HG23 ' A' ' 420' ' ' VAL . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 1.3 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 322' ' ' PHE . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.75 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 1.33 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.527 ' CD2' HD11 ' A' ' 431' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.7 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.79 109.689 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.086 0.469 . . . . 6.1 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 445' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.94 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.95 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.82 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 334' ' ' ALA . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.53 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.49 ' O ' HD23 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 1.28 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.533 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.44 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 2.3 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.37 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.79 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 2.53 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.76 110.042 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 1.21 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 1.62 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 1.39 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.475 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 1.34 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 1.29 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.603 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 2.22 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.24 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.83 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.66 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 4.28 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 44.1 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.84 110.447 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 351' ' ' SER . 94.1 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.21 0.529 . . . . 3.25 110.148 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.56 109.967 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 354' ' ' ILE . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 4.07 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 318' ' ' GLN . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.79 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.465 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 2.19 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.8 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 350' ' ' ARG . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.99 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.521 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.83 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.603 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 1.07 109.784 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH2' HD21 ' A' ' 339' ' ' LEU . 56.3 mtm180 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.351 0.596 . . . . 4.66 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 3.11 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.64 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.93 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.46 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.7 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.76 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.488 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.82 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.51 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.39 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.89 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.51 HG13 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.66 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 5.26 110.959 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.515 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 6.59 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.91 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.79 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.92 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.98 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.62 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.539 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.09 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.88 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.13 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.537 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.86 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.462 ' ND2' ' HE3' ' A' ' 392' ' ' MET . 2.9 m120 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.26 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.86 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.85 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.51 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 3.03 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.462 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.45 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.548 HG13 ' CD1' ' A' ' 339' ' ' LEU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 2.27 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.57 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 3.45 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 2.2 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.82 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.62 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 1.19 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.59 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 1.28 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.579 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 1.37 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 3.13 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 3.14 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 3.05 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 1.43 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.16 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.61 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.474 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.28 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 2.34 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.44 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.95 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.613 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 4.15 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.51 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 2.25 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.87 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 1.43 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.81 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.97 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 3.09 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 1.4 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.05 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 25.7 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.89 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.525 HG13 ' CB ' ' A' ' 444' ' ' ALA . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.65 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.66 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.75 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 3.33 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.21 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.6 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.9 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.53 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 445' ' ' LEU . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.98 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 1.15 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.73 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 1.32 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.532 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.42 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.474 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.82 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 4.21 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.73 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 2.29 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.38 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.535 HG12 ' CG2' ' A' ' 420' ' ' VAL . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 1.3 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 322' ' ' PHE . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.75 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 1.33 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.7 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp . . . . . 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.79 109.307 170.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 21.4 pt20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.082 0.467 . . . . 6.1 109.941 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.94 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.95 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.82 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 334' ' ' ALA . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.53 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.493 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 1.28 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.44 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 2.3 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.37 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.79 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 2.53 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.493 ' N ' HG12 ' A' ' 328' ' ' VAL . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.76 110.137 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 1.21 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.518 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 1.62 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 1.39 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 365' ' ' ARG . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.48 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 1.34 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.515 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 1.29 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.599 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 2.22 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.24 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 338' ' ' GLN . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.83 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.66 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 4.28 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.6 p30 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.84 110.486 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.356 0.598 . . . . 3.25 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.56 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 4.07 109.998 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.79 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.492 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 2.19 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.466 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.8 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 351' ' ' SER . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.99 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.527 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.83 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.599 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 1.07 109.559 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.326 0.584 . . . . 4.66 109.883 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 3.11 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.64 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.93 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.46 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.7 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.76 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.82 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.449 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.39 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.89 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.66 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 5.26 111.118 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 6.59 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.91 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.79 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.92 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.98 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.528 ' CD ' ' HB3' ' A' ' 397' ' ' SER . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.62 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.09 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.88 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.13 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.86 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 8.6 m120 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.26 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.86 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.563 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.85 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.51 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.467 ' O ' HG21 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 3.03 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.45 109.603 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 2.27 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 3.45 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.463 ' HG3' HG21 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 2.2 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.82 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.528 ' HB3' ' CD ' ' A' ' 382' ' ' ARG . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.62 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 1.19 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.59 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 1.28 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 434' ' ' VAL . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 1.37 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.472 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 3.13 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 3.14 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 3.05 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.487 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 1.43 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.16 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.61 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.28 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.487 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 2.34 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.4 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.95 110.254 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 4.15 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.51 110.595 -177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 2.25 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.87 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.591 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 1.43 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.81 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.97 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 3.09 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 1.4 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.05 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.89 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.65 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.66 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.75 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 3.33 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.21 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.6 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.9 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.529 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.53 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 445' ' ' LEU . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.98 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 420' ' ' VAL . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 1.15 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.73 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 1.32 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.42 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.82 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 4.21 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.73 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 2.29 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.52 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.38 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 420' ' ' VAL . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 1.3 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 322' ' ' PHE . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.75 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 1.33 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.7 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.455 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.79 109.662 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.074 0.464 . . . . 6.1 110.173 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.59 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.94 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.95 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 323' ' ' ILE . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.82 110.854 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.53 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 1.28 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.44 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 2.3 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.37 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.79 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 2.53 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.528 ' CG ' ' HD3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.76 110.277 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 1.21 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.528 HD13 ' CA ' ' A' ' 441' ' ' GLY . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 1.62 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 1.39 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.521 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 1.34 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.499 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 1.29 110.412 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.545 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 2.22 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.517 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.24 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.83 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.66 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.529 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 4.28 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.84 110.232 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.339 0.59 . . . . 3.25 110.137 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.56 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 4.07 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.79 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 2.19 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.8 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.99 110.677 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.59 ' CD1' ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.83 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.545 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 1.07 109.246 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.55 ' NH1' ' NH2' ' A' ' 391' ' ' ARG . 28.4 ptt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.335 0.588 . . . . 4.66 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 3.11 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.64 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.93 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.46 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.54 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.7 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.76 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.5 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.82 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.39 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.89 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.537 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.66 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 5.26 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 6.59 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.91 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.79 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.92 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.98 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.62 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.09 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.88 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.452 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.13 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.86 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.6 m120 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.26 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.86 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.85 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.51 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 3.03 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.45 109.165 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 2.27 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.537 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 3.45 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.453 ' HG3' HG21 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 2.2 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.469 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.82 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.62 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 1.19 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.59 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 1.28 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.578 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 1.37 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 3.13 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 3.14 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.561 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 3.05 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.523 HG13 ' CA ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 1.43 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.16 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.61 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.28 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 2.34 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.439 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.95 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 4.15 109.985 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.51 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 2.25 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.87 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 1.43 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.81 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.97 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 3.09 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 398' ' ' VAL . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 1.4 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.05 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.89 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.65 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.66 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.75 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 3.33 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.21 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.6 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.9 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.528 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.53 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 445' ' ' LEU . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.98 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 420' ' ' VAL . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 1.15 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.73 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 1.32 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.42 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.82 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 4.21 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.522 ' CG1' HG13 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.73 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 2.29 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.528 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.38 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 420' ' ' VAL . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 1.3 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 322' ' ' PHE . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.75 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 1.33 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.7 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.79 109.71 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 46.0 mm-40 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.472 -0.566 . . . . 6.1 109.472 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.94 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.95 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.82 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.525 ' O ' ' CD1' ' A' ' 323' ' ' ILE . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.53 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 1.28 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.538 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.44 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.538 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 2.3 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.37 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.79 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 2.53 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.529 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.76 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.21 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 1.62 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 1.39 109.762 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 1.34 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.515 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 1.29 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.594 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.557 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 2.22 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.24 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.83 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.66 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 4.28 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.84 110.078 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.443 0.64 . . . . 3.25 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.56 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 354' ' ' ILE . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 4.07 109.535 172.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 318' ' ' GLN . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.79 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.454 HG22 ' OE1' ' A' ' 338' ' ' GLN . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 2.19 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.8 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 350' ' ' ARG . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.99 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.83 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.594 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 1.07 109.477 174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.372 0.606 . . . . 4.66 110.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 3.11 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.64 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.93 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.46 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.7 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.412 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.76 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.496 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.82 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.39 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.89 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.508 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.66 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 5.26 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.527 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 6.59 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.91 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.79 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.92 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.98 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.62 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.09 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.88 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.13 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.86 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 372' ' ' ALA . 3.0 m120 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.26 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.86 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.412 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.85 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.51 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 3.03 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.422 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.45 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.557 HG13 ' CD1' ' A' ' 339' ' ' LEU . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 2.27 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.516 ' HG3' ' NE2' ' A' ' 404' ' ' HIS . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 3.45 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.457 ' HG2' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 2.2 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.82 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.62 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.579 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 1.19 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.59 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 1.28 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 1.37 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 3.13 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 3.14 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.516 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 3.05 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.517 HG11 ' CA ' ' A' ' 410' ' ' GLY . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 1.43 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.16 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.61 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.0 m120 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.28 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.517 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 2.34 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.95 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 4.15 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.51 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 2.25 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.87 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 1.43 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.81 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.97 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.516 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 3.09 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 1.4 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.05 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.1 mm-40 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.89 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.529 ' CG1' ' HB1' ' A' ' 444' ' ' ALA . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.65 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.66 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.75 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 3.33 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.21 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.6 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.9 108.992 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.521 ' CG ' HG12 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.53 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 443' ' ' ILE . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.98 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.513 ' CG1' HG12 ' A' ' 439' ' ' VAL . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 1.15 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 395' ' ' LYS . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.73 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.58 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 1.32 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.42 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.82 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 4.21 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.513 HG12 ' CG1' ' A' ' 432' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.73 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 2.29 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.38 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 420' ' ' VAL . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 1.3 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 430' ' ' PRO . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.75 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 1.33 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.7 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 38.3 tttp . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.79 109.645 174.634 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.063 0.458 . . . . 6.1 110.231 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.94 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.95 110.653 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.82 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 334' ' ' ALA . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.53 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.491 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 1.28 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.44 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.582 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 2.3 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.37 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.79 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 2.53 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.76 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 1.21 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' A' ' 440' ' ' LEU . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.62 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 322' ' ' PHE . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 1.39 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 1.34 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.46 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 1.29 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.618 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 2.22 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.24 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.83 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.66 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 4.28 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.84 110.053 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.264 0.555 . . . . 3.25 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.56 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 4.07 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.511 ' OG ' ' CB ' ' A' ' 318' ' ' GLN . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.79 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.551 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 2.19 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.8 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 351' ' ' SER . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.99 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.561 ' CD1' ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.83 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 1.07 109.998 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 339' ' ' LEU . 57.7 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.398 0.618 . . . . 4.66 109.975 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 3.11 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.619 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.64 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.93 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.46 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.526 ' CD1' HD13 ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.7 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.76 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.82 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.39 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.619 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.89 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.509 HG13 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.66 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 5.26 111.244 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 6.59 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.91 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.79 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.92 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.98 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.62 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.526 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.09 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.88 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.439 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.13 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.86 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.44 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.26 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.86 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.85 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.51 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 3.03 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.45 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 2.27 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HG3' ' NE2' ' A' ' 404' ' ' HIS . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 3.45 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 2.2 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.82 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.62 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 1.19 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.59 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 1.28 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.573 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 1.37 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 3.13 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 3.14 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.515 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 3.05 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.502 HG13 ' CA ' ' A' ' 410' ' ' GLY . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 1.43 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.16 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.61 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.3 m120 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.28 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.502 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 2.34 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.95 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.577 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 4.15 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.51 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 2.25 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.87 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.582 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 1.43 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.81 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.97 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 3.09 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.4 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.05 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.52 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.89 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.65 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.66 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.75 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 3.33 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.21 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.6 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.9 109.275 174.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' HG13 ' A' ' 423' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.53 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.519 HD11 ' CD2' ' A' ' 445' ' ' LEU . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.98 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.502 ' CG1' HG11 ' A' ' 439' ' ' VAL . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 1.15 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.427 HG21 ' HG2' ' A' ' 395' ' ' LYS . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.73 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.573 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 1.32 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.42 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.82 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 4.21 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.502 HG11 ' CG1' ' A' ' 432' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.73 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.525 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 2.29 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.503 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.38 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.531 HG12 ' CG2' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 1.3 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.523 HD12 ' CG ' ' A' ' 333' ' ' LEU . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.75 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 1.33 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.7 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.79 109.52 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 16.6 mt-30 . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.659 -0.497 . . . . 6.1 109.659 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.94 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.95 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.82 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.619 ' O ' ' CD1' ' A' ' 322' ' ' PHE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.53 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 1.28 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.44 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.521 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 2.3 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.37 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.79 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 2.53 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.76 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 1.21 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.537 ' CD2' ' CD1' ' A' ' 443' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 1.62 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 1.39 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.469 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 1.34 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 1.29 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.604 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.535 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 2.22 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.521 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.24 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.83 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.66 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 4.28 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 341' ' ' SER . 2.5 p30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.84 110.228 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.415 0.626 . . . . 3.25 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.56 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 4.07 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.79 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 319' ' ' ALA . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 2.19 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.8 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 350' ' ' ARG . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.99 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.83 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.604 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 1.07 109.841 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.356 0.598 . . . . 4.66 109.788 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.47 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 3.11 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.64 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.93 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.46 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.7 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.76 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.82 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.453 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.39 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.89 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.563 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.66 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 5.26 110.999 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.539 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 6.59 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.91 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.79 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.92 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.98 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.62 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.525 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.09 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.88 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.442 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.13 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.518 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.86 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 8.6 m120 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.26 109.06 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.86 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . 0.557 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.85 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.51 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 3.03 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.45 109.453 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 2.27 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.563 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 3.45 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 396' ' ' GLY . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 2.2 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.82 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.62 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.571 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 1.19 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.59 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.525 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 1.28 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 434' ' ' VAL . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 1.37 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 3.13 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 3.14 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 3.05 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.517 HG11 ' CA ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 1.43 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.16 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.61 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.6 m120 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.28 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.517 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 2.34 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.95 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.541 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 4.15 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.51 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 2.25 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.87 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.541 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 1.43 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.81 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.97 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 3.09 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 1.4 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.05 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.89 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.65 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.66 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.75 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 3.33 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.21 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.6 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.9 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.48 ' CG ' HG12 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.53 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.469 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.98 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.515 ' CG2' HG21 ' A' ' 420' ' ' VAL . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 1.15 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.463 HG13 HD22 ' A' ' 440' ' ' LEU . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.73 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 1.32 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.42 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.82 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 4.21 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.73 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 2.29 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.38 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.525 HG13 ' CG2' ' A' ' 420' ' ' VAL . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 1.3 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.537 ' CD1' ' CD2' ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.75 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.515 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 1.33 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.7 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.79 109.291 172.763 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 15.5 mt-30 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.403 -0.592 . . . . 6.1 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.94 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' SER . . . . . 0.477 ' CA ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.95 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.82 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.53 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.468 HG21 ' HD2' ' A' ' 324' ' ' PRO . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 1.28 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.542 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.44 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 2.3 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.37 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.79 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 2.53 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 329' ' ' ASP . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.542 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.431 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.76 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 1.21 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 440' ' ' LEU . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 1.62 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 1.39 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.48 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 1.34 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 1.29 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' GLN . . . . . 0.61 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 2.22 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.5 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.24 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.83 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 339' ' ' LEU . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.66 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 4.28 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . 0.471 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.1 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.84 110.186 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 351' ' ' SER . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.346 0.593 . . . . 3.25 110.102 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.56 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 4.07 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.79 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.516 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 2.19 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.8 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.99 110.27 169.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.83 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 1.07 109.726 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.58 0.705 . . . . 4.66 110.245 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 3.11 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.64 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.93 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.46 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.534 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.7 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.76 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . 0.529 ' CB ' HG11 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.82 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.39 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.89 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . 0.491 ' N ' ' HB3' ' A' ' 343' ' ' ALA . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.66 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 5.26 111.354 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' PHE . . . . . 0.534 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 6.59 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.91 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.79 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.92 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.98 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.62 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' MET . . . . . 0.537 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.09 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' SER . . . . . 0.534 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.88 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.13 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.86 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 3.0 m120 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.26 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.534 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.86 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.85 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.51 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 3.03 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.45 109.069 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 2.27 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.431 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 3.45 110.393 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.48 ' NZ ' ' CD1' ' A' ' 352' ' ' ILE . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 2.2 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.82 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.503 ' OG ' ' NE ' ' A' ' 382' ' ' ARG . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.62 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.572 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 1.19 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.59 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ALA . . . . . 0.537 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 1.28 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 434' ' ' VAL . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 1.37 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 3.13 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 3.14 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' HIS . . . . . 0.431 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 56.0 t-80 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 3.05 110.723 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.488 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 1.43 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.16 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.61 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.517 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.28 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.488 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 2.34 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' HIS . . . . . 0.457 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.95 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 4.15 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.51 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 2.25 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ASP . . . . . 0.538 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.87 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . 0.571 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 1.43 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.81 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.97 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 3.09 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.572 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 1.4 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 425' ' ' ARG . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.05 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.89 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.552 ' CG1' ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.65 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.66 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.75 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 3.33 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.21 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.6 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.9 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.53 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 442' ' ' VAL . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.98 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.5 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 1.15 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 395' ' ' LYS . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.73 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 1.32 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.42 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.82 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ARG . . . . . 0.515 ' NH2' ' OE1' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 4.21 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.73 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 2.29 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.52 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.38 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 420' ' ' VAL . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 1.3 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 333' ' ' LEU . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.75 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 1.33 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.7 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm . . . . . 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.79 109.679 173.96 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.499 ' ND2' ' CG2' ' A' ' 449' ' ' VAL . 86.3 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.243 0.544 . . . . 6.68 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -133.67 137.47 45.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 6.57 110.243 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 -137.01 140.22 41.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.847 . . . . 6.1 110.12 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.94 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.95 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.469 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.82 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 355' ' ' LEU . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.53 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.478 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 1.28 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.44 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.526 ' CB ' HG22 ' A' ' 416' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 2.3 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.37 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.79 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 2.53 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.537 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.76 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 1.21 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 1.62 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.569 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 1.39 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 440' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 1.34 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 1.29 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.604 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 2.22 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.24 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.83 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 339' ' ' LEU . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.66 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 4.28 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -80.24 138.0 36.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.84 110.112 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 6.69 48.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 3.2 110.334 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.566 HG21 ' CD2' ' A' ' 377' ' ' PHE . 42.8 p -77.65 145.28 70.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 2.72 110.1 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.84 -33.97 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.955 1.502 . . . . 2.52 110.221 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.491 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.13 -37.51 87.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 3.25 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.56 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 4.07 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB2' ' HG3' ' A' ' 318' ' ' GLN . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.79 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.522 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 2.19 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.8 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 350' ' ' ARG . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.99 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 322' ' ' PHE . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.83 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.604 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -65.95 -36.61 83.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 1.07 109.743 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 361' ' ' ASN . 17.9 tptm -53.16 -55.79 21.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.846 -1.159 . . . . 1.65 110.651 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -66.84 -40.85 88.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.716 -1.24 . . . . 2.42 109.915 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.443 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 55.2 mmm-85 -68.98 -40.48 78.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 3.25 111.425 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.578 ' CE1' ' HG3' ' A' ' 331' ' ' LYS . 91.0 m-85 -115.96 -14.71 11.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.804 -1.185 . . . . 4.16 110.275 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.7 t30 60.42 50.13 6.26 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.747 0.784 . . . . 2.42 110.216 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 360' ' ' PHE . 23.3 mt -113.28 178.24 4.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.786 -0.571 . . . . 3.46 109.85 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -118.3 157.12 27.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.97 -1.081 . . . . 4.96 110.961 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.468 ' HB3' HD12 ' A' ' 342' ' ' LEU . 96.1 mt-10 -54.95 150.36 10.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.24 109.747 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 -95.53 135.05 37.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.05 . . . . 4.66 109.914 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 3.11 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.64 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.93 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.46 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.7 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.76 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.499 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.82 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.514 ' N ' HG11 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.39 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.89 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.577 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.66 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 5.26 111.268 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.567 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 6.59 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.91 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.79 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.92 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.98 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.62 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.53 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.09 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.542 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.88 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.13 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.86 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.476 ' ND2' ' HE1' ' A' ' 392' ' ' MET . 3.0 m120 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.26 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.86 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.85 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.51 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 3.03 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.476 ' HE1' ' ND2' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.45 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 2.27 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.577 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 3.45 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.577 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 2.2 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.82 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 382' ' ' ARG . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.62 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 1.19 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.59 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 1.28 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.556 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 1.37 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 3.13 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 3.14 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.504 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 3.05 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 1.43 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.16 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.61 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.28 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.518 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 2.34 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.95 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 4.15 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.51 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 2.25 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.87 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 325' ' ' ALA . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 1.43 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.81 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.97 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 3.09 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 1.4 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.05 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.89 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.65 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.66 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.75 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 3.33 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.21 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.6 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.9 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.533 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.53 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.584 ' CD2' " O2'" ' A' 1001 ' ' ANP . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.98 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.515 HG13 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 1.15 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.461 HG22 ' HG3' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.73 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.556 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 1.32 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.505 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.42 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.82 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 4.21 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.471 ' HA ' HG13 ' A' ' 434' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.73 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 2.29 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.38 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 420' ' ' VAL . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 1.3 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.494 ' CD1' HD23 ' A' ' 333' ' ' LEU . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.75 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.468 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 1.33 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.7 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.499 ' HG2' ' N ' ' A' ' 447' ' ' ASP . 0.0 OUTLIER -84.84 145.76 27.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.79 109.511 170.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.499 ' N ' ' HG2' ' A' ' 446' ' ' LYS . 32.9 p30 -95.9 116.5 29.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.294 -0.879 . . . . 3.91 110.093 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 316' ' ' ASN . 62.9 mt -57.1 -45.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.88 . . . . 4.06 109.607 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.499 ' CG2' ' ND2' ' A' ' 316' ' ' ASN . 59.6 t -98.48 134.37 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 5.64 110.196 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -91.64 133.12 35.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 7.84 110.191 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.97 -1.461 . . . . 7.3 109.563 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.584 " O2'" ' CD2' ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.503 ' N ' HG22 ' A' ' 449' ' ' VAL . 30.7 t30 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.253 0.549 . . . . 6.68 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.65 140.42 49.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 6.57 110.274 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.477 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 -147.04 155.74 42.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 6.1 110.147 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.523 ' HB3' ' CD2' ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.94 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.522 ' CA ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.95 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.466 ' HG2' HD13 ' A' ' 323' ' ' ILE . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.82 110.881 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.53 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.523 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 1.28 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.44 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.555 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 2.3 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.37 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.79 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 324' ' ' PRO . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 2.53 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.465 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.76 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 1.21 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.527 ' CD1' HD12 ' A' ' 440' ' ' LEU . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 1.62 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 1.39 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.482 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 1.34 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 1.29 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 2.22 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 393' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.24 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.83 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.66 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.524 ' HB2' ' CA ' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 4.28 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.7 p30 -99.07 140.87 32.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.84 110.161 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.25 7.16 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 3.2 110.129 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.4 p -77.05 144.16 71.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 2.72 110.013 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.3 -32.08 96.16 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.978 1.515 . . . . 2.52 110.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.504 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 98.2 mt-10 -64.5 -39.29 93.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 3.25 110.169 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.453 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.56 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 4.07 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.477 ' HB2' ' CB ' ' A' ' 318' ' ' GLN . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.79 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.485 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 2.19 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.8 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.99 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.83 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.546 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.82 -37.21 85.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 1.07 109.388 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.1 tptm -58.54 -51.79 68.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.777 -1.202 . . . . 1.65 110.784 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.502 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 13.0 pt20 -65.98 -39.02 90.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.534 -1.354 . . . . 2.42 109.773 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.502 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 33.4 mmt180 -68.7 -46.32 69.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 3.25 111.421 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.581 ' CB ' ' CD1' ' A' ' 362' ' ' LEU . 62.6 m-85 -116.18 -14.93 11.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.694 -1.254 . . . . 4.16 110.582 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 357' ' ' LYS . 20.7 t30 60.19 50.14 6.65 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.84 . . . . 2.42 109.883 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.581 ' CD1' ' CB ' ' A' ' 360' ' ' PHE . 22.7 mt -106.99 179.68 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.704 -0.622 . . . . 3.46 109.931 -176.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -111.75 154.62 24.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.033 . . . . 4.96 110.046 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.482 ' CD ' ' CG1' ' A' ' 353' ' ' VAL . 69.4 mm-40 -76.38 167.38 21.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 2.24 110.006 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 -105.71 129.19 53.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 4.66 110.569 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 3.11 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.64 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.93 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.46 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.525 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.7 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.76 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.495 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.82 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.39 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.89 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.528 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.66 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 5.26 111.207 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.522 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 6.59 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.91 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.79 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.92 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.98 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.528 ' HG3' " O4'" ' A' 1001 ' ' ANP . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.62 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.09 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.88 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.13 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.86 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.26 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.525 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.86 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.85 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.51 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 3.03 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.45 109.09 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.546 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 2.27 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 3.45 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.461 ' HG3' HG21 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 2.2 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.82 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.479 ' OG ' ' HB1' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.62 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 1.19 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.59 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 1.28 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.557 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 1.37 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 3.13 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 3.14 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.576 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.7 t-80 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 3.05 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.516 HG11 ' CA ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 1.43 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.16 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.61 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 437' ' ' SER . 18.1 m120 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.28 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.516 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 2.34 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.467 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.95 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.523 ' CZ ' HG12 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 4.15 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.51 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 2.25 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.87 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 1.43 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.81 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 26.6 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.97 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 3.09 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 1.4 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.05 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.89 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.65 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.66 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.75 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 3.33 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.21 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.6 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.9 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 428' ' ' ALA . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.53 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.525 HD22 " O2'" ' A' 1001 ' ' ANP . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.98 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.523 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 1.15 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.461 HG21 ' HG3' ' A' ' 395' ' ' LYS . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.73 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.557 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 1.32 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.42 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.82 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.509 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 4.21 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.514 ' CG1' HG13 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.73 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.527 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 2.29 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.38 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 420' ' ' VAL . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 1.3 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.532 HD12 ' CB ' ' A' ' 322' ' ' PHE . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.75 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.526 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 1.33 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.521 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.7 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -84.75 141.52 30.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.79 110.022 172.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 36.9 p-10 -95.98 114.5 26.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.836 -0.746 . . . . 3.91 110.155 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 0.8 OUTLIER -56.13 -43.7 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 4.06 109.646 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 316' ' ' ASN . 47.8 t -98.6 134.49 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 5.64 110.153 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -91.97 133.05 36.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 7.84 110.152 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 CA-C-O 118.021 -1.433 . . . . 7.3 109.541 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.528 " O4'" ' HG3' ' A' ' 382' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 448' ' ' ILE . 40.2 t-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.098 0.475 . . . . 6.68 110.163 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 317' ' ' ARG . 65.7 mtt85 -124.19 137.58 54.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 6.57 110.515 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 351' ' ' SER . 25.5 mt-30 -129.17 143.83 51.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.467 -0.771 . . . . 6.1 109.234 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.519 ' N ' ' HG ' ' A' ' 445' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.94 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.52 ' CA ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.95 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.82 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.53 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.5 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 1.28 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.44 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 2.3 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.37 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.79 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 2.53 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.465 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.531 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.76 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 1.21 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 440' ' ' LEU . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.62 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 1.39 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.535 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.458 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 1.34 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 1.29 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.562 ' CG ' ' HB2' ' A' ' 356' ' ' ALA . 0.9 OUTLIER -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.546 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 2.22 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.24 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.83 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 364' ' ' GLU . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.66 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 4.28 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.2 p30 -96.06 137.59 34.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.84 110.126 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.37 7.4 46.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 3.2 110.356 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.548 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 24.7 p -74.08 141.02 77.43 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 2.72 110.143 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.07 -38.87 94.63 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.027 1.541 . . . . 2.52 110.246 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 96.9 mt-10 -63.84 -34.73 78.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 3.25 110.081 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.56 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 4.07 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.79 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.52 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 2.19 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.8 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.99 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 358' ' ' GLN . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.83 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 338' ' ' GLN . . . -63.03 -38.27 90.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 1.07 109.478 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.1 mttt -60.1 -46.88 88.1 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.522 -1.271 . . . . 1.65 110.459 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 11.0 pt20 -64.03 -38.65 91.86 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.358 -1.464 . . . . 2.42 109.938 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.471 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 40.8 mmt180 -76.76 -44.28 33.63 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 3.25 111.518 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 331' ' ' LYS . 88.3 m-85 -115.73 -13.8 11.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.864 -1.147 . . . . 4.16 110.132 -174.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.6 t30 60.55 50.06 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.869 0.842 . . . . 2.42 110.285 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.522 HD11 ' CB ' ' A' ' 360' ' ' PHE . 23.3 mt -115.08 177.93 4.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.858 -0.526 . . . . 3.46 109.662 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -122.66 159.48 27.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 4.96 110.993 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.52 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.4 pt-20 -53.06 154.27 3.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.68 -0.638 . . . . 2.24 109.918 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -99.83 135.76 40.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.065 . . . . 4.66 110.028 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 3.11 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.64 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.93 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.46 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.516 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.7 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.76 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.82 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.39 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.89 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.569 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.66 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 5.26 111.355 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.565 ' CE2' ' C4 ' ' A' 1001 ' ' ANP . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 6.59 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.91 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.79 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.92 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.98 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 381' ' ' SER . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.62 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.551 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.09 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.88 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.427 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.13 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.86 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.8 m120 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.26 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.86 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.51 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 3.03 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.45 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 2.27 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.571 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 3.45 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.583 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 2.2 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.49 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.82 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.62 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.58 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 1.19 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.59 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 1.28 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.572 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 1.37 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 3.13 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 3.14 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.571 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 3.05 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.516 HG12 ' CA ' ' A' ' 410' ' ' GLY . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 1.43 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.16 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.61 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.28 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.516 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 2.34 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.95 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 4.15 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.51 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 2.25 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.531 ' N ' ' CG2' ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.87 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 1.43 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.81 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.97 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 3.09 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.58 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.4 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.05 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.89 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.65 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.66 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.75 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 422' ' ' GLN . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 3.33 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.21 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.6 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.9 108.985 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.53 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.582 ' CD2' " O2'" ' A' 1001 ' ' ANP . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.98 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.516 ' CG1' HG12 ' A' ' 439' ' ' VAL . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 1.15 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.73 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.572 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 1.32 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.42 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.82 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 4.21 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 432' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.73 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 2.29 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.38 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 1.3 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.469 ' CD1' ' CB ' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.75 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 1.33 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.7 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -90.2 141.57 28.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.79 109.604 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 34.1 p30 -95.88 130.42 42.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.33 -0.856 . . . . 3.91 110.492 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 448' ' ' ILE . 4.3 mm -55.13 -47.83 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.116 -0.99 . . . . 4.06 109.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.89 136.09 35.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.258 0.551 . . . . 5.64 110.324 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.457 ' HD3' ' OD2' ' A' ' 447' ' ' ASP . 14.4 tptm -144.14 130.21 19.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 7.84 110.122 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 CA-C-O 118.034 -1.425 . . . . 7.3 109.54 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.583 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 448' ' ' ILE . 20.7 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.562 . . . . 6.68 110.122 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.439 ' NH1' ' O2A' ' A' 1001 ' ' ANP . 98.3 mtt180 -128.43 140.51 51.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 6.57 110.36 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.473 ' HB2' ' OG ' ' A' ' 351' ' ' SER . 14.3 pt20 -140.58 145.52 36.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.428 -0.795 . . . . 6.1 110.149 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.94 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.469 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.95 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.82 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.591 ' CE2' ' HD2' ' A' ' 359' ' ' ARG . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.53 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.501 ' C ' ' CD2' ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 1.28 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.44 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 416' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 2.3 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.37 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.79 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 2.53 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.76 110.51 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 1.21 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 1.62 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 1.39 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.467 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 1.34 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.507 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 1.29 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.611 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 2.22 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.24 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.83 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 364' ' ' GLU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.66 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 4.28 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -78.47 138.34 38.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.84 110.107 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.51 6.66 48.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 3.2 110.294 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.573 HG23 ' CD2' ' A' ' 377' ' ' PHE . 25.4 p -76.07 144.2 75.12 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 2.72 110.099 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.66 -34.47 96.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.912 1.48 . . . . 2.52 110.166 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.17 -35.51 81.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 3.25 110.142 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.56 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 4.07 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 318' ' ' GLN . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.79 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.469 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 2.19 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 338' ' ' GLN . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.8 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.99 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.83 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.611 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -64.57 -37.27 86.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 1.07 109.58 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 21.3 tptm -54.34 -54.81 35.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.845 -1.159 . . . . 1.65 110.677 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 19.3 pt20 -67.15 -41.62 85.75 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.525 -1.36 . . . . 2.42 110.084 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.591 ' HD2' ' CE2' ' A' ' 322' ' ' PHE . 90.9 mtt-85 -71.05 -39.04 72.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 3.25 111.888 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 331' ' ' LYS . 57.2 m-85 -115.96 -14.39 11.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.671 -1.268 . . . . 4.16 110.409 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.29 50.22 6.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.89 0.852 . . . . 2.42 110.213 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 360' ' ' PHE . 24.8 mt -107.02 172.63 6.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.567 -0.531 . . . . 3.46 109.567 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -118.92 150.36 40.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.788 -1.195 . . . . 4.96 110.273 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.502 ' CG ' HD21 ' A' ' 342' ' ' LEU . 95.7 mt-10 -57.11 148.74 21.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 2.24 109.503 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.528 ' CZ ' HD23 ' A' ' 339' ' ' LEU . 10.8 ptp180 -98.76 134.8 41.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.971 -1.081 . . . . 4.66 110.317 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 3.11 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 374' ' ' PHE . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.64 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.93 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.46 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.523 ' CD1' HD12 ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.7 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.76 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.528 ' CB ' HG11 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.82 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.39 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.89 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.519 ' N ' ' HB2' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.66 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 5.26 111.119 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' A' ' 346' ' ' THR . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 6.59 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.91 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.79 110.528 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.92 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.98 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 381' ' ' SER . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.62 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.522 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.09 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.629 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.88 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.433 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.13 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.86 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 3.3 m120 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.26 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.86 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.85 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.51 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 3.03 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.45 109.317 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 2.27 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 3.45 110.069 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.646 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 2.2 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.82 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.62 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 1.19 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.59 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.524 ' CB ' ' OG ' ' A' ' 397' ' ' SER . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 1.28 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 1.37 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 3.13 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 3.14 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.514 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 55.5 t-80 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 3.05 110.722 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.511 HG13 ' CA ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 1.43 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.16 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.61 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.28 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.511 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 2.34 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.95 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 4.15 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.51 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 2.25 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.87 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 412' ' ' PHE . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 1.43 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.81 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 9.2 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.97 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.519 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 3.09 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.531 ' O ' ' CG ' ' A' ' 430' ' ' PRO . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 1.4 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.05 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.89 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 444' ' ' ALA . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.65 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.66 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.75 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 3.33 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.21 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.6 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.9 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.53 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.561 ' CD1' ' CG ' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.98 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.512 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 1.15 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.517 HG22 ' CG ' ' A' ' 395' ' ' LYS . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.73 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 1.32 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.525 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.42 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.82 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 4.21 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.73 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 2.29 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.525 ' HA3' ' CD1' ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.38 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.529 HG12 ' CG2' ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 1.3 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 431' ' ' LEU . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.75 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 1.33 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.7 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -89.01 144.17 26.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.79 109.382 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -95.86 137.29 35.14 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.08 -1.013 . . . . 3.91 110.284 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.502 HD12 ' N ' ' A' ' 448' ' ' ILE . 5.5 mm -57.99 -50.09 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 4.06 109.679 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.68 134.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.187 0.518 . . . . 5.64 110.274 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -144.89 130.44 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 7.84 110.135 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 7.3 109.526 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.646 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.459 ' O ' HD11 ' A' ' 448' ' ' ILE . 16.0 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.332 0.587 . . . . 6.68 110.294 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -41.95 141.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 6.57 110.417 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 -148.56 140.39 23.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.521 -0.737 . . . . 6.1 110.384 -176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.94 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.95 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.82 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 334' ' ' ALA . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.53 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.509 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 1.28 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.531 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.44 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 2.3 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.462 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.37 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.79 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 2.53 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.413 ' N ' HG11 ' A' ' 328' ' ' VAL . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.531 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.76 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 1.21 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 1.62 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 1.39 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 1.34 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.501 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 1.29 110.099 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.597 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.542 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 2.22 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.24 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.83 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.66 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 4.28 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.2 p30 -77.47 137.87 38.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.84 110.007 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.34 6.72 48.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 3.2 110.291 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.553 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 43.7 p -76.69 142.66 70.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 2.72 110.055 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.415 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 10.8 Cg_endo -59.23 -35.23 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.98 1.516 . . . . 2.52 110.134 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.506 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -63.98 -35.96 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 3.25 110.136 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.56 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 4.07 109.444 171.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.79 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.472 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 2.19 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.8 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.99 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.55 HD21 ' CE1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.83 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.597 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -65.32 -36.68 84.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 1.07 109.634 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 46.1 tptt -58.57 -49.09 78.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.92 -1.112 . . . . 1.65 110.805 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 12.2 pt20 -65.15 -39.45 92.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.455 -1.403 . . . . 2.42 109.696 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -73.79 -46.26 46.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 3.25 111.522 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.573 ' CE1' ' HG2' ' A' ' 331' ' ' LYS . 72.9 m-85 -116.15 -15.0 11.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.638 -1.289 . . . . 4.16 110.454 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.5 t-20 58.39 41.23 23.3 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.543 -0.723 . . . . 2.42 109.952 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.51 -176.6 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.681 -0.637 . . . . 3.46 109.787 175.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -124.36 151.89 43.82 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.124 -0.985 . . . . 4.96 109.886 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.71 148.87 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 2.24 109.394 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.518 ' HD3' ' CD1' ' A' ' 370' ' ' LEU . 25.3 ttm180 -96.79 142.09 29.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.004 -1.06 . . . . 4.66 109.997 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.482 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 3.11 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.64 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.93 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.482 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.46 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.7 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.76 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.82 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.39 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.89 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.516 HG22 ' CA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.66 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 5.26 111.331 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.553 ' CD2' ' CG2' ' A' ' 346' ' ' THR . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 6.59 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.91 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.79 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.92 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.98 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.62 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.09 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.535 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.88 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.425 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.13 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.86 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.456 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.26 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.86 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.85 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.51 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 3.03 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.45 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.542 HG13 ' CD1' ' A' ' 339' ' ' LEU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 2.27 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.517 ' NH2' ' HE2' ' A' ' 383' ' ' MET . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 3.45 110.419 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.608 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 2.2 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 395' ' ' LYS . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.82 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.486 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.62 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.528 ' CG2' HG11 ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 1.19 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.59 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 1.28 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 1.37 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 3.13 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 3.14 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.454 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 85.7 t60 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 3.05 110.58 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.5 HG13 ' CA ' ' A' ' 410' ' ' GLY . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 1.43 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.16 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.61 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.28 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.5 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 2.34 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.403 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.95 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.608 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 4.15 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.51 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 2.25 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.87 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.608 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 1.43 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.81 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.97 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 3.09 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 1.4 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.05 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.89 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.65 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.66 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.75 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 3.33 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.21 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.6 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.9 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.492 ' HB2' HG11 ' A' ' 420' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.53 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.559 ' CD2' " O2'" ' A' 1001 ' ' ANP . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.98 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 420' ' ' VAL . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 1.15 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.73 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 1.32 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.42 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.82 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.495 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 4.21 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.515 HG11 ' CG1' ' A' ' 432' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.73 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 2.29 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.38 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.525 HG12 ' CG2' ' A' ' 420' ' ' VAL . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 1.3 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 322' ' ' PHE . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.75 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.525 ' HA ' ' CG1' ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 1.33 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD2' HD11 ' A' ' 431' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.7 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -86.71 139.44 30.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.79 109.162 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -95.93 129.65 43.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.15 -0.969 . . . . 3.91 110.532 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -59.08 -49.12 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 4.06 109.536 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 448' ' ' ILE . 46.3 t -101.69 134.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 5.64 110.234 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -93.15 145.26 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 7.84 110.202 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.003 -1.443 . . . . 7.3 109.507 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.608 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 448' ' ' ILE . 84.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.154 0.502 . . . . 6.68 110.187 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.9 137.71 52.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.97 . . . . 6.57 110.449 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 -136.45 144.42 44.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.434 -0.791 . . . . 6.1 109.837 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.486 ' N ' ' HG ' ' A' ' 445' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.94 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.434 ' C ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.95 110.564 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.468 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.82 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.574 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.53 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.543 ' N ' ' CD2' ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 1.28 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.54 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.44 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 416' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 2.3 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.37 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.79 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 2.53 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.76 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.21 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 323' ' ' ILE . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 1.62 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.574 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 1.39 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.478 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 1.34 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.457 ' HB1' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 1.29 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.553 ' HG2' ' CB ' ' A' ' 356' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 2.22 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.566 ' N ' ' CD1' ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.24 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.83 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 364' ' ' GLU . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.66 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 4.28 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 -71.68 138.02 48.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.84 110.309 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.66 6.97 47.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 3.2 110.193 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.505 HG21 ' CD2' ' A' ' 377' ' ' PHE . 40.0 p -73.81 142.56 80.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 2.72 110.161 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.81 -36.81 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 2.52 110.26 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.26 -36.87 85.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 3.25 110.143 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.456 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.56 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 4.07 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.525 ' OG ' ' CB ' ' A' ' 318' ' ' GLN . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.79 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.483 ' O ' ' CG ' ' A' ' 338' ' ' GLN . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.19 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.524 HG12 ' CG ' ' A' ' 364' ' ' GLU . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.8 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 350' ' ' ARG . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.99 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' A' ' 358' ' ' GLN . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.83 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.553 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -67.93 -39.12 83.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 1.07 109.561 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 361' ' ' ASN . 69.5 mttt -61.14 -46.24 91.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.759 -1.213 . . . . 1.65 110.926 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -66.63 -38.4 86.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.218 -1.551 . . . . 2.42 109.549 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.477 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 41.8 mmt180 -73.9 -41.49 62.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.228 -0.92 . . . . 3.25 111.745 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 362' ' ' LEU . 62.9 m-85 -101.12 -15.0 17.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.797 -1.19 . . . . 4.16 109.609 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.0 t30 60.73 47.83 7.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.688 0.756 . . . . 2.42 110.431 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 361' ' ' ASN . 19.6 mt -142.72 -159.57 0.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.723 -0.611 . . . . 3.46 109.652 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -119.94 158.42 26.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 4.96 110.189 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 342' ' ' LEU . 67.7 mm-40 -65.54 -170.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 2.24 109.882 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 342' ' ' LEU . 82.6 mtp180 -105.03 134.75 47.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 4.66 110.171 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 3.11 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.642 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.64 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.93 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.46 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.7 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 29.7 m170 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.76 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.82 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.39 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.89 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.66 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 5.26 111.162 -175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.574 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 6.59 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.91 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.79 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.92 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.98 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.62 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.535 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.09 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.572 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.88 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.461 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.13 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.86 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.414 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 7.9 m120 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.26 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.86 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.85 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.51 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.531 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 3.03 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.45 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 2.27 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.563 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 3.45 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.472 ' HE3' ' C2 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 2.2 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.467 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.82 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.62 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 1.19 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.59 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.535 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 1.28 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 434' ' ' VAL . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 1.37 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 3.13 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 3.14 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.563 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 57.7 t-80 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 3.05 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 1.43 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.16 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.61 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.28 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.489 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 2.34 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.95 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 4.15 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.51 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 2.25 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.87 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.519 HG23 ' CB ' ' A' ' 325' ' ' ALA . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 1.43 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.81 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.97 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.538 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 3.09 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 1.4 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.05 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.89 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.65 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.66 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.75 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 3.33 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.21 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.6 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.9 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.521 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.53 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.585 ' CD2' " O2'" ' A' 1001 ' ' ANP . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.98 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 420' ' ' VAL . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 1.15 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.73 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 1.32 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.471 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.42 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.82 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 4.21 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.73 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 336' ' ' ALA . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 2.29 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.38 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 420' ' ' VAL . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 1.3 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 333' ' ' LEU . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.75 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.462 ' HA ' HG12 ' A' ' 423' ' ' VAL . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 1.33 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.7 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.89 145.27 27.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.79 109.772 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 35.5 p30 -95.89 133.54 39.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 3.91 110.329 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 448' ' ' ILE . 4.5 mm -55.07 -48.89 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 4.06 109.359 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.97 135.0 40.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.154 0.502 . . . . 5.64 110.264 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -91.02 132.55 35.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 7.84 110.154 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.491 -1.444 . . . . 7.3 109.491 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.585 " O2'" ' CD2' ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.47 ' HA ' HG12 ' A' ' 448' ' ' ILE . 29.7 p-10 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.334 0.587 . . . . 6.68 110.482 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 348' ' ' GLU . 32.3 ptt180 -37.43 134.99 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.598 0.713 . . . . 6.57 110.961 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 -147.9 155.65 41.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.492 -0.755 . . . . 6.1 109.544 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.94 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.95 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.467 ' HG2' HD12 ' A' ' 323' ' ' ILE . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.82 110.739 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.53 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.526 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 1.28 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.537 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.44 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 2.3 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.37 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.79 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 2.53 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.537 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.76 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 1.21 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 1.62 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 1.39 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.479 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 1.34 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.513 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 1.29 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.606 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.535 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 2.22 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.24 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.83 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.66 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.529 ' HB3' ' CA ' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 4.28 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.76 139.65 30.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.84 110.12 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.56 6.73 48.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 3.2 110.291 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.561 HG23 ' CD2' ' A' ' 377' ' ' PHE . 36.4 p -77.91 142.6 65.13 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 2.72 110.137 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.52 -33.42 96.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.987 1.519 . . . . 2.52 110.268 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.79 -36.54 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 3.25 110.067 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.56 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 4.07 109.653 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' GLN . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.79 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.528 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 2.19 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.8 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.99 110.491 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.53 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.83 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.606 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -64.54 -38.12 89.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 1.07 109.606 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 361' ' ' ASN . 42.2 tptt -58.66 -52.82 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.763 -1.211 . . . . 1.65 111.05 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -65.74 -39.0 90.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.511 -1.368 . . . . 2.42 109.865 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.419 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -71.6 -44.87 63.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 3.25 111.35 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.572 ' CE2' ' HA ' ' A' ' 331' ' ' LYS . 33.6 m-85 -116.24 -14.93 11.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.69 -1.256 . . . . 4.16 110.726 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.27 50.07 6.57 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.292 -0.88 . . . . 2.42 109.925 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.523 ' CG ' ' HB3' ' A' ' 360' ' ' PHE . 21.5 mt -99.54 -178.42 3.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.764 -0.585 . . . . 3.46 109.914 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -106.89 159.51 16.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 4.96 110.732 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 353' ' ' VAL . 73.1 mm-40 -77.56 166.97 22.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.602 -0.686 . . . . 2.24 109.85 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' A' ' 339' ' ' LEU . 58.5 mtp85 -101.57 132.64 47.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 4.66 110.563 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 3.11 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.64 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.93 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.46 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.54 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.7 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.76 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.517 ' HB3' ' CG1' ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.82 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.39 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.593 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.89 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.491 HG22 ' CA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.66 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 5.26 111.27 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.561 ' CD2' HG23 ' A' ' 346' ' ' THR . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 6.59 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.91 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.79 110.472 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.92 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.98 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.62 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.52 ' HE2' ' NH2' ' A' ' 394' ' ' ARG . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.09 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.88 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.13 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.86 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 3.2 m120 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.26 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.86 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.51 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 3.03 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.45 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 2.27 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.52 ' NH2' ' HE2' ' A' ' 383' ' ' MET . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 3.45 110.393 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 396' ' ' GLY . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 2.2 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 395' ' ' LYS . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.82 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.62 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 1.19 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.59 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 1.28 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 1.37 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 3.13 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 3.14 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.7 t60 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 3.05 110.56 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.492 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 1.43 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.16 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.61 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.28 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.492 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 2.34 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.407 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.95 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.46 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 4.15 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.51 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 2.25 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.87 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.43 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.81 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.97 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 3.09 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.4 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.05 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 25.5 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.89 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.65 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.66 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.75 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 3.33 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.21 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.6 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.9 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.53 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.489 HD22 " C1'" ' A' 1001 ' ' ANP . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.98 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.526 HG23 ' CG2' ' A' ' 420' ' ' VAL . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 1.15 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.465 HG21 ' HG2' ' A' ' 395' ' ' LYS . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.73 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 1.32 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.535 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.42 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.82 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 4.21 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.73 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 2.29 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.38 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.526 HG11 ' CG2' ' A' ' 420' ' ' VAL . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 1.3 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.528 HD13 ' CB ' ' A' ' 322' ' ' PHE . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.75 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.526 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 1.33 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.7 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -84.74 136.65 33.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.79 109.89 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -96.19 141.76 29.17 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.445 -0.784 . . . . 3.91 110.204 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -57.53 -42.98 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 4.06 108.915 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.89 135.83 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.751 -0.593 . . . . 5.64 110.199 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -144.26 130.58 19.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 7.84 110.124 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.947 -1.474 . . . . 7.3 109.511 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.489 " C1'" HD22 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.526 ' HB2' ' CG1' ' A' ' 448' ' ' ILE . 83.8 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.228 0.537 . . . . 6.68 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.512 ' NH1' ' OD2' ' A' ' 447' ' ' ASP . 91.1 mtt-85 -121.83 130.46 53.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -0.96 . . . . 6.57 110.107 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 -123.6 142.61 50.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 6.1 109.881 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.94 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.454 ' O ' HD11 ' A' ' 355' ' ' LEU . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.95 110.543 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.473 ' HG3' HD11 ' A' ' 323' ' ' ILE . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.82 110.641 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.53 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.481 ' O ' HD23 ' A' ' 333' ' ' LEU . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 1.28 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.536 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.44 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 2.3 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.37 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.79 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 2.53 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.445 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.536 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.583 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.76 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 1.21 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 322' ' ' PHE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 1.62 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 1.39 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 1.34 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.492 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 1.29 110.087 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.6 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 2.22 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.24 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.83 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.66 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.53 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 4.28 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.2 p30 -85.49 138.15 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.84 110.062 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.42 6.86 47.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 3.2 110.262 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.2 p -73.18 143.56 83.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 2.72 110.087 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.84 -36.52 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.949 1.499 . . . . 2.52 110.035 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.503 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.89 -36.07 82.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 3.25 110.117 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.56 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 4.07 109.498 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 318' ' ' GLN . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.79 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 319' ' ' ALA . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 2.19 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.8 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.99 110.342 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.83 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -64.82 -37.91 89.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 1.07 109.663 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 361' ' ' ASN . 0.5 OUTLIER -59.35 -51.49 69.71 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.777 -1.202 . . . . 1.65 110.827 -175.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 21.3 pt20 -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.514 -1.366 . . . . 2.42 109.841 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.46 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.1 mmm180 -71.51 -44.34 64.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 3.25 111.487 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.583 ' CE1' ' HG2' ' A' ' 331' ' ' LYS . 38.2 m-85 -116.12 -14.69 11.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.818 -1.176 . . . . 4.16 110.372 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 357' ' ' LYS . 13.4 t-20 60.38 50.17 6.29 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.937 0.875 . . . . 2.42 110.006 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.518 ' O ' ' CE ' ' A' ' 357' ' ' LYS . 21.7 mt -95.57 -178.61 4.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.62 -0.511 . . . . 3.46 109.62 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -117.86 149.77 40.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 4.96 110.92 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.77 149.12 22.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.561 -0.712 . . . . 2.24 109.555 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.518 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 88.5 mtt180 -98.32 123.79 42.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.859 -1.151 . . . . 4.66 110.233 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.458 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 3.11 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.64 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.93 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.46 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.7 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.76 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.511 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.82 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.39 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.89 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 386' ' ' ILE . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.66 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 5.26 111.172 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 6.59 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.91 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.79 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.92 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.98 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.62 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.529 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.09 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.512 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.88 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.429 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.13 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.86 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 3.4 m120 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.26 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.86 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.85 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.51 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 3.03 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.45 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.547 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 2.27 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.452 ' HB3' HG21 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 3.45 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.623 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 2.2 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.472 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.82 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.487 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.62 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.524 ' CG2' HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 1.19 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.59 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.529 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 1.28 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 1.37 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 3.13 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 3.14 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 3.05 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.474 HG12 ' CA ' ' A' ' 410' ' ' GLY . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 1.43 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.16 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.61 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.28 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.474 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 2.34 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.95 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 4.15 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.51 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 2.25 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.87 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 1.43 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.81 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.97 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 3.09 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 1.4 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.05 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.89 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.65 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.66 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.75 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 3.33 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.21 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.6 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.9 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.53 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.53 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.585 ' CD2' " O2'" ' A' 1001 ' ' ANP . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.98 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 1.15 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.73 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 1.32 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.42 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.516 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.82 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 4.21 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.524 HG13 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.73 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 2.29 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.38 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 420' ' ' VAL . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 1.3 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 445' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.75 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 423' ' ' VAL . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 1.33 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.7 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt -94.22 128.12 40.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.79 109.279 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.512 ' OD2' ' NH1' ' A' ' 317' ' ' ARG . 77.4 m-20 -88.1 133.39 34.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.964 -1.085 . . . . 3.91 109.897 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 448' ' ' ILE . 4.7 mm -55.0 -49.82 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 4.06 109.23 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.84 133.82 44.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.3 0.571 . . . . 5.64 110.108 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -91.58 132.96 35.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 7.84 110.184 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.969 -1.461 . . . . 7.3 109.482 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.623 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.473 ' O ' HD12 ' A' ' 448' ' ' ILE . 15.2 m120 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.326 0.584 . . . . 6.68 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.554 ' NH2' " H3'" ' A' 1001 ' ' ANP . 57.3 ttp180 -42.6 137.51 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 6.57 110.382 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 -150.44 151.78 33.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 6.1 110.314 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.94 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.431 ' C ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.95 110.413 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.498 ' HA ' ' NH1' ' A' ' 359' ' ' ARG . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.82 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 359' ' ' ARG . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.53 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.492 ' C ' ' CD2' ' A' ' 333' ' ' LEU . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 1.28 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.535 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.44 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.531 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 2.3 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.37 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.79 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 2.53 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.454 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.76 109.645 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 1.21 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.528 HD11 ' CD1' ' A' ' 440' ' ' LEU . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 1.62 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 1.39 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.523 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 1.34 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.441 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 1.29 109.987 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.599 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 2.22 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.24 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.83 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 339' ' ' LEU . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.66 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 4.28 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.565 ' OD2' ' N6 ' ' A' 1001 ' ' ANP . 8.2 p-10 -107.47 149.96 27.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.84 110.287 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -99.65 8.5 44.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 3.2 110.171 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.574 HG22 ' CD2' ' A' ' 377' ' ' PHE . 45.7 p -80.15 141.25 53.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.335 -0.853 . . . . 2.72 110.111 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -57.58 -31.48 91.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.93 1.49 . . . . 2.52 110.239 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.89 -37.14 86.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 3.25 110.104 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 353' ' ' VAL . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.56 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 4.07 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' A' ' 318' ' ' GLN . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.79 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.467 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 2.19 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.8 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.99 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.527 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.83 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.599 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -65.07 -36.44 84.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 1.07 109.565 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.9 tptt -54.82 -54.64 39.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.886 -1.134 . . . . 1.65 110.775 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.5 pt20 -66.52 -43.03 86.33 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.509 -1.369 . . . . 2.42 109.858 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 322' ' ' PHE . 39.9 mtp180 -69.67 -40.13 76.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 3.25 111.697 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.561 ' CB ' ' CD1' ' A' ' 362' ' ' LEU . 76.6 m-85 -116.09 -14.73 11.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.735 -1.228 . . . . 4.16 110.604 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.29 50.11 6.51 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.809 . . . . 2.42 109.925 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.561 ' CD1' ' CB ' ' A' ' 360' ' ' PHE . 23.7 mt -107.2 175.44 5.5 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.788 -0.57 . . . . 3.46 109.829 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -117.6 154.98 30.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.865 -1.147 . . . . 4.96 110.271 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' A' ' 342' ' ' LEU . 95.9 mt-10 -51.86 152.5 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 2.24 109.589 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 -94.68 144.36 25.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 4.66 110.52 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 3.11 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.64 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.93 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.46 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.7 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.76 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.491 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.82 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.432 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.39 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.89 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.66 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 5.26 111.371 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.574 ' CD2' HG22 ' A' ' 346' ' ' THR . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 6.59 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.91 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.79 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.92 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.98 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 381' ' ' SER . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.62 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.519 ' CG ' ' HB3' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.09 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.528 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.88 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.13 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.86 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.421 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 3.7 m120 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.26 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.86 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.85 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.51 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 3.03 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.45 109.236 167.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 2.27 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 3.45 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.63 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 2.2 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.82 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.483 ' HB2' ' HB1' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.62 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 1.19 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.59 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' A' ' 383' ' ' MET . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 1.28 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 1.37 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 3.13 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 3.14 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.549 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 3.05 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.52 HG13 ' CA ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 1.43 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.16 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.61 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.28 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.52 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 2.34 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.95 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.577 ' CD1' ' OD1' ' A' ' 417' ' ' ASP . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 4.15 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.51 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.543 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 2.25 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.543 ' N ' ' CG2' ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.87 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.531 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 1.43 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.81 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.97 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 3.09 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 398' ' ' VAL . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 1.4 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.05 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.89 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.65 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.66 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.75 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 3.33 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.21 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.6 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.9 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.525 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.53 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.586 ' CD2' " O2'" ' A' 1001 ' ' ANP . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.98 108.32 165.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 401' ' ' ILE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 1.15 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.73 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 1.32 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.42 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.82 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 4.21 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.464 ' HA ' HG13 ' A' ' 434' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.73 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 333' ' ' LEU . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 2.29 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.38 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 420' ' ' VAL . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 1.3 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 ' CB ' ' A' ' 322' ' ' PHE . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.75 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 1.33 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.7 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -88.37 145.68 25.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.79 109.717 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 34.3 p30 -95.79 117.36 30.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 3.91 110.611 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -54.59 -47.18 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 4.06 109.468 176.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.32 134.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.588 -0.695 . . . . 5.64 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -93.0 144.94 24.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 7.84 110.214 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.035 -1.425 . . . . 7.3 109.576 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.63 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.469 ' O ' HD11 ' A' ' 448' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 6.68 110.384 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.462 ' O ' ' OE1' ' A' ' 348' ' ' GLU . 97.9 mtt180 -45.56 143.62 1.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 6.57 110.252 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 -156.28 141.95 17.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.49 -0.756 . . . . 6.1 110.438 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.94 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.95 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.82 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.53 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.472 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 1.28 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.44 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 2.3 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.463 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.37 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.79 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 2.53 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.53 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.76 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 1.21 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 440' ' ' LEU . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 1.62 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 1.39 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 1.34 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.506 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 1.29 109.967 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.601 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 2.22 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.24 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.531 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.83 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.517 ' CD2' ' OE1' ' A' ' 364' ' ' GLU . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.66 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 4.28 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -74.11 139.1 44.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.84 110.151 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.55 7.25 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 3.2 110.186 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.524 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 67.3 p -78.43 144.45 65.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 2.72 110.102 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.62 -32.62 96.24 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.943 1.496 . . . . 2.52 110.125 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 77.1 mm-40 -64.16 -36.0 82.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 3.25 110.217 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.434 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.56 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 4.07 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.79 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 319' ' ' ALA . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 2.19 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.531 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.8 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.99 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.83 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.601 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -67.28 -39.49 86.05 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 1.07 109.864 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 361' ' ' ASN . 6.2 mtmt -66.26 -46.02 78.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 1.65 111.273 -175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.2 pt20 -63.55 -37.49 87.52 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.205 -1.559 . . . . 2.42 109.491 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.464 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 27.7 mmm180 -77.01 -47.49 20.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.199 -0.938 . . . . 3.25 111.474 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 331' ' ' LYS . 22.7 m-85 -115.92 -14.72 11.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.766 -1.209 . . . . 4.16 110.344 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.1 t30 60.16 39.86 18.92 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.462 -0.773 . . . . 2.42 110.111 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.69 -171.89 2.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.575 -0.703 . . . . 3.46 109.575 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -123.24 151.87 41.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.19 -0.944 . . . . 4.96 110.503 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.524 ' OE2' ' CG1' ' A' ' 353' ' ' VAL . 65.1 mm-40 -64.48 158.12 24.79 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.462 -0.774 . . . . 2.24 110.064 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -102.96 131.74 49.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 4.66 110.515 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.463 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 3.11 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.64 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.93 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.46 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.7 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.76 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.82 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.39 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.89 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.571 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.66 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 5.26 111.332 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.531 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 6.59 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.91 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.498 ' CB ' ' O3G' ' A' 1001 ' ' ANP . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.79 110.458 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.92 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.98 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.62 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.09 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.88 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.434 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.13 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.86 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.26 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.535 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.86 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.85 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.51 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 3.03 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.45 109.174 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 2.27 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.571 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 3.45 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.626 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 2.2 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.82 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.62 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.529 HG22 ' CG1' ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 1.19 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.59 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.549 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 1.28 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.563 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 1.37 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 3.13 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 3.14 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.542 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 3.05 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.526 HG13 ' CA ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 1.43 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.16 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.61 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.28 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.526 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 2.34 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.95 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 4.15 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.51 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 2.25 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.87 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.58 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 1.43 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.81 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.97 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 3.09 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.529 ' CG1' HG22 ' A' ' 398' ' ' VAL . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 1.4 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.05 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.89 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.65 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.66 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.75 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 3.33 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.21 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.6 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.9 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.5 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.53 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.495 HD23 " C2'" ' A' 1001 ' ' ANP . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.98 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 1.15 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.73 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.563 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 1.32 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.46 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.42 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.485 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.82 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 4.21 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.517 ' CG1' HG13 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.73 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 2.29 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.38 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 420' ' ' VAL . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 1.3 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.516 HD12 ' CB ' ' A' ' 322' ' ' PHE . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.75 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.515 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 1.33 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.7 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -85.51 140.03 31.0 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.79 109.635 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 34.9 p30 -96.0 115.81 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 3.91 110.602 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.5 mp -56.77 -46.4 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 4.06 109.417 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.93 136.42 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.635 -0.665 . . . . 5.64 110.254 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -89.95 132.69 35.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 7.84 110.149 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.959 -1.467 . . . . 7.3 109.531 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.626 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 448' ' ' ILE . 35.4 t30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.174 0.511 . . . . 6.68 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -125.36 137.87 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 6.57 110.304 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.46 ' NE2' HD11 ' A' ' 448' ' ' ILE . 14.9 mt-30 -135.77 149.52 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 6.1 109.436 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' ' CG1' ' A' ' 352' ' ' ILE . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.94 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.95 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.458 ' HG2' HD12 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.82 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.53 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 333' ' ' LEU . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 1.28 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.44 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 2.3 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.37 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.79 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 2.53 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.76 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 1.21 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 1.62 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 1.39 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.484 ' O ' HD22 ' A' ' 339' ' ' LEU . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 1.34 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.458 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 1.29 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.558 ' HG2' ' CB ' ' A' ' 356' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 2.22 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.24 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.83 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 364' ' ' GLU . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.66 109.894 174.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 4.28 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -82.51 136.87 34.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.84 110.155 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.92 6.85 47.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 3.2 110.265 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.552 HG22 ' CD2' ' A' ' 377' ' ' PHE . 35.3 p -77.06 146.26 74.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 2.72 110.255 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.58 -35.35 90.37 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.966 1.508 . . . . 2.52 110.281 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.504 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.1 -37.34 87.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 3.25 110.114 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.56 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 4.07 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.79 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 2.19 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 364' ' ' GLU . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.8 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 350' ' ' ARG . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.99 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.516 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.83 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.558 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -64.84 -37.26 87.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 1.07 109.357 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 31.7 tptt -58.22 -53.01 63.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.776 -1.202 . . . . 1.65 111.031 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -68.53 -41.3 80.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.452 -1.405 . . . . 2.42 110.165 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.463 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 30.7 mmt180 -67.65 -38.96 84.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 3.25 111.318 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.514 ' HB3' ' CD1' ' A' ' 362' ' ' LEU . 97.1 m-85 -115.79 -14.9 11.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.125 . . . . 4.16 110.22 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 357' ' ' LYS . 11.4 t-20 60.52 50.03 6.18 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.749 0.785 . . . . 2.42 109.931 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 360' ' ' PHE . 29.0 mt -130.7 -179.14 5.12 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.675 -0.641 . . . . 3.46 109.875 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -106.53 153.71 21.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.001 -1.062 . . . . 4.96 109.921 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.533 ' HG3' ' CG1' ' A' ' 353' ' ' VAL . 77.6 mm-40 -67.88 -174.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 2.24 109.777 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.52 ' CZ ' HD23 ' A' ' 339' ' ' LEU . 58.8 mtm180 -104.2 135.12 46.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 4.66 110.362 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.458 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 3.11 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.64 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.93 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.46 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.527 ' CD1' HD12 ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.7 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.76 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.492 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.82 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.39 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.89 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.431 ' HB ' ' C ' ' A' ' 385' ' ' GLY . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.66 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 5.26 111.181 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.56 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 6.59 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.91 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.79 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.92 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.98 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 381' ' ' SER . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.62 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.533 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.09 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.88 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.431 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.13 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.86 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 2.9 m120 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.26 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.527 HD12 ' CD1' ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.86 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.85 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 29.7 t30 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.51 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 3.03 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.458 ' O ' HD11 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.45 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 2.27 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 3.45 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.484 ' HE3' ' C2 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.2 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.487 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.82 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.62 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 1.19 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.59 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 1.28 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.589 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 1.37 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 3.13 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.538 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 3.14 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 3.05 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.52 HG12 ' CA ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 1.43 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.16 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.61 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.482 ' CB ' ' CB ' ' A' ' 437' ' ' SER . 18.3 m120 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.28 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.52 ' CA ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 2.34 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.95 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 4.15 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.51 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 2.25 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.87 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.56 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 1.43 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.81 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.97 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.532 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 3.09 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 1.4 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.05 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.89 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.65 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.66 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.75 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 3.33 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.21 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.6 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.9 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.53 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.524 HD23 " O2'" ' A' 1001 ' ' ANP . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.98 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 401' ' ' ILE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 1.15 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.466 HG22 ' HG3' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.73 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 1.32 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.42 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.482 ' CB ' ' CB ' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.82 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 4.21 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.73 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 2.29 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.38 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 420' ' ' VAL . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 1.3 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.526 HD11 ' CB ' ' A' ' 322' ' ' PHE . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.75 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.497 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 1.33 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.7 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -96.5 143.03 27.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.79 109.869 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 33.2 p30 -95.94 129.45 43.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 3.91 110.35 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 448' ' ' ILE . 4.5 mm -54.0 -48.79 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 4.06 109.324 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.17 136.05 37.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.225 0.536 . . . . 5.64 110.304 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.7 132.49 35.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 7.84 110.142 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 118.013 -1.437 . . . . 7.3 109.522 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.542 ' O1B' ' O3G' ' A' 1001 ' ' ANP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.487 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 7.1 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.321 0.581 . . . . 6.68 110.394 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.474 ' NH2' ' OG1' ' A' ' 429' ' ' THR . 53.1 mtp180 -42.48 139.61 1.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.49 -0.756 . . . . 6.57 110.435 -176.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 -153.9 146.28 23.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.528 -0.732 . . . . 6.1 110.279 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.564 ' CB ' ' CD2' ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.94 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.459 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.95 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.82 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.681 ' CZ ' ' CE2' ' A' ' 360' ' ' PHE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.53 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.53 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 1.28 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.531 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.44 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.544 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 2.3 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.37 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.79 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 2.53 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.76 110.706 -178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 1.21 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 323' ' ' ILE . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 1.62 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 1.39 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 1.34 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 338' ' ' GLN . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 1.29 109.443 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.624 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.532 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 2.22 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.24 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.83 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.66 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 4.28 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.2 p30 -77.62 136.7 38.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.84 110.007 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.44 6.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 3.2 110.256 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 44.7 p -74.69 139.5 74.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 2.72 110.043 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -56.42 -35.86 96.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 2.52 110.203 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.01 -35.92 82.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 3.25 110.122 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.56 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 4.07 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 318' ' ' GLN . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.79 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.55 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 2.19 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.8 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.99 110.481 170.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.83 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.57 ' CB ' ' NE2' ' A' ' 338' ' ' GLN . . . -64.09 -36.91 85.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 1.07 109.369 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 361' ' ' ASN . 8.0 tptm -59.94 -51.49 69.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.905 -1.122 . . . . 1.65 111.028 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.2 pt20 -65.46 -39.49 92.05 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.321 -1.487 . . . . 2.42 109.869 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.569 ' HD2' ' CE2' ' A' ' 322' ' ' PHE . 86.5 mtt-85 -73.25 -44.15 59.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 3.25 111.699 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.681 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 21.2 m-85 -116.05 -15.04 11.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.704 -1.247 . . . . 4.16 110.81 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.2 t-20 59.79 43.09 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 2.42 110.061 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.75 -177.32 5.84 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.554 -0.716 . . . . 3.46 109.622 173.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -123.75 152.55 42.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.031 -1.043 . . . . 4.96 110.618 176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.56 145.14 29.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.795 -0.762 . . . . 2.24 109.472 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.409 ' HD2' ' HB3' ' A' ' 339' ' ' LEU . 95.3 mtt-85 -100.87 126.93 47.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.028 -1.045 . . . . 4.66 110.195 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 3.11 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.64 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.93 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.46 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.53 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.7 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.76 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.513 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.82 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.39 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.89 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.501 HG22 ' CA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.66 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 5.26 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.49 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 6.59 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.91 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.79 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.92 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.98 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.62 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.534 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.09 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.88 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.13 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.86 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 372' ' ' ALA . 2.8 m120 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.26 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.53 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.86 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.85 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.51 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 3.03 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.45 109.111 167.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 2.27 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 3.45 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.633 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 2.2 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.82 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.62 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 1.19 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.59 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 1.28 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 1.37 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 3.13 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 3.14 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 3.05 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.507 HG13 ' CA ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 1.43 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.16 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.61 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 97.7 m-20 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.28 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.507 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 2.34 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.95 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 4.15 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.51 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 2.25 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.87 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 1.43 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.81 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.473 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.97 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 3.09 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 1.4 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.05 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.89 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 444' ' ' ALA . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.65 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.66 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.75 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 3.33 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.21 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.6 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.474 ' OG1' ' NH2' ' A' ' 317' ' ' ARG . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.9 108.916 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.53 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.585 ' CD2' " O2'" ' A' 1001 ' ' ANP . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.98 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 420' ' ' VAL . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 1.15 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.508 HG23 ' CG ' ' A' ' 395' ' ' LYS . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.73 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 1.32 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.525 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.42 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.82 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 4.21 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.73 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.527 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 2.29 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.38 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG1' HG23 ' A' ' 420' ' ' VAL . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 1.3 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 322' ' ' PHE . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.75 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 1.33 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.527 ' CD2' HD11 ' A' ' 431' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.7 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt -85.89 141.45 29.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.79 109.689 172.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 447' ' ' ASP . 33.6 p30 -95.86 120.06 35.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 3.91 110.66 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -55.32 -48.22 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 4.06 109.353 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.96 135.09 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 5.64 110.214 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -92.63 145.22 24.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 7.84 110.22 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.984 -1.453 . . . . 7.3 109.556 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.633 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 11.4 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.578 . . . . 6.68 110.422 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' ASN . 66.1 mtt85 -41.07 142.98 0.44 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.556 -0.715 . . . . 6.57 110.516 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 -148.12 156.05 42.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 6.1 110.269 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 445' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.94 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.95 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.82 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 334' ' ' ALA . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.53 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.49 ' O ' HD23 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 1.28 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.533 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.44 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 2.3 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.37 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.79 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 2.53 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 328' ' ' VAL . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.76 110.042 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 1.21 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 1.62 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 1.39 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.475 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 1.34 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 1.29 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.603 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 2.22 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 393' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.24 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.83 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 364' ' ' GLU . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.66 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 4.28 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 44.1 p30 -104.19 127.51 51.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.84 110.447 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.91 18.59 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.148 -0.97 . . . . 3.2 110.501 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 80.1 p -58.72 160.45 10.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 2.72 110.04 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.519 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 35.2 Cg_exo -51.67 -54.5 5.23 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.95 1.5 . . . . 2.52 110.167 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.513 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 94.1 mt-10 -66.13 -35.52 80.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 3.25 110.148 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.456 ' HA2' ' N6 ' ' A' 1001 ' ' ANP . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.56 109.967 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.519 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 4.07 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 318' ' ' GLN . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.79 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.465 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 2.19 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.8 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.99 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.521 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.83 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.603 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -65.74 -36.91 84.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 1.07 109.784 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 361' ' ' ASN . 20.6 tptp -53.5 -55.23 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.824 -1.172 . . . . 1.65 110.447 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 20.4 pt20 -66.64 -39.65 88.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.737 -1.227 . . . . 2.42 109.949 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.466 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.6 mmm180 -69.56 -40.5 76.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.314 -0.866 . . . . 3.25 111.491 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.552 ' CB ' ' CD1' ' A' ' 362' ' ' LEU . 98.4 m-85 -116.02 -14.72 11.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 4.16 110.088 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.54 ' N ' ' O ' ' A' ' 357' ' ' LYS . 22.6 t30 60.31 50.14 6.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.765 0.793 . . . . 2.42 110.125 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.552 ' CD1' ' CB ' ' A' ' 360' ' ' PHE . 22.4 mt -109.98 178.6 4.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.666 -0.647 . . . . 3.46 109.791 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -118.88 151.78 37.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.078 . . . . 4.96 110.161 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 342' ' ' LEU . 95.7 mt-10 -55.81 149.62 14.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 2.24 109.677 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH2' HD21 ' A' ' 339' ' ' LEU . 56.3 mtm180 -97.59 132.17 43.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.99 -1.069 . . . . 4.66 110.05 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 3.11 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.64 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.93 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.46 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.7 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.76 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.488 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.82 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.51 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.39 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.89 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.51 HG13 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.66 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 5.26 110.959 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.612 ' CE2' ' C5 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 6.59 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.91 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.79 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.92 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.98 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.62 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.539 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.09 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.88 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.13 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.537 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.86 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.462 ' ND2' ' HE3' ' A' ' 392' ' ' MET . 2.9 m120 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.26 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.86 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.85 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.51 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 3.03 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.462 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.45 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.548 HG13 ' CD1' ' A' ' 339' ' ' LEU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 2.27 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.57 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 3.45 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 2.2 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.506 ' N ' HD12 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.82 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.62 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.584 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 1.19 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.59 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 1.28 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.579 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 1.37 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 3.13 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 3.14 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 3.05 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 1.43 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.16 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.61 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.474 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.28 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.447 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 2.34 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.44 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.95 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.613 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 4.15 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.51 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 2.25 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.87 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 1.43 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.81 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.97 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 3.09 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 1.4 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.05 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 25.7 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.89 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.525 HG13 ' CB ' ' A' ' 444' ' ' ALA . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.65 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.66 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.75 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 3.33 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.21 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.6 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.9 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.53 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 445' ' ' LEU . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.98 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 1.15 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.73 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 1.32 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.532 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.42 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.474 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.82 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 4.21 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.73 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 2.29 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.38 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.535 HG12 ' CG2' ' A' ' 420' ' ' VAL . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 1.3 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 322' ' ' PHE . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.75 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 1.33 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.529 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.7 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp -84.93 137.85 32.86 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.79 109.307 170.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -95.97 132.2 41.54 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.154 -0.967 . . . . 3.91 110.446 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -58.94 -49.41 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 4.06 109.498 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 448' ' ' ILE . 45.7 t -102.42 134.7 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.717 . . . . 5.64 110.181 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -92.85 144.25 25.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 7.84 110.235 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.463 -1.455 . . . . 7.3 109.463 -179.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.612 ' C5 ' ' CE2' ' A' ' 377' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.51 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 85.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.214 0.53 . . . . 6.68 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CZ ' " O3'" ' A' 1001 ' ' ANP . 80.9 mtm180 -128.81 143.45 50.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 6.57 110.459 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.46 ' OE1' HD12 ' A' ' 448' ' ' ILE . 21.4 pt20 -144.26 154.55 43.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 6.1 109.941 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.94 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 355' ' ' LEU . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.95 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.82 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 334' ' ' ALA . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.53 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.493 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 1.28 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.44 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 2.3 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.37 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.79 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 2.53 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.493 ' N ' HG12 ' A' ' 328' ' ' VAL . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.76 110.137 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 1.21 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.518 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 1.62 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 1.39 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 365' ' ' ARG . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.48 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 1.34 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.515 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 1.29 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.599 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 2.22 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.24 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 338' ' ' GLN . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.83 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.66 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 4.28 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.6 p30 -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.84 110.486 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.63 18.94 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 3.2 110.317 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 65.6 p -86.93 154.38 55.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 2.72 110.297 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.515 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 11.5 Cg_endo -60.32 -40.27 60.08 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.98 1.516 . . . . 2.52 110.216 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.494 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -66.26 -38.95 89.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 3.25 110.123 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.56 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 4.07 109.998 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.79 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.492 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 2.19 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.466 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.8 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.99 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.527 ' CD2' ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.83 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.599 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -64.75 -37.01 86.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 1.07 109.559 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 361' ' ' ASN . 19.4 tptt -55.67 -54.32 45.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.878 -1.139 . . . . 1.65 110.794 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.8 pt20 -66.41 -39.56 89.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.525 -1.359 . . . . 2.42 109.952 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.5 mmt180 -69.77 -41.37 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 3.25 111.5 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 331' ' ' LYS . 52.6 m-85 -116.0 -14.75 11.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.725 -1.234 . . . . 4.16 110.441 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.54 ' N ' ' O ' ' A' ' 357' ' ' LYS . 25.8 t30 60.53 50.16 6.05 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.793 0.806 . . . . 2.42 110.251 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.531 ' CD1' ' HB3' ' A' ' 360' ' ' PHE . 22.1 mt -109.86 179.72 4.04 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.814 -0.554 . . . . 3.46 109.773 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -114.99 150.15 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 4.96 110.882 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 342' ' ' LEU . 21.3 pt-20 -61.58 155.57 21.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 2.24 109.732 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 -97.07 123.09 40.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 4.66 109.883 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 3.11 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.64 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.93 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.46 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.7 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.76 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.82 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.449 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.39 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.89 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.66 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 5.26 111.118 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.577 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 6.59 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.91 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.79 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.92 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.98 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.568 ' NH2' " O2'" ' A' 1001 ' ' ANP . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.62 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.09 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.622 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.88 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.13 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.86 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 8.6 m120 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.26 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.86 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.563 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.85 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.51 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.467 ' O ' HG21 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 3.03 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.45 109.603 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 2.27 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 3.45 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.63 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 2.2 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.82 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.528 ' HB3' ' CD ' ' A' ' 382' ' ' ARG . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.62 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 1.19 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.59 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 1.28 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 434' ' ' VAL . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 1.37 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.472 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 3.13 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 3.14 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 3.05 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.487 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 1.43 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.16 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.61 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.28 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.487 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 2.34 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.4 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.95 110.254 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 4.15 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.51 110.595 -177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 2.25 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.87 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.591 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 1.43 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.81 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.97 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 3.09 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 1.4 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.05 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.89 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.65 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.66 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.75 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 3.33 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.21 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.6 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.9 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.529 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.53 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 445' ' ' LEU . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.98 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 420' ' ' VAL . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 1.15 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.486 ' CG1' HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.73 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 1.32 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.42 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.82 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 4.21 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.73 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 2.29 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.52 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.38 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 420' ' ' VAL . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 1.3 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 322' ' ' PHE . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.75 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 1.33 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.7 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.455 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt -84.96 147.01 26.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.79 109.662 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 33.2 p30 -95.42 121.43 37.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 3.91 110.488 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -54.21 -47.47 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 4.06 109.379 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.458 HG21 HG21 ' A' ' 448' ' ' ILE . 46.1 t -101.2 135.67 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.555 -0.716 . . . . 5.64 110.241 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -92.49 144.61 25.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 7.84 110.184 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.987 -1.452 . . . . 7.3 109.536 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.63 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 84.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.239 0.543 . . . . 6.68 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -131.79 139.58 48.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 6.57 110.444 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.461 ' OE1' HD13 ' A' ' 448' ' ' ILE . 14.4 pt20 -145.0 150.93 37.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 6.1 110.173 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.59 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.94 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.95 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.463 ' HG3' HD11 ' A' ' 323' ' ' ILE . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.82 110.854 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.53 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 333' ' ' LEU . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 1.28 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.44 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 2.3 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.37 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.79 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 2.53 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.528 ' CG ' ' HD3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.76 110.277 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 1.21 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.528 HD13 ' CA ' ' A' ' 441' ' ' GLY . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 1.62 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 1.39 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.521 ' CB ' HD13 ' A' ' 440' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 1.34 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.499 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 1.29 110.412 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.545 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 2.22 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.517 ' HA ' ' CG2' ' A' ' 386' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.24 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.83 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.66 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.529 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 4.28 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 -101.49 147.2 26.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.84 110.232 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.89 6.33 47.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 3.2 110.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.8 p -85.37 140.84 36.45 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 2.72 110.193 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.25 -30.82 88.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.001 1.527 . . . . 2.52 110.23 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.6 mt-10 -63.9 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 3.25 110.137 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.56 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 4.07 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.79 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 319' ' ' ALA . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 2.19 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.8 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.99 110.677 171.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.59 ' CD1' ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.83 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.545 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -61.39 -37.99 85.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 1.07 109.246 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.4 tptm -61.32 -46.05 91.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 1.65 111.092 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 9.2 pt20 -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.46 -1.4 . . . . 2.42 109.892 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.6 mmt180 -79.16 -47.33 16.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 3.25 111.423 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 331' ' ' LYS . 78.9 m-85 -116.29 -14.95 11.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.814 -1.179 . . . . 4.16 110.509 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 24.0 t30 59.62 38.14 22.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.407 -0.808 . . . . 2.42 110.086 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.83 -178.6 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.565 -0.709 . . . . 3.46 109.572 172.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -128.33 154.49 45.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.96 -1.087 . . . . 4.96 110.76 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 342' ' ' LEU . 13.6 pt-20 -54.69 145.49 19.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 2.24 109.523 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.55 ' NH1' ' NH2' ' A' ' 391' ' ' ARG . 28.4 ptt180 -101.38 134.69 44.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 4.66 110.277 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 3.11 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.64 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.93 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.46 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.54 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.7 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.76 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.5 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.82 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.39 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.89 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.537 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.66 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 5.26 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 6.59 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.91 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.79 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.92 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.98 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.62 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.527 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.09 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.539 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.88 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.452 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.13 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.86 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.6 m120 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.26 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.86 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.85 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.51 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 3.03 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.45 109.165 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 2.27 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.537 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 3.45 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.578 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 2.2 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.469 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.82 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.62 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 1.19 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.59 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 1.28 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.578 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 1.37 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 3.13 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 3.14 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.561 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 3.05 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.523 HG13 ' CA ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 1.43 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.16 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.61 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.28 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 2.34 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.439 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.95 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 4.15 109.985 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.51 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 2.25 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.87 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 1.43 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.81 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.97 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 3.09 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 398' ' ' VAL . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 1.4 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.05 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.89 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.65 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.66 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.75 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 3.33 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.21 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.6 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.9 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.528 ' HB2' ' CG1' ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.53 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 445' ' ' LEU . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.98 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 420' ' ' VAL . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 1.15 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.73 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 1.32 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.42 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.82 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 4.21 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.522 ' CG1' HG13 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.73 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 2.29 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.528 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.38 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 420' ' ' VAL . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 1.3 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 322' ' ' PHE . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.75 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 1.33 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 431' ' ' LEU . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.7 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt -84.9 142.9 29.37 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.79 109.71 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 35.1 p30 -95.94 117.29 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 3.91 110.379 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -53.55 -47.03 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 4.06 109.334 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.406 HG21 HG23 ' A' ' 448' ' ' ILE . 47.1 t -101.62 134.62 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.53 -0.731 . . . . 5.64 110.197 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -90.93 133.5 35.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 7.84 110.229 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.967 -1.463 . . . . 7.3 109.581 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.578 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.475 ' N ' HG12 ' A' ' 448' ' ' ILE . 81.6 m-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.07 0.462 . . . . 6.68 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.43 ' C ' ' NE2' ' A' ' 318' ' ' GLN . 73.9 mtt85 -124.7 136.21 53.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 6.57 110.332 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 46.0 mm-40 -127.2 142.75 51.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.798 . . . . 6.1 109.472 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 355' ' ' LEU . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.94 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.95 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.82 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.646 ' CD1' ' NH1' ' A' ' 359' ' ' ARG . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.53 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 1.28 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.538 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.44 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.538 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 2.3 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.37 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.79 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 2.53 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.529 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.76 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 1.21 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' A' ' 440' ' ' LEU . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 1.62 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.57 ' CB ' ' NH2' ' A' ' 359' ' ' ARG . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 1.39 109.762 -176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 1.34 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.515 ' HB1' ' NE2' ' A' ' 338' ' ' GLN . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 1.29 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.594 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.557 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 2.22 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.24 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.83 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.524 ' CD2' ' HG3' ' A' ' 364' ' ' GLU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.66 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 4.28 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -76.37 136.03 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.84 110.078 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -96.25 7.49 46.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 3.2 110.359 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.585 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 15.9 p -78.0 145.6 70.02 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 2.72 110.206 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.6 -37.46 79.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 2.52 110.175 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.486 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.66 -34.74 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 3.25 109.978 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.56 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 354' ' ' ILE . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 4.07 109.535 172.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 318' ' ' GLN . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.79 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.454 HG22 ' OE1' ' A' ' 338' ' ' GLN . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 2.19 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.8 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 350' ' ' ARG . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.99 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.549 ' HG ' ' NH1' ' A' ' 359' ' ' ARG . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.83 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.594 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -63.62 -37.21 86.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 1.07 109.477 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.0 ttpt -58.19 -49.9 75.42 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.777 -1.202 . . . . 1.65 110.621 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -66.1 -44.92 82.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.2 -1.562 . . . . 2.42 110.187 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.646 ' NH1' ' CD1' ' A' ' 322' ' ' PHE . 25.0 mtm180 -62.13 -44.82 95.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.917 -1.114 . . . . 3.25 111.757 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.522 ' HB3' ' CD1' ' A' ' 362' ' ' LEU . 97.8 m-85 -115.75 -14.5 11.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.175 . . . . 4.16 109.942 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.4 t-20 60.65 50.21 5.82 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.895 0.855 . . . . 2.42 110.336 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 360' ' ' PHE . 26.1 mt -118.21 172.35 7.49 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.535 . . . . 3.46 109.687 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -119.22 167.32 11.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 4.96 110.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.524 ' HG3' ' CD2' ' A' ' 342' ' ' LEU . 5.0 tt0 -57.94 148.68 25.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.518 -0.739 . . . . 2.24 109.418 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -100.92 140.04 35.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 4.66 110.068 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 3.11 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.64 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.93 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.46 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.7 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.412 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.76 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.496 ' C ' ' CG1' ' A' ' 367' ' ' VAL . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.82 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.39 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.89 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.508 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.66 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 5.26 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.585 ' CD2' ' CG2' ' A' ' 346' ' ' THR . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 6.59 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.91 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.79 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.92 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.98 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.62 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.09 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.88 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.13 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.86 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 372' ' ' ALA . 3.0 m120 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.26 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.86 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.412 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.85 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.51 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 3.03 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.422 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.45 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.557 HG13 ' CD1' ' A' ' 339' ' ' LEU . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 2.27 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.516 ' HG3' ' NE2' ' A' ' 404' ' ' HIS . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 3.45 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.566 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 2.2 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.82 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.62 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.579 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 1.19 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.59 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 1.28 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 1.37 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 3.13 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 3.14 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.516 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 3.05 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.517 HG11 ' CA ' ' A' ' 410' ' ' GLY . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 1.43 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.16 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.61 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.0 m120 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.28 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.517 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 2.34 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.95 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 4.15 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.51 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 2.25 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.87 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 1.43 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.81 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.97 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.516 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 3.09 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 1.4 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.05 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.1 mm-40 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.89 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.529 ' CG1' ' HB1' ' A' ' 444' ' ' ALA . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.65 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.66 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.75 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 3.33 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.21 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.6 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.406 ' OG1' ' HD3' ' A' ' 317' ' ' ARG . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.9 108.992 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.521 ' CG ' HG12 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.53 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.491 HD21 " C2'" ' A' 1001 ' ' ANP . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.98 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.513 ' CG1' HG12 ' A' ' 439' ' ' VAL . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 1.15 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 395' ' ' LYS . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.73 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.58 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 1.32 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.42 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.82 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 4.21 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.513 HG12 ' CG1' ' A' ' 432' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.73 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 2.29 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.38 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 420' ' ' VAL . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 1.3 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 430' ' ' PRO . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.75 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 1.33 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.7 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 317' ' ' ARG . 38.3 tttp -86.2 140.22 30.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.79 109.645 174.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 36.6 p30 -95.86 130.24 42.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.289 -0.882 . . . . 3.91 110.647 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 448' ' ' ILE . 4.4 mm -55.52 -48.65 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.066 -1.021 . . . . 4.06 109.417 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.55 135.68 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.205 0.526 . . . . 5.64 110.27 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -92.4 145.71 24.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 7.84 110.225 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 7.3 109.515 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.566 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.472 ' N ' ' HB ' ' A' ' 448' ' ' ILE . 80.8 m-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.273 0.558 . . . . 6.68 110.213 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 447' ' ' ASP . 25.8 mmt85 -123.45 139.91 53.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 6.57 110.327 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 -140.93 141.82 34.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.449 -0.782 . . . . 6.1 110.231 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.94 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.514 ' O ' ' NH2' ' A' ' 359' ' ' ARG . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.95 110.653 175.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.82 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 360' ' ' PHE . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.53 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.491 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 1.28 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.44 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.582 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 2.3 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.37 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.79 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 2.53 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.76 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 1.21 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' A' ' 440' ' ' LEU . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.62 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 322' ' ' PHE . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 1.39 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 1.34 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.46 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 1.29 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.618 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 2.22 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.24 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.83 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.66 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 4.28 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.21 138.28 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.84 110.053 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.58 6.71 48.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.108 -0.995 . . . . 3.2 110.246 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.508 HG21 ' CD2' ' A' ' 377' ' ' PHE . 32.0 p -76.1 141.47 70.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 2.72 110.08 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -56.8 -34.2 96.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.848 1.446 . . . . 2.52 110.204 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -37.14 86.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 3.25 110.25 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.56 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 4.07 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.511 ' OG ' ' CB ' ' A' ' 318' ' ' GLN . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.79 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.551 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 2.19 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.8 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 358' ' ' GLN . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.99 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.561 ' CD1' ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.83 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -68.52 -39.04 81.36 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 1.07 109.998 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 27.3 mttt -65.55 -42.99 91.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.673 -1.267 . . . . 1.65 110.739 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -62.73 -39.34 93.76 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.096 -1.627 . . . . 2.42 109.722 176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 320' ' ' SER . 26.3 mmt85 -75.89 -47.49 25.18 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.122 -0.987 . . . . 3.25 111.579 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 27.8 m-85 -115.87 -14.58 11.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.776 -1.203 . . . . 4.16 110.272 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 26.8 t30 60.13 42.92 14.82 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.542 -0.724 . . . . 2.42 110.385 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.517 ' CD2' ' HB1' ' A' ' 356' ' ' ALA . 0.7 OUTLIER -77.36 -173.2 2.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.447 -0.783 . . . . 3.46 109.626 171.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -129.07 153.45 47.63 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 4.96 109.929 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.33 146.23 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 2.24 109.523 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 339' ' ' LEU . 57.7 mtp180 -97.17 128.19 43.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 4.66 109.975 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 3.11 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.619 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.64 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.93 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.46 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.526 ' CD1' HD13 ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.7 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.76 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.82 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.39 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.619 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.89 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.509 HG13 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.66 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 5.26 111.244 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.53 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 6.59 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.91 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.79 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.92 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.98 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.62 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.526 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.09 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.88 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.439 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.13 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.86 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.44 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 2.9 m120 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.26 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.86 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.85 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.51 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 3.03 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.45 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 2.27 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.515 ' HG3' ' NE2' ' A' ' 404' ' ' HIS . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 3.45 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.479 ' HE3' ' C2 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 2.2 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.82 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.62 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 1.19 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.59 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 1.28 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.573 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 1.37 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 3.13 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 3.14 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.515 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 3.05 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.502 HG13 ' CA ' ' A' ' 410' ' ' GLY . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 1.43 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.16 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.61 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.3 m120 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.28 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.502 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 2.34 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.95 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.577 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 4.15 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.51 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 2.25 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.87 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.582 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 1.43 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.81 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.97 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 3.09 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.4 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.05 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.52 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.89 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.65 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.66 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.75 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 3.33 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.21 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.479 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.6 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.9 109.275 174.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' HG13 ' A' ' 423' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.53 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.522 HD22 " O2'" ' A' 1001 ' ' ANP . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.98 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.502 ' CG1' HG11 ' A' ' 439' ' ' VAL . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 1.15 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.427 HG21 ' HG2' ' A' ' 395' ' ' LYS . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.73 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.573 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 1.32 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.42 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.82 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 4.21 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.502 HG11 ' CG1' ' A' ' 432' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.73 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.525 ' O ' ' CG1' ' A' ' 328' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 2.29 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.503 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.38 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.531 HG12 ' CG2' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 1.3 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.523 HD12 ' CG ' ' A' ' 333' ' ' LEU . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.75 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 1.33 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.7 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.8 146.84 27.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.79 109.52 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 35.0 p30 -91.93 122.0 34.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 3.91 110.617 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -53.57 -47.69 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 4.06 109.545 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 448' ' ' ILE . 45.3 t -101.62 135.53 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.505 -0.747 . . . . 5.64 110.252 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -90.51 132.9 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 7.84 110.143 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 7.3 109.533 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.548 ' H8 ' " H3'" ' A' 1001 ' ' ANP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.463 ' HB2' ' HB ' ' A' ' 448' ' ' ILE . 97.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.229 0.538 . . . . 6.68 110.247 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -136.64 144.14 43.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.244 -0.91 . . . . 6.57 110.467 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 16.6 mt-30 -135.47 148.6 49.3 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.82 . . . . 6.1 109.659 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.94 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.95 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.82 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.619 ' O ' ' CD1' ' A' ' 322' ' ' PHE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.53 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 1.28 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.44 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.521 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 2.3 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.37 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.79 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 2.53 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.76 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 1.21 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.537 ' CD2' ' CD1' ' A' ' 443' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 1.62 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 1.39 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.469 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 1.34 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 1.29 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.604 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.535 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 2.22 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.521 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.24 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.83 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 364' ' ' GLU . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.66 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 4.28 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 341' ' ' SER . 2.5 p30 -93.9 138.86 31.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.84 110.228 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.46 7.0 47.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 3.2 110.296 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.0 p -71.48 141.0 85.0 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 2.72 110.05 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -57.03 -36.74 99.41 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.909 1.479 . . . . 2.52 110.25 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.505 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 95.6 mt-10 -64.52 -36.37 83.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 3.25 110.11 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.56 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 4.07 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 318' ' ' GLN . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.79 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 319' ' ' ALA . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 2.19 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.8 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 350' ' ' ARG . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.99 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.83 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.604 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -66.86 -38.52 86.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 1.07 109.841 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 361' ' ' ASN . 52.6 mtmt -62.89 -47.6 82.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.753 -1.217 . . . . 1.65 111.379 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -64.73 -40.03 94.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.146 -1.596 . . . . 2.42 109.535 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.458 ' HD3' HD22 ' A' ' 355' ' ' LEU . 63.8 mtp85 -75.7 -41.57 53.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 3.25 111.476 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 331' ' ' LYS . 94.4 m-85 -115.72 -13.63 11.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.938 -1.102 . . . . 4.16 110.311 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.6 t-20 60.56 50.04 6.11 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.949 0.88 . . . . 2.42 110.169 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 357' ' ' LYS . 23.0 mt -108.26 177.74 4.71 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.534 -0.543 . . . . 3.46 109.534 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -119.91 151.15 39.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.93 -1.107 . . . . 4.96 110.068 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.454 ' HB2' HD12 ' A' ' 342' ' ' LEU . 12.3 pt-20 -54.75 149.02 11.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 2.24 109.517 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -95.53 123.99 39.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.009 -1.057 . . . . 4.66 109.788 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.47 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 3.11 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.636 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.64 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.93 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.46 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.7 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.76 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.82 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.453 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.39 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.636 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.89 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.563 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.66 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 5.26 110.999 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.553 ' CE2' ' C4 ' ' A' 1001 ' ' ANP . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 6.59 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.91 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.79 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.92 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.98 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.62 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.525 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.09 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.88 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.442 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.13 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.518 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.86 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 8.6 m120 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.26 109.06 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.86 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.557 ' N ' ' CD1' ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.85 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.51 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 3.03 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.45 109.453 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 2.27 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.563 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 3.45 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.633 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 2.2 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.82 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.62 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.571 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 1.19 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.59 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.525 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 1.28 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 434' ' ' VAL . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 1.37 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 3.13 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 3.14 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 3.05 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.517 HG11 ' CA ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 1.43 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.16 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.61 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.6 m120 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.28 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.517 ' CA ' HG11 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 2.34 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.95 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.541 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 4.15 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.51 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 2.25 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.87 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.541 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 1.43 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.81 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.97 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 3.09 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 1.4 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.05 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.89 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.65 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.66 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.75 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 3.33 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.21 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.6 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.9 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.48 ' CG ' HG12 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.53 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.585 ' CD2' " O2'" ' A' 1001 ' ' ANP . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.98 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.515 ' CG2' HG21 ' A' ' 420' ' ' VAL . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 1.15 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.463 HG13 HD22 ' A' ' 440' ' ' LEU . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.73 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 1.32 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.42 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.82 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 4.21 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.73 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 2.29 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.509 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.38 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.525 HG13 ' CG2' ' A' ' 420' ' ' VAL . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 1.3 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.537 ' CD1' ' CD2' ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.75 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.515 ' CB ' HG11 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 1.33 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.7 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -88.11 142.52 27.7 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.79 109.291 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 36.5 p30 -95.74 118.53 32.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.195 -0.941 . . . . 3.91 110.727 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 0.9 OUTLIER -52.89 -46.97 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 4.06 109.563 177.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.04 134.36 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 5.64 110.124 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -91.26 132.75 35.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 7.84 110.181 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.003 -1.443 . . . . 7.3 109.565 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.633 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.483 ' HB3' ' CG1' ' A' ' 448' ' ' ILE . 18.7 t-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.157 0.503 . . . . 6.68 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' A' ' 348' ' ' GLU . 87.6 mtm-85 -121.99 140.25 52.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.081 . . . . 6.57 110.519 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.507 ' NE2' HD11 ' A' ' 448' ' ' ILE . 15.5 mt-30 -135.62 150.55 49.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 6.1 109.403 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.94 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.477 ' CA ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.95 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.82 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.53 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.468 HG21 ' HD2' ' A' ' 324' ' ' PRO . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 1.28 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.542 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.44 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 2.3 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.37 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.79 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 2.53 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 329' ' ' ASP . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.542 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.76 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 1.21 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 440' ' ' LEU . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 1.62 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 1.39 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.48 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 1.34 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 1.29 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.61 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.539 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 2.22 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.5 ' CB ' HG21 ' A' ' 393' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.24 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.83 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 364' ' ' GLU . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.66 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 4.28 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.471 ' OD2' ' O ' ' A' ' 341' ' ' SER . 1.1 p30 -97.02 138.27 34.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.84 110.186 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.97 7.13 47.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 3.2 110.244 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.626 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 82.6 p -75.32 141.12 73.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 2.72 110.194 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.4 -37.58 97.04 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.962 1.506 . . . . 2.52 110.174 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.514 ' OE2' ' NH2' ' A' ' 317' ' ' ARG . 96.9 mt-10 -63.93 -35.28 80.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 3.25 110.102 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.56 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 4.07 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 318' ' ' GLN . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.79 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.516 ' CG1' ' HB1' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 2.19 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.8 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.401 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.99 110.27 169.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.83 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -66.15 -37.63 86.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 1.07 109.726 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 361' ' ' ASN . 39.1 mtmt -62.55 -47.87 81.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.697 -1.252 . . . . 1.65 111.026 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.485 ' HG3' ' HG2' ' A' ' 359' ' ' ARG . 21.0 pt20 -64.85 -40.62 95.45 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.32 -1.487 . . . . 2.42 109.707 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.485 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 56.9 mmm-85 -73.18 -44.86 59.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.119 -0.988 . . . . 3.25 111.604 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.486 ' CB ' HD11 ' A' ' 362' ' ' LEU . 76.2 m-85 -115.73 -13.61 11.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 4.16 110.368 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER 60.62 50.1 5.94 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.885 0.85 . . . . 2.42 110.192 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 360' ' ' PHE . 22.5 mt -110.68 -178.81 3.58 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.588 -0.523 . . . . 3.46 109.588 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -123.09 152.12 41.35 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.818 -1.176 . . . . 4.96 110.225 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.511 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.2 pt-20 -52.01 153.25 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 2.24 109.738 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -98.81 136.11 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.03 -1.044 . . . . 4.66 110.245 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 3.11 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.64 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.93 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.46 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.534 ' CD1' ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.7 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.76 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.529 ' CB ' HG11 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.82 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.39 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.89 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.491 ' N ' ' HB3' ' A' ' 343' ' ' ALA . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.66 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 5.26 111.354 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CD2' ' CG2' ' A' ' 346' ' ' THR . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 6.59 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.91 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.79 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.92 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.98 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.62 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.537 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.09 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.534 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.88 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.13 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.86 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.436 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 3.0 m120 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.26 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.534 ' CD1' ' CD1' ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.86 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.85 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.51 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 3.03 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.45 109.069 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 2.27 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.431 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 3.45 110.393 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.621 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 2.2 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 383' ' ' MET . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.82 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.503 ' OG ' ' NE ' ' A' ' 382' ' ' ARG . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.62 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.572 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 1.19 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.59 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.537 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 1.28 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 434' ' ' VAL . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 1.37 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 3.13 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 3.14 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.431 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 56.0 t-80 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 3.05 110.723 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.488 ' CG1' ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 1.43 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.16 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.61 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.517 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.28 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.488 ' C ' ' CG1' ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 2.34 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.457 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.95 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CE1' ' CG1' ' A' ' 416' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 4.15 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.51 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 2.25 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.538 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.87 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.571 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 1.43 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.81 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.97 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 3.09 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.572 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 1.4 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 425' ' ' ARG . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.05 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.497 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.89 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.552 ' CG1' ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.65 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.66 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.75 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 3.33 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.21 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.6 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.9 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.53 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.584 ' CD2' " O2'" ' A' 1001 ' ' ANP . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.98 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.5 HG12 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 1.15 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 395' ' ' LYS . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.73 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 1.32 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.42 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.82 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.515 ' NH2' ' OE1' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 4.21 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 434' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.73 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 2.29 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.52 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.38 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 420' ' ' VAL . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 1.3 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 333' ' ' LEU . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.75 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' ' CG1' ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 1.33 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.7 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -95.39 144.08 26.21 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.79 109.679 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 40.6 t0 -95.86 137.45 34.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.197 -0.939 . . . . 3.91 110.173 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 448' ' ' ILE . 4.1 mm -54.23 -44.29 64.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.124 0.964 . . . . 4.06 108.947 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -97.83 134.56 35.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.805 -0.634 . . . . 5.64 110.114 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -90.99 132.76 35.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 7.84 110.133 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 117.962 -1.465 . . . . 7.3 109.549 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.621 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.003 0.43 . . . . 5.58 110.12 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.42 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.6 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.465 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.82 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.733 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.14 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.802 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.53 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.565 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.44 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.778 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 1.58 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.0 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.52 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 1.73 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.475 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.03 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.9 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.825 ' HA ' HD12 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 0.93 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.591 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 0.87 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.76 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.72 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 1.58 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.24 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.56 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.36 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 3.81 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.84 110.112 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.314 0.578 . . . . 3.25 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.42 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 3.62 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.751 ' HA ' HD12 ' A' ' 354' ' ' ILE . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.4 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.699 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 1.39 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.18 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 351' ' ' SER . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.36 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 319' ' ' ALA . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.15 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.61 109.743 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.187 0.518 . . . . 4.16 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 2.86 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.04 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.69 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.05 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.14 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.1 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.12 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.488 ' N ' HG13 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.11 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.09 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.969 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.0 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 4.63 111.268 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.557 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 5.79 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.29 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.13 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.74 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.82 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.25 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.715 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.09 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.23 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.13 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.26 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.597 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.2 m-20 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.04 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.11 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.85 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.33 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 2.69 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.476 ' HE3' ' OD1' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.02 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 339' ' ' LEU . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 1.68 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.969 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 2.78 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 1.57 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.602 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.82 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.17 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 0.53 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.59 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 0.85 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.602 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 0.81 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 2.62 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 2.48 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.514 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 2.43 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.619 HG12 ' C ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 0.94 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.16 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.53 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.28 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.619 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 1.72 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.16 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 3.31 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.23 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 1.75 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.554 ' N ' HG23 ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.87 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 439' ' ' VAL . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 0.71 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.81 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.6 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 2.49 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.017 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 0.79 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.05 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.33 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.0 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.24 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.538 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.11 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 2.92 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.16 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.07 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.21 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.017 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.2 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.537 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.4 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 0.52 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.08 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.79 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 0.9 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.515 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.42 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.42 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 3.52 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 416' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.41 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.79 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.02 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 443' ' ' ILE . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 0.57 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.05 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.46 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.11 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.48 109.511 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.491 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.105 0.479 . . . . 5.58 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.993 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.42 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.75 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.6 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.82 110.881 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.807 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.14 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 0.53 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.44 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.733 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 1.58 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.0 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.52 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 1.73 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.03 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.9 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 441' ' ' GLY . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 0.93 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 0.87 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' HD23 ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 0.76 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 0.72 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.768 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.755 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 1.58 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.24 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.56 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.36 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 3.81 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.7 p30 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.84 110.161 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.387 0.613 . . . . 3.25 110.169 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.42 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 3.62 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.4 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.639 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 1.39 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 341' ' ' SER . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.18 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 351' ' ' SER . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.36 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.993 HD22 ' HB1' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.15 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.768 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 0.61 109.388 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.369 0.604 . . . . 4.16 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 2.86 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.04 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.69 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.05 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.14 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.1 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.775 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.12 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.11 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.09 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 1.008 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.0 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 4.63 111.207 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 5.79 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.29 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.13 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.74 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.82 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.49 ' HD2' ' HB3' ' A' ' 397' ' ' SER . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.25 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.809 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.09 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.23 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.13 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.26 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.568 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.0 m-20 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.04 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.11 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.85 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.33 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 2.69 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.424 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.02 109.09 166.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.553 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 1.68 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 1.008 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 2.78 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.872 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 1.57 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.648 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.82 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.17 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.867 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 0.53 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.59 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.809 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.85 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.648 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 0.81 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 2.62 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 2.48 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.657 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 61.7 t60 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 2.43 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.638 HG12 ' C ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 0.94 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.16 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.53 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.533 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 79.1 m-20 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.28 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.638 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 1.72 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.16 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 3.31 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.23 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 1.75 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.87 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 439' ' ' VAL . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 0.71 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.81 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 83.7 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.6 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.988 ' O ' HG23 ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 2.49 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.904 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 0.79 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.05 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 30.1 mm100 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.33 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.0 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.24 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.11 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 2.92 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.16 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.07 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.21 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.904 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.2 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.628 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.4 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 0.52 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.931 HG12 HD21 ' A' ' 440' ' ' LEU . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.08 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 0.9 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.42 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.42 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 3.52 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.41 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.931 HD21 HG12 ' A' ' 433' ' ' VAL . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 1.79 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.02 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.904 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 0.57 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.05 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.812 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 0.46 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.11 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.48 110.022 172.602 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 25.5 mt-30 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.234 -0.654 . . . . 5.58 109.234 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.012 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.42 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.613 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.6 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.82 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.14 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.554 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 0.53 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.558 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.44 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 1.58 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.0 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.52 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 1.73 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.03 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.9 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 441' ' ' GLY . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 0.93 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.87 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.536 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.435 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.76 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 0.72 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 1.086 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 2.8 mp0 -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 1.58 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.24 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.56 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.36 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 3.81 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.84 110.126 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.445 0.641 . . . . 3.25 110.081 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.42 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 3.62 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.4 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 319' ' ' ALA . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 1.39 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.18 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.36 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.012 HD22 ' HB1' ' A' ' 319' ' ' ALA . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.15 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 1.086 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 0.61 109.478 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.401 0.619 . . . . 4.16 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 2.86 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 372' ' ' ALA . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.04 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.69 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.05 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.856 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.14 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.1 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.976 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.12 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.11 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.703 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.09 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 1.028 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.0 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 4.63 111.355 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.553 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 5.79 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.29 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.13 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.74 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.82 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.25 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.583 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.09 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.439 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.13 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.26 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.552 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 7.8 m-20 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.04 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.856 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.11 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.33 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 2.69 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.02 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 1.68 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 1.028 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 2.78 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.844 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 1.57 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.82 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.17 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.53 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.59 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 0.85 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 0.81 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 2.62 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 2.48 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 2.43 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 0.94 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.16 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.53 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.28 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.632 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 1.72 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.16 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.792 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 3.31 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.23 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 1.75 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.87 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 439' ' ' VAL . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.71 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.81 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.6 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 2.49 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 0.79 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.05 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.33 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.0 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.24 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.11 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 2.92 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.16 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.07 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.21 108.985 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.828 ' HB2' HG13 ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.2 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.4 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 0.52 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.996 HG12 HD21 ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.08 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.728 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 0.9 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.688 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.42 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.748 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.42 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 3.52 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 416' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.41 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.996 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 1.79 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.02 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.666 HG11 ' HA ' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 0.57 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.05 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.916 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 0.46 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.11 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.8 tttt . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.48 109.604 174.21 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 351' ' ' SER . 14.3 pt20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.903 0.383 . . . . 5.58 110.149 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.42 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.6 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.82 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.78 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.14 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.824 ' C ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.53 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.44 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 1.58 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.0 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.52 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 1.73 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.03 110.51 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 0.9 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.974 HD13 ' HA3' ' A' ' 441' ' ' GLY . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.93 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.87 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.595 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.641 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 0.76 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.63 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 0.72 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.757 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 386' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 1.58 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.24 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.56 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.36 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 3.81 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.84 110.107 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.276 0.56 . . . . 3.25 110.142 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.42 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 3.62 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 354' ' ' ILE . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.4 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.642 HG22 ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 1.39 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 338' ' ' GLN . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.18 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 351' ' ' SER . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.36 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.15 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.757 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.61 109.58 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.548 ' CZ ' HD22 ' A' ' 339' ' ' LEU . 10.8 ptp180 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.46 0.647 . . . . 4.16 110.317 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.491 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 2.86 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 372' ' ' ALA . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.04 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.69 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.05 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.14 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.1 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.895 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.12 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.11 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.655 ' CE1' HG21 ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.09 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.521 ' N ' ' HB1' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.0 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 4.63 111.119 -175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 5.79 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.29 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.13 110.528 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.74 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.82 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.25 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.606 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.09 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 377' ' ' PHE . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.23 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.445 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.13 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 339' ' ' LEU . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.26 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.408 HD22 HG22 ' A' ' 375' ' ' VAL . 9.6 m-20 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.04 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.11 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.85 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.33 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 2.69 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.695 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.02 109.317 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.846 HG13 HD11 ' A' ' 339' ' ' LEU . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 1.68 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 2.78 110.069 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 1.021 ' HD3' HD13 ' A' ' 431' ' ' LEU . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 1.57 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.788 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.82 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.585 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.17 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.042 HG21 HG11 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.53 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.59 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 0.85 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.788 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 0.81 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 2.62 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 2.48 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 2.43 110.722 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.611 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 0.94 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.16 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.53 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.28 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.611 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 1.72 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.16 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 3.31 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.23 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 1.75 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 418' ' ' GLN . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.87 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 439' ' ' VAL . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 0.71 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.81 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 415' ' ' ASP . 13.5 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.6 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 2.49 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.042 HG11 HG21 ' A' ' 398' ' ' VAL . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.79 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.05 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.33 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.0 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.24 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.11 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 2.92 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.16 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.07 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.21 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.014 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.2 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 1.021 HD13 ' HD3' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.4 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 0.52 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.7 HG12 HD21 ' A' ' 440' ' ' LEU . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.08 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 0.9 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.42 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.42 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.524 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 3.52 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 416' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.41 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.879 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 1.79 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.974 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.02 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.755 ' CG1' HG22 ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 0.57 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 322' ' ' PHE . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.05 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 0.46 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.11 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.48 109.382 170.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.153 0.501 . . . . 5.58 110.384 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.42 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.6 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.411 ' OE2' HD11 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.82 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.033 ' CD1' HD21 ' A' ' 355' ' ' LEU . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.14 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.53 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.44 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.802 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 1.58 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.0 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.52 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.909 HG11 ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 1.73 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.546 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.03 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.9 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 443' ' ' ILE . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.93 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.804 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 0.87 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 0.76 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 0.72 110.099 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.656 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 1.58 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.24 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.56 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.36 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 3.81 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.84 110.007 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.275 0.56 . . . . 3.25 110.136 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.42 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 3.62 109.444 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.762 ' HA ' HD12 ' A' ' 354' ' ' ILE . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.4 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.613 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 1.39 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.18 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.36 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.15 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.656 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 0.61 109.634 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.51 ' HD3' ' CD1' ' A' ' 370' ' ' LEU . 25.3 ttm180 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.663 0.744 . . . . 4.16 109.997 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 2.86 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.731 HG21 ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.04 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.69 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.05 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.14 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.1 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.12 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.11 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.731 ' CE1' HG21 ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.09 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.654 HG23 ' HA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.0 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 4.63 111.331 -175.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.557 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 5.79 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.29 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.13 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.74 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.82 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.25 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.575 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.09 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.436 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.13 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.26 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.606 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.4 m-20 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.04 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.891 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.11 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.85 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.33 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 2.69 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.02 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.706 HD13 ' HG2' ' A' ' 435' ' ' GLU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 1.68 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 2.78 110.419 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 1.57 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.67 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.82 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.17 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.845 HG21 ' CG1' ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.53 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.59 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.85 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.67 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 0.81 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 2.62 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 2.48 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 2.43 110.58 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 437' ' ' SER . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.94 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.16 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.53 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.28 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.61 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 1.72 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.16 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.828 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 3.31 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.23 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 1.75 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.87 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 439' ' ' VAL . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 0.71 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.81 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.6 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 2.49 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 0.79 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.05 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 30.2 mm100 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.33 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.0 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.24 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.11 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 2.92 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.16 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.07 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.21 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.669 ' HA ' HG11 ' A' ' 423' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.2 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.587 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.4 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.766 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 0.52 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.123 HG12 HD21 ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.08 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.743 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.9 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.706 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.42 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.42 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 3.52 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 416' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.41 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.123 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 1.79 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.661 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.02 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.817 ' O ' HD13 ' A' ' 443' ' ' ILE . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 0.57 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.05 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.773 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.46 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.11 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.48 109.162 169.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.837 -0.431 . . . . 5.58 109.837 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.42 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.6 110.564 175.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.508 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.82 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.864 ' CD2' ' HB2' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.14 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.838 ' O ' HD22 ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.53 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.44 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.808 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 1.58 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.0 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.52 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 1.73 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.03 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.9 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.852 HD21 ' O ' ' A' ' 442' ' ' VAL . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.93 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.864 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.87 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 0.76 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.72 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.701 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 1.58 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.24 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.56 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 365' ' ' ARG . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.36 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 3.81 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.84 110.309 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.56 . . . . 3.25 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.42 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 3.62 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.763 ' HA ' HD12 ' A' ' 354' ' ' ILE . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.4 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 319' ' ' ALA . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 1.39 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 338' ' ' GLN . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.18 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 351' ' ' SER . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.36 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.965 HD22 ' HB1' ' A' ' 319' ' ' ALA . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.15 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.556 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 0.61 109.561 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 342' ' ' LEU . 82.6 mtp180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.171 0.51 . . . . 4.16 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 2.86 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 372' ' ' ALA . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.04 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.69 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.05 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.14 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 7.8 m-70 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.1 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.806 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.12 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.11 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.09 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.595 HG23 ' HA ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.0 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 4.63 111.162 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.588 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 5.79 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.29 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.13 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.74 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.82 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.25 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.09 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.588 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.23 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.679 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.13 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.855 HG22 ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.26 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.489 ' ND2' HG22 ' A' ' 375' ' ' VAL . 36.3 m-20 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.04 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.056 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.11 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 1.056 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.85 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.33 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 2.69 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.838 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.02 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.855 ' HB ' HG22 ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 1.68 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.694 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 2.78 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.57 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.722 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.82 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.17 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.937 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 0.53 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.59 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 0.85 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.722 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 0.81 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 2.62 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 2.48 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.694 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 67.5 t60 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 2.43 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.609 HG12 ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 0.94 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.16 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.53 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.28 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.609 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 1.72 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.16 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 3.31 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.23 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 1.75 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.87 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.71 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.81 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.6 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.942 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 2.49 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 0.79 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.05 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.33 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.0 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.24 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.537 ' HB3' ' NH1' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.11 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 2.92 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.16 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.07 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.21 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.018 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.2 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.581 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.4 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 0.52 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.889 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.08 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.803 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 0.9 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.42 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.42 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 3.52 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.41 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 1.79 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.66 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.02 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.852 ' O ' HD21 ' A' ' 333' ' ' LEU . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 0.57 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.05 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.582 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 0.46 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.11 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.48 109.772 174.374 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.544 -0.539 . . . . 5.58 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.03 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.42 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.6 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.82 110.739 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.93 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.14 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.53 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.44 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.731 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 1.58 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.0 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.52 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 1.73 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.03 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.9 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' HA3' ' A' ' 441' ' ' GLY . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.93 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.93 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 0.87 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 0.76 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 0.72 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.726 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.912 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 1.58 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.24 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.56 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.36 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 3.81 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.84 110.12 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.311 0.577 . . . . 3.25 110.067 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.454 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.42 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 3.62 109.653 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.4 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.726 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 1.39 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.18 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.36 110.491 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.15 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.682 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 0.61 109.606 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.843 ' CD ' HD22 ' A' ' 339' ' ' LEU . 58.5 mtp85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.671 0.748 . . . . 4.16 110.563 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 2.86 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.767 HG21 ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.04 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.69 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.446 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.05 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.14 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.1 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.12 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.11 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.09 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.0 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 4.63 111.27 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 5.79 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.29 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.13 110.472 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.74 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.82 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.25 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.662 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.09 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.23 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.13 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.912 HG21 HD12 ' A' ' 339' ' ' LEU . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.26 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.9 m-20 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.04 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.11 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.33 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 2.69 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.02 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.683 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 1.68 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 2.78 110.393 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.887 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 1.57 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.704 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.82 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.17 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.53 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.59 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.662 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 0.85 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.81 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 2.62 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 2.48 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 2.43 110.56 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 437' ' ' SER . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.94 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.16 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.53 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.28 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 1.72 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.411 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.16 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 3.31 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.23 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 1.75 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.87 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 439' ' ' VAL . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 0.71 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.81 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.6 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.969 ' O ' HG23 ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 2.49 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 430' ' ' PRO . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 0.79 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.05 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 81.8 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.33 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.0 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.24 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.11 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 2.92 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.16 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.07 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.21 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.041 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.2 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.639 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.4 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.786 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 0.52 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.031 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.08 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.756 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 0.9 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.683 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.42 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.857 ' O ' HG13 ' A' ' 405' ' ' VAL . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.42 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 3.52 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.41 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.031 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 1.79 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.02 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.897 ' O ' HD13 ' A' ' 443' ' ' ILE . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 0.57 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.05 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.678 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 0.46 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.11 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.48 109.89 174.507 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.881 -0.414 . . . . 5.58 109.881 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.067 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.42 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.6 110.543 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.82 110.641 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.916 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.14 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.53 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.44 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.79 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 1.58 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.0 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.52 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.936 HG11 ' O ' ' A' ' 440' ' ' LEU . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 1.73 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.457 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.03 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 0.9 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 443' ' ' ILE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.93 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.515 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 0.87 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.76 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 0.72 110.087 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 1.58 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.24 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.56 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.36 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 3.81 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.84 110.062 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.371 0.605 . . . . 3.25 110.117 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.42 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 3.62 109.498 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.4 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.72 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 1.39 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.18 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.36 110.342 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.067 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.15 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.705 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 0.61 109.663 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.518 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 88.5 mtt180 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.258 0.552 . . . . 4.16 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.484 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 2.86 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.04 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.69 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.05 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.14 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.1 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.12 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.11 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.659 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.09 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.615 HG11 ' NH1' ' A' ' 394' ' ' ARG . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.0 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 4.63 111.172 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 5.79 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.29 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.13 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.74 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.82 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.25 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.686 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.09 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.23 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.13 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.26 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.592 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 11.1 m-20 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.04 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.868 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.11 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.85 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.33 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 2.69 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.02 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 1.68 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.638 ' HB3' HG22 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 2.78 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.879 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 1.57 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.82 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.17 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.803 HG21 HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.53 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.59 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.686 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 0.85 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.753 HG23 ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 0.81 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 2.62 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 2.48 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 2.43 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 437' ' ' SER . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 0.94 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.16 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.53 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.28 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.621 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 1.72 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.16 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 3.31 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.23 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 1.75 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.87 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.035 ' CG1' HG11 ' A' ' 439' ' ' VAL . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 0.71 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.81 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.6 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 2.49 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 0.79 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.05 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.33 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.0 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.24 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.11 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 2.92 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.16 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.07 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.21 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.998 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.2 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.4 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.834 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 0.52 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.044 HG12 HD21 ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.08 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.875 ' C ' HD23 ' A' ' 440' ' ' LEU . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 0.9 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.653 ' HG3' HD22 ' A' ' 440' ' ' LEU . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.42 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.896 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.42 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 3.52 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.41 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.044 HD21 HG12 ' A' ' 433' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 1.79 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.02 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.859 ' O ' HD13 ' A' ' 443' ' ' ILE . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 0.57 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.903 HD11 HD11 ' A' ' 333' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.05 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.644 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.46 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.11 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.48 109.279 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.154 0.502 . . . . 5.58 110.314 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.01 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.42 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.6 110.413 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.431 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.82 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.923 ' O ' HD13 ' A' ' 323' ' ' ILE . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.14 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 0.53 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.548 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.44 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 1.58 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.0 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.52 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 440' ' ' LEU . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 1.73 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.03 109.645 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 0.9 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 443' ' ' ILE . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.93 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 0.87 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.76 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.72 109.987 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.665 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.894 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 1.58 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.24 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.56 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.36 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 3.81 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 377' ' ' PHE . 8.2 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.84 110.287 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.361 0.6 . . . . 3.25 110.104 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.42 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 3.62 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.4 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.599 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.39 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.18 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 351' ' ' SER . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.36 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.01 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.15 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.665 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 0.61 109.565 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.685 0.755 . . . . 4.16 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 2.86 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.04 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.69 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.05 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.919 HD13 ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.14 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.1 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.12 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.11 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.09 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 1.012 HG11 ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.0 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 4.63 111.371 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 5.79 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.29 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.13 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.74 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.82 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.452 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.25 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.516 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.09 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.23 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.13 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.894 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.26 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 12.3 m-20 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.04 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.919 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.11 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.85 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.33 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 2.69 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.02 109.236 167.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.667 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 1.68 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 1.012 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 2.78 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 1.57 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.578 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.82 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.17 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.703 HG21 HG11 ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.53 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.59 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 0.85 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 0.81 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 2.62 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.48 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 2.43 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.637 HG12 ' C ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.94 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.16 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.53 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.28 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.16 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 3.31 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.23 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.559 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 1.75 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.87 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 439' ' ' VAL . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 0.71 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.81 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.6 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 2.49 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 0.79 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.05 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 30.1 mm100 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.33 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.0 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.24 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.11 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 2.92 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.16 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.07 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.21 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.2 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.4 108.32 165.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 0.52 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.07 HG12 HD21 ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.08 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.639 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 0.9 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.42 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 405' ' ' VAL . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.42 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 3.52 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 416' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.41 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.07 HD21 HG12 ' A' ' 433' ' ' VAL . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 1.79 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.02 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 443' ' ' ILE . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 0.57 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.893 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.05 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.765 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 0.46 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.502 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.11 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.48 109.717 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.043 0.449 . . . . 5.58 110.438 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.42 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.6 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.82 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.09 ' CD1' HD21 ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.14 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 323' ' ' ILE . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.53 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.44 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 1.58 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.0 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.52 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.896 HG11 ' O ' ' A' ' 440' ' ' LEU . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 1.73 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.03 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.9 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.71 HD22 ' HA3' ' A' ' 441' ' ' GLY . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.93 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 0.87 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 0.76 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.72 109.967 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.627 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 1.58 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.24 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.604 ' OG ' HG23 ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.56 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.36 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 3.81 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.84 110.151 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.353 0.597 . . . . 3.25 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.42 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 3.62 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.733 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.4 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.623 HG22 ' OE1' ' A' ' 338' ' ' GLN . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 1.39 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.604 HG23 ' OG ' ' A' ' 341' ' ' SER . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.18 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.36 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.09 HD21 ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.15 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.627 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 0.61 109.864 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 4.16 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.489 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 2.86 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.04 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.69 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.05 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.14 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.1 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.12 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.11 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.09 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 1.015 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.0 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 4.63 111.332 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 5.79 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.29 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.13 110.458 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.74 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.82 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.25 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.531 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.09 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.23 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.446 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.13 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.924 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.26 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.59 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.9 m-20 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.04 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.903 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.11 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.85 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.33 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 2.69 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.02 109.174 167.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.653 HG13 HD11 ' A' ' 339' ' ' LEU . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 1.68 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 1.015 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 2.78 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 1.57 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.657 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.82 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.17 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.653 ' CG2' HG11 ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.53 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.59 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.59 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 0.85 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 0.81 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 2.62 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 2.48 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.535 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 2.43 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.687 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 0.94 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.16 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.53 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.28 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.687 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 1.72 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.16 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.808 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 3.31 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.23 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 1.75 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.87 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 439' ' ' VAL . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 0.71 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.81 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.6 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.983 ' O ' HG23 ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 2.49 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.79 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.05 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 30.1 mm100 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.33 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.0 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.24 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.11 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 2.92 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.16 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.07 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.21 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.963 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.2 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.557 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.4 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.808 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 0.52 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.966 HG12 HD21 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.08 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.652 ' CA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 0.9 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.42 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.42 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 3.52 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.41 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.966 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 1.79 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.71 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.02 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 443' ' ' ILE . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 0.57 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.05 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.46 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.11 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.48 109.635 172.542 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 14.9 mt-30 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.436 -0.579 . . . . 5.58 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.42 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.6 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.466 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.82 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.816 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.14 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.53 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.44 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.746 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 1.58 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.0 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.52 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 1.73 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.567 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.03 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.9 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.93 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.87 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.664 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.76 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.72 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.721 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 1.58 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.946 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.24 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.56 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.36 109.894 174.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 3.81 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.84 110.155 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.437 0.637 . . . . 3.25 110.114 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.42 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 3.62 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.4 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.677 HG12 ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 1.39 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 338' ' ' GLN . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.18 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 351' ' ' SER . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.36 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.946 HD12 ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.15 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.61 109.357 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.803 HH21 HD13 ' A' ' 339' ' ' LEU . 58.8 mtm180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.175 0.512 . . . . 4.16 110.362 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 2.86 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 372' ' ' ALA . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.04 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.69 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.05 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.88 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.14 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.1 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.759 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.12 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.11 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.723 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.09 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 387' ' ' ASN . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.0 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 4.63 111.181 -175.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 5.79 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.29 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.13 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.74 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.82 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.25 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.619 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.09 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.575 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.23 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.633 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.13 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.871 HG22 ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.26 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.562 HD22 HG22 ' A' ' 375' ' ' VAL . 8.2 m-20 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.04 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.88 ' CD1' HD13 ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.11 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.85 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 9.1 t-20 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.33 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 2.69 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.615 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.02 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.871 ' HB ' HG22 ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 1.68 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 2.78 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.886 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 1.57 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.746 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.82 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.17 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.953 ' CG2' HG11 ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.53 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.59 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.619 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 0.85 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.746 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 0.81 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 2.62 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 2.48 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 2.43 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.663 HG12 ' C ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 0.94 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.16 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.53 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 81.0 m-20 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.28 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.663 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 1.72 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.16 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.821 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 3.31 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.23 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 1.75 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.87 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 439' ' ' VAL . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 0.71 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.81 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.6 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.971 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 2.49 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.016 HG13 ' HB2' ' A' ' 430' ' ' PRO . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 0.79 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.05 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.33 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.0 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.24 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.11 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 2.92 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.16 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.07 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.21 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.016 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.2 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.649 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.4 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.821 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 0.52 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.886 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.08 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.807 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 0.9 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.42 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.42 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.527 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 3.52 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 416' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.41 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.881 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 1.79 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.65 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.02 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 443' ' ' ILE . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 0.57 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 442' ' ' VAL . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.05 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.697 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 0.46 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.11 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.48 109.869 176.446 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.094 0.473 . . . . 5.58 110.279 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.951 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.42 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.6 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.82 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.14 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.616 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 0.53 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.44 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 1.58 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.0 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.52 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 1.73 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.03 110.706 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 0.9 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.992 ' HA ' HD12 ' A' ' 440' ' ' LEU . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.93 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 0.87 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 0.76 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 0.72 109.443 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.624 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 386' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 1.58 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.68 ' HB1' ' HA2' ' A' ' 385' ' ' GLY . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.24 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.56 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.36 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 3.81 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.84 110.007 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.325 0.583 . . . . 3.25 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.42 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 3.62 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.4 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 1.39 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.18 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.36 110.481 170.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.951 HD22 ' HB1' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.15 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.61 109.369 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.467 ' HD2' HD22 ' A' ' 339' ' ' LEU . 95.3 mtt-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.373 0.606 . . . . 4.16 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 2.86 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.04 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.69 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.05 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.872 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.14 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.1 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.667 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.12 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.11 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.668 ' CE1' HG21 ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.09 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.0 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 4.63 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 5.79 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.29 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.13 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.74 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.82 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.25 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.656 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.09 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.23 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.68 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.13 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 339' ' ' LEU . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.26 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.4 m-20 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.04 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.11 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.85 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.33 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 2.69 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.514 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.02 109.111 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 339' ' ' LEU . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 1.68 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 2.78 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.613 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 1.57 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.55 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.82 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.17 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 0.53 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.59 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.656 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 0.85 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.81 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 2.62 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 2.48 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 2.43 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 0.94 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.16 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.53 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 8.8 m120 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.28 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.625 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 1.72 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.16 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 3.31 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.23 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 1.75 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.542 ' N ' HG23 ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.87 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 439' ' ' VAL . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.71 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.81 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.6 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 2.49 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 430' ' ' PRO . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 0.79 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.05 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.33 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.0 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.24 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.11 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 2.92 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.16 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.07 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.21 108.916 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 1.029 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.2 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.591 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.4 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.794 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 0.52 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.08 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.811 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 0.9 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.55 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.42 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 405' ' ' VAL . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.42 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 3.52 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 416' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.41 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.992 HD12 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 1.79 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.773 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.02 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.019 ' O ' HD13 ' A' ' 443' ' ' ILE . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 0.57 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 1.019 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.05 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.98 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 0.46 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.11 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.48 109.689 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.086 0.469 . . . . 5.58 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.879 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.42 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.6 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.82 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.674 ' CB ' HD12 ' A' ' 443' ' ' ILE . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.14 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.57 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.53 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.642 ' HB3' HG12 ' A' ' 328' ' ' VAL . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.44 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 1.58 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.0 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.52 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 440' ' ' LEU . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 1.73 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.449 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.03 110.042 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 0.9 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 443' ' ' ILE . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.93 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.67 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 0.87 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.76 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 0.72 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.704 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 1.58 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.24 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 344' ' ' ASP . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.56 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.36 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 3.81 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 341' ' ' SER . 44.1 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.84 110.447 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' SER . 94.1 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.21 0.529 . . . . 3.25 110.148 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.42 109.967 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 354' ' ' ILE . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 3.62 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.609 ' HA ' HD12 ' A' ' 354' ' ' ILE . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.4 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 1.39 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.18 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.36 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.879 HD22 ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.15 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.704 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.61 109.784 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.672 ' NH2' HD13 ' A' ' 339' ' ' LEU . 56.3 mtm180 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.351 0.596 . . . . 4.16 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 2.86 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.04 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.69 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.05 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.912 HD13 ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.14 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.1 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.12 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.525 ' C ' HG11 ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.11 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.09 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.656 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.0 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 4.63 110.959 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.512 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 5.79 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.29 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.13 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.74 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.82 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.25 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.755 ' CE ' HD13 ' A' ' 401' ' ' ILE . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.09 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.23 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.13 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.26 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.9 m-20 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.04 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.912 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.11 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.85 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.33 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 2.69 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.467 ' HE3' ' OD1' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.02 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 435' ' ' GLU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 1.68 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.656 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 2.78 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.884 ' CE ' HD13 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 1.57 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 1.008 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.82 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.17 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.752 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 0.53 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.59 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 0.85 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 1.008 HD11 ' N ' ' A' ' 396' ' ' GLY . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 0.81 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 2.62 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 400' ' ' ALA . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 2.48 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 2.43 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 0.94 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.16 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.53 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.28 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.589 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 1.72 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.16 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 3.31 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.23 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 1.75 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.87 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 439' ' ' VAL . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 0.71 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.81 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.6 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 2.49 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.847 HG13 ' HB2' ' A' ' 430' ' ' PRO . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 0.79 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.05 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 82.6 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.33 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.0 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.24 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.11 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 2.92 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.16 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.07 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.21 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.847 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.2 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.884 HD13 ' CE ' ' A' ' 395' ' ' LYS . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.4 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 0.52 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.08 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.725 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 0.9 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.726 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.42 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.821 ' O ' HG13 ' A' ' 405' ' ' VAL . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.42 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 3.52 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 416' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.41 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 1.79 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.02 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.84 ' O ' HD13 ' A' ' 443' ' ' ILE . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 0.57 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.05 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.776 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.46 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.11 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp . . . . . 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.48 109.307 170.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 21.4 pt20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.082 0.467 . . . . 5.58 109.941 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.42 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.6 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.82 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.699 ' CB ' HD12 ' A' ' 443' ' ' ILE . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.14 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.549 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 0.53 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.654 ' HB3' HG12 ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.44 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 1.58 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.0 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.52 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 440' ' ' LEU . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 1.73 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.462 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.03 110.137 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.9 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 443' ' ' ILE . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.93 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 0.87 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.76 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.417 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.72 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 1.58 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.24 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.495 ' HA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.56 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.36 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.425 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 3.81 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.84 110.486 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.356 0.598 . . . . 3.25 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.42 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 3.62 109.998 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 354' ' ' ILE . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.4 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 1.39 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.455 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.18 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 351' ' ' SER . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.36 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.15 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 0.61 109.559 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.326 0.584 . . . . 4.16 109.883 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 2.86 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.04 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.69 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.05 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.14 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.1 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.12 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.576 ' C ' HG11 ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.11 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CD1' HG21 ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.09 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.0 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 4.63 111.118 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 5.79 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.29 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.13 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.74 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.82 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.544 ' CD ' ' HB3' ' A' ' 397' ' ' SER . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.25 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.804 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.09 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.592 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.13 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.927 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.26 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.43 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 46.0 m-20 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.04 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.066 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.11 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.85 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.33 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.604 ' O ' HG22 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 2.69 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.491 ' O ' HD13 ' A' ' 393' ' ' ILE . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.02 109.603 173.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 1.68 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 2.78 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.873 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 1.57 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.548 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.82 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.17 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.902 ' CG2' HG11 ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 0.53 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.59 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 0.85 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.81 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.503 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 2.62 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 2.48 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 2.43 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 0.94 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.16 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.53 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.28 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 1.72 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.16 110.254 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.83 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 3.31 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.23 110.595 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 1.75 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.87 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 439' ' ' VAL . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 0.71 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.81 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.6 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 2.49 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 0.79 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.05 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.33 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.24 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.11 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 2.92 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.16 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.07 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.21 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.2 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.546 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.4 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.83 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 0.52 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.13 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.08 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 0.9 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.42 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.553 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.42 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 3.52 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 416' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.41 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.13 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 1.79 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.542 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.02 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.862 ' O ' HD13 ' A' ' 443' ' ' ILE . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 0.57 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.05 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 0.46 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.11 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.48 109.662 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.074 0.464 . . . . 5.58 110.173 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.125 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.42 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.6 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.82 110.854 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.036 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.14 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' PHE . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 0.53 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.557 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.44 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 1.58 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.0 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.52 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.91 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 1.73 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.03 110.277 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 0.9 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 440' ' ' LEU . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.93 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 1.036 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 0.87 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 0.76 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 0.72 110.412 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.799 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 1.58 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.24 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.564 ' OG ' HG23 ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.56 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.36 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 3.81 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.84 110.232 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.339 0.59 . . . . 3.25 110.137 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.487 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.42 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 3.62 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.4 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.682 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 1.39 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.564 HG23 ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.18 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 351' ' ' SER . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.36 110.677 171.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.125 HD12 ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.15 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.799 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 0.61 109.246 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.578 ' CZ ' HD13 ' A' ' 339' ' ' LEU . 28.4 ptt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.335 0.588 . . . . 4.16 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 2.86 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' A' ' 372' ' ' ALA . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.04 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.69 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.05 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.937 HD13 ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.14 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.1 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.956 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.12 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.11 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.09 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.955 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.0 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 4.63 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 5.79 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.29 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.13 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.74 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.82 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.47 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.25 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.505 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.09 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.23 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.13 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.799 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.26 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.632 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 7.7 m-20 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.04 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.937 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.11 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.85 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.33 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 2.69 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.02 109.165 167.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.606 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 1.68 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.955 ' NH1' HG11 ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 2.78 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 1.57 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.608 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.82 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.17 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.722 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 0.53 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.59 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 397' ' ' SER . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 0.85 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 0.81 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 2.62 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 2.48 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.559 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 2.43 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.66 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 0.94 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.16 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.53 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.28 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.66 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 1.72 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.16 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.822 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 3.31 109.985 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.23 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 1.75 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.87 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.71 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.81 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.6 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.979 ' O ' HG23 ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 2.49 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 430' ' ' PRO . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 0.79 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.05 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.33 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.979 HG23 ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.0 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.24 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.11 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 2.92 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.16 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.07 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.21 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.97 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.2 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.559 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.4 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.822 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 0.52 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.08 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 0.9 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.42 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 405' ' ' VAL . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.42 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 3.52 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.41 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.91 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 1.79 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.709 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.02 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.898 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 0.57 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.05 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.694 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.46 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.11 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.48 109.71 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 46.0 mm-40 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.472 -0.566 . . . . 5.58 109.472 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.844 ' HB2' HG13 ' A' ' 352' ' ' ILE . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.42 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.6 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.82 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.037 ' O ' HD13 ' A' ' 323' ' ' ILE . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.14 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 1.037 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 0.53 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.44 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.891 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 1.58 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.0 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.52 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.918 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 1.73 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.528 ' N ' ' HG3' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.03 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 0.9 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 323' ' ' ILE . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.93 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 0.87 109.762 -176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 0.76 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.72 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.644 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 1.58 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.785 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.24 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.895 ' OG ' HG22 ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.56 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.36 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.482 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 3.81 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.84 110.078 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.443 0.64 . . . . 3.25 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.879 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.42 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 3.62 109.535 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.4 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 319' ' ' ALA . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 1.39 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.895 HG22 ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.18 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 351' ' ' SER . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.36 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 319' ' ' ALA . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.15 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.644 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 0.61 109.477 174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.372 0.606 . . . . 4.16 110.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 2.86 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.661 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.04 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.69 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.05 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.892 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.14 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.1 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.12 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.519 ' C ' HG11 ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.11 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.09 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.0 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 4.63 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 5.79 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.29 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.13 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.74 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.82 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.25 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.617 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.09 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.23 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.13 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.26 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.2 m-20 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.04 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.892 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.11 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.85 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.33 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 2.69 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.409 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.02 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 340' ' ' ALA . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 1.68 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 2.78 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.839 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 1.57 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.545 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.82 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.17 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.844 HG21 ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.53 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.59 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.85 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 0.81 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 2.62 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 2.48 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.526 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 2.43 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 437' ' ' SER . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.94 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.16 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.53 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 80.2 m-20 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.28 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.602 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 1.72 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.429 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.16 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.801 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 3.31 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.23 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 1.75 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.87 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 0.71 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.81 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.6 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.985 ' O ' HG23 ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 2.49 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.844 ' CG1' HG21 ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.79 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.05 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 29.9 mm100 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.33 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 419' ' ' LYS . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.0 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.24 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.11 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 2.92 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.16 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.07 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.21 108.992 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.2 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.559 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.4 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.801 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 0.52 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.99 HG12 HD21 ' A' ' 440' ' ' LEU . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.08 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 0.9 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.719 ' HG2' HD13 ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.42 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 405' ' ' VAL . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.42 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 3.52 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.41 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.99 HD21 HG12 ' A' ' 433' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 1.79 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.776 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.02 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.831 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 0.57 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.05 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.962 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 0.46 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.11 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 38.3 tttp . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.48 109.645 174.634 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.063 0.458 . . . . 5.58 110.231 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.091 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.42 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.6 110.653 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.82 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.654 ' HB3' HD12 ' A' ' 443' ' ' ILE . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.14 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.8 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 0.53 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.44 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 1.58 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.0 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.52 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 440' ' ' LEU . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 1.73 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.03 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.9 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 323' ' ' ILE . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 0.93 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 0.87 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.76 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.432 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 0.72 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.618 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 335' ' ' ASP . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 1.58 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.24 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.56 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.36 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 3.81 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.84 110.053 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.264 0.555 . . . . 3.25 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.42 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 3.62 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.741 ' HA ' HD12 ' A' ' 354' ' ' ILE . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.4 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.619 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.39 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.18 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 351' ' ' SER . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.36 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.091 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.15 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 0.61 109.998 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 339' ' ' LEU . 57.7 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.398 0.618 . . . . 4.16 109.975 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 2.86 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.75 HG21 ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.04 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.69 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.495 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.05 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.14 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.1 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.728 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.12 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.11 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.75 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.09 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.963 HG11 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.0 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 4.63 111.244 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.521 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 5.79 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.29 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.13 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.74 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.82 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.25 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.738 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.09 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.23 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.13 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.622 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.26 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.507 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.8 m-20 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.04 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.11 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.85 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.33 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 2.69 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.02 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.705 HD13 ' HG2' ' A' ' 435' ' ' GLU . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 1.68 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.963 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 2.78 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.825 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.57 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.65 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.82 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.587 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.17 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.764 ' CG2' HG11 ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.53 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.59 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.738 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 0.85 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.65 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 0.81 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 2.62 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 2.48 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' HIS . . . . . 0.528 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 2.43 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 437' ' ' SER . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 0.94 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.16 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.53 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 80.8 m-20 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.28 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 1.72 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.16 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.8 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 3.31 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.23 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 1.75 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.87 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 439' ' ' VAL . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 0.71 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.81 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.6 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.975 ' O ' HG23 ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 2.49 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.764 HG11 ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 0.79 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.05 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.535 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.33 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.976 HG13 ' CB ' ' A' ' 444' ' ' ALA . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.0 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.24 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.535 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.11 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 2.92 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.16 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.07 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.21 109.275 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.764 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.2 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.648 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.4 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 0.52 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.915 HG12 HD21 ' A' ' 440' ' ' LEU . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.08 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 0.9 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.705 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.42 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.42 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 3.52 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.41 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 433' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 1.79 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.02 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 0.57 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 322' ' ' PHE . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.05 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.976 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 0.46 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.11 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.48 109.52 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 16.6 mt-30 . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.659 -0.497 . . . . 5.58 109.659 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.42 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.6 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.525 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.82 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 1.048 ' O ' HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.14 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 0.53 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.556 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.44 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 1.58 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.0 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.52 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 1.73 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.481 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.03 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.9 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.985 HD22 ' O ' ' A' ' 323' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.93 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 0.87 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.618 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.457 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.76 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 0.72 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.677 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.95 HD11 HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 1.58 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.24 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.56 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.36 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 3.81 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 2.5 p30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.84 110.228 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.415 0.626 . . . . 3.25 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.42 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 3.62 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.744 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.4 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.64 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 1.39 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.18 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 351' ' ' SER . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.36 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.15 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.677 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 0.61 109.841 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.356 0.598 . . . . 4.16 109.788 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 2.86 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.04 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.69 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.05 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 388' ' ' ILE . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.14 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.1 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.795 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.12 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.599 ' C ' HG11 ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.11 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.643 ' CD1' HG21 ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.09 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.84 HG11 ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.0 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 4.63 110.999 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 5.79 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.29 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.13 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.74 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.82 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.494 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.25 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.515 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.09 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.13 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 339' ' ' LEU . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.26 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.04 109.06 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.059 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.11 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 1.059 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.85 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.33 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 2.69 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 393' ' ' ILE . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.02 109.453 168.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.95 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 1.68 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.84 ' NH1' HG11 ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 2.78 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.929 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 1.57 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.698 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.82 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.17 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.892 HG21 ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.53 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.59 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 0.85 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.698 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 0.81 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 2.62 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 2.48 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 2.43 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.641 HG12 ' C ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.94 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.16 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.53 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 83.0 m-20 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.28 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.641 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 1.72 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.16 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.811 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 3.31 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.23 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 1.75 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.87 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 439' ' ' VAL . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 0.71 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.81 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.6 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 2.49 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.892 ' CG1' HG21 ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.79 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.05 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.33 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.0 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.24 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.11 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 2.92 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.16 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.07 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.21 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.661 ' HA ' HG11 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.2 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.6 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.4 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 0.52 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.929 HG22 ' HG3' ' A' ' 395' ' ' LYS . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.08 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 0.9 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.42 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 405' ' ' VAL . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.42 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 3.52 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 416' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.41 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.923 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 1.79 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.799 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.02 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.889 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 0.57 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.964 ' CD1' HD21 ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.05 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 0.804 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 0.46 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.11 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.48 109.291 172.763 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 15.5 mt-30 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.403 -0.592 . . . . 5.58 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.42 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' SER . . . . . 0.594 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.6 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.82 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.652 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.14 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.53 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.44 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.698 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 1.58 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.0 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.52 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 1.73 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 332' ' ' THR . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.431 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.03 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.9 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 443' ' ' ILE . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.93 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 0.87 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 0.76 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 0.72 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' GLN . . . . . 0.669 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 339' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 1.58 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.24 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.56 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.36 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 3.81 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.1 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.84 110.186 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 351' ' ' SER . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.346 0.593 . . . . 3.25 110.102 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.42 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 3.62 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.589 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.4 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 1.39 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.18 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 351' ' ' SER . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.36 110.27 169.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.15 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 0.61 109.726 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.58 0.705 . . . . 4.16 110.245 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 2.86 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.927 HG13 ' HB3' ' A' ' 372' ' ' ALA . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.04 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.69 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.05 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.883 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.14 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.1 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ALA . . . . . 0.927 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.12 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.11 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.09 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.0 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 4.63 111.354 -175.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 5.79 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.29 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.13 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.74 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.82 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.25 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' MET . . . . . 0.62 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.09 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.23 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.13 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.26 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ASN . . . . . 0.587 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.4 m-20 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.04 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.883 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.11 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.85 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.33 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 2.69 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.02 109.069 167.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 1.68 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.78 110.393 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.881 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 1.57 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLY . . . . . 0.733 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.82 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.17 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.748 ' CG2' HG11 ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 0.53 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.59 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ALA . . . . . 0.62 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 0.85 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.733 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 0.81 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 2.62 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 2.48 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 2.43 110.723 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.583 HG12 ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.94 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.16 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.53 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.548 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 81.4 m-20 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.28 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.583 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 1.72 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.16 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.772 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 3.31 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.23 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 1.75 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ASP . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 419' ' ' LYS . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.87 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 439' ' ' VAL . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 0.71 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.81 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.6 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.995 ' O ' HG23 ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 2.49 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 430' ' ' PRO . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.79 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 424' ' ' ALA . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.05 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.33 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 1.01 HG13 ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.0 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.24 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ARG . . . . . 0.513 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.11 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 2.92 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.16 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.07 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.21 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.816 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.2 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.451 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.4 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 0.52 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.08 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 439' ' ' VAL . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 0.9 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.546 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.42 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.42 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ARG . . . . . 0.531 ' NH2' ' HB3' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 3.52 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 416' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.41 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 1.79 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.588 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.02 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.837 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.57 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.837 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.05 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ALA . . . . . 1.01 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.46 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.11 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm . . . . . 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.48 109.679 173.96 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.665 ' OD1' HG21 ' A' ' 449' ' ' VAL . 9.9 m120 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.243 0.544 . . . . 6.08 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -133.67 137.47 45.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 5.83 110.243 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 -137.01 140.22 41.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.847 . . . . 5.58 110.12 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.42 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.6 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.465 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.82 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.733 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.14 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.802 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.53 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.565 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.44 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.778 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 1.58 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.0 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.52 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 1.73 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.574 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.03 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.9 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.825 ' HA ' HD12 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 0.93 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.591 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 0.87 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.76 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.72 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 1.58 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.24 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.56 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.502 HD11 ' H ' ' A' ' 365' ' ' ARG . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.36 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 3.81 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -80.24 138.0 36.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.84 110.112 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 6.69 48.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 2.99 110.334 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 42.8 p -77.65 145.28 70.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 2.07 110.1 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.84 -33.97 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.955 1.502 . . . . 2.38 110.221 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.13 -37.51 87.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 3.25 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.42 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 3.62 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.751 ' HA ' HD12 ' A' ' 354' ' ' ILE . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.4 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.699 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 1.39 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.18 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 351' ' ' SER . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.36 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 319' ' ' ALA . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.15 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.95 -36.61 83.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.61 109.743 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 361' ' ' ASN . 17.9 tptm -53.16 -55.79 21.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.846 -1.159 . . . . 1.16 110.651 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -66.84 -40.85 88.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.716 -1.24 . . . . 1.9 109.915 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 55.2 mmm-85 -68.98 -40.48 78.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 2.63 111.425 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.789 ' HB3' HD11 ' A' ' 362' ' ' LEU . 91.0 m-85 -115.96 -14.71 11.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.804 -1.185 . . . . 3.32 110.275 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.7 t30 60.42 50.13 6.26 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.747 0.784 . . . . 1.9 110.216 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.3 mt -113.28 178.24 4.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.786 -0.571 . . . . 2.8 109.85 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -118.3 157.12 27.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.97 -1.081 . . . . 4.4 110.961 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.468 ' OE2' HG11 ' A' ' 353' ' ' VAL . 96.1 mt-10 -54.95 150.36 10.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.24 109.747 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 -95.53 135.05 37.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.05 . . . . 4.16 109.914 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 2.86 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.04 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.69 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.05 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.14 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.1 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.12 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.488 ' N ' HG13 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.11 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.09 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.969 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.0 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 4.63 111.268 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.567 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 5.79 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.29 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.13 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.74 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.82 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.25 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.715 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.09 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.23 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.13 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.26 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.597 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.2 m-20 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.04 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.11 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.85 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.33 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 2.69 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.476 ' HE3' ' OD1' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.02 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 339' ' ' LEU . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 1.68 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.969 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 2.78 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 1.57 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.602 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.82 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.17 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 0.53 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.59 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 0.85 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.602 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 0.81 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 2.62 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 2.48 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.514 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 2.43 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.619 HG12 ' C ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 0.94 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.16 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.53 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.28 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.619 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 1.72 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.16 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 3.31 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.23 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 1.75 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.554 ' N ' HG23 ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.87 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 439' ' ' VAL . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 0.71 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.81 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.6 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 2.49 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.017 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 0.79 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.05 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.33 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.0 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.24 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.538 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.11 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 2.92 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.16 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.07 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.21 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.017 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.2 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.902 HD21 " O2'" ' A' 1001 ' ' ANP . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.4 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 0.52 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.08 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.79 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 0.9 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.515 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.42 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.42 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 3.52 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 416' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.41 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.79 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.02 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 443' ' ' ILE . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 0.57 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.05 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.46 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.11 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 447' ' ' ASP . 0.0 OUTLIER -84.84 145.76 27.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.48 109.511 170.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 446' ' ' LYS . 32.9 p30 -95.9 116.5 29.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.294 -0.879 . . . . 3.91 110.093 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 316' ' ' ASN . 62.9 mt -57.1 -45.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.88 . . . . 3.61 109.607 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.665 HG21 ' OD1' ' A' ' 316' ' ' ASN . 59.6 t -98.48 134.37 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 5.09 110.196 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -91.64 133.12 35.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 7.5 110.191 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.97 -1.461 . . . . 7.3 109.563 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.902 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.493 ' N ' ' HB ' ' A' ' 448' ' ' ILE . 30.7 t30 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.253 0.549 . . . . 6.08 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.65 140.42 49.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 5.83 110.274 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.491 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 -147.04 155.74 42.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 5.58 110.147 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.993 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.42 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.75 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.6 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.82 110.881 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.807 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.14 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 0.53 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.44 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.733 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 1.58 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.0 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.52 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 1.73 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.03 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.9 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 441' ' ' GLY . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 0.93 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 0.87 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' HD23 ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 0.76 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 0.72 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.768 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.755 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 1.58 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.24 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.56 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.36 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 3.81 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.7 p30 -99.07 140.87 32.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.84 110.161 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.25 7.16 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 2.99 110.129 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.4 p -77.05 144.16 71.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 2.07 110.013 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.3 -32.08 96.16 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.978 1.515 . . . . 2.38 110.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.535 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 98.2 mt-10 -64.5 -39.29 93.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 3.25 110.169 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.42 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 3.62 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.4 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.639 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 1.39 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.882 HG13 ' CD ' ' A' ' 364' ' ' GLU . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.18 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 351' ' ' SER . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.36 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.993 HD22 ' HB1' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.15 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.768 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -62.82 -37.21 85.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 0.61 109.388 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.1 tptm -58.54 -51.79 68.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.777 -1.202 . . . . 1.16 110.784 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 13.0 pt20 -65.98 -39.02 90.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.534 -1.354 . . . . 1.9 109.773 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.519 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 33.4 mmt180 -68.7 -46.32 69.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 2.63 111.421 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 362' ' ' LEU . 62.6 m-85 -116.18 -14.93 11.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.694 -1.254 . . . . 3.32 110.582 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 357' ' ' LYS . 20.7 t30 60.19 50.14 6.65 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.84 . . . . 1.9 109.883 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.7 mt -106.99 179.68 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.704 -0.622 . . . . 2.8 109.931 -176.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -111.75 154.62 24.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.033 . . . . 4.4 110.046 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.882 ' CD ' HG13 ' A' ' 353' ' ' VAL . 69.4 mm-40 -76.38 167.38 21.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 2.24 110.006 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 -105.71 129.19 53.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 4.16 110.569 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 2.86 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.04 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.69 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.05 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.14 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.1 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.775 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.12 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.11 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.09 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 1.008 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.0 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 4.63 111.207 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 5.79 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.29 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.13 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.74 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.82 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.55 ' HG3' " O4'" ' A' 1001 ' ' ANP . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.25 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.809 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.09 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.23 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.13 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.26 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.568 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.0 m-20 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.04 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.11 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.85 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.33 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 2.69 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.424 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.02 109.09 166.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.553 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 1.68 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 1.008 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 2.78 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.872 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 1.57 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.648 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.82 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.17 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.867 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 0.53 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.59 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.809 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.85 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.648 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 0.81 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 2.62 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 2.48 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.657 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 61.7 t60 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 2.43 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.638 HG12 ' C ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 0.94 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.16 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.53 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.533 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 79.1 m-20 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.28 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.638 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 1.72 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.16 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 3.31 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.23 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 1.75 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.87 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 439' ' ' VAL . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 0.71 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.81 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 83.7 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.6 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.988 ' O ' HG23 ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 2.49 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.904 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 0.79 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.05 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 30.1 mm100 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.33 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.0 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.24 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.11 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 2.92 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.16 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.07 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.21 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.904 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.2 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.871 HD21 " C2'" ' A' 1001 ' ' ANP . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.4 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 0.52 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.931 HG12 HD21 ' A' ' 440' ' ' LEU . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.08 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 0.9 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.42 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.42 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 3.52 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.41 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.931 HD21 HG12 ' A' ' 433' ' ' VAL . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 1.79 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.02 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.904 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 0.57 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.05 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.812 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 0.46 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.11 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -84.75 141.52 30.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.48 110.022 172.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 36.9 p-10 -95.98 114.5 26.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.836 -0.746 . . . . 3.91 110.155 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 0.8 OUTLIER -56.13 -43.7 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 3.61 109.646 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 316' ' ' ASN . 47.8 t -98.6 134.49 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 5.09 110.153 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -91.97 133.05 36.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 7.5 110.152 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 CA-C-O 118.021 -1.433 . . . . 7.3 109.541 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.871 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 40.2 t-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.098 0.475 . . . . 6.08 110.163 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 446' ' ' LYS . 65.7 mtt85 -124.19 137.58 54.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 5.83 110.515 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.524 ' NE2' HD11 ' A' ' 448' ' ' ILE . 25.5 mt-30 -129.17 143.83 51.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.467 -0.771 . . . . 5.58 109.234 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.012 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.42 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.613 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.6 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.82 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.14 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.554 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 0.53 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.558 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.44 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 1.58 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.0 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.52 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 1.73 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.03 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.9 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 441' ' ' GLY . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 0.93 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.87 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.536 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.435 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.76 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 0.72 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 1.086 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 2.8 mp0 -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 1.58 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.24 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.56 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 365' ' ' ARG . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.36 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 3.81 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -96.06 137.59 34.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.84 110.126 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.37 7.4 46.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 2.99 110.356 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.785 HG21 ' CD2' ' A' ' 377' ' ' PHE . 24.7 p -74.08 141.02 77.43 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 2.07 110.143 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.7 Cg_exo -57.07 -38.87 94.63 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.027 1.541 . . . . 2.38 110.246 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.575 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 96.9 mt-10 -63.84 -34.73 78.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 3.25 110.081 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.42 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 3.62 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.4 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 319' ' ' ALA . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 1.39 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.18 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.36 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.012 HD22 ' HB1' ' A' ' 319' ' ' ALA . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.15 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 1.086 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -63.03 -38.27 90.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 0.61 109.478 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.1 mttt -60.1 -46.88 88.1 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.522 -1.271 . . . . 1.16 110.459 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 11.0 pt20 -64.03 -38.65 91.86 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.358 -1.464 . . . . 1.9 109.938 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.484 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 40.8 mmt180 -76.76 -44.28 33.63 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 2.63 111.518 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.712 ' HB3' HD11 ' A' ' 362' ' ' LEU . 88.3 m-85 -115.73 -13.8 11.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.864 -1.147 . . . . 3.32 110.132 -174.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.6 t30 60.55 50.06 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.869 0.842 . . . . 1.9 110.285 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.3 mt -115.08 177.93 4.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.858 -0.526 . . . . 2.8 109.662 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -122.66 159.48 27.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 4.4 110.993 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.4 pt-20 -53.06 154.27 3.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.68 -0.638 . . . . 2.24 109.918 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.644 ' H ' HD11 ' A' ' 342' ' ' LEU . 92.6 mtt-85 -99.83 135.76 40.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.065 . . . . 4.16 110.028 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 2.86 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 372' ' ' ALA . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.04 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.69 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.05 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.856 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.14 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.1 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.976 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.12 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.11 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.703 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.09 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 1.028 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.0 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 4.63 111.355 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 5.79 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.29 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.13 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.74 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.82 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.25 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.583 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.09 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.439 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.13 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.26 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.552 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 7.8 m-20 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.04 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.856 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.11 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.33 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 2.69 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.02 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 1.68 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 1.028 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 2.78 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.844 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 1.57 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.82 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.17 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.53 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.59 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 0.85 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 0.81 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 2.62 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 2.48 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 2.43 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 0.94 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.16 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.53 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.28 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.632 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 1.72 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.16 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.792 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 3.31 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.23 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 1.75 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.87 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 439' ' ' VAL . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.71 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.81 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.6 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 2.49 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 0.79 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.05 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.33 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.0 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.24 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.11 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 2.92 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.16 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.07 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.21 108.985 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.828 ' HB2' HG13 ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.2 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.723 HD21 " H2'" ' A' 1001 ' ' ANP . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.4 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 0.52 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.996 HG12 HD21 ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.08 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.728 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 0.9 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.688 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.42 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.748 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.42 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 3.52 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 416' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.41 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.996 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 1.79 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.02 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.666 HG11 ' HA ' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 0.57 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.05 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.916 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 0.46 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.11 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' ARG . 75.8 tttt -90.2 141.57 28.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.48 109.604 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 34.1 p30 -95.88 130.42 42.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.33 -0.856 . . . . 3.91 110.492 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.524 HD11 ' NE2' ' A' ' 318' ' ' GLN . 4.3 mm -55.13 -47.83 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.116 -0.99 . . . . 3.61 109.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.89 136.09 35.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.258 0.551 . . . . 5.09 110.324 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.482 ' HD3' ' OD2' ' A' ' 447' ' ' ASP . 14.4 tptm -144.14 130.21 19.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 7.5 110.122 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 CA-C-O 118.034 -1.425 . . . . 7.3 109.54 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.723 " H2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 448' ' ' ILE . 20.7 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.562 . . . . 6.08 110.122 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.439 ' NH1' ' O2A' ' A' 1001 ' ' ANP . 98.3 mtt180 -128.43 140.51 51.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 5.83 110.36 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.502 ' OE1' HD11 ' A' ' 448' ' ' ILE . 14.3 pt20 -140.58 145.52 36.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.428 -0.795 . . . . 5.58 110.149 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.42 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.6 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.82 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.78 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.14 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.824 ' C ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.53 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.44 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 1.58 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.0 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.52 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 1.73 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.03 110.51 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 0.9 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.974 HD13 ' HA3' ' A' ' 441' ' ' GLY . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.93 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.87 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.595 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.641 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 0.76 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.63 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 0.72 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.757 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 386' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 1.58 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.24 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.56 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.36 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 3.81 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -78.47 138.34 38.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.84 110.107 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.51 6.66 48.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 2.99 110.294 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.523 HG21 ' CD2' ' A' ' 377' ' ' PHE . 25.4 p -76.07 144.2 75.12 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 2.07 110.099 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.66 -34.47 96.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.912 1.48 . . . . 2.38 110.166 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.17 -35.51 81.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 3.25 110.142 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.42 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 3.62 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 354' ' ' ILE . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.4 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.642 HG22 ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 1.39 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.562 HG11 ' OE2' ' A' ' 364' ' ' GLU . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.18 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 351' ' ' SER . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.36 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.15 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.757 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.57 -37.27 86.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.61 109.58 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 21.3 tptm -54.34 -54.81 35.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.845 -1.159 . . . . 1.16 110.677 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.506 ' HG3' ' HG3' ' A' ' 359' ' ' ARG . 19.3 pt20 -67.15 -41.62 85.75 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.525 -1.36 . . . . 1.9 110.084 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.624 ' HD2' ' CE2' ' A' ' 322' ' ' PHE . 90.9 mtt-85 -71.05 -39.04 72.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.63 111.888 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.672 ' HB3' HD11 ' A' ' 362' ' ' LEU . 57.2 m-85 -115.96 -14.39 11.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.671 -1.268 . . . . 3.32 110.409 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.29 50.22 6.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.89 0.852 . . . . 1.9 110.213 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 360' ' ' PHE . 24.8 mt -107.02 172.63 6.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.567 -0.531 . . . . 2.8 109.567 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -118.92 150.36 40.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.788 -1.195 . . . . 4.4 110.273 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.562 ' OE2' HG11 ' A' ' 353' ' ' VAL . 95.7 mt-10 -57.11 148.74 21.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 2.24 109.503 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.548 ' CZ ' HD22 ' A' ' 339' ' ' LEU . 10.8 ptp180 -98.76 134.8 41.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.971 -1.081 . . . . 4.16 110.317 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.491 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 2.86 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 372' ' ' ALA . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.04 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.69 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.05 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.14 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.1 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.895 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.12 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.11 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.655 ' CE1' HG21 ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.09 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.521 ' N ' ' HB1' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.0 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 4.63 111.119 -175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.523 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 5.79 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.29 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.13 110.528 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.74 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.82 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.25 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.606 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.09 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.629 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.23 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.445 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.13 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 339' ' ' LEU . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.26 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.408 HD22 HG22 ' A' ' 375' ' ' VAL . 9.6 m-20 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.04 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.11 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.85 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.33 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 2.69 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.695 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.02 109.317 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.846 HG13 HD11 ' A' ' 339' ' ' LEU . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 1.68 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 2.78 110.069 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 1.021 ' HD3' HD13 ' A' ' 431' ' ' LEU . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 1.57 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.788 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.82 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.585 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.17 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.042 HG21 HG11 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.53 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.59 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 0.85 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.788 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 0.81 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 2.62 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 2.48 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 2.43 110.722 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.611 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 0.94 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.16 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.53 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.28 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.611 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 1.72 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.16 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 3.31 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.23 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 1.75 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 418' ' ' GLN . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.87 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 439' ' ' VAL . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 0.71 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.81 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 415' ' ' ASP . 13.5 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.6 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 2.49 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.042 HG11 HG21 ' A' ' 398' ' ' VAL . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.79 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.05 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.33 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.0 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.24 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.11 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 2.92 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.16 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.07 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.21 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.014 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.2 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 1.021 HD13 ' HD3' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.4 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 0.52 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.7 HG12 HD21 ' A' ' 440' ' ' LEU . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.08 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 0.9 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.42 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.42 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.524 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 3.52 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 416' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.41 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.879 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 1.79 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.974 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.02 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.755 ' CG1' HG22 ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 0.57 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 322' ' ' PHE . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.05 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 0.46 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.11 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -89.01 144.17 26.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.48 109.382 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -95.86 137.29 35.14 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.08 -1.013 . . . . 3.91 110.284 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.502 HD11 ' OE1' ' A' ' 318' ' ' GLN . 5.5 mm -57.99 -50.09 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 3.61 109.679 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.68 134.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.187 0.518 . . . . 5.09 110.274 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -144.89 130.44 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 7.5 110.135 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 7.3 109.526 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.632 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.472 ' O ' HD13 ' A' ' 448' ' ' ILE . 16.0 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.332 0.587 . . . . 6.08 110.294 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -41.95 141.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 5.83 110.417 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 -148.56 140.39 23.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.521 -0.737 . . . . 5.58 110.384 -176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.42 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.6 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.411 ' OE2' HD11 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.82 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.033 ' CD1' HD21 ' A' ' 355' ' ' LEU . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.14 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.53 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.44 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.802 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 1.58 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.0 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.52 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.909 HG11 ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 1.73 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.546 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.578 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.03 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.9 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 443' ' ' ILE . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.93 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.804 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 0.87 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 0.76 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 0.72 110.099 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.656 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 1.58 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.24 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.56 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.606 HD11 ' H ' ' A' ' 365' ' ' ARG . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.36 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 3.81 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -77.47 137.87 38.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.84 110.007 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.34 6.72 48.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 2.99 110.291 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.805 HG21 ' CD2' ' A' ' 377' ' ' PHE . 43.7 p -76.69 142.66 70.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 2.07 110.055 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.447 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 10.8 Cg_endo -59.23 -35.23 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.98 1.516 . . . . 2.38 110.134 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.574 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -63.98 -35.96 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 3.25 110.136 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.42 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 3.62 109.444 171.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.762 ' HA ' HD12 ' A' ' 354' ' ' ILE . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.4 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.613 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 1.39 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.18 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.36 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.15 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 1.033 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -65.32 -36.68 84.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 0.61 109.634 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 46.1 tptt -58.57 -49.09 78.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.92 -1.112 . . . . 1.16 110.805 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 12.2 pt20 -65.15 -39.45 92.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.455 -1.403 . . . . 1.9 109.696 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -73.79 -46.26 46.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 2.63 111.522 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.807 ' HB2' HD23 ' A' ' 362' ' ' LEU . 72.9 m-85 -116.15 -15.0 11.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.638 -1.289 . . . . 3.32 110.454 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.5 t-20 58.39 41.23 23.3 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.543 -0.723 . . . . 1.9 109.952 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 1.033 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.51 -176.6 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.681 -0.637 . . . . 2.8 109.787 175.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -124.36 151.89 43.82 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.124 -0.985 . . . . 4.4 109.886 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.71 148.87 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 2.24 109.394 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.606 ' H ' HD11 ' A' ' 342' ' ' LEU . 25.3 ttm180 -96.79 142.09 29.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.004 -1.06 . . . . 4.16 109.997 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 2.86 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.731 HG21 ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.04 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.69 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.05 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.14 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.1 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.12 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.11 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.731 ' CE1' HG21 ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.09 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.654 HG23 ' HA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.0 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 4.63 111.331 -175.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 5.79 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.29 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.13 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.74 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.82 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.25 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.575 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.09 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.436 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.13 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.26 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.606 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.4 m-20 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.04 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.891 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.11 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.85 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.33 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 2.69 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.02 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.706 HD13 ' HG2' ' A' ' 435' ' ' GLU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 1.68 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 2.78 110.419 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 1.57 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.67 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.82 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.17 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.845 HG21 ' CG1' ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.53 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.59 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.85 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.67 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 0.81 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 2.62 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 2.48 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 2.43 110.58 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 437' ' ' SER . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.94 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.16 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.53 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.28 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.61 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 1.72 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.16 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.828 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 3.31 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.23 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 1.75 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.87 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 439' ' ' VAL . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 0.71 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.81 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.6 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 2.49 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 0.79 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.05 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 30.2 mm100 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.33 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.0 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.24 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.11 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 2.92 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.16 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.07 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.21 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.669 ' HA ' HG11 ' A' ' 423' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.2 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.823 HD21 " O2'" ' A' 1001 ' ' ANP . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.4 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.766 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 0.52 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.123 HG12 HD21 ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.08 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.743 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.9 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.706 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.42 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.42 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 3.52 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 416' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.41 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.123 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 1.79 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.661 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.02 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.817 ' O ' HD13 ' A' ' 443' ' ' ILE . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 0.57 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.05 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.773 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.46 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.11 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -86.71 139.44 30.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.48 109.162 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -95.93 129.65 43.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.15 -0.969 . . . . 3.91 110.532 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -59.08 -49.12 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 3.61 109.536 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.3 t -101.69 134.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 5.09 110.234 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -93.15 145.26 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 7.5 110.202 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.003 -1.443 . . . . 7.3 109.507 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.823 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 84.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.154 0.502 . . . . 6.08 110.187 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.9 137.71 52.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.97 . . . . 5.83 110.449 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 -136.45 144.42 44.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.434 -0.791 . . . . 5.58 109.837 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.42 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.6 110.564 175.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.508 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.82 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.864 ' CD2' ' HB2' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.14 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.838 ' O ' HD22 ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.53 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.44 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.808 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 1.58 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.0 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.52 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 1.73 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.03 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.9 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.852 HD21 ' O ' ' A' ' 442' ' ' VAL . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.93 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.864 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.87 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 0.76 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.72 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.701 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 1.58 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.24 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.56 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 364' ' ' GLU . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.36 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 3.81 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 -71.68 138.02 48.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.84 110.309 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.66 6.97 47.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 2.99 110.193 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 377' ' ' PHE . 40.0 p -73.81 142.56 80.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 2.07 110.161 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 25.8 Cg_exo -57.81 -36.81 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 2.38 110.26 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.26 -36.87 85.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 3.25 110.143 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.42 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 3.62 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.763 ' HA ' HD12 ' A' ' 354' ' ' ILE . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.4 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 319' ' ' ALA . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 1.39 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.969 HG13 ' CG ' ' A' ' 364' ' ' GLU . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.18 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 351' ' ' SER . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.36 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.965 HD22 ' HB1' ' A' ' 319' ' ' ALA . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.15 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.556 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -67.93 -39.12 83.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 0.61 109.561 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.723 ' HE3' HG12 ' A' ' 353' ' ' VAL . 69.5 mttt -61.14 -46.24 91.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.759 -1.213 . . . . 1.16 110.926 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -66.63 -38.4 86.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.218 -1.551 . . . . 1.9 109.549 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.498 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 41.8 mmt180 -73.9 -41.49 62.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.228 -0.92 . . . . 2.63 111.745 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 362' ' ' LEU . 62.9 m-85 -101.12 -15.0 17.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.797 -1.19 . . . . 3.32 109.609 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.892 ' O ' HD23 ' A' ' 362' ' ' LEU . 44.0 t30 60.73 47.83 7.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.688 0.756 . . . . 1.9 110.431 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.892 HD23 ' O ' ' A' ' 361' ' ' ASN . 19.6 mt -142.72 -159.57 0.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.723 -0.611 . . . . 2.8 109.652 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -119.94 158.42 26.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 4.4 110.189 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 1.0 ' HB3' HD11 ' A' ' 342' ' ' LEU . 67.7 mm-40 -65.54 -170.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 2.24 109.882 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 342' ' ' LEU . 82.6 mtp180 -105.03 134.75 47.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 4.16 110.171 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 2.86 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 372' ' ' ALA . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.04 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.69 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.05 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.14 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 7.8 m-70 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.1 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.806 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.12 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.11 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.09 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.595 HG23 ' HA ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.0 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 4.63 111.162 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.588 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 5.79 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.29 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.13 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.74 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.82 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.25 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.09 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.588 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.23 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.679 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.13 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.855 HG22 ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.26 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.489 ' ND2' HG22 ' A' ' 375' ' ' VAL . 36.3 m-20 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.04 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.056 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.11 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 1.056 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.85 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.33 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 2.69 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.838 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.02 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.855 ' HB ' HG22 ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 1.68 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.694 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 2.78 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.57 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.722 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.82 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.17 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.937 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 0.53 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.59 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 0.85 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.722 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 0.81 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 2.62 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 2.48 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.694 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 67.5 t60 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 2.43 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.609 HG12 ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 0.94 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.16 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.53 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.28 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.609 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 1.72 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.16 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 3.31 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.23 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 1.75 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.87 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.71 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.81 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.6 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.942 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 2.49 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 0.79 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.05 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.33 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.0 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.24 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.537 ' HB3' ' NH1' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.11 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 2.92 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.16 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.07 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.21 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.018 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.2 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.904 HD21 " O2'" ' A' 1001 ' ' ANP . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.4 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 0.52 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.889 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.08 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.803 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 0.9 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.42 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.42 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 3.52 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.41 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 1.79 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.66 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.02 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.852 ' O ' HD21 ' A' ' 333' ' ' LEU . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 0.57 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.05 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.582 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 0.46 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.11 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.89 145.27 27.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.48 109.772 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 35.5 p30 -95.89 133.54 39.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 3.91 110.329 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 316' ' ' ASN . 4.5 mm -55.07 -48.89 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 3.61 109.359 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.97 135.0 40.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.154 0.502 . . . . 5.09 110.264 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -91.02 132.55 35.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 7.5 110.154 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.491 -1.444 . . . . 7.3 109.491 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.904 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 316' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.334 0.587 . . . . 6.08 110.482 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 348' ' ' GLU . 32.3 ptt180 -37.43 134.99 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.598 0.713 . . . . 5.83 110.961 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 -147.9 155.65 41.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.492 -0.755 . . . . 5.58 109.544 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.03 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.42 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.6 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.82 110.739 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.93 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.14 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.53 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.44 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.731 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 1.58 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.0 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.52 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 1.73 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.03 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.9 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' HA3' ' A' ' 441' ' ' GLY . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.93 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.93 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 0.87 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 0.76 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 0.72 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.726 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.912 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 1.58 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.24 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.56 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 364' ' ' GLU . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.36 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 3.81 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.76 139.65 30.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.84 110.12 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.56 6.73 48.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 2.99 110.291 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 36.4 p -77.91 142.6 65.13 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 2.07 110.137 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.7 Cg_exo -57.52 -33.42 96.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.987 1.519 . . . . 2.38 110.268 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.79 -36.54 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 3.25 110.067 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.454 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.42 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 3.62 109.653 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.4 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.726 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 1.39 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.636 HG13 ' CD ' ' A' ' 364' ' ' GLU . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.18 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.36 110.491 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.15 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.682 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.54 -38.12 89.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 0.61 109.606 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 361' ' ' ASN . 42.2 tptt -58.66 -52.82 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.763 -1.211 . . . . 1.16 111.05 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -65.74 -39.0 90.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.511 -1.368 . . . . 1.9 109.865 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -71.6 -44.87 63.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 2.63 111.35 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.667 ' HB3' HD21 ' A' ' 362' ' ' LEU . 33.6 m-85 -116.24 -14.93 11.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.69 -1.256 . . . . 3.32 110.726 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.27 50.07 6.57 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.292 -0.88 . . . . 1.9 109.925 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 360' ' ' PHE . 21.5 mt -99.54 -178.42 3.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.764 -0.585 . . . . 2.8 109.914 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -106.89 159.51 16.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 4.4 110.732 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.755 ' OE1' HD21 ' A' ' 342' ' ' LEU . 73.1 mm-40 -77.56 166.97 22.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.602 -0.686 . . . . 2.24 109.85 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.843 ' CD ' HD22 ' A' ' 339' ' ' LEU . 58.5 mtp85 -101.57 132.64 47.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 4.16 110.563 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 2.86 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.767 HG21 ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.04 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.69 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.446 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.05 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.14 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.1 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.12 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.11 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.09 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.0 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 4.63 111.27 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 5.79 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.29 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.13 110.472 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.74 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.82 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.25 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.662 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.09 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.23 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.13 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.912 HG21 HD12 ' A' ' 339' ' ' LEU . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.26 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.9 m-20 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.04 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.11 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.85 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.33 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 2.69 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.02 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.683 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 1.68 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 2.78 110.393 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.887 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 1.57 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.704 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.82 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.17 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.53 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.59 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.662 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 0.85 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.81 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 2.62 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 2.48 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 2.43 110.56 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 437' ' ' SER . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.94 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.16 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.53 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.28 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 1.72 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.411 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.16 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 3.31 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.23 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 1.75 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.87 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 439' ' ' VAL . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 0.71 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.81 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.6 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.969 ' O ' HG23 ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 2.49 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 430' ' ' PRO . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 0.79 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.05 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 81.8 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.33 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.0 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.24 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.11 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 2.92 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.16 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.07 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.21 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.041 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.2 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.738 HD21 " O2'" ' A' 1001 ' ' ANP . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.4 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.786 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 0.52 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.031 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.08 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.756 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 0.9 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.683 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.42 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.857 ' O ' HG13 ' A' ' 405' ' ' VAL . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.42 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 3.52 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.41 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.031 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 1.79 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.02 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.897 ' O ' HD13 ' A' ' 443' ' ' ILE . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 0.57 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.05 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.678 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 0.46 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.11 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -84.74 136.65 33.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.48 109.89 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -96.19 141.76 29.17 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.445 -0.784 . . . . 3.91 110.204 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -57.53 -42.98 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 3.61 108.915 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.89 135.83 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.751 -0.593 . . . . 5.09 110.199 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -144.26 130.58 19.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 7.5 110.124 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.947 -1.474 . . . . 7.3 109.511 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.738 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 448' ' ' ILE . 83.8 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.228 0.537 . . . . 6.08 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.512 ' NH1' ' OD2' ' A' ' 447' ' ' ASP . 91.1 mtt-85 -121.83 130.46 53.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -0.96 . . . . 5.83 110.107 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 -123.6 142.61 50.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 5.58 109.881 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.067 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.42 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.6 110.543 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.82 110.641 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.916 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.14 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.53 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.44 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.79 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 1.58 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.0 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.52 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.936 HG11 ' O ' ' A' ' 440' ' ' LEU . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 1.73 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.457 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.592 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.03 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 0.9 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 443' ' ' ILE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.93 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.515 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 0.87 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.76 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 0.72 110.087 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 1.58 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.24 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.56 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.525 HD11 ' H ' ' A' ' 365' ' ' ARG . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.36 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 3.81 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -85.49 138.15 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.84 110.062 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.42 6.86 47.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 2.99 110.262 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.2 p -73.18 143.56 83.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 2.07 110.087 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.405 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 11.0 Cg_endo -59.84 -36.52 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.949 1.499 . . . . 2.38 110.035 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.574 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.89 -36.07 82.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 3.25 110.117 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.42 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 3.62 109.498 172.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.4 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.72 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 1.39 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.18 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.36 110.342 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.067 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.15 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.705 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.82 -37.91 89.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 0.61 109.663 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.651 ' HZ3' ' HA ' ' A' ' 363' ' ' ARG . 0.5 OUTLIER -59.35 -51.49 69.71 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.777 -1.202 . . . . 1.16 110.827 -175.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 21.3 pt20 -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.514 -1.366 . . . . 1.9 109.841 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.477 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.1 mmm180 -71.51 -44.34 64.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 2.63 111.487 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CE1' ' HG2' ' A' ' 331' ' ' LYS . 38.2 m-85 -116.12 -14.69 11.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.818 -1.176 . . . . 3.32 110.372 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 357' ' ' LYS . 13.4 t-20 60.38 50.17 6.29 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.937 0.875 . . . . 1.9 110.006 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 360' ' ' PHE . 21.7 mt -95.57 -178.61 4.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.62 -0.511 . . . . 2.8 109.62 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.651 ' HA ' ' HZ3' ' A' ' 357' ' ' LYS . 63.6 mtp180 -117.86 149.77 40.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 4.4 110.92 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.77 149.12 22.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.561 -0.712 . . . . 2.24 109.555 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.525 ' H ' HD11 ' A' ' 342' ' ' LEU . 88.5 mtt180 -98.32 123.79 42.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.859 -1.151 . . . . 4.16 110.233 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.484 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 2.86 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.04 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.69 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.05 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.14 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.1 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.12 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.11 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.659 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.09 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.615 HG11 ' NH1' ' A' ' 394' ' ' ARG . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.0 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 4.63 111.172 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 5.79 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.29 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.13 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.74 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.82 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.25 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.686 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.09 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.23 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.13 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.26 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.592 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 11.1 m-20 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.04 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.868 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.11 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.85 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.33 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 2.69 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.02 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 1.68 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.638 ' HB3' HG22 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 2.78 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.879 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 1.57 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.82 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.17 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.803 HG21 HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.53 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.59 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.686 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 0.85 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.753 HG23 ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 0.81 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 2.62 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 2.48 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 2.43 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 437' ' ' SER . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 0.94 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.16 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.53 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.28 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.621 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 1.72 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.16 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 3.31 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.23 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 1.75 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.87 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.035 ' CG1' HG11 ' A' ' 439' ' ' VAL . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 0.71 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.81 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.6 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 2.49 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 0.79 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.05 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.33 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.0 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.24 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.11 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 2.92 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.16 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.07 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.21 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.998 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.2 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.925 HD21 " O2'" ' A' 1001 ' ' ANP . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.4 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.834 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 0.52 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.044 HG12 HD21 ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.08 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.875 ' C ' HD23 ' A' ' 440' ' ' LEU . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 0.9 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.653 ' HG3' HD22 ' A' ' 440' ' ' LEU . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.42 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.896 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.42 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 3.52 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.41 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.044 HD21 HG12 ' A' ' 433' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 1.79 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.02 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.859 ' O ' HD13 ' A' ' 443' ' ' ILE . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 0.57 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.903 HD11 HD11 ' A' ' 333' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.05 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.644 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.46 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.11 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt -94.22 128.12 40.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.48 109.279 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.512 ' OD2' ' NH1' ' A' ' 317' ' ' ARG . 77.4 m-20 -88.1 133.39 34.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.964 -1.085 . . . . 3.91 109.897 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 316' ' ' ASN . 4.7 mm -55.0 -49.82 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 3.61 109.23 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.84 133.82 44.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.3 0.571 . . . . 5.09 110.108 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -91.58 132.96 35.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 7.5 110.184 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.969 -1.461 . . . . 7.3 109.482 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.925 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 448' ' ' ILE . 15.2 m120 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.326 0.584 . . . . 6.08 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.637 ' NH2' " H3'" ' A' 1001 ' ' ANP . 57.3 ttp180 -42.6 137.51 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 5.83 110.382 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 -150.44 151.78 33.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 5.58 110.314 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.01 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.42 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.6 110.413 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.528 ' HA ' ' NH1' ' A' ' 359' ' ' ARG . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.82 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.923 ' O ' HD13 ' A' ' 323' ' ' ILE . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.14 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 0.53 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.548 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.44 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 1.58 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.0 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.52 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 440' ' ' LEU . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 1.73 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.03 109.645 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 0.9 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 443' ' ' ILE . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.93 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 0.87 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.76 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.72 109.987 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.665 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.894 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 1.58 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.24 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.56 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.595 HD11 ' H ' ' A' ' 365' ' ' ARG . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.36 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 3.81 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.565 ' OD2' ' N6 ' ' A' 1001 ' ' ANP . 8.2 p-10 -107.47 149.96 27.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.84 110.287 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -99.65 8.5 44.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 2.99 110.171 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 45.7 p -80.15 141.25 53.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.335 -0.853 . . . . 2.07 110.111 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.3 Cg_exo -57.58 -31.48 91.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.93 1.49 . . . . 2.38 110.239 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.89 -37.14 86.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 3.25 110.104 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.42 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 3.62 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.4 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.599 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.39 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.18 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 351' ' ' SER . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.36 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.01 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.15 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.665 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.07 -36.44 84.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 0.61 109.565 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.9 tptt -54.82 -54.64 39.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.886 -1.134 . . . . 1.16 110.775 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.5 pt20 -66.52 -43.03 86.33 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.509 -1.369 . . . . 1.9 109.858 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 322' ' ' PHE . 39.9 mtp180 -69.67 -40.13 76.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 2.63 111.697 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.774 ' HB3' HD11 ' A' ' 362' ' ' LEU . 76.6 m-85 -116.09 -14.73 11.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.735 -1.228 . . . . 3.32 110.604 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.29 50.11 6.51 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.809 . . . . 1.9 109.925 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.7 mt -107.2 175.44 5.5 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.788 -0.57 . . . . 2.8 109.829 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -117.6 154.98 30.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.865 -1.147 . . . . 4.4 110.271 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 152.5 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 2.24 109.589 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' H ' HD11 ' A' ' 342' ' ' LEU . 73.8 mmt-85 -94.68 144.36 25.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 4.16 110.52 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 2.86 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.04 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.69 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.05 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.919 HD13 ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.14 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.1 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.12 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.11 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.09 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 1.012 HG11 ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.0 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 4.63 111.371 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 5.79 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.29 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.13 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.74 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.82 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.452 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.25 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.516 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.09 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.23 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.13 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.894 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.26 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 12.3 m-20 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.04 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.919 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.11 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.85 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.33 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 2.69 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.02 109.236 167.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.667 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 1.68 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 1.012 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 2.78 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 1.57 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.578 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.82 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.17 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.703 HG21 HG11 ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.53 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.59 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 0.85 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 0.81 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 2.62 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.48 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 2.43 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.637 HG12 ' C ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.94 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.16 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.53 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.28 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.16 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 3.31 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.23 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.559 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 1.75 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.87 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 439' ' ' VAL . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 0.71 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.81 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.6 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 2.49 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 0.79 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.05 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 30.1 mm100 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.33 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.0 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.24 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.11 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 2.92 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.16 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.07 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.21 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.2 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.909 HD21 " O2'" ' A' 1001 ' ' ANP . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.4 108.32 165.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 0.52 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.07 HG12 HD21 ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.08 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.639 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 0.9 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.42 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 405' ' ' VAL . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.42 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 3.52 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 416' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.41 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.07 HD21 HG12 ' A' ' 433' ' ' VAL . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 1.79 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.02 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 443' ' ' ILE . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 0.57 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.893 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.05 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.765 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 0.46 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.502 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.11 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -88.37 145.68 25.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.48 109.717 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 34.3 p30 -95.79 117.36 30.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 3.91 110.611 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -54.59 -47.18 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 3.61 109.468 176.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.32 134.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.588 -0.695 . . . . 5.09 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -93.0 144.94 24.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 7.5 110.214 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.035 -1.425 . . . . 7.3 109.576 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.909 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.543 ' O ' HD13 ' A' ' 448' ' ' ILE . 9.9 p30 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 6.08 110.384 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 97.9 mtt180 -45.56 143.62 1.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 5.83 110.252 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 -156.28 141.95 17.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.49 -0.756 . . . . 5.58 110.438 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.42 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.6 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.82 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.09 ' CD1' HD21 ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.14 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 323' ' ' ILE . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.53 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.44 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 1.58 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.0 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.52 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.896 HG11 ' O ' ' A' ' 440' ' ' LEU . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 1.73 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.03 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.9 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.71 HD22 ' HA3' ' A' ' 441' ' ' GLY . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.93 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 0.87 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 0.76 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.72 109.967 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.627 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 1.58 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.24 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.604 ' OG ' HG23 ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.56 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.911 HD21 ' OE1' ' A' ' 364' ' ' GLU . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.36 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 3.81 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -74.11 139.1 44.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.84 110.151 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.55 7.25 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 2.99 110.186 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.752 HG21 ' CD2' ' A' ' 377' ' ' PHE . 67.3 p -78.43 144.45 65.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 2.07 110.102 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.62 -32.62 96.24 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.943 1.496 . . . . 2.38 110.125 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.463 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 77.1 mm-40 -64.16 -36.0 82.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 3.25 110.217 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.42 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 3.62 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.733 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.4 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.623 HG22 ' OE1' ' A' ' 338' ' ' GLN . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 1.39 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 1.027 HG13 ' OE2' ' A' ' 364' ' ' GLU . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.18 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.36 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.09 HD21 ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.15 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -67.28 -39.49 86.05 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 0.61 109.864 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 361' ' ' ASN . 6.2 mtmt -66.26 -46.02 78.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 1.16 111.273 -175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.2 pt20 -63.55 -37.49 87.52 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.205 -1.559 . . . . 1.9 109.491 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.479 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 27.7 mmm180 -77.01 -47.49 20.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.199 -0.938 . . . . 2.63 111.474 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.762 ' HB2' HD23 ' A' ' 362' ' ' LEU . 22.7 m-85 -115.92 -14.72 11.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.766 -1.209 . . . . 3.32 110.344 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.1 t30 60.16 39.86 18.92 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.462 -0.773 . . . . 1.9 110.111 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.69 -171.89 2.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.575 -0.703 . . . . 2.8 109.575 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -123.24 151.87 41.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.19 -0.944 . . . . 4.4 110.503 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 1.027 ' OE2' HG13 ' A' ' 353' ' ' VAL . 65.1 mm-40 -64.48 158.12 24.79 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.462 -0.774 . . . . 2.24 110.064 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.538 ' H ' HD11 ' A' ' 342' ' ' LEU . 97.2 mtt180 -102.96 131.74 49.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 4.16 110.515 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.489 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 2.86 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.04 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.69 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.05 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.14 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.1 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.12 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.11 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.09 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 1.015 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.0 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 4.63 111.332 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.752 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 5.79 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.29 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.498 ' CB ' ' O3G' ' A' 1001 ' ' ANP . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.13 110.458 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.74 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.82 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.25 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.531 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.09 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.23 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.446 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.13 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.924 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.26 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.59 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.9 m-20 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.04 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.903 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.11 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.85 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.33 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 2.69 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.02 109.174 167.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.653 HG13 HD11 ' A' ' 339' ' ' LEU . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 1.68 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 1.015 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 2.78 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 1.57 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.657 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.82 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.17 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.653 ' CG2' HG11 ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.53 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.59 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.59 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 0.85 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 0.81 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 2.62 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 2.48 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.535 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 2.43 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.687 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 0.94 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.16 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.53 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.28 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.687 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 1.72 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.16 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.808 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 3.31 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.23 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 1.75 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.87 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 439' ' ' VAL . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 0.71 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.81 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.6 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.983 ' O ' HG23 ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 2.49 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.79 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.05 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 30.1 mm100 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.33 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.0 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.24 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.11 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 2.92 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.16 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.07 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.21 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.963 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.2 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.653 HD21 " C2'" ' A' 1001 ' ' ANP . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.4 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.808 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 0.52 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.966 HG12 HD21 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.08 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.652 ' CA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 0.9 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.42 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.42 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 3.52 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.41 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.966 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 1.79 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.71 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.02 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 443' ' ' ILE . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 0.57 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.05 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.46 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.11 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -85.51 140.03 31.0 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.48 109.635 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 34.9 p30 -96.0 115.81 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 3.91 110.602 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.594 HD12 ' N ' ' A' ' 448' ' ' ILE . 1.5 mp -56.77 -46.4 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 3.61 109.417 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.93 136.42 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.635 -0.665 . . . . 5.09 110.254 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -89.95 132.69 35.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 7.5 110.149 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.959 -1.467 . . . . 7.3 109.531 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.653 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 35.4 t30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.174 0.511 . . . . 6.08 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -125.36 137.87 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 5.83 110.304 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 9.7 mt-30 -135.77 149.52 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 5.58 109.436 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.42 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.6 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.466 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.82 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.816 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.14 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.53 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.44 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.746 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 1.58 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.0 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.52 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 1.73 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.567 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.03 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.9 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.93 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.87 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.664 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.76 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.72 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.721 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 1.58 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.946 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.24 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.56 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 364' ' ' GLU . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.36 109.894 174.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 3.81 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -82.51 136.87 34.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.84 110.155 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.92 6.85 47.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 2.99 110.265 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 35.3 p -77.06 146.26 74.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 2.07 110.255 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.58 -35.35 90.37 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.966 1.508 . . . . 2.38 110.281 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.1 -37.34 87.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 3.25 110.114 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.42 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 3.62 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.4 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.677 HG12 ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 1.39 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.704 HG13 ' CG ' ' A' ' 364' ' ' GLU . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.18 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 351' ' ' SER . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.36 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.946 HD12 ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.15 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -64.84 -37.26 87.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.61 109.357 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 31.7 tptt -58.22 -53.01 63.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.776 -1.202 . . . . 1.16 111.031 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -68.53 -41.3 80.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.452 -1.405 . . . . 1.9 110.165 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 30.7 mmt180 -67.65 -38.96 84.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 2.63 111.318 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.536 ' HB3' ' CD1' ' A' ' 362' ' ' LEU . 97.1 m-85 -115.79 -14.9 11.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.125 . . . . 3.32 110.22 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.597 ' O ' HD23 ' A' ' 362' ' ' LEU . 11.4 t-20 60.52 50.03 6.18 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.749 0.785 . . . . 1.9 109.931 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 361' ' ' ASN . 29.0 mt -130.7 -179.14 5.12 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.675 -0.641 . . . . 2.8 109.875 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -106.53 153.71 21.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.001 -1.062 . . . . 4.4 109.921 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.812 ' HB3' HD11 ' A' ' 342' ' ' LEU . 77.6 mm-40 -67.88 -174.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 2.24 109.777 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.803 HH21 HD13 ' A' ' 339' ' ' LEU . 58.8 mtm180 -104.2 135.12 46.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 4.16 110.362 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 2.86 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 372' ' ' ALA . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.04 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.69 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.05 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.88 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.14 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.1 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.759 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.12 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.11 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.723 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.09 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 387' ' ' ASN . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.0 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 4.63 111.181 -175.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 5.79 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.29 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.13 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.74 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.82 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.25 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.619 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.09 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.575 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.23 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.633 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.13 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.871 HG22 ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.26 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.562 HD22 HG22 ' A' ' 375' ' ' VAL . 8.2 m-20 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.04 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.88 ' CD1' HD13 ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.11 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.85 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 9.1 t-20 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.33 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 2.69 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.615 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.02 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.871 ' HB ' HG22 ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 1.68 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 2.78 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.886 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 1.57 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.746 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.82 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.17 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.953 ' CG2' HG11 ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.53 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.59 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.619 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 0.85 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.746 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 0.81 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 2.62 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 2.48 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 2.43 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.663 HG12 ' C ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 0.94 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.16 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.53 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 81.0 m-20 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.28 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.663 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 1.72 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.16 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.821 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 3.31 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.23 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 1.75 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.87 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 439' ' ' VAL . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 0.71 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.81 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.6 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.971 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 2.49 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.016 HG13 ' HB2' ' A' ' 430' ' ' PRO . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 0.79 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.05 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.33 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.0 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.24 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.11 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 2.92 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.16 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.07 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.21 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.016 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.2 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.854 HD21 " C2'" ' A' 1001 ' ' ANP . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.4 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.821 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 0.52 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.886 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.08 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.807 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 0.9 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.42 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.42 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.527 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 3.52 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 416' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.41 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.881 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 1.79 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.65 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.02 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 443' ' ' ILE . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 0.57 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 442' ' ' VAL . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.05 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.697 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 0.46 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.11 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -96.5 143.03 27.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.48 109.869 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 33.2 p30 -95.94 129.45 43.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 3.91 110.35 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 448' ' ' ILE . 4.5 mm -54.0 -48.79 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 3.61 109.324 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.17 136.05 37.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.225 0.536 . . . . 5.09 110.304 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.7 132.49 35.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 7.5 110.142 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 118.013 -1.437 . . . . 7.3 109.522 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.854 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.487 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 7.1 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.321 0.581 . . . . 6.08 110.394 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.474 ' NH2' ' OG1' ' A' ' 429' ' ' THR . 53.1 mtp180 -42.48 139.61 1.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.49 -0.756 . . . . 5.83 110.435 -176.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 -153.9 146.28 23.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.528 -0.732 . . . . 5.58 110.279 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.951 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.42 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.6 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.82 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.14 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.616 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 0.53 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.44 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 1.58 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.0 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.52 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 1.73 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.589 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.03 110.706 -178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 0.9 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.992 ' HA ' HD12 ' A' ' 440' ' ' LEU . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.93 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 0.87 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 0.76 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 0.72 109.443 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.624 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 386' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 1.58 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.68 ' HB1' ' HA2' ' A' ' 385' ' ' GLY . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.24 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.56 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.564 HD11 ' H ' ' A' ' 365' ' ' ARG . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.36 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 3.81 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -77.62 136.7 38.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.84 110.007 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.44 6.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 2.99 110.256 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.635 HG21 ' CD2' ' A' ' 377' ' ' PHE . 44.7 p -74.69 139.5 74.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 2.07 110.043 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 29.4 Cg_exo -56.42 -35.86 96.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 2.38 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.01 -35.92 82.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 3.25 110.122 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.42 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 3.62 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.4 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 1.39 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.18 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.36 110.481 170.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.951 HD22 ' HB1' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.15 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.804 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -64.09 -36.91 85.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.61 109.369 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 361' ' ' ASN . 8.0 tptm -59.94 -51.49 69.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.905 -1.122 . . . . 1.16 111.028 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.2 pt20 -65.46 -39.49 92.05 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.321 -1.487 . . . . 1.9 109.869 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.643 ' HE ' HD11 ' A' ' 355' ' ' LEU . 86.5 mtt-85 -73.25 -44.15 59.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 2.63 111.699 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.681 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 21.2 m-85 -116.05 -15.04 11.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.704 -1.247 . . . . 3.32 110.81 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.2 t-20 59.79 43.09 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 1.9 110.061 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.75 -177.32 5.84 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.554 -0.716 . . . . 2.8 109.622 173.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -123.75 152.55 42.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.031 -1.043 . . . . 4.4 110.618 176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.56 145.14 29.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.795 -0.762 . . . . 2.24 109.472 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.564 ' H ' HD11 ' A' ' 342' ' ' LEU . 95.3 mtt-85 -100.87 126.93 47.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.028 -1.045 . . . . 4.16 110.195 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 2.86 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.04 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.69 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.05 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.872 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.14 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.1 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.667 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.12 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.11 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.668 ' CE1' HG21 ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.09 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.0 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 4.63 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 5.79 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.29 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.13 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.74 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.82 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.25 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.656 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.09 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.23 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.68 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.13 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 339' ' ' LEU . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.26 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.4 m-20 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.04 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.11 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.85 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.33 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 2.69 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.514 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.02 109.111 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 339' ' ' LEU . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 1.68 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 2.78 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.613 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 1.57 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.55 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.82 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.17 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 0.53 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.59 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.656 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 0.85 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.81 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 2.62 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 2.48 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 2.43 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 0.94 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.16 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.53 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 8.8 m120 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.28 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.625 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 1.72 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.16 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 3.31 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.23 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 1.75 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.542 ' N ' HG23 ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.87 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 439' ' ' VAL . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.71 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.81 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.6 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 2.49 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 430' ' ' PRO . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 0.79 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.05 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.33 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.0 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.24 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.11 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 2.92 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.16 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.07 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.474 ' OG1' ' NH2' ' A' ' 317' ' ' ARG . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.21 108.916 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 1.029 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.2 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.941 HD21 " O2'" ' A' 1001 ' ' ANP . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.4 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.794 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 0.52 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.08 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.811 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 0.9 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.55 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.42 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 405' ' ' VAL . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.42 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 3.52 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 416' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.41 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.992 HD12 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 1.79 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.773 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.02 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.019 ' O ' HD13 ' A' ' 443' ' ' ILE . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 0.57 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 1.019 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.05 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.98 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 0.46 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.11 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt -85.89 141.45 29.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.48 109.689 172.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 447' ' ' ASP . 33.6 p30 -95.86 120.06 35.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 3.91 110.66 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -55.32 -48.22 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 3.61 109.353 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.96 135.09 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 5.09 110.214 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -92.63 145.22 24.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 7.5 110.22 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.984 -1.453 . . . . 7.3 109.556 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.941 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 11.4 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.578 . . . . 6.08 110.422 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' ASN . 66.1 mtt85 -41.07 142.98 0.44 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.556 -0.715 . . . . 5.83 110.516 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 -148.12 156.05 42.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 5.58 110.269 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.879 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.42 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.6 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.82 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.674 ' CB ' HD12 ' A' ' 443' ' ' ILE . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.14 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.57 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.53 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.642 ' HB3' HG12 ' A' ' 328' ' ' VAL . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.44 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 1.58 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.0 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.52 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 440' ' ' LEU . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 1.73 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.449 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.03 110.042 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 0.9 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 443' ' ' ILE . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.93 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.67 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 0.87 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.76 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 0.72 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.704 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 1.58 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.24 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 344' ' ' ASP . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.56 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.58 HD11 ' H ' ' A' ' 365' ' ' ARG . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.36 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 3.81 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 341' ' ' SER . 44.1 p30 -104.19 127.51 51.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.84 110.447 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.91 18.59 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.148 -0.97 . . . . 2.99 110.501 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 80.1 p -58.72 160.45 10.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 2.07 110.04 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.546 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 35.2 Cg_exo -51.67 -54.5 5.23 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.95 1.5 . . . . 2.38 110.167 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 94.1 mt-10 -66.13 -35.52 80.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 3.25 110.148 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.471 ' HA2' ' N6 ' ' A' 1001 ' ' ANP . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.42 109.967 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.546 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 3.62 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.609 ' HA ' HD12 ' A' ' 354' ' ' ILE . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.4 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 1.39 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.649 HG11 ' OE2' ' A' ' 364' ' ' GLU . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.18 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.36 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.879 HD22 ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.15 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.704 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.74 -36.91 84.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.61 109.784 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 361' ' ' ASN . 20.6 tptp -53.5 -55.23 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.824 -1.172 . . . . 1.16 110.447 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 20.4 pt20 -66.64 -39.65 88.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.737 -1.227 . . . . 1.9 109.949 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.6 mmm180 -69.56 -40.5 76.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.314 -0.866 . . . . 2.63 111.491 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 362' ' ' LEU . 98.4 m-85 -116.02 -14.72 11.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 3.32 110.088 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.54 ' N ' ' O ' ' A' ' 357' ' ' LYS . 22.6 t30 60.31 50.14 6.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.765 0.793 . . . . 1.9 110.125 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.796 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.4 mt -109.98 178.6 4.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.666 -0.647 . . . . 2.8 109.791 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -118.88 151.78 37.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.078 . . . . 4.4 110.161 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.649 ' OE2' HG11 ' A' ' 353' ' ' VAL . 95.7 mt-10 -55.81 149.62 14.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 2.24 109.677 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.672 ' NH2' HD13 ' A' ' 339' ' ' LEU . 56.3 mtm180 -97.59 132.17 43.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.99 -1.069 . . . . 4.16 110.05 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 2.86 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.04 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.69 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.05 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.912 HD13 ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.14 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.1 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.12 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.525 ' C ' HG11 ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.11 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.09 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.656 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.0 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 4.63 110.959 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.612 ' CE2' ' C5 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 5.79 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.29 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.13 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.74 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.82 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.25 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.755 ' CE ' HD13 ' A' ' 401' ' ' ILE . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.09 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.23 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.13 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.26 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.9 m-20 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.04 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.912 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.11 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.85 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.33 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 2.69 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.467 ' HE3' ' OD1' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.02 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 435' ' ' GLU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 1.68 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.656 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 2.78 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.884 ' CE ' HD13 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 1.57 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 1.008 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.82 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.17 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.752 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 0.53 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.59 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 0.85 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 1.008 HD11 ' N ' ' A' ' 396' ' ' GLY . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 0.81 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 2.62 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 400' ' ' ALA . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 2.48 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 2.43 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 0.94 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.16 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.53 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.28 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.589 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 1.72 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.16 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 3.31 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.23 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 1.75 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.87 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 439' ' ' VAL . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 0.71 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.81 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.6 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 2.49 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.847 HG13 ' HB2' ' A' ' 430' ' ' PRO . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 0.79 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.05 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 82.6 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.33 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.0 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.24 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.11 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 2.92 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.16 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.07 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.21 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.847 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.2 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.884 HD13 ' CE ' ' A' ' 395' ' ' LYS . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.4 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 0.52 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.08 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.725 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 0.9 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.726 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.42 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.821 ' O ' HG13 ' A' ' 405' ' ' VAL . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.42 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 3.52 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 416' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.41 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 1.79 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.02 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.84 ' O ' HD13 ' A' ' 443' ' ' ILE . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 0.57 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.05 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.776 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.46 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.11 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp -84.93 137.85 32.86 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.48 109.307 170.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -95.97 132.2 41.54 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.154 -0.967 . . . . 3.91 110.446 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -58.94 -49.41 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 3.61 109.498 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 448' ' ' ILE . 45.7 t -102.42 134.7 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.717 . . . . 5.09 110.181 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -92.85 144.25 25.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 7.5 110.235 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.463 -1.455 . . . . 7.3 109.463 -179.905 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.612 ' C5 ' ' CE2' ' A' ' 377' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 85.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.214 0.53 . . . . 6.08 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.644 ' NH2' H5'1 ' A' 1001 ' ' ANP . 80.9 mtm180 -128.81 143.45 50.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 5.83 110.459 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 21.4 pt20 -144.26 154.55 43.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 5.58 109.941 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.42 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.6 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.82 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.699 ' CB ' HD12 ' A' ' 443' ' ' ILE . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.14 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.549 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 0.53 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.654 ' HB3' HG12 ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.44 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 1.58 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.0 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.52 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 440' ' ' LEU . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 1.73 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.462 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.03 110.137 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.9 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 443' ' ' ILE . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.93 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 0.87 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.76 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.417 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.72 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 1.58 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.24 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.495 ' HA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.56 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.36 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.425 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 3.81 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.6 p30 -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.84 110.486 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.63 18.94 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 2.99 110.317 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 65.6 p -86.93 154.38 55.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 2.07 110.297 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.535 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 11.5 Cg_endo -60.32 -40.27 60.08 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.98 1.516 . . . . 2.38 110.216 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.573 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -66.26 -38.95 89.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 3.25 110.123 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.42 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 3.62 109.998 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 354' ' ' ILE . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.4 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 1.39 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.455 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.18 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 351' ' ' SER . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.36 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.15 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.75 -37.01 86.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 0.61 109.559 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 361' ' ' ASN . 19.4 tptt -55.67 -54.32 45.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.878 -1.139 . . . . 1.16 110.794 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.8 pt20 -66.41 -39.56 89.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.525 -1.359 . . . . 1.9 109.952 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.459 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.5 mmt180 -69.77 -41.37 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 2.63 111.5 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.705 ' HB3' HD11 ' A' ' 362' ' ' LEU . 52.6 m-85 -116.0 -14.75 11.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.725 -1.234 . . . . 3.32 110.441 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 357' ' ' LYS . 25.8 t30 60.53 50.16 6.05 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.793 0.806 . . . . 1.9 110.251 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.705 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.1 mt -109.86 179.72 4.04 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.814 -0.554 . . . . 2.8 109.773 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -114.99 150.15 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 4.4 110.882 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.422 ' HB2' HD21 ' A' ' 342' ' ' LEU . 21.3 pt-20 -61.58 155.57 21.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 2.24 109.732 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 -97.07 123.09 40.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 4.16 109.883 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 2.86 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.04 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.69 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.05 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.14 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.1 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.12 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.576 ' C ' HG11 ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.11 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CD1' HG21 ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.09 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.0 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 4.63 111.118 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 5.79 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.29 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.13 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.74 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.82 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.568 ' NH2' " O2'" ' A' 1001 ' ' ANP . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.25 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.804 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.09 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.604 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.13 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.927 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.26 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.43 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 46.0 m-20 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.04 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.066 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.11 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.85 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.33 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.604 ' O ' HG22 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 2.69 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.491 ' O ' HD13 ' A' ' 393' ' ' ILE . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.02 109.603 173.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 1.68 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 2.78 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.873 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 1.57 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.548 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.82 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.17 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.902 ' CG2' HG11 ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 0.53 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.59 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 0.85 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.81 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.503 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 2.62 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 2.48 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 2.43 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 0.94 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.16 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.53 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.28 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 1.72 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.16 110.254 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.83 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 3.31 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.23 110.595 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 1.75 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.87 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 439' ' ' VAL . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 0.71 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.81 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.6 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 2.49 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 0.79 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.05 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.33 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.24 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.11 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 2.92 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.16 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.07 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.21 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.2 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.717 HD21 " C2'" ' A' 1001 ' ' ANP . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.4 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.83 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 0.52 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.13 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.08 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 0.9 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.42 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.553 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.42 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 3.52 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 416' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.41 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.13 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 1.79 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.542 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.02 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.862 ' O ' HD13 ' A' ' 443' ' ' ILE . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 0.57 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.05 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 0.46 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.11 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt -84.96 147.01 26.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.48 109.662 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 33.2 p30 -95.42 121.43 37.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 3.91 110.488 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.2 mp -54.21 -47.47 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 3.61 109.379 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.2 135.67 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.555 -0.716 . . . . 5.09 110.241 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -92.49 144.61 25.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 7.5 110.184 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.987 -1.452 . . . . 7.3 109.536 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.717 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 84.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.239 0.543 . . . . 6.08 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -131.79 139.58 48.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 5.83 110.444 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.469 ' OE1' HD11 ' A' ' 448' ' ' ILE . 14.4 pt20 -145.0 150.93 37.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 5.58 110.173 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.125 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.42 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.6 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.82 110.854 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.036 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.14 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' PHE . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 0.53 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.557 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.44 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 1.58 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.0 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.52 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.91 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 1.73 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.03 110.277 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 0.9 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 440' ' ' LEU . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.93 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 1.036 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 0.87 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 0.76 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 0.72 110.412 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.799 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 1.58 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.24 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.564 ' OG ' HG23 ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.56 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.36 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 3.81 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 -101.49 147.2 26.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.84 110.232 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.89 6.33 47.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 2.99 110.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.8 p -85.37 140.84 36.45 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 2.07 110.193 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.25 -30.82 88.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.001 1.527 . . . . 2.38 110.23 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.565 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.6 mt-10 -63.9 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 3.25 110.137 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.487 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.42 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 3.62 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.4 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.682 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 1.39 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.564 HG23 ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.18 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.36 110.677 171.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.125 HD12 ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.15 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -61.39 -37.99 85.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 0.61 109.246 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.4 tptm -61.32 -46.05 91.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 1.16 111.092 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 9.4 pt20 -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.46 -1.4 . . . . 1.9 109.892 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.47 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.6 mmt180 -79.16 -47.33 16.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 2.63 111.423 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.821 ' HB2' HD23 ' A' ' 362' ' ' LEU . 78.9 m-85 -116.29 -14.95 11.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.814 -1.179 . . . . 3.32 110.509 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 24.0 t30 59.62 38.14 22.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.407 -0.808 . . . . 1.9 110.086 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.83 -178.6 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.565 -0.709 . . . . 2.8 109.572 172.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -128.33 154.49 45.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.96 -1.087 . . . . 4.4 110.76 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 13.6 pt-20 -54.69 145.49 19.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 2.24 109.523 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.578 ' CZ ' HD13 ' A' ' 339' ' ' LEU . 28.4 ptt180 -101.38 134.69 44.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 4.16 110.277 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 2.86 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' A' ' 372' ' ' ALA . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.04 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.69 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.05 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.937 HD13 ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.14 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.1 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.956 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.12 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.11 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.09 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.955 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.0 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 4.63 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 5.79 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.29 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.13 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.74 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.82 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.47 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.25 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.505 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.09 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.23 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.13 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.799 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.26 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.632 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 7.7 m-20 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.04 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.937 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.11 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.85 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.33 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 2.69 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.02 109.165 167.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.606 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 1.68 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.955 ' NH1' HG11 ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 2.78 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 1.57 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.608 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.82 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.17 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.722 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 0.53 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.59 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 397' ' ' SER . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 0.85 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 0.81 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 2.62 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 2.48 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.559 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 2.43 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.66 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 0.94 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.16 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.53 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.28 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.66 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 1.72 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.16 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.822 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 3.31 109.985 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.23 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 1.75 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.87 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.71 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.81 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.6 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.979 ' O ' HG23 ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 2.49 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 430' ' ' PRO . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 0.79 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.05 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.33 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.979 HG23 ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.0 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.24 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.11 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 2.92 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.16 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.07 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.21 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.97 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.2 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.76 HD21 " C2'" ' A' 1001 ' ' ANP . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.4 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.822 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 0.52 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.08 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 0.9 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.42 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 405' ' ' VAL . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.42 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 3.52 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.41 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.91 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 1.79 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.709 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.02 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.898 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 0.57 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.05 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.694 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.46 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.11 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt -84.9 142.9 29.37 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.48 109.71 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 35.1 p30 -95.94 117.29 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 3.91 110.379 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -53.55 -47.03 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 3.61 109.334 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.62 134.62 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.53 -0.731 . . . . 5.09 110.197 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -90.93 133.5 35.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 7.5 110.229 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.967 -1.463 . . . . 7.3 109.581 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.76 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 81.6 m-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.07 0.462 . . . . 6.08 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.506 HH22 HNB1 ' A' 1001 ' ' ANP . 73.9 mtt85 -124.7 136.21 53.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 5.83 110.332 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 11.9 mm100 -127.2 142.75 51.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.798 . . . . 5.58 109.472 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.844 ' HB2' HG13 ' A' ' 352' ' ' ILE . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.42 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.6 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.82 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.037 ' O ' HD13 ' A' ' 323' ' ' ILE . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.14 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 1.037 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 0.53 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.44 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.891 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 1.58 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.0 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.52 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.918 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 1.73 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.528 ' N ' ' HG3' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.03 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 0.9 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 323' ' ' ILE . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.93 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.962 ' HB1' ' NH2' ' A' ' 359' ' ' ARG . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 0.87 109.762 -176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 0.76 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.72 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.644 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 1.58 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.785 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.24 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.895 ' OG ' HG22 ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.56 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 364' ' ' GLU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.36 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.482 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 3.81 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -76.37 136.03 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.84 110.078 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -96.25 7.49 46.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 2.99 110.359 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.734 HG21 ' CE2' ' A' ' 377' ' ' PHE . 15.9 p -78.0 145.6 70.02 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 2.07 110.206 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.6 -37.46 79.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 2.38 110.175 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.568 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.66 -34.74 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 3.25 109.978 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.879 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.42 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 3.62 109.535 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.4 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 319' ' ' ALA . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 1.39 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.895 HG22 ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.18 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 351' ' ' SER . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.36 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 319' ' ' ALA . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.15 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.644 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -63.62 -37.21 86.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 0.61 109.477 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.0 ttpt -58.19 -49.9 75.42 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.777 -1.202 . . . . 1.16 110.621 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -66.1 -44.92 82.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.2 -1.562 . . . . 1.9 110.187 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.962 ' NH2' ' HB1' ' A' ' 334' ' ' ALA . 25.0 mtm180 -62.13 -44.82 95.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.917 -1.114 . . . . 2.63 111.757 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.626 ' HB3' HD11 ' A' ' 362' ' ' LEU . 97.8 m-85 -115.75 -14.5 11.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.175 . . . . 3.32 109.942 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.4 t-20 60.65 50.21 5.82 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.895 0.855 . . . . 1.9 110.336 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 360' ' ' PHE . 26.1 mt -118.21 172.35 7.49 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.535 . . . . 2.8 109.687 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -119.22 167.32 11.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 4.4 110.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.887 ' HG3' HD22 ' A' ' 342' ' ' LEU . 5.0 tt0 -57.94 148.68 25.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.518 -0.739 . . . . 2.24 109.418 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.454 ' H ' HD11 ' A' ' 342' ' ' LEU . 59.5 mtm180 -100.92 140.04 35.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 4.16 110.068 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 2.86 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.661 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.04 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.69 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.05 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.892 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.14 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.1 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.12 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.519 ' C ' HG11 ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.11 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.09 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.0 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 4.63 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.734 ' CE2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 5.79 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.29 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.13 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.74 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.82 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.25 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.617 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.09 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.23 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.13 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.26 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.2 m-20 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.04 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.892 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.11 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.85 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.33 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 2.69 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.409 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.02 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 340' ' ' ALA . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 1.68 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 2.78 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.839 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 1.57 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.545 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.82 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.17 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.844 HG21 ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.53 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.59 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.85 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 0.81 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 2.62 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 2.48 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.526 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 2.43 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 437' ' ' SER . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.94 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.16 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.53 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 80.2 m-20 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.28 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.602 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 1.72 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.429 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.16 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.801 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 3.31 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.23 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 1.75 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.87 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 0.71 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.81 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.6 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.985 ' O ' HG23 ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 2.49 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.844 ' CG1' HG21 ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.79 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.05 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 29.9 mm100 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.33 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 419' ' ' LYS . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.0 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.24 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.11 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 2.92 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.16 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.07 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 317' ' ' ARG . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.21 108.992 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.2 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.69 HD21 " C2'" ' A' 1001 ' ' ANP . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.4 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.801 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 0.52 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.99 HG12 HD21 ' A' ' 440' ' ' LEU . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.08 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 0.9 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.719 ' HG2' HD13 ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.42 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 405' ' ' VAL . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.42 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 3.52 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.41 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.99 HD21 HG12 ' A' ' 433' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 1.79 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.776 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.02 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.831 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 0.57 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.05 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.962 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 0.46 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.11 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 317' ' ' ARG . 38.3 tttp -86.2 140.22 30.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.48 109.645 174.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 36.6 p30 -95.86 130.24 42.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.289 -0.882 . . . . 3.91 110.647 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 448' ' ' ILE . 4.4 mm -55.52 -48.65 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.066 -1.021 . . . . 3.61 109.417 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.55 135.68 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.205 0.526 . . . . 5.09 110.27 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -92.4 145.71 24.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 7.5 110.225 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 7.3 109.515 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.69 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.474 ' N ' ' HB ' ' A' ' 448' ' ' ILE . 80.8 m-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.273 0.558 . . . . 6.08 110.213 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 447' ' ' ASP . 25.8 mmt85 -123.45 139.91 53.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 5.83 110.327 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 -140.93 141.82 34.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.449 -0.782 . . . . 5.58 110.231 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.091 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.42 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.514 ' O ' ' NH2' ' A' ' 359' ' ' ARG . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.6 110.653 175.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.82 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 360' ' ' PHE . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.14 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.8 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 0.53 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.44 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 1.58 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.0 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.52 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 440' ' ' LEU . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 1.73 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.03 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.9 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 323' ' ' ILE . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 0.93 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 0.87 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.76 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.432 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 0.72 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.618 ' N ' ' OE1' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 335' ' ' ASP . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 1.58 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.24 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.56 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.56 HD11 ' H ' ' A' ' 365' ' ' ARG . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.36 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 3.81 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.21 138.28 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.84 110.053 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.58 6.71 48.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.108 -0.995 . . . . 2.99 110.246 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 32.0 p -76.1 141.47 70.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 2.07 110.08 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.9 Cg_exo -56.8 -34.2 96.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.848 1.446 . . . . 2.38 110.204 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -37.14 86.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 3.25 110.25 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.42 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 3.62 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.741 ' HA ' HD12 ' A' ' 354' ' ' ILE . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.4 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.619 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.39 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.18 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 351' ' ' SER . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.36 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.091 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.15 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -68.52 -39.04 81.36 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 0.61 109.998 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 27.3 mttt -65.55 -42.99 91.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.673 -1.267 . . . . 1.16 110.739 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -62.73 -39.34 93.76 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.096 -1.627 . . . . 1.9 109.722 176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 320' ' ' SER . 26.3 mmt85 -75.89 -47.49 25.18 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.122 -0.987 . . . . 2.63 111.579 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 27.8 m-85 -115.87 -14.58 11.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.776 -1.203 . . . . 3.32 110.272 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 26.8 t30 60.13 42.92 14.82 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.542 -0.724 . . . . 1.9 110.385 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.7 OUTLIER -77.36 -173.2 2.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.447 -0.783 . . . . 2.8 109.626 171.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -129.07 153.45 47.63 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 4.4 109.929 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.33 146.23 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 2.24 109.523 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.56 ' H ' HD11 ' A' ' 342' ' ' LEU . 57.7 mtp180 -97.17 128.19 43.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 4.16 109.975 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 2.86 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.75 HG21 ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.04 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.69 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.495 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.05 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.14 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.1 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.728 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.12 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.11 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.75 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.09 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.963 HG11 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.0 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 4.63 111.244 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.53 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 5.79 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.29 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.13 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.74 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.82 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.25 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.738 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.09 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.23 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.13 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.622 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.26 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.507 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 8.8 m-20 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.04 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.11 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.85 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.33 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 2.69 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.02 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.705 HD13 ' HG2' ' A' ' 435' ' ' GLU . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 1.68 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.963 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 2.78 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.825 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.57 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.65 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.82 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.587 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.17 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.764 ' CG2' HG11 ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.53 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.59 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.738 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 0.85 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.65 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 0.81 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 2.62 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 2.48 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.528 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 2.43 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 437' ' ' SER . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 0.94 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.16 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.53 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 80.8 m-20 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.28 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 1.72 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.16 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.8 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 3.31 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.23 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 1.75 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.87 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 439' ' ' VAL . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 0.71 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.81 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.6 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.975 ' O ' HG23 ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 2.49 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.764 HG11 ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 0.79 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.05 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.535 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.33 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.976 HG13 ' CB ' ' A' ' 444' ' ' ALA . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.0 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.24 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.535 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.11 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 2.92 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.16 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.07 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.21 109.275 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.764 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.2 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.919 HD21 " C2'" ' A' 1001 ' ' ANP . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.4 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 0.52 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.915 HG12 HD21 ' A' ' 440' ' ' LEU . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.08 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 0.9 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.705 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.42 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.42 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 3.52 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.41 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 433' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 1.79 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.02 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 0.57 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 322' ' ' PHE . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.05 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.976 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 0.46 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.11 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.8 146.84 27.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.48 109.52 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 35.0 p30 -91.93 122.0 34.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 3.91 110.617 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -53.57 -47.69 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 3.61 109.545 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.62 135.53 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.505 -0.747 . . . . 5.09 110.252 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -90.51 132.9 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 7.5 110.143 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 7.3 109.533 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.919 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.473 ' HB2' HG12 ' A' ' 448' ' ' ILE . 97.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.229 0.538 . . . . 6.08 110.247 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -136.64 144.14 43.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.244 -0.91 . . . . 5.83 110.467 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 448' ' ' ILE . 16.6 mt-30 -135.47 148.6 49.3 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.82 . . . . 5.58 109.659 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.42 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.6 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.525 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.82 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.048 ' O ' HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.14 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 0.53 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.556 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.44 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 1.58 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.0 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.52 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 1.73 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.481 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.03 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.9 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.985 HD22 ' O ' ' A' ' 323' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.93 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 0.87 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.618 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.457 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.76 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 0.72 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.677 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.95 HD11 HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 1.58 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.24 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.56 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 364' ' ' GLU . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.36 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 3.81 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 2.5 p30 -93.9 138.86 31.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.84 110.228 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.46 7.0 47.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 2.99 110.296 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 22.0 p -71.48 141.0 85.0 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 2.07 110.05 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.6 Cg_exo -57.03 -36.74 99.41 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.909 1.479 . . . . 2.38 110.25 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.587 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 95.6 mt-10 -64.52 -36.37 83.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 3.25 110.11 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.42 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 3.62 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.744 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.4 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.64 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 1.39 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.681 HG12 ' HE2' ' A' ' 357' ' ' LYS . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.18 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 351' ' ' SER . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.36 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.15 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.677 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -66.86 -38.52 86.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 0.61 109.841 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.681 ' HE2' HG12 ' A' ' 353' ' ' VAL . 52.6 mtmt -62.89 -47.6 82.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.753 -1.217 . . . . 1.16 111.379 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -64.73 -40.03 94.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.146 -1.596 . . . . 1.9 109.535 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.497 ' HG3' ' HG3' ' A' ' 358' ' ' GLN . 63.8 mtp85 -75.7 -41.57 53.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 2.63 111.476 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.704 ' HB3' HD11 ' A' ' 362' ' ' LEU . 94.4 m-85 -115.72 -13.63 11.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.938 -1.102 . . . . 3.32 110.311 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.6 t-20 60.56 50.04 6.11 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.949 0.88 . . . . 1.9 110.169 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.0 mt -108.26 177.74 4.71 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.534 -0.543 . . . . 2.8 109.534 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -119.91 151.15 39.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.93 -1.107 . . . . 4.4 110.068 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 12.3 pt-20 -54.75 149.02 11.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 2.24 109.517 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 342' ' ' LEU . 92.6 mtt-85 -95.53 123.99 39.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.009 -1.057 . . . . 4.16 109.788 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 2.86 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.04 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.69 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.05 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 388' ' ' ILE . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.14 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.1 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.795 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.12 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.599 ' C ' HG11 ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.11 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.643 ' CD1' HG21 ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.09 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.84 HG11 ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.0 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 4.63 110.999 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 5.79 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.29 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.13 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.74 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.82 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.494 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.25 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.515 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.09 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.13 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 339' ' ' LEU . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.26 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.04 109.06 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.059 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.11 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 1.059 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.85 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.33 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 2.69 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 393' ' ' ILE . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.02 109.453 168.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.95 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 1.68 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.84 ' NH1' HG11 ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 2.78 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.929 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 1.57 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.698 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.82 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.17 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.892 HG21 ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.53 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.59 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 0.85 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.698 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 0.81 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 2.62 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 2.48 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 2.43 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.641 HG12 ' C ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.94 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.16 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.53 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 83.0 m-20 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.28 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.641 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 1.72 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.16 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.811 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 3.31 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.23 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 1.75 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.87 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 439' ' ' VAL . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 0.71 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.81 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.6 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 2.49 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.892 ' CG1' HG21 ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.79 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.05 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.33 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.0 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.24 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.11 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 2.92 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.16 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.07 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.21 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.661 ' HA ' HG11 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.2 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.939 HD21 " O2'" ' A' 1001 ' ' ANP . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.4 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 0.52 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.929 HG22 ' HG3' ' A' ' 395' ' ' LYS . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.08 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 0.9 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.42 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 405' ' ' VAL . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.42 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 3.52 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 416' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.41 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.923 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 1.79 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.799 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.02 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.889 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 0.57 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.964 ' CD1' HD21 ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.05 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.804 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 0.46 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.11 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -88.11 142.52 27.7 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.48 109.291 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 36.5 p30 -95.74 118.53 32.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.195 -0.941 . . . . 3.91 110.727 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 0.9 OUTLIER -52.89 -46.97 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 3.61 109.563 177.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.04 134.36 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 5.09 110.124 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -91.26 132.75 35.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 7.5 110.181 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.003 -1.443 . . . . 7.3 109.565 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.939 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 18.7 t-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.157 0.503 . . . . 6.08 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' A' ' 348' ' ' GLU . 87.6 mtm-85 -121.99 140.25 52.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.081 . . . . 5.83 110.519 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.568 ' NE2' HD11 ' A' ' 448' ' ' ILE . 15.5 mt-30 -135.62 150.55 49.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 5.58 109.403 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.42 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.594 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.6 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.82 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.652 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.14 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.53 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.44 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.698 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 1.58 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.0 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.52 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 1.73 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 332' ' ' THR . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.453 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.03 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.9 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 443' ' ' ILE . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.93 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 0.87 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 0.76 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 0.72 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.669 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 1.58 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.24 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.56 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.662 HD11 ' H ' ' A' ' 365' ' ' ARG . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.36 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 3.81 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.1 p30 -97.02 138.27 34.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.84 110.186 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.97 7.13 47.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 2.99 110.244 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.873 HG21 ' CD2' ' A' ' 377' ' ' PHE . 82.6 p -75.32 141.12 73.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 2.07 110.194 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.7 Cg_exo -57.4 -37.58 97.04 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.962 1.506 . . . . 2.38 110.174 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.562 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 96.9 mt-10 -63.93 -35.28 80.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 3.25 110.102 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.42 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 3.62 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.589 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.4 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 1.39 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.18 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 351' ' ' SER . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.36 110.27 169.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.15 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -66.15 -37.63 86.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 0.61 109.726 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 361' ' ' ASN . 39.1 mtmt -62.55 -47.87 81.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.697 -1.252 . . . . 1.16 111.026 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 359' ' ' ARG . 21.0 pt20 -64.85 -40.62 95.45 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.32 -1.487 . . . . 1.9 109.707 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.508 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 56.9 mmm-85 -73.18 -44.86 59.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.119 -0.988 . . . . 2.63 111.604 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.699 ' HB3' HD11 ' A' ' 362' ' ' LEU . 76.2 m-85 -115.73 -13.61 11.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 3.32 110.368 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 357' ' ' LYS . 11.3 t-20 60.62 50.1 5.94 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.885 0.85 . . . . 1.9 110.192 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.5 mt -110.68 -178.81 3.58 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.588 -0.523 . . . . 2.8 109.588 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -123.09 152.12 41.35 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.818 -1.176 . . . . 4.4 110.225 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.53 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.2 pt-20 -52.01 153.25 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 2.24 109.738 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.662 ' H ' HD11 ' A' ' 342' ' ' LEU . 73.1 mtp180 -98.81 136.11 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.03 -1.044 . . . . 4.16 110.245 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 2.86 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.927 HG13 ' HB3' ' A' ' 372' ' ' ALA . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.04 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.69 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.05 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.883 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.14 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.1 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.927 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.12 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.11 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.09 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.0 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 4.63 111.354 -175.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.873 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 5.79 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.29 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.13 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.74 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.82 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.25 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.62 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.09 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.23 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.13 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.26 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.587 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.4 m-20 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.04 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.883 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.11 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.85 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.33 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 2.69 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.02 109.069 167.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 1.68 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.78 110.393 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.881 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 1.57 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.733 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.82 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.17 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.748 ' CG2' HG11 ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 0.53 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.59 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.62 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 0.85 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.733 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 0.81 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 2.62 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 2.48 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 2.43 110.723 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.583 HG12 ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.94 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.16 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.53 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.548 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 81.4 m-20 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.28 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.583 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 1.72 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.16 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.772 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 3.31 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.23 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 1.75 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 419' ' ' LYS . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.87 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 439' ' ' VAL . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 0.71 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.81 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.6 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.995 ' O ' HG23 ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 2.49 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 430' ' ' PRO . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.79 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 424' ' ' ALA . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.05 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.33 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 1.01 HG13 ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.0 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.24 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.513 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.11 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 2.92 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.16 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.07 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.21 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.816 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.2 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.584 ' CD2' " O2'" ' A' 1001 ' ' ANP . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.4 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 0.52 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.08 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 439' ' ' VAL . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 0.9 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.546 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.42 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.42 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.531 ' NH2' ' HB3' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 3.52 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 416' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.41 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 1.79 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.588 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.02 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.837 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.57 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.837 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.05 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 1.01 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.46 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.11 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -95.39 144.08 26.21 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.48 109.679 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 40.6 t0 -95.86 137.45 34.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.197 -0.939 . . . . 3.91 110.173 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.568 HD11 ' NE2' ' A' ' 318' ' ' GLN . 4.1 mm -54.23 -44.29 64.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.124 0.964 . . . . 3.61 108.947 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -97.83 134.56 35.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.805 -0.634 . . . . 5.09 110.114 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -90.99 132.76 35.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 7.5 110.133 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 117.962 -1.465 . . . . 7.3 109.549 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.611 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.003 0.43 . . . . 5.5800000000000001 110.12 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.4199999999999999 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.6000000000000001 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.465 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.8200000000000001 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.733 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.1399999999999999 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.802 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.53000000000000003 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.565 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.4399999999999999 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.778 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 1.5800000000000001 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.0 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.52 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 1.73 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.565 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7000000000000002 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.475 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.0299999999999998 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.90000000000000002 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.825 ' HA ' HD12 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 0.93000000000000005 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.591 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 0.87 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.76000000000000001 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.71999999999999997 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 1.5800000000000001 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.2400000000000002 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.5600000000000001 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.3600000000000003 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 3.8100000000000001 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.8399999999999999 110.112 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.314 0.578 . . . . 3.25 110.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.4199999999999999 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 3.6200000000000001 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.751 ' HA ' HD12 ' A' ' 354' ' ' ILE . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.3999999999999999 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.699 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 1.3899999999999999 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.1799999999999999 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 351' ' ' SER . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.3600000000000001 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 319' ' ' ALA . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.1499999999999999 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.60999999999999999 109.743 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.187 0.518 . . . . 4.1600000000000001 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 2.8599999999999999 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.04 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.6899999999999999 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.0499999999999998 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.1400000000000001 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.1000000000000001 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.1200000000000001 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.488 ' N ' HG13 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.1099999999999999 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.0899999999999999 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.969 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.0 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 4.6299999999999999 111.268 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.557 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 5.79 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.29 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.1299999999999999 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.7400000000000002 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.8199999999999998 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.25 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.715 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.0899999999999999 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.23 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.1299999999999999 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.26 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.603 ' ND2' ' HE3' ' A' ' 392' ' ' MET . 3.0 m120 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.04 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.1099999999999999 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.8500000000000001 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.3300000000000001 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 2.6899999999999999 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.603 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.02 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 339' ' ' LEU . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 1.6799999999999999 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.969 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 1.5700000000000001 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.602 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.81999999999999995 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.1699999999999999 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 0.53000000000000003 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.5900000000000001 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 0.84999999999999998 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.602 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 0.81000000000000005 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 2.6200000000000001 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 2.48 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.514 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 2.4300000000000002 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.619 HG12 ' C ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 0.93999999999999995 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.1600000000000001 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.53 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.2799999999999998 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.619 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 1.72 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.1600000000000001 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 3.3100000000000001 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.23 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 1.75 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.554 ' N ' HG23 ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.8700000000000001 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 439' ' ' VAL . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 0.70999999999999996 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.8100000000000001 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.6000000000000001 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 2.4900000000000002 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.017 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 0.79000000000000004 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.0499999999999998 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.3300000000000001 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.0 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.24 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.538 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.1100000000000003 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 2.9199999999999999 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.0700000000000001 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.21 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.017 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.2 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.537 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.3999999999999999 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 0.52000000000000002 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.0800000000000001 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.79 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 0.90000000000000002 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.515 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.4199999999999999 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.4199999999999999 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 3.52 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 416' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.4099999999999999 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.79 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.02 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 443' ' ' ILE . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 0.56999999999999995 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.05 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.46000000000000002 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.1099999999999999 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.4800000000000004 109.511 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.491 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.105 0.479 . . . . 5.5800000000000001 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.993 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.4199999999999999 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.75 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.6000000000000001 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.8200000000000001 110.881 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.807 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.1399999999999999 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 0.53000000000000003 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.4399999999999999 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.733 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 1.5800000000000001 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.0 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.52 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 1.73 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7000000000000002 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.0299999999999998 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.90000000000000002 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 441' ' ' GLY . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 0.93000000000000005 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 0.87 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' HD23 ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 0.76000000000000001 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 0.71999999999999997 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.768 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.755 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 1.5800000000000001 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.2400000000000002 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.5600000000000001 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.3600000000000003 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 3.8100000000000001 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.7 p30 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.8399999999999999 110.161 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.387 0.613 . . . . 3.25 110.169 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.4199999999999999 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 3.6200000000000001 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.3999999999999999 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.639 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 1.3899999999999999 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 341' ' ' SER . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.1799999999999999 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 351' ' ' SER . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.3600000000000001 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.993 HD22 ' HB1' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.1499999999999999 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.768 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 0.60999999999999999 109.388 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.369 0.604 . . . . 4.1600000000000001 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 2.8599999999999999 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.04 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.6899999999999999 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.0499999999999998 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.1400000000000001 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.1000000000000001 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.775 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.1200000000000001 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.1099999999999999 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.0899999999999999 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 1.008 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.0 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 4.6299999999999999 111.207 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 5.79 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.29 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.1299999999999999 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.7400000000000002 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.8199999999999998 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.49 ' HD2' ' HB3' ' A' ' 397' ' ' SER . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.25 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.809 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.0899999999999999 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.23 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.1299999999999999 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.26 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.568 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.04 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.1099999999999999 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.8500000000000001 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.3300000000000001 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 2.6899999999999999 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.424 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.02 109.09 166.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.553 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 1.6799999999999999 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 1.008 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 2.7799999999999998 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.872 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 1.5700000000000001 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.648 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.81999999999999995 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.1699999999999999 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.867 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 0.53000000000000003 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.5900000000000001 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.809 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.648 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 0.81000000000000005 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 2.6200000000000001 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 2.48 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.7 t-80 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 2.4300000000000002 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.638 HG12 ' C ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 0.93999999999999995 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.1600000000000001 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.53 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.533 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.1 m120 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.2799999999999998 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.638 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 1.72 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.1600000000000001 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 3.3100000000000001 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.23 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 1.75 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.8700000000000001 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 439' ' ' VAL . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 0.70999999999999996 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.8100000000000001 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 26.6 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.6000000000000001 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.988 ' O ' HG23 ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 2.4900000000000002 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.904 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 0.79000000000000004 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.0499999999999998 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.3300000000000001 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.0 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.24 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.1100000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 2.9199999999999999 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.1599999999999999 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.0700000000000001 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.21 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.904 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.2 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.628 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.3999999999999999 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 0.52000000000000002 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.931 HG12 HD21 ' A' ' 440' ' ' LEU . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.0800000000000001 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.464 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.4199999999999999 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.4199999999999999 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 3.52 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.4099999999999999 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.931 HD21 HG12 ' A' ' 433' ' ' VAL . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 1.79 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.02 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.904 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 0.56999999999999995 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.05 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.812 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 0.46000000000000002 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.1099999999999999 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.4800000000000004 110.022 172.602 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 25.5 mt-30 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.234 -0.654 . . . . 5.5800000000000001 109.234 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.012 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.4199999999999999 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.613 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.6000000000000001 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.8200000000000001 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.1399999999999999 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.554 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 0.53000000000000003 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.558 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.4399999999999999 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 1.5800000000000001 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.0 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.52 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 1.73 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7000000000000002 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.495 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.0299999999999998 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.90000000000000002 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 441' ' ' GLY . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 0.93000000000000005 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.87 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.536 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.435 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.76000000000000001 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 0.71999999999999997 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.936 ' OE1' ' HB2' ' A' ' 356' ' ' ALA . 0.9 OUTLIER -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 1.5800000000000001 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.2400000000000002 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.5600000000000001 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.3600000000000003 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 3.8100000000000001 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.8399999999999999 110.126 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.445 0.641 . . . . 3.25 110.081 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.4199999999999999 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 3.6200000000000001 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.3999999999999999 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 319' ' ' ALA . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 1.3899999999999999 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.1799999999999999 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.3600000000000001 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.012 HD22 ' HB1' ' A' ' 319' ' ' ALA . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.1499999999999999 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.936 ' HB2' ' OE1' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 0.60999999999999999 109.478 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.401 0.619 . . . . 4.1600000000000001 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 2.8599999999999999 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 372' ' ' ALA . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.04 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.6899999999999999 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.0499999999999998 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.856 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.1400000000000001 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.1000000000000001 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.976 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.1200000000000001 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.1099999999999999 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.703 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.0899999999999999 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 1.028 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.0 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 4.6299999999999999 111.355 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.553 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 5.79 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.29 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.1299999999999999 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.7400000000000002 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.8199999999999998 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.25 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.583 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.0899999999999999 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.439 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.1299999999999999 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.26 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.669 HD21 HG21 ' A' ' 375' ' ' VAL . 2.8 m120 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.04 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.856 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.1099999999999999 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.8500000000000001 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.3300000000000001 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 2.6899999999999999 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.02 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 1.6799999999999999 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 1.028 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 2.7799999999999998 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.844 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 1.5700000000000001 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.81999999999999995 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.1699999999999999 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.53000000000000003 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.5900000000000001 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 0.84999999999999998 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 0.81000000000000005 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 2.6200000000000001 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 2.48 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 2.4300000000000002 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 0.93999999999999995 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.1600000000000001 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.53 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.2799999999999998 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.632 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 1.72 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.1600000000000001 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.792 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 3.3100000000000001 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.23 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 1.75 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.8700000000000001 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 439' ' ' VAL . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.70999999999999996 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.8100000000000001 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.6000000000000001 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 2.4900000000000002 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 0.79000000000000004 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.0499999999999998 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.3300000000000001 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.0 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.24 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.1100000000000003 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 2.9199999999999999 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.1599999999999999 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.0700000000000001 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.21 108.985 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.828 ' HB2' HG13 ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.2 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.3999999999999999 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 0.52000000000000002 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.996 HG12 HD21 ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.0800000000000001 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.728 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 0.90000000000000002 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.688 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.4199999999999999 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.748 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.4199999999999999 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 3.52 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 416' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.4099999999999999 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.996 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 1.79 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.02 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.666 HG11 ' HA ' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 0.56999999999999995 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.05 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.916 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 0.46000000000000002 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.1099999999999999 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.8 tttt . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.4800000000000004 109.604 174.21 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 351' ' ' SER . 14.3 pt20 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.903 0.383 . . . . 5.5800000000000001 110.149 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.6000000000000001 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.8200000000000001 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.78 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.1399999999999999 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.824 ' C ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.53000000000000003 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.4399999999999999 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 1.5800000000000001 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.0 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.52 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 1.73 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7000000000000002 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.0299999999999998 110.51 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 0.90000000000000002 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.974 HD13 ' HA3' ' A' ' 441' ' ' GLY . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.93000000000000005 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.87 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.595 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.641 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 0.76000000000000001 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.63 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 0.71999999999999997 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.757 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 386' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 1.5800000000000001 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.2400000000000002 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.5600000000000001 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.3600000000000003 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 3.8100000000000001 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.8399999999999999 110.107 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.276 0.56 . . . . 3.25 110.142 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.4199999999999999 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 3.6200000000000001 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 354' ' ' ILE . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.3999999999999999 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.642 HG22 ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 1.3899999999999999 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 338' ' ' GLN . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 351' ' ' SER . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.3600000000000001 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.1499999999999999 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.757 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.60999999999999999 109.58 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.548 ' CZ ' HD22 ' A' ' 339' ' ' LEU . 10.8 ptp180 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.46 0.647 . . . . 4.1600000000000001 110.317 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.491 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 2.8599999999999999 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 372' ' ' ALA . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.04 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.6899999999999999 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.0499999999999998 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.1000000000000001 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.895 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.1200000000000001 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.1099999999999999 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.655 ' CE1' HG21 ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.0899999999999999 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.521 ' N ' ' HB1' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.0 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 4.6299999999999999 111.119 -175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 5.79 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.29 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.1299999999999999 110.528 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.7400000000000002 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.8199999999999998 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.25 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.606 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.0899999999999999 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 377' ' ' PHE . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.23 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.445 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.1299999999999999 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 339' ' ' LEU . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.26 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 375' ' ' VAL . 3.3 m120 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.04 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.1099999999999999 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.8500000000000001 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.3300000000000001 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 2.6899999999999999 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.695 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.02 109.317 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.846 HG13 HD11 ' A' ' 339' ' ' LEU . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 1.6799999999999999 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.514 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 2.7799999999999998 110.069 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 1.021 ' HD3' HD13 ' A' ' 431' ' ' LEU . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 1.5700000000000001 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.788 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.81999999999999995 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.585 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.1699999999999999 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.042 HG21 HG11 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.53000000000000003 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.5900000000000001 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.788 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 0.81000000000000005 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 2.6200000000000001 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 2.48 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.514 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 55.5 t-80 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 2.4300000000000002 110.722 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.611 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 0.93999999999999995 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.1600000000000001 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.53 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.2799999999999998 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.611 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 1.72 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.1600000000000001 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 3.3100000000000001 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.23 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 1.75 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 418' ' ' GLN . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.8700000000000001 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 439' ' ' VAL . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 0.70999999999999996 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.8100000000000001 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 415' ' ' ASP . 9.2 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.6000000000000001 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 2.4900000000000002 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.042 HG11 HG21 ' A' ' 398' ' ' VAL . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.79000000000000004 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.0499999999999998 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.3300000000000001 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.0 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.24 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.1100000000000003 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 2.9199999999999999 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.1599999999999999 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.0700000000000001 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.21 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.014 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.2 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 1.021 HD13 ' HD3' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.3999999999999999 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 0.52000000000000002 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.7 HG12 HD21 ' A' ' 440' ' ' LEU . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.0800000000000001 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 0.90000000000000002 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.4199999999999999 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.4199999999999999 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.524 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 3.52 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 416' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.4099999999999999 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.879 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 1.79 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.974 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.02 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.755 ' CG1' HG22 ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 0.56999999999999995 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 322' ' ' PHE . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.05 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.1099999999999999 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.4800000000000004 109.382 170.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.153 0.501 . . . . 5.5800000000000001 110.384 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.4199999999999999 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.6000000000000001 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.411 ' OE2' HD11 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.8200000000000001 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.033 ' CD1' HD21 ' A' ' 355' ' ' LEU . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.1399999999999999 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.53000000000000003 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.4399999999999999 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.802 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 1.5800000000000001 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.0 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.52 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.909 HG11 ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 1.73 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.546 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7000000000000002 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.0299999999999998 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.90000000000000002 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 443' ' ' ILE . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.93000000000000005 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.804 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 0.87 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 0.76000000000000001 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 0.71999999999999997 110.099 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.656 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 1.5800000000000001 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.2400000000000002 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.5600000000000001 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.3600000000000003 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 3.8100000000000001 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.8399999999999999 110.007 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.275 0.56 . . . . 3.25 110.136 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.4199999999999999 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 3.6200000000000001 109.444 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.762 ' HA ' HD12 ' A' ' 354' ' ' ILE . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.3999999999999999 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.613 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 1.3899999999999999 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.1799999999999999 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.3600000000000001 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.1499999999999999 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.656 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 0.60999999999999999 109.634 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.51 ' HD3' ' CD1' ' A' ' 370' ' ' LEU . 25.3 ttm180 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.663 0.744 . . . . 4.1600000000000001 109.997 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 2.8599999999999999 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.731 HG21 ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.04 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.6899999999999999 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.0499999999999998 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.1400000000000001 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.1000000000000001 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.1200000000000001 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.1099999999999999 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.731 ' CE1' HG21 ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.0899999999999999 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.654 HG23 ' HA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.0 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 4.6299999999999999 111.331 -175.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.557 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 5.79 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.29 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.1299999999999999 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.7400000000000002 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.8199999999999998 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.25 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.575 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.0899999999999999 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.436 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.1299999999999999 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.26 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.606 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.04 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.891 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.1099999999999999 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.8500000000000001 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.3300000000000001 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 2.6899999999999999 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.02 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.706 HD13 ' HG2' ' A' ' 435' ' ' GLU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 1.6799999999999999 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.454 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 2.7799999999999998 110.419 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 1.5700000000000001 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.67 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.81999999999999995 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.1699999999999999 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.845 HG21 ' CG1' ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.53000000000000003 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.5900000000000001 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.84999999999999998 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.67 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 0.81000000000000005 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 2.6200000000000001 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 2.48 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.454 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 85.7 t60 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 2.4300000000000002 110.58 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 437' ' ' SER . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.93999999999999995 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.1600000000000001 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.53 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.2799999999999998 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.61 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 1.72 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.1600000000000001 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.828 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 3.3100000000000001 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.23 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 1.75 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.8700000000000001 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 439' ' ' VAL . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 0.70999999999999996 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.8100000000000001 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.6000000000000001 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 2.4900000000000002 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 0.79000000000000004 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.0499999999999998 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.3300000000000001 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.0 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.24 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.1100000000000003 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 2.9199999999999999 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.1599999999999999 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.0700000000000001 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.21 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.669 ' HA ' HG11 ' A' ' 423' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.2 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.587 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.3999999999999999 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.766 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 0.52000000000000002 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.123 HG12 HD21 ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.0800000000000001 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.743 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.90000000000000002 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.706 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.4199999999999999 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.4199999999999999 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 3.52 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 416' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.4099999999999999 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.123 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 1.79 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.661 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.02 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.817 ' O ' HD13 ' A' ' 443' ' ' ILE . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 0.56999999999999995 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.05 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.773 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.46000000000000002 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.1099999999999999 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.4800000000000004 109.162 169.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.837 -0.431 . . . . 5.5800000000000001 109.837 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.4199999999999999 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.6000000000000001 110.564 175.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.508 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.8200000000000001 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.864 ' CD2' ' HB2' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.1399999999999999 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.838 ' O ' HD22 ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.53000000000000003 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.4399999999999999 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.808 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 1.5800000000000001 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.0 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.52 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 1.73 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7000000000000002 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.0299999999999998 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.90000000000000002 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.852 HD21 ' O ' ' A' ' 442' ' ' VAL . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.93000000000000005 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.864 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.87 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 0.76000000000000001 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.71999999999999997 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.701 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 1.5800000000000001 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.2400000000000002 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.5600000000000001 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 365' ' ' ARG . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.3600000000000003 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 3.8100000000000001 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.8399999999999999 110.309 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.56 . . . . 3.25 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.4199999999999999 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 3.6200000000000001 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.763 ' HA ' HD12 ' A' ' 354' ' ' ILE . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.3999999999999999 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 319' ' ' ALA . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 1.3899999999999999 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 338' ' ' GLN . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.1799999999999999 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 351' ' ' SER . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.3600000000000001 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.965 HD22 ' HB1' ' A' ' 319' ' ' ALA . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.1499999999999999 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.556 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 0.60999999999999999 109.561 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 342' ' ' LEU . 82.6 mtp180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.171 0.51 . . . . 4.1600000000000001 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 2.8599999999999999 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 372' ' ' ALA . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.04 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.6899999999999999 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.0499999999999998 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.1400000000000001 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 29.7 m170 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.1000000000000001 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.806 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.1200000000000001 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.1099999999999999 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.0899999999999999 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.595 HG23 ' HA ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.0 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 4.6299999999999999 111.162 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.588 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 5.79 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.29 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.1299999999999999 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.7400000000000002 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.8199999999999998 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.25 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.0899999999999999 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.588 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.23 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.679 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.1299999999999999 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.855 HG22 ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.26 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.414 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 7.9 m120 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.04 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.056 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.1099999999999999 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 1.056 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.8500000000000001 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.3300000000000001 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 2.6899999999999999 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.838 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.02 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.855 ' HB ' HG22 ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 1.6799999999999999 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 2.7799999999999998 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.5700000000000001 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.722 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.81999999999999995 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.1699999999999999 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.937 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 0.53000000000000003 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.5900000000000001 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 0.84999999999999998 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.722 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 0.81000000000000005 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 2.6200000000000001 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 2.48 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.569 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 57.7 t-80 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 2.4300000000000002 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.609 HG12 ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 0.93999999999999995 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.1600000000000001 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.53 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.2799999999999998 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.609 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 1.72 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.1600000000000001 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 3.3100000000000001 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.23 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 1.75 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.8700000000000001 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.70999999999999996 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.8100000000000001 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.6000000000000001 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.942 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 2.4900000000000002 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 0.79000000000000004 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.0499999999999998 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.3300000000000001 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.0 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.24 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.537 ' HB3' ' NH1' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.1100000000000003 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 2.9199999999999999 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.1599999999999999 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.0700000000000001 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.21 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.018 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.2 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.581 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.3999999999999999 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 0.52000000000000002 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.889 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.0800000000000001 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.803 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 0.90000000000000002 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.4199999999999999 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.4199999999999999 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 3.52 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.4099999999999999 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 1.79 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.66 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.02 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.852 ' O ' HD21 ' A' ' 333' ' ' LEU . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 0.56999999999999995 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.05 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.582 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 0.46000000000000002 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.1099999999999999 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.4800000000000004 109.772 174.374 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.544 -0.539 . . . . 5.5800000000000001 109.544 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.03 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.4199999999999999 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.6000000000000001 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.8200000000000001 110.739 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.93 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.1399999999999999 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.53000000000000003 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.4399999999999999 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.731 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 1.5800000000000001 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.0 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.52 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 1.73 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7000000000000002 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.0299999999999998 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.90000000000000002 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' HA3' ' A' ' 441' ' ' GLY . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.93000000000000005 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.93 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 0.87 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 0.76000000000000001 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 0.71999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.726 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.912 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 1.5800000000000001 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.2400000000000002 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.5600000000000001 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.3600000000000003 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 3.8100000000000001 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.8399999999999999 110.12 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.311 0.577 . . . . 3.25 110.067 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.454 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.4199999999999999 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 3.6200000000000001 109.653 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.3999999999999999 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.726 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.1799999999999999 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.3600000000000001 110.491 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.1499999999999999 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.682 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 0.60999999999999999 109.606 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.843 ' CD ' HD22 ' A' ' 339' ' ' LEU . 58.5 mtp85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.671 0.748 . . . . 4.1600000000000001 110.563 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 2.8599999999999999 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.767 HG21 ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.04 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.6899999999999999 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.446 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.0499999999999998 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.1400000000000001 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.1099999999999999 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.0899999999999999 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.0 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 4.6299999999999999 111.27 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 5.79 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.29 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.1299999999999999 110.472 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.7400000000000002 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.8199999999999998 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.25 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.662 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.0899999999999999 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.23 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.1299999999999999 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.912 HG21 HD12 ' A' ' 339' ' ' LEU . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.26 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.2 m120 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.04 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.1099999999999999 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.8500000000000001 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.3300000000000001 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 2.6899999999999999 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.02 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.683 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 1.6799999999999999 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.5 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 2.7799999999999998 110.393 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.887 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 1.5700000000000001 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.704 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.81999999999999995 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.1699999999999999 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.53000000000000003 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.5900000000000001 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.662 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 0.84999999999999998 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.81000000000000005 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 2.6200000000000001 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 2.48 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.7 t60 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 2.4300000000000002 110.56 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 437' ' ' SER . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.93999999999999995 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.1600000000000001 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.53 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.2799999999999998 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 1.72 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.411 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.1600000000000001 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 3.3100000000000001 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.23 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 1.75 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.8700000000000001 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 439' ' ' VAL . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 0.70999999999999996 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.8100000000000001 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.6000000000000001 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.969 ' O ' HG23 ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 2.4900000000000002 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 430' ' ' PRO . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 0.79000000000000004 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.0499999999999998 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 25.5 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.3300000000000001 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.0 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.24 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.1100000000000003 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 2.9199999999999999 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.1599999999999999 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.0700000000000001 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.21 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.041 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.2 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.639 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.3999999999999999 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.786 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 0.52000000000000002 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.031 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.0800000000000001 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.756 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 0.90000000000000002 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.683 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.4199999999999999 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.857 ' O ' HG13 ' A' ' 405' ' ' VAL . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.4199999999999999 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 3.52 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.4099999999999999 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.031 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 1.79 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.02 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.897 ' O ' HD13 ' A' ' 443' ' ' ILE . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 0.56999999999999995 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.05 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.678 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.1099999999999999 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.4800000000000004 109.89 174.507 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.881 -0.414 . . . . 5.5800000000000001 109.881 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.067 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.4199999999999999 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.6000000000000001 110.543 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.8200000000000001 110.641 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.916 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.1399999999999999 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.53000000000000003 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.4399999999999999 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.79 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 1.5800000000000001 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.0 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.52 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.936 HG11 ' O ' ' A' ' 440' ' ' LEU . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 1.73 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.457 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7000000000000002 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.0299999999999998 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 0.90000000000000002 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 443' ' ' ILE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.93000000000000005 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.515 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 0.87 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.76000000000000001 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 0.71999999999999997 110.087 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 1.5800000000000001 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.2400000000000002 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.5600000000000001 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.3600000000000003 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 3.8100000000000001 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.8399999999999999 110.062 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.371 0.605 . . . . 3.25 110.117 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.4199999999999999 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 3.6200000000000001 109.498 172.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.3999999999999999 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.72 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 1.3899999999999999 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.1799999999999999 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.3600000000000001 110.342 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.067 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.1499999999999999 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.705 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 0.60999999999999999 109.663 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.518 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 88.5 mtt180 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.258 0.552 . . . . 4.1600000000000001 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.484 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 2.8599999999999999 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.04 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.6899999999999999 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.0499999999999998 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.1400000000000001 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.1000000000000001 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.1200000000000001 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.1099999999999999 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.659 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.0899999999999999 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.615 HG11 ' NH1' ' A' ' 394' ' ' ARG . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.0 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 4.6299999999999999 111.172 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 5.79 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.29 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.1299999999999999 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.7400000000000002 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.8199999999999998 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.25 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.686 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.0899999999999999 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.23 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.1299999999999999 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.26 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.592 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.4 m120 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.04 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.868 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.1099999999999999 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.8500000000000001 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.3300000000000001 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 2.6899999999999999 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.02 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 1.6799999999999999 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.638 ' HB3' HG22 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.879 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 1.5700000000000001 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.81999999999999995 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.1699999999999999 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.803 HG21 HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.53000000000000003 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.5900000000000001 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.686 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 0.84999999999999998 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.753 HG23 ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 0.81000000000000005 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 2.6200000000000001 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 2.48 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 2.4300000000000002 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 437' ' ' SER . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 0.93999999999999995 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.1600000000000001 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.53 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.2799999999999998 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.621 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 1.72 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.1600000000000001 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 3.3100000000000001 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.23 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 1.75 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.8700000000000001 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.035 ' CG1' HG11 ' A' ' 439' ' ' VAL . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 0.70999999999999996 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.8100000000000001 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.6000000000000001 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 2.4900000000000002 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 0.79000000000000004 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.0499999999999998 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.3300000000000001 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.0 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.24 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.1100000000000003 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 2.9199999999999999 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.1599999999999999 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.0700000000000001 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.21 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.998 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.2 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.3999999999999999 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.834 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 0.52000000000000002 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.044 HG12 HD21 ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.0800000000000001 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.875 ' C ' HD23 ' A' ' 440' ' ' LEU . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 0.90000000000000002 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.653 ' HG3' HD22 ' A' ' 440' ' ' LEU . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.4199999999999999 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.896 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.4199999999999999 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 3.52 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.4099999999999999 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.044 HD21 HG12 ' A' ' 433' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 1.79 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.02 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.859 ' O ' HD13 ' A' ' 443' ' ' ILE . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 0.56999999999999995 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.903 HD11 HD11 ' A' ' 333' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.05 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.644 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.46000000000000002 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.4800000000000004 109.279 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.154 0.502 . . . . 5.5800000000000001 110.314 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.01 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.4199999999999999 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 110.413 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.431 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.8200000000000001 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.923 ' O ' HD13 ' A' ' 323' ' ' ILE . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.1399999999999999 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 0.53000000000000003 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.548 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.4399999999999999 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 1.5800000000000001 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.0 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.52 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 440' ' ' LEU . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 1.73 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7000000000000002 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.0299999999999998 109.645 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 443' ' ' ILE . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.93000000000000005 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 0.87 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.76000000000000001 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.71999999999999997 109.987 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.665 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.894 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 1.5800000000000001 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.2400000000000002 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.5600000000000001 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.3600000000000003 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 3.8100000000000001 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 377' ' ' PHE . 8.2 p-10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.8399999999999999 110.287 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.361 0.6 . . . . 3.25 110.104 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.4199999999999999 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 3.6200000000000001 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.3999999999999999 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.599 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.3899999999999999 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.1799999999999999 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 351' ' ' SER . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.3600000000000001 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.01 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.1499999999999999 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.665 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 0.60999999999999999 109.565 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.685 0.755 . . . . 4.1600000000000001 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 2.8599999999999999 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.04 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.6899999999999999 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.0499999999999998 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.919 HD13 ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.1400000000000001 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.1000000000000001 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.1200000000000001 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.0899999999999999 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 1.012 HG11 ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.0 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 4.6299999999999999 111.371 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 5.79 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.29 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.1299999999999999 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.7400000000000002 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.8199999999999998 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.452 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.25 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.516 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.0899999999999999 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.23 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.1299999999999999 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.894 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.26 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.7 m120 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.04 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.919 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.1099999999999999 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.8500000000000001 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.3300000000000001 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 2.6899999999999999 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.02 109.236 167.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.667 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 1.6799999999999999 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 1.012 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 2.7799999999999998 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 1.5700000000000001 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.578 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.81999999999999995 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.1699999999999999 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.703 HG21 HG11 ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.5900000000000001 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 0.84999999999999998 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 0.81000000000000005 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 2.6200000000000001 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.48 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 2.4300000000000002 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.637 HG12 ' C ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.93999999999999995 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.1600000000000001 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.53 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.2799999999999998 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.1600000000000001 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 3.3100000000000001 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.23 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.559 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 1.75 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.8700000000000001 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 439' ' ' VAL . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 0.70999999999999996 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.8100000000000001 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.6000000000000001 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 2.4900000000000002 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 0.79000000000000004 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.0499999999999998 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.3300000000000001 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.0 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.24 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.1100000000000003 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 2.9199999999999999 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.1599999999999999 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.0700000000000001 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.21 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.2 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.3999999999999999 108.32 165.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 0.52000000000000002 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.07 HG12 HD21 ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.0800000000000001 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.639 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 0.90000000000000002 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.4199999999999999 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 405' ' ' VAL . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.4199999999999999 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 3.52 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 416' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.4099999999999999 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.07 HD21 HG12 ' A' ' 433' ' ' VAL . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 1.79 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.02 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 443' ' ' ILE . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 0.56999999999999995 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.893 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.05 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.765 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 0.46000000000000002 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.502 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.1099999999999999 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.4800000000000004 109.717 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.043 0.449 . . . . 5.5800000000000001 110.438 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.4199999999999999 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.6000000000000001 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.8200000000000001 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.09 ' CD1' HD21 ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.1399999999999999 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 323' ' ' ILE . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.53000000000000003 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.4399999999999999 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 1.5800000000000001 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.0 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.52 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.896 HG11 ' O ' ' A' ' 440' ' ' LEU . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 1.73 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7000000000000002 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.512 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.0299999999999998 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.90000000000000002 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.71 HD22 ' HA3' ' A' ' 441' ' ' GLY . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.93000000000000005 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 0.87 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 0.76000000000000001 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.71999999999999997 109.967 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.627 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 1.5800000000000001 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.604 ' OG ' HG23 ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.5600000000000001 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.3600000000000003 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 3.8100000000000001 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.8399999999999999 110.151 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.353 0.597 . . . . 3.25 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.4199999999999999 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 3.6200000000000001 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.733 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.3999999999999999 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.623 HG22 ' OE1' ' A' ' 338' ' ' GLN . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 1.3899999999999999 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.604 HG23 ' OG ' ' A' ' 341' ' ' SER . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.1799999999999999 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.3600000000000001 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.09 HD21 ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.1499999999999999 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.627 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 0.60999999999999999 109.864 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 4.1600000000000001 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.489 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 2.8599999999999999 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.04 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.6899999999999999 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.0499999999999998 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.1400000000000001 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.1000000000000001 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.1200000000000001 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.1099999999999999 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.0899999999999999 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 1.015 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.0 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 4.6299999999999999 111.332 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.556 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 5.79 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.29 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.1299999999999999 110.458 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.7400000000000002 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.8199999999999998 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.25 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.531 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.0899999999999999 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.23 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.446 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.1299999999999999 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.924 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.26 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.59 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.04 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.903 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.1099999999999999 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.8500000000000001 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.3300000000000001 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 2.6899999999999999 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.02 109.174 167.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.653 HG13 HD11 ' A' ' 339' ' ' LEU . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 1.6799999999999999 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 1.015 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 2.7799999999999998 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 1.5700000000000001 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.657 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.81999999999999995 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.1699999999999999 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.653 ' CG2' HG11 ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.53000000000000003 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.5900000000000001 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.59 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 0.84999999999999998 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 0.81000000000000005 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 2.6200000000000001 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 2.48 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.535 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 2.4300000000000002 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.687 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 0.93999999999999995 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.1600000000000001 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.53 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.2799999999999998 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.687 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 1.72 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.1600000000000001 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.808 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 3.3100000000000001 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.23 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 1.75 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.8700000000000001 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 439' ' ' VAL . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 0.70999999999999996 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.8100000000000001 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.6000000000000001 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.983 ' O ' HG23 ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 2.4900000000000002 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.79000000000000004 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.0499999999999998 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.3300000000000001 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.0 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.24 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.1100000000000003 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 2.9199999999999999 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.1599999999999999 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.0700000000000001 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.21 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.963 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.2 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.557 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.3999999999999999 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.808 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 0.52000000000000002 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.966 HG12 HD21 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.0800000000000001 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.652 ' CA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 0.90000000000000002 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.4199999999999999 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.4199999999999999 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 3.52 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.4099999999999999 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.966 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 1.79 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.71 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.02 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 443' ' ' ILE . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 0.56999999999999995 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.05 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.46000000000000002 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.1099999999999999 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.4800000000000004 109.635 172.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 14.9 mt-30 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.436 -0.579 . . . . 5.5800000000000001 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.4199999999999999 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.6000000000000001 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.466 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.8200000000000001 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.816 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.1399999999999999 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.53000000000000003 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.4399999999999999 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.746 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 1.5800000000000001 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.0 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.52 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 1.73 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.567 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7000000000000002 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.0299999999999998 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.90000000000000002 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.93000000000000005 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.87 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.664 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.76000000000000001 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.71999999999999997 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.721 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 1.5800000000000001 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.946 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.2400000000000002 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.5600000000000001 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.3600000000000003 109.894 174.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 3.8100000000000001 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.8399999999999999 110.155 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.437 0.637 . . . . 3.25 110.114 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.4199999999999999 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 3.6200000000000001 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.3999999999999999 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.677 HG12 ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 1.3899999999999999 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 338' ' ' GLN . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.1799999999999999 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 351' ' ' SER . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.3600000000000001 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.946 HD12 ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.1499999999999999 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.60999999999999999 109.357 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.803 HH21 HD13 ' A' ' 339' ' ' LEU . 58.8 mtm180 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.175 0.512 . . . . 4.1600000000000001 110.362 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 2.8599999999999999 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 372' ' ' ALA . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.04 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.6899999999999999 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.0499999999999998 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.88 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.1400000000000001 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.1000000000000001 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.759 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.1200000000000001 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.1099999999999999 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.723 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.0899999999999999 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 387' ' ' ASN . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.0 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 4.6299999999999999 111.181 -175.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 5.79 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.29 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.1299999999999999 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.7400000000000002 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.8199999999999998 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.25 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.619 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.0899999999999999 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.575 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.23 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.633 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.1299999999999999 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.871 HG22 ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.26 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.667 HD21 HG21 ' A' ' 375' ' ' VAL . 2.9 m120 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.04 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.88 ' CD1' HD13 ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.1099999999999999 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.8500000000000001 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 29.7 t30 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.3300000000000001 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 2.6899999999999999 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.615 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.02 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.871 ' HB ' HG22 ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 1.6799999999999999 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 2.7799999999999998 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.886 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 1.5700000000000001 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.746 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.81999999999999995 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.1699999999999999 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.953 ' CG2' HG11 ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.53000000000000003 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.5900000000000001 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.619 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 0.84999999999999998 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.746 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 0.81000000000000005 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 2.6200000000000001 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 2.48 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 2.4300000000000002 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.663 HG12 ' C ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 0.93999999999999995 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.1600000000000001 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.53 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 18.3 m120 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.2799999999999998 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.663 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 1.72 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.1600000000000001 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.821 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 3.3100000000000001 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.23 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 1.75 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.8700000000000001 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 439' ' ' VAL . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 0.70999999999999996 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.8100000000000001 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.6000000000000001 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.971 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 2.4900000000000002 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.016 HG13 ' HB2' ' A' ' 430' ' ' PRO . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 0.79000000000000004 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.0499999999999998 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.3300000000000001 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.0 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.24 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.1100000000000003 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 2.9199999999999999 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.1599999999999999 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.0700000000000001 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.21 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.016 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.2 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.649 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.3999999999999999 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.821 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 0.52000000000000002 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.886 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.0800000000000001 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.807 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 0.90000000000000002 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.4199999999999999 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.4199999999999999 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.527 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 3.52 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 416' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.4099999999999999 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.881 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 1.79 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.65 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.02 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 443' ' ' ILE . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 0.56999999999999995 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 442' ' ' VAL . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.05 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.697 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 0.46000000000000002 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.4800000000000004 109.869 176.446 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.094 0.473 . . . . 5.5800000000000001 110.279 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.951 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.4199999999999999 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.8200000000000001 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.1399999999999999 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.616 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 0.53000000000000003 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.4399999999999999 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 1.5800000000000001 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.0 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.52 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 1.73 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7000000000000002 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.0299999999999998 110.706 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 0.90000000000000002 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.992 ' HA ' HD12 ' A' ' 440' ' ' LEU . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 0.87 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 0.76000000000000001 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 0.71999999999999997 109.443 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 386' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 1.5800000000000001 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.68 ' HB1' ' HA2' ' A' ' 385' ' ' GLY . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.2400000000000002 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.5600000000000001 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.3600000000000003 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 3.8100000000000001 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.8399999999999999 110.007 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.325 0.583 . . . . 3.25 110.122 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.4199999999999999 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 3.6200000000000001 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.3999999999999999 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 1.3899999999999999 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.3600000000000001 110.481 170.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.951 HD22 ' HB1' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.1499999999999999 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.60999999999999999 109.369 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.467 ' HD2' HD22 ' A' ' 339' ' ' LEU . 95.3 mtt-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.373 0.606 . . . . 4.1600000000000001 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 2.8599999999999999 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.04 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.6899999999999999 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.0499999999999998 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.872 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.1400000000000001 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.1000000000000001 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.667 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.1200000000000001 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.1099999999999999 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.668 ' CE1' HG21 ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.0899999999999999 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.0 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 4.6299999999999999 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 5.79 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.29 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.1299999999999999 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.7400000000000002 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.8199999999999998 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.25 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.656 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.0899999999999999 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.23 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.68 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.1299999999999999 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 339' ' ' LEU . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.26 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.8 m120 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.04 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.1099999999999999 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.8500000000000001 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.3300000000000001 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 2.6899999999999999 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.514 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.02 109.111 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 339' ' ' LEU . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 1.6799999999999999 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 2.7799999999999998 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.613 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 1.5700000000000001 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.55 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.81999999999999995 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.1699999999999999 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 0.53000000000000003 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.5900000000000001 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.656 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 0.84999999999999998 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.81000000000000005 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 2.6200000000000001 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 2.48 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 2.4300000000000002 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 0.93999999999999995 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.1600000000000001 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.53 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.7 m-20 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.2799999999999998 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.625 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 1.72 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.1600000000000001 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 3.3100000000000001 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.23 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 1.75 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.542 ' N ' HG23 ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.8700000000000001 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 439' ' ' VAL . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.70999999999999996 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.8100000000000001 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.6000000000000001 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 2.4900000000000002 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 430' ' ' PRO . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 0.79000000000000004 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.0499999999999998 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.0 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.24 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 2.9199999999999999 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.1599999999999999 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.0700000000000001 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.21 108.916 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 1.029 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.2 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.591 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.3999999999999999 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.794 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 0.52000000000000002 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.0800000000000001 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.811 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 0.90000000000000002 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.55 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.4199999999999999 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 405' ' ' VAL . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.4199999999999999 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 3.52 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 416' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.4099999999999999 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.992 HD12 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 1.79 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.773 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.02 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.019 ' O ' HD13 ' A' ' 443' ' ' ILE . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 0.56999999999999995 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 1.019 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.05 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.98 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 0.46000000000000002 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.1099999999999999 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.4800000000000004 109.689 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.086 0.469 . . . . 5.5800000000000001 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.879 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.4199999999999999 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.6000000000000001 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.8200000000000001 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.674 ' CB ' HD12 ' A' ' 443' ' ' ILE . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.1399999999999999 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.57 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.53000000000000003 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.642 ' HB3' HG12 ' A' ' 328' ' ' VAL . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.4399999999999999 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 1.5800000000000001 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.0 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.52 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 440' ' ' LEU . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 1.73 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.449 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7000000000000002 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.0299999999999998 110.042 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 0.90000000000000002 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 443' ' ' ILE . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.93000000000000005 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.67 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 0.87 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.76000000000000001 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 0.71999999999999997 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.704 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 1.5800000000000001 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.2400000000000002 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 344' ' ' ASP . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.5600000000000001 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.3600000000000003 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 3.8100000000000001 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 341' ' ' SER . 44.1 p30 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.8399999999999999 110.447 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' SER . 94.1 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.21 0.529 . . . . 3.25 110.148 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.4199999999999999 109.967 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 354' ' ' ILE . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 3.6200000000000001 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.609 ' HA ' HD12 ' A' ' 354' ' ' ILE . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.3999999999999999 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 1.3899999999999999 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.1799999999999999 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.3600000000000001 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.879 HD22 ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.704 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.60999999999999999 109.784 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.672 ' NH2' HD13 ' A' ' 339' ' ' LEU . 56.3 mtm180 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.351 0.596 . . . . 4.1600000000000001 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 2.8599999999999999 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.04 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.6899999999999999 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.0499999999999998 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.912 HD13 ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.1400000000000001 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.1000000000000001 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.1200000000000001 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.525 ' C ' HG11 ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.1099999999999999 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.0899999999999999 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.656 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.0 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 4.6299999999999999 110.959 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.512 ' HB2' ' CB ' ' A' ' 384' ' ' SER . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 5.79 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.29 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.1299999999999999 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.7400000000000002 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.8199999999999998 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.25 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.755 ' CE ' HD13 ' A' ' 401' ' ' ILE . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.0899999999999999 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.23 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.1299999999999999 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.26 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.04 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.912 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.1099999999999999 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.8500000000000001 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.3300000000000001 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 2.6899999999999999 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.576 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.02 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 435' ' ' GLU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 1.6799999999999999 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.656 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 2.7799999999999998 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.884 ' CE ' HD13 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 1.5700000000000001 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 1.008 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.81999999999999995 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.1699999999999999 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.752 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 0.53000000000000003 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.5900000000000001 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 1.008 HD11 ' N ' ' A' ' 396' ' ' GLY . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 0.81000000000000005 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 2.6200000000000001 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 400' ' ' ALA . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 2.48 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 2.4300000000000002 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 0.93999999999999995 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.1600000000000001 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.53 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.2799999999999998 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.589 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 1.72 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.1600000000000001 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 3.3100000000000001 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.23 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 1.75 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.8700000000000001 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 439' ' ' VAL . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 0.70999999999999996 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.8100000000000001 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.6000000000000001 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 2.4900000000000002 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.847 HG13 ' HB2' ' A' ' 430' ' ' PRO . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 0.79000000000000004 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.0499999999999998 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 25.7 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.3300000000000001 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.0 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.24 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.1100000000000003 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 2.9199999999999999 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.1599999999999999 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.0700000000000001 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.21 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.847 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.2 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.884 HD13 ' CE ' ' A' ' 395' ' ' LYS . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.3999999999999999 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 0.52000000000000002 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.0800000000000001 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.725 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 0.90000000000000002 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.726 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.4199999999999999 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.821 ' O ' HG13 ' A' ' 405' ' ' VAL . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.4199999999999999 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 3.52 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 416' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.4099999999999999 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 1.79 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.02 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.84 ' O ' HD13 ' A' ' 443' ' ' ILE . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 0.56999999999999995 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.05 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.776 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.46000000000000002 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp . . . . . 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.4800000000000004 109.307 170.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 21.4 pt20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.082 0.467 . . . . 5.5800000000000001 109.941 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.4199999999999999 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.6000000000000001 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.8200000000000001 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.699 ' CB ' HD12 ' A' ' 443' ' ' ILE . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.549 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 0.53000000000000003 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.654 ' HB3' HG12 ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.4399999999999999 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 1.5800000000000001 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.0 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.52 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 440' ' ' LEU . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 1.73 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.462 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7000000000000002 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.0299999999999998 110.137 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.90000000000000002 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 443' ' ' ILE . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.93000000000000005 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 0.87 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.76000000000000001 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.417 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.71999999999999997 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 1.5800000000000001 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.2400000000000002 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.495 ' HA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.5600000000000001 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.3600000000000003 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.425 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 3.8100000000000001 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.6 p30 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.8399999999999999 110.486 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.356 0.598 . . . . 3.25 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.4199999999999999 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 3.6200000000000001 109.998 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 354' ' ' ILE . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.3999999999999999 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 1.3899999999999999 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.455 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 351' ' ' SER . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.3600000000000001 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.1499999999999999 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 0.60999999999999999 109.559 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.326 0.584 . . . . 4.1600000000000001 109.883 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 2.8599999999999999 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.04 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.6899999999999999 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.0499999999999998 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.1400000000000001 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.1000000000000001 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.1200000000000001 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.576 ' C ' HG11 ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.1099999999999999 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CD1' HG21 ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.0899999999999999 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.0 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 4.6299999999999999 111.118 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 5.79 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.29 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.1299999999999999 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.7400000000000002 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.8199999999999998 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.544 ' CD ' ' HB3' ' A' ' 397' ' ' SER . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.25 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.804 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.0899999999999999 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.592 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.1299999999999999 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.927 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.26 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.43 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 8.6 m120 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.04 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.066 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.1099999999999999 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.8500000000000001 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.3300000000000001 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.604 ' O ' HG22 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 2.6899999999999999 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.491 ' O ' HD13 ' A' ' 393' ' ' ILE . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.02 109.603 173.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 1.6799999999999999 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 2.7799999999999998 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.873 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 1.5700000000000001 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.548 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.81999999999999995 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.1699999999999999 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.902 ' CG2' HG11 ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 0.53000000000000003 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.5900000000000001 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 0.84999999999999998 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.503 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 2.6200000000000001 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 2.48 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 2.4300000000000002 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 0.93999999999999995 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.1600000000000001 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.53 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.2799999999999998 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 1.72 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.1600000000000001 110.254 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.83 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 3.3100000000000001 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.23 110.595 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 1.75 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.8700000000000001 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 439' ' ' VAL . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 0.70999999999999996 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.8100000000000001 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.6000000000000001 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 2.4900000000000002 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 0.79000000000000004 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.0499999999999998 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.3300000000000001 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.24 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.1100000000000003 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 2.9199999999999999 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.1599999999999999 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.0700000000000001 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.21 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.2 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.546 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.3999999999999999 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.83 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 0.52000000000000002 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.13 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.0800000000000001 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 0.90000000000000002 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.4199999999999999 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.553 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.4199999999999999 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 3.52 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 416' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.4099999999999999 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.13 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 1.79 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.542 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.02 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.862 ' O ' HD13 ' A' ' 443' ' ' ILE . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 0.56999999999999995 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.05 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 0.46000000000000002 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.1099999999999999 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.4800000000000004 109.662 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.4 pt20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.074 0.464 . . . . 5.5800000000000001 110.173 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.125 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.4199999999999999 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.6000000000000001 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.8200000000000001 110.854 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.036 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.1399999999999999 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' PHE . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 0.53000000000000003 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.557 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.4399999999999999 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 1.5800000000000001 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.0 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.52 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.91 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 1.73 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7000000000000002 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.0299999999999998 110.277 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 0.90000000000000002 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 440' ' ' LEU . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.93000000000000005 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 1.036 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 0.87 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 0.76000000000000001 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 0.71999999999999997 110.412 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.799 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 1.5800000000000001 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.2400000000000002 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.564 ' OG ' HG23 ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.5600000000000001 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.3600000000000003 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 3.8100000000000001 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.8399999999999999 110.232 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 351' ' ' SER . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.339 0.59 . . . . 3.25 110.137 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.487 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.4199999999999999 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 3.6200000000000001 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.3999999999999999 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.682 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 1.3899999999999999 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.564 HG23 ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.1799999999999999 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 351' ' ' SER . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.3600000000000001 110.677 171.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.125 HD12 ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.1499999999999999 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.799 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 0.60999999999999999 109.246 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.578 ' CZ ' HD13 ' A' ' 339' ' ' LEU . 28.4 ptt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.335 0.588 . . . . 4.1600000000000001 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 2.8599999999999999 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' A' ' 372' ' ' ALA . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.04 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.6899999999999999 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.0499999999999998 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.937 HD13 ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.1400000000000001 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.1000000000000001 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.956 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.1200000000000001 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.1099999999999999 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.0899999999999999 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.955 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.0 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 4.6299999999999999 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 5.79 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.29 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.1299999999999999 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.7400000000000002 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.8199999999999998 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.47 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.25 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.505 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.0899999999999999 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.23 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.1299999999999999 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.799 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.26 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.632 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.6 m120 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.04 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.937 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.1099999999999999 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.8500000000000001 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.3300000000000001 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 2.6899999999999999 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.02 109.165 167.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.606 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 1.6799999999999999 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.955 ' NH1' HG11 ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 2.7799999999999998 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 1.5700000000000001 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.608 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.81999999999999995 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.1699999999999999 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.722 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 0.53000000000000003 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.5900000000000001 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 397' ' ' SER . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 0.84999999999999998 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 0.81000000000000005 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 2.6200000000000001 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 2.48 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.559 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 2.4300000000000002 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.66 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 0.93999999999999995 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.1600000000000001 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.53 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.2799999999999998 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.66 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 1.72 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.1600000000000001 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.822 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 3.3100000000000001 109.985 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.23 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 1.75 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.8700000000000001 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.70999999999999996 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.8100000000000001 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.6000000000000001 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.979 ' O ' HG23 ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 2.4900000000000002 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 430' ' ' PRO . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 0.79000000000000004 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.0499999999999998 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.3300000000000001 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.979 HG23 ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.0 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.24 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.1100000000000003 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 2.9199999999999999 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.1599999999999999 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.0700000000000001 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.21 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.97 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.2 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.559 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.3999999999999999 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.822 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 0.52000000000000002 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.0800000000000001 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 0.90000000000000002 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.4199999999999999 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 405' ' ' VAL . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.4199999999999999 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 3.52 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.4099999999999999 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.91 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 1.79 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.709 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.02 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.898 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 0.56999999999999995 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.05 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.694 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.46000000000000002 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.4800000000000004 109.71 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 46.0 mm-40 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.472 -0.566 . . . . 5.5800000000000001 109.472 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.844 ' HB2' HG13 ' A' ' 352' ' ' ILE . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.4199999999999999 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.6000000000000001 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.8200000000000001 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.037 ' O ' HD13 ' A' ' 323' ' ' ILE . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.1399999999999999 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 1.037 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 0.53000000000000003 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.4399999999999999 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.891 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 1.5800000000000001 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.0 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.52 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.918 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 1.73 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7000000000000002 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.528 ' N ' ' HG3' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.0299999999999998 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 0.90000000000000002 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 323' ' ' ILE . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.93000000000000005 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 0.87 109.762 -176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 0.76000000000000001 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.71999999999999997 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.644 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 1.5800000000000001 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.785 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.2400000000000002 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.895 ' OG ' HG22 ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.5600000000000001 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.3600000000000003 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.482 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 3.8100000000000001 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.8399999999999999 110.078 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.443 0.64 . . . . 3.25 109.978 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.879 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.4199999999999999 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 3.6200000000000001 109.535 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.3999999999999999 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 319' ' ' ALA . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 1.3899999999999999 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.895 HG22 ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.1799999999999999 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 351' ' ' SER . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.3600000000000001 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 319' ' ' ALA . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.1499999999999999 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.644 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 0.60999999999999999 109.477 174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.372 0.606 . . . . 4.1600000000000001 110.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 2.8599999999999999 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.661 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.04 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.6899999999999999 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.0499999999999998 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.892 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.1400000000000001 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.1000000000000001 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.1200000000000001 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.519 ' C ' HG11 ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.1099999999999999 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.0899999999999999 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.0 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 4.6299999999999999 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 5.79 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.29 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.1299999999999999 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.7400000000000002 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.8199999999999998 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.25 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.617 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.0899999999999999 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.23 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.1299999999999999 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.26 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.04 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.892 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.1099999999999999 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.8500000000000001 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.3300000000000001 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 2.6899999999999999 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.409 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.02 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 340' ' ' ALA . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 1.6799999999999999 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 2.7799999999999998 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.839 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 1.5700000000000001 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.545 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.81999999999999995 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.1699999999999999 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.844 HG21 ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.53000000000000003 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.5900000000000001 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 0.81000000000000005 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 2.6200000000000001 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 2.48 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.526 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 2.4300000000000002 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 437' ' ' SER . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.93999999999999995 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.1600000000000001 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.53 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.0 m120 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.2799999999999998 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.602 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 1.72 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.429 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.1600000000000001 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.801 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 3.3100000000000001 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.23 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 1.75 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.8700000000000001 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 0.70999999999999996 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.8100000000000001 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.6000000000000001 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.985 ' O ' HG23 ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 2.4900000000000002 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.844 ' CG1' HG21 ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.79000000000000004 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.0499999999999998 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.1 mm-40 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.3300000000000001 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 419' ' ' LYS . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.0 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.24 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.1100000000000003 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 2.9199999999999999 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.1599999999999999 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.0700000000000001 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.21 108.992 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.2 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.559 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.3999999999999999 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.801 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 0.52000000000000002 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.99 HG12 HD21 ' A' ' 440' ' ' LEU . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.0800000000000001 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 0.90000000000000002 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.719 ' HG2' HD13 ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.4199999999999999 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 405' ' ' VAL . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.4199999999999999 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 3.52 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.4099999999999999 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.99 HD21 HG12 ' A' ' 433' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 1.79 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.776 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.02 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.831 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 0.56999999999999995 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.05 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.962 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 0.46000000000000002 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.1099999999999999 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 38.3 tttp . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.4800000000000004 109.645 174.634 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.063 0.458 . . . . 5.5800000000000001 110.231 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.091 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.4199999999999999 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.6000000000000001 110.653 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.8200000000000001 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.654 ' HB3' HD12 ' A' ' 443' ' ' ILE . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.1399999999999999 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.8 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 0.53000000000000003 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.4399999999999999 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 1.5800000000000001 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.0 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.52 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 440' ' ' LEU . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 1.73 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7000000000000002 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.0299999999999998 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.90000000000000002 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 323' ' ' ILE . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 0.93000000000000005 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 0.87 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.76000000000000001 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.432 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 0.71999999999999997 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.618 ' OE1' ' N ' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 335' ' ' ASP . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 1.5800000000000001 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.2400000000000002 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.5600000000000001 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.3600000000000003 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 3.8100000000000001 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.8399999999999999 110.053 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.264 0.555 . . . . 3.25 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.4199999999999999 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 3.6200000000000001 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.741 ' HA ' HD12 ' A' ' 354' ' ' ILE . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.3999999999999999 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.619 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.3899999999999999 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.1799999999999999 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 351' ' ' SER . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.3600000000000001 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.091 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.1499999999999999 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 0.60999999999999999 109.998 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . 0.485 ' HD3' ' HB3' ' A' ' 339' ' ' LEU . 57.7 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.398 0.618 . . . . 4.1600000000000001 109.975 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 2.8599999999999999 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.75 HG21 ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.04 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.6899999999999999 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.495 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.0499999999999998 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.1400000000000001 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.1000000000000001 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.728 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.1200000000000001 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.1099999999999999 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.75 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.0899999999999999 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.963 HG11 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.0 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 4.6299999999999999 111.244 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.521 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 5.79 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.29 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.1299999999999999 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.7400000000000002 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.8199999999999998 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.25 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.738 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.0899999999999999 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.23 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.1299999999999999 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.622 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.26 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.589 HD21 HG21 ' A' ' 375' ' ' VAL . 2.9 m120 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.04 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.1099999999999999 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.8500000000000001 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.3300000000000001 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 2.6899999999999999 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.02 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.705 HD13 ' HG2' ' A' ' 435' ' ' GLU . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 1.6799999999999999 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.963 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.825 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.5700000000000001 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.65 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.81999999999999995 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.587 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.1699999999999999 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.764 ' CG2' HG11 ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.53000000000000003 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.5900000000000001 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.738 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 0.84999999999999998 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.65 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 0.81000000000000005 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 2.6200000000000001 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 2.48 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.528 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 2.4300000000000002 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 437' ' ' SER . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 0.93999999999999995 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.1600000000000001 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.53 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.3 m120 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.2799999999999998 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 1.72 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.1600000000000001 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.8 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 3.3100000000000001 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.23 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 1.75 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.8700000000000001 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 439' ' ' VAL . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 0.70999999999999996 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.8100000000000001 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.6000000000000001 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.975 ' O ' HG23 ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 2.4900000000000002 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.764 HG11 ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 0.79000000000000004 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.0499999999999998 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.535 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.3300000000000001 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.976 HG13 ' CB ' ' A' ' 444' ' ' ALA . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.0 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.24 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.535 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.1100000000000003 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 2.9199999999999999 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.1599999999999999 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.0700000000000001 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.21 109.275 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.764 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.2 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.648 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.3999999999999999 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 0.52000000000000002 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.915 HG12 HD21 ' A' ' 440' ' ' LEU . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.0800000000000001 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 0.90000000000000002 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.705 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.4199999999999999 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.4199999999999999 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 3.52 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.4099999999999999 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 433' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 1.79 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.02 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 0.56999999999999995 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 322' ' ' PHE . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.05 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.976 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 0.46000000000000002 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.1099999999999999 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.4800000000000004 109.52 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 16.6 mt-30 . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.659 -0.497 . . . . 5.5800000000000001 109.659 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.4199999999999999 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.6000000000000001 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.525 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.8200000000000001 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 1.048 ' O ' HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.1399999999999999 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 0.53000000000000003 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.556 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.4399999999999999 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 1.5800000000000001 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.0 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.52 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 1.73 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.481 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7000000000000002 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.0299999999999998 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.90000000000000002 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.985 HD22 ' O ' ' A' ' 323' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.93000000000000005 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 0.87 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.618 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.457 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.76000000000000001 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 0.71999999999999997 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.677 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.95 HD11 HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 1.5800000000000001 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.2400000000000002 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.5600000000000001 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.3600000000000003 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 3.8100000000000001 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 2.5 p30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.8399999999999999 110.228 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.415 0.626 . . . . 3.25 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.4199999999999999 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 3.6200000000000001 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.744 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.3999999999999999 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.64 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 1.3899999999999999 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.527 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.1799999999999999 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 351' ' ' SER . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.3600000000000001 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.1499999999999999 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.677 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 109.841 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.356 0.598 . . . . 4.1600000000000001 109.788 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 2.8599999999999999 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.04 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.6899999999999999 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.0499999999999998 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 388' ' ' ILE . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.1400000000000001 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.1000000000000001 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.795 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.1200000000000001 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.599 ' C ' HG11 ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.1099999999999999 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.643 ' CD1' HG21 ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.0899999999999999 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.84 HG11 ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.0 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 4.6299999999999999 110.999 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 5.79 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.29 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.1299999999999999 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.7400000000000002 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.8199999999999998 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.494 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.25 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.515 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.0899999999999999 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.1299999999999999 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 339' ' ' LEU . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.26 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 8.6 m120 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.04 109.06 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.059 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.1099999999999999 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 1.059 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.8500000000000001 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.3300000000000001 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 2.6899999999999999 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 393' ' ' ILE . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.02 109.453 168.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.95 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 1.6799999999999999 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.84 ' NH1' HG11 ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 2.7799999999999998 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.929 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 1.5700000000000001 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.698 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.81999999999999995 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.1699999999999999 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.892 HG21 ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.53000000000000003 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.5900000000000001 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 0.84999999999999998 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.698 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 0.81000000000000005 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 2.6200000000000001 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 2.48 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 2.4300000000000002 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.641 HG12 ' C ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.93999999999999995 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.1600000000000001 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.53 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.6 m120 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.2799999999999998 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.641 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 1.72 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.1600000000000001 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.811 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 3.3100000000000001 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.23 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 1.75 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.8700000000000001 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 439' ' ' VAL . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 0.70999999999999996 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.8100000000000001 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.6000000000000001 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 2.4900000000000002 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.892 ' CG1' HG21 ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.79000000000000004 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.0499999999999998 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.3300000000000001 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.0 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.24 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.1100000000000003 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 2.9199999999999999 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.1599999999999999 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.0700000000000001 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.21 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.661 ' HA ' HG11 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.2 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.6 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.3999999999999999 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 0.52000000000000002 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.929 HG22 ' HG3' ' A' ' 395' ' ' LYS . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.0800000000000001 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 0.90000000000000002 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.4199999999999999 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 405' ' ' VAL . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.4199999999999999 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 3.52 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 416' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.4099999999999999 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.923 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 1.79 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.799 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.02 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.889 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 0.56999999999999995 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.964 ' CD1' HD21 ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.05 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 0.804 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 0.46000000000000002 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.1099999999999999 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.4800000000000004 109.291 172.763 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 15.5 mt-30 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.403 -0.592 . . . . 5.5800000000000001 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.4199999999999999 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' SER . . . . . 0.594 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.6000000000000001 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.8200000000000001 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.652 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.53000000000000003 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.4399999999999999 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.698 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 1.5800000000000001 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.0 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.52 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 1.73 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 332' ' ' THR . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7000000000000002 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.431 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.0299999999999998 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.90000000000000002 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 443' ' ' ILE . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.93000000000000005 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 0.87 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 0.76000000000000001 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 0.71999999999999997 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' GLN . . . . . 0.669 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 1.5800000000000001 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.2400000000000002 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.5600000000000001 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.3600000000000003 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 3.8100000000000001 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.1 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.8399999999999999 110.186 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 351' ' ' SER . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.346 0.593 . . . . 3.25 110.102 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.4199999999999999 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 3.6200000000000001 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.589 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.3999999999999999 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 1.3899999999999999 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.1799999999999999 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 351' ' ' SER . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.3600000000000001 110.27 169.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.1499999999999999 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . . . . . . 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 0.60999999999999999 109.726 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.58 0.705 . . . . 4.1600000000000001 110.245 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 2.8599999999999999 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.927 HG13 ' HB3' ' A' ' 372' ' ' ALA . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.04 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.6899999999999999 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.0499999999999998 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.883 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.1400000000000001 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.1000000000000001 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . 0.927 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.1200000000000001 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.1099999999999999 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.0899999999999999 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 387' ' ' ASN . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.0 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 4.6299999999999999 111.354 -175.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' PHE . . . . . 0.549 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 5.79 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.29 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.1299999999999999 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.7400000000000002 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.8199999999999998 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.25 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' MET . . . . . 0.62 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.0899999999999999 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.23 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.1299999999999999 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.26 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ASN . . . . . 0.608 HD21 HG21 ' A' ' 375' ' ' VAL . 3.0 m120 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.04 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.883 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.1099999999999999 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.8500000000000001 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.3300000000000001 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 2.6899999999999999 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.02 109.069 167.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 1.6799999999999999 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.431 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.7799999999999998 110.393 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.881 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 1.5700000000000001 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLY . . . . . 0.733 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.81999999999999995 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.1699999999999999 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.748 ' CG2' HG11 ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 0.53000000000000003 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.5900000000000001 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ALA . . . . . 0.62 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 0.84999999999999998 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.733 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 0.81000000000000005 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 2.6200000000000001 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 2.48 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' HIS . . . . . 0.431 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 56.0 t-80 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 2.4300000000000002 110.723 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.583 HG12 ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.93999999999999995 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.1600000000000001 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.53 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.548 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.2799999999999998 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.583 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 1.72 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.1600000000000001 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.772 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 3.3100000000000001 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.23 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 1.75 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ASP . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 419' ' ' LYS . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.8700000000000001 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 439' ' ' VAL . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 0.70999999999999996 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.8100000000000001 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.6000000000000001 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.995 ' O ' HG23 ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 2.4900000000000002 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 430' ' ' PRO . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.79000000000000004 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 424' ' ' ALA . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.0499999999999998 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.3300000000000001 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 1.01 HG13 ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.0 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.24 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ARG . . . . . 0.513 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.1100000000000003 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 2.9199999999999999 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.1599999999999999 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.0700000000000001 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.21 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.816 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.2 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.451 HD13 ' NZ ' ' A' ' 395' ' ' LYS . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.3999999999999999 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 0.52000000000000002 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.0800000000000001 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 439' ' ' VAL . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 0.90000000000000002 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.546 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.4199999999999999 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.4199999999999999 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ARG . . . . . 0.531 ' NH2' ' HB3' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 3.52 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 416' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.4099999999999999 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 1.79 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.588 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.02 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.837 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.56999999999999995 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.837 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.05 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . 1.01 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.46000000000000002 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.1099999999999999 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm . . . . . 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.4800000000000004 109.679 173.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.815 ' ND2' HG21 ' A' ' 449' ' ' VAL . 86.3 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.243 0.544 . . . . 6.0800000000000001 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -133.67 137.47 45.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 5.8300000000000001 110.243 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 57.3 tt0 -137.01 140.22 41.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.847 . . . . 5.5800000000000001 110.12 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.75 133.2 48.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.862 -1.149 . . . . 1.4199999999999999 109.938 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.62 -40.03 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.131 -0.98 . . . . 1.6000000000000001 110.501 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.465 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.4 tt0 -144.27 148.41 34.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.072 -1.017 . . . . 1.8200000000000001 110.976 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.733 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.8 p90 -117.33 144.46 44.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.101 -1.0 . . . . 1.1399999999999999 110.23 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.802 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.7 mm -128.39 134.49 26.32 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.53000000000000003 110.402 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.565 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.9 Cg_exo -62.54 157.57 45.88 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.839 1.442 . . . . 1.4399999999999999 111.304 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.778 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -78.05 -165.99 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.382 -0.824 . . . . 1.5800000000000001 109.503 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.6 tt0 -63.02 105.69 0.72 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.247 -0.908 . . . . 4.0 110.364 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.42 51.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.442 -1.063 . . . . 1.52 110.442 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.4 t -105.99 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.961 -1.317 . . . . 1.73 110.776 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -87.83 144.19 26.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.189 -0.945 . . . . 2.02 110.119 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.565 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -66.18 -38.51 88.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.187 -0.946 . . . . 2.7000000000000002 110.503 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.574 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 58.7 tttt -59.0 -39.01 80.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 3.0299999999999998 109.715 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 81.5 m -59.65 -47.37 85.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.90000000000000002 110.457 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.825 ' HA ' HD12 ' A' ' 440' ' ' LEU . 37.0 tp -62.06 -45.17 94.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.969 -1.082 . . . . 0.93000000000000005 111.059 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.591 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.54 -38.62 88.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.193 -0.942 . . . . 0.87 109.937 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.6 t70 -66.28 -46.24 77.71 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.922 -1.111 . . . . 1.96 111.222 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -64.55 -36.95 85.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.76000000000000001 110.288 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.96 77.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.71999999999999997 110.18 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.95 -52.34 30.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 1.72 111.29 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.6 -37.49 73.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.696 -1.252 . . . . 1.5800000000000001 110.424 -177.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.34 -12.6 61.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 2.2400000000000002 110.328 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 79.3 p -96.57 -16.4 21.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.273 -0.892 . . . . 3.5600000000000001 110.253 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.502 HD11 ' H ' ' A' ' 365' ' ' ARG . 33.9 mt -59.24 -27.07 65.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.087 -1.008 . . . . 4.3600000000000003 110.169 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.45 -20.27 26.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 3.8100000000000001 110.872 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -80.24 138.0 36.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 2.8399999999999999 110.112 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 6.69 48.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 2.9900000000000002 110.334 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 42.8 p -77.65 145.28 70.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 2.0699999999999998 110.1 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.84 -33.97 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.955 1.502 . . . . 2.3799999999999999 110.221 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.13 -37.51 87.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 3.25 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.08 -27.53 62.62 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.484 -1.447 . . . . 1.4199999999999999 109.484 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 354' ' ' ILE . 74.4 mtt180 -75.52 -36.5 60.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.912 -1.346 . . . . 3.6200000000000001 109.491 172.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.751 ' HA ' HD12 ' A' ' 354' ' ' ILE . 6.7 p -54.94 -44.64 74.49 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.218 -0.926 . . . . 2.3999999999999999 109.725 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.699 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.0 mt -67.15 -47.17 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 1.3899999999999999 111.135 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 78.6 t -55.61 -30.21 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.66 -1.275 . . . . 1.1799999999999999 110.095 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 351' ' ' SER . 60.9 mt -68.9 -46.96 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.835 -1.166 . . . . 1.3600000000000001 110.492 170.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 319' ' ' ALA . 5.5 tt -47.3 -52.93 14.85 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.165 -0.96 . . . . 1.1499999999999999 110.15 -174.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.95 -36.61 83.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.60999999999999999 109.743 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 361' ' ' ASN . 17.9 tptm -53.16 -55.79 21.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.846 -1.159 . . . . 1.1599999999999999 110.651 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -66.84 -40.85 88.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.716 -1.24 . . . . 1.8999999999999999 109.915 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 55.2 mmm-85 -68.98 -40.48 78.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 2.6299999999999999 111.425 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.789 ' HB3' HD11 ' A' ' 362' ' ' LEU . 91.0 m-85 -115.96 -14.71 11.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.804 -1.185 . . . . 3.3199999999999998 110.275 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.7 t30 60.42 50.13 6.26 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.747 0.784 . . . . 1.8999999999999999 110.216 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.3 mt -113.28 178.24 4.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.786 -0.571 . . . . 2.7999999999999998 109.85 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -118.3 157.12 27.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.97 -1.081 . . . . 4.4000000000000004 110.961 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.468 ' OE2' HG11 ' A' ' 353' ' ' VAL . 96.1 mt-10 -54.95 150.36 10.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.2400000000000002 109.747 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 335' ' ' ASP . 90.3 mtt180 -95.53 135.05 37.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.05 . . . . 4.1600000000000001 109.914 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 369' ' ' SER . 56.0 t0 -79.22 121.17 24.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 2.8599999999999999 110.039 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' A' ' 374' ' ' PHE . 37.4 t -72.19 -44.75 64.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 121.162 0.506 . . . . 3.04 110.452 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -75.39 -19.08 59.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 3.6899999999999999 111.106 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 366' ' ' ASP . 47.4 t -72.88 -29.18 62.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.781 -1.199 . . . . 3.0499999999999998 109.267 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 36.1 mt -90.38 4.1 51.86 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.377 -0.827 . . . . 2.1400000000000001 109.767 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 90.6 m-70 56.62 27.91 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.073 -1.017 . . . . 2.1000000000000001 108.798 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -87.86 -165.6 1.36 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.531 0.682 . . . . 1.1200000000000001 110.272 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.488 ' N ' HG13 ' A' ' 367' ' ' VAL . 46.5 m -138.79 143.68 39.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.1099999999999999 110.535 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 367' ' ' VAL . 65.6 m-85 -88.14 144.81 26.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.931 -1.106 . . . . 3.0899999999999999 109.517 172.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.969 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -110.77 112.43 56.1 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.782 -1.199 . . . . 4.0 109.851 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.36 151.1 30.92 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.119 1.589 . . . . 4.6299999999999999 111.268 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.567 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -97.77 122.33 40.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.613 -0.679 . . . . 5.79 109.844 178.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.2 p -110.9 140.24 45.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 5.29 109.781 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.64 -30.23 59.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.628 -0.67 . . . . 6.1299999999999999 110.453 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.01 -45.4 86.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.144 -0.973 . . . . 7.7400000000000002 109.989 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 63.8 p -91.19 -18.21 24.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 3.8199999999999998 109.746 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.489 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 67.4 mtt180 64.34 53.14 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.501 -0.749 . . . . 4.25 109.615 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.715 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.6 mtp -149.62 144.55 26.24 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.102 -1.039 . . . . 2.0899999999999999 111.252 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 33.9 p -145.39 167.77 22.13 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.805 -1.183 . . . . 1.23 107.805 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -174.13 -165.78 31.24 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.596 -1.764 . . . . 1.1299999999999999 110.435 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.1 149.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 O-C-N 121.906 -0.761 . . . . 1.26 109.023 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.603 ' ND2' ' HE3' ' A' ' 392' ' ' MET . 3.0 m120 -121.37 144.35 48.7 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.231 -0.918 . . . . 2.04 108.631 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.8 tt -145.0 164.97 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.626 -1.296 . . . . 2.1099999999999999 110.326 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.488 0.921 . . . . 3.8500000000000001 113.488 -171.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.4 t30 -145.81 3.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.135 -1.603 . . . . 2.3300000000000001 111.474 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.53 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 96.3 mtt180 -157.26 159.98 38.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.547 -1.346 . . . . 2.6899999999999999 110.938 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.603 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 91.8 mmm -129.93 140.64 50.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 2.02 109.176 167.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 339' ' ' LEU . 28.4 mm -130.76 139.34 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.75 -1.219 . . . . 1.6799999999999999 110.228 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.969 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.1 mmt180 -140.21 142.6 35.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 110.383 175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 1.5700000000000001 109.397 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.602 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.26 -154.38 14.68 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.402 -1.38 . . . . 0.81999999999999995 110.265 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 23.9 m -70.74 157.93 37.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 1.1699999999999999 110.581 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.892 ' CG2' HG11 ' A' ' 420' ' ' VAL . 73.5 t -59.67 -48.3 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -0.94 . . . . 0.53000000000000003 109.931 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.51 -37.9 82.63 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.01 -1.056 . . . . 1.5900000000000001 109.089 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.37 -50.13 74.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.444 -0.785 . . . . 0.84999999999999998 110.572 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.602 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.1 mm -67.32 -38.15 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.773 -1.204 . . . . 0.81000000000000005 111.113 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 57.9 ttp180 -58.41 -41.76 85.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.848 -1.157 . . . . 2.6200000000000001 110.1 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.1 mtm180 -67.25 -37.95 84.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.034 -1.041 . . . . 2.48 110.85 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.514 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.3 t60 -63.91 -40.63 96.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.142 . . . . 2.4300000000000002 110.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.619 HG12 ' C ' ' A' ' 410' ' ' GLY . 92.2 t -64.99 -45.3 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.077 . . . . 0.93999999999999995 110.468 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.63 -35.27 79.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.837 -1.164 . . . . 2.1600000000000001 110.815 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.21 87.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 1.53 109.736 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.37 -26.16 66.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.823 . . . . 2.75 109.26 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 24.91 13.33 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.236 -1.546 . . . . 2.2799999999999998 109.236 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.619 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.83 -170.28 40.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 1.72 109.465 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.36 149.19 42.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 4.1600000000000001 110.325 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.8 t80 -92.33 109.58 38.96 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 3.3100000000000001 110.058 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.9 Cg_exo -60.22 141.84 96.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.913 1.481 . . . . 1.23 110.882 -176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.16 -43.49 92.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.867 . . . . 1.75 110.489 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.554 ' N ' HG23 ' A' ' 414' ' ' THR . 51.1 t0 -54.27 -40.41 67.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 1.8700000000000001 110.04 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 439' ' ' VAL . 76.9 t -70.1 -39.99 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.005 -1.059 . . . . 0.70999999999999996 110.607 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.579 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 82.8 m-20 -60.89 -38.82 86.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.001 -1.062 . . . . 1.8100000000000001 110.238 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mt-30 -65.19 -42.05 93.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.195 -0.94 . . . . 2.6000000000000001 110.797 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 59.6 mttm -63.53 -39.11 93.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.705 -1.247 . . . . 2.4900000000000002 110.763 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.017 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.9 t -66.12 -39.81 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.108 -0.995 . . . . 0.79000000000000004 110.433 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -68.22 -43.65 77.52 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.569 -0.707 . . . . 2.0499999999999998 110.615 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 91.7 mt-30 -66.46 -31.09 71.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.902 . . . . 2.3300000000000001 109.773 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 69.3 t -60.98 -41.64 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.015 -1.053 . . . . 1.0 109.54 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.91 -53.74 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 1.24 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.538 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 34.7 ptt180 -55.22 -20.06 9.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 4.1100000000000003 109.781 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 92.0 mm-40 -91.44 5.41 49.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.446 -0.784 . . . . 2.9199999999999999 110.731 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.09 65.72 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.865 -1.294 . . . . 1.1599999999999999 109.865 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -102.91 154.4 19.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -1.125 . . . . 1.0700000000000001 109.901 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.6 m -93.31 109.21 38.81 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 1.21 109.103 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.017 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 Cg_exo -77.9 111.83 3.17 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.971 1.511 . . . . 1.2 110.246 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.902 HD21 " O2'" ' A' 1001 ' ' ANP . 71.8 mt -90.05 160.37 16.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.766 -1.209 . . . . 1.3999999999999999 108.373 165.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 67.6 t -123.89 138.25 54.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.687 -1.258 . . . . 0.52000000000000002 110.266 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.7 t -118.62 136.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.681 -0.637 . . . . 1.0800000000000001 109.587 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.79 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.15 154.58 40.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.504 -0.878 . . . . 0.90000000000000002 110.726 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.515 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.0 mt-10 -99.78 121.95 42.03 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.014 -0.735 . . . . 1.79 109.014 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.46 -109.72 1.91 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.625 -1.79 . . . . 1.4199999999999999 108.625 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 16.1 p -114.73 13.5 17.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -1.143 . . . . 1.4199999999999999 111.199 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt85 -123.18 139.91 53.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.756 -1.215 . . . . 3.52 110.279 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.06 HG11 HG11 ' A' ' 416' ' ' VAL . 38.1 t -79.08 126.73 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 1.4099999999999999 111.042 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.4 OUTLIER -90.48 -29.87 17.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.79 110.458 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 179.33 -178.16 48.6 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.172 -1.49 . . . . 1.02 110.851 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 443' ' ' ILE . 47.5 t -123.24 157.69 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.552 -0.97 . . . . 0.56999999999999995 109.809 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.4 mm -122.68 128.53 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.033 -1.042 . . . . 1.05 110.937 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.88 119.82 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.46000000000000002 110.143 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.0 mp -104.97 143.52 33.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.1099999999999999 110.557 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 447' ' ' ASP . 0.0 OUTLIER -84.84 145.76 27.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 4.4800000000000004 109.511 170.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.495 ' N ' ' HG2' ' A' ' 446' ' ' LYS . 32.9 p30 -95.9 116.5 29.01 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.294 -0.879 . . . . 3.9100000000000001 110.093 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 316' ' ' ASN . 62.9 mt -57.1 -45.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.88 . . . . 3.6099999999999999 109.607 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.815 HG21 ' ND2' ' A' ' 316' ' ' ASN . 59.6 t -98.48 134.37 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 5.0899999999999999 110.196 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -91.64 133.12 35.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 7.5 110.191 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 117.97 -1.461 . . . . 7.2999999999999998 109.563 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.902 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.493 ' N ' ' HB ' ' A' ' 448' ' ' ILE . 30.7 t30 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.253 0.549 . . . . 6.0800000000000001 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.65 140.42 49.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 5.8300000000000001 110.274 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.491 ' CB ' ' HB2' ' A' ' 351' ' ' SER . 21.5 pt20 -147.04 155.74 42.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 5.5800000000000001 110.147 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.993 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.26 135.05 48.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 1.4199999999999999 110.209 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.75 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.62 -39.66 4.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.126 -0.984 . . . . 1.6000000000000001 110.419 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -147.88 147.09 29.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.127 -0.983 . . . . 1.8200000000000001 110.881 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.807 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.9 p90 -117.47 146.95 43.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.163 -0.961 . . . . 1.1399999999999999 110.361 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.9 mm -129.48 134.45 26.26 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.292 -0.88 . . . . 0.53000000000000003 110.42 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.8 Cg_exo -61.88 159.18 34.63 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.022 1.538 . . . . 1.4399999999999999 111.45 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.733 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.52 -165.18 0.82 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.525 -0.735 . . . . 1.5800000000000001 109.647 171.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -62.36 104.14 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.358 -0.839 . . . . 4.0 110.462 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.3 17.32 50.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.036 -1.078 . . . . 1.52 110.428 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.3 t -104.72 150.3 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.988 -1.301 . . . . 1.73 110.865 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.29 142.75 27.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 2.02 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.9 -40.97 92.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.07 -1.019 . . . . 2.7000000000000002 110.755 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 16.3 ttpt -61.19 -43.1 99.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 3.0299999999999998 110.135 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 87.1 m -59.88 -45.9 91.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.90000000000000002 110.288 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 441' ' ' GLY . 20.8 tp -60.91 -44.31 97.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.004 . . . . 0.93000000000000005 111.132 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.85 -40.73 89.57 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.128 -0.983 . . . . 0.87 109.705 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.545 ' O ' HD23 ' A' ' 339' ' ' LEU . 60.9 t0 -63.61 -44.77 92.97 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.105 -0.997 . . . . 1.96 111.426 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.26 -36.59 84.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.006 -1.059 . . . . 0.76000000000000001 110.102 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.35 -34.4 78.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.01 . . . . 0.71999999999999997 110.263 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.768 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 3.4 mm-40 -68.17 -54.73 15.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 1.72 110.87 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.755 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -67.66 -35.68 79.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.629 -1.295 . . . . 1.5800000000000001 110.27 -174.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.07 -15.57 63.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 2.2400000000000002 110.273 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 353' ' ' VAL . 77.9 p -96.32 -16.52 21.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 3.5600000000000001 110.132 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 47.8 mt -58.25 -25.51 61.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.949 . . . . 4.3600000000000003 110.046 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.24 -7.83 54.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 3.8100000000000001 110.863 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.7 p30 -99.07 140.87 32.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.951 -1.093 . . . . 2.8399999999999999 110.161 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.25 7.16 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 2.9900000000000002 110.129 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 22.4 p -77.05 144.16 71.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 2.0699999999999998 110.013 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.3 -32.08 96.16 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.978 1.515 . . . . 2.3799999999999999 110.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.535 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 98.2 mt-10 -64.5 -39.29 93.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 3.25 110.169 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.477 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -59.49 -28.56 65.11 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.419 -1.472 . . . . 1.4199999999999999 109.419 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.7 mtt180 -76.98 -36.94 56.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.3 . . . . 3.6200000000000001 109.645 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.4 p -55.68 -41.01 73.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.097 -1.002 . . . . 2.3999999999999999 109.528 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.639 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.6 mt -70.04 -48.05 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 1.3899999999999999 111.113 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.882 HG13 ' CD ' ' A' ' 364' ' ' GLU . 93.8 t -56.74 -30.25 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.534 -1.354 . . . . 1.1799999999999999 110.298 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 351' ' ' SER . 76.2 mt -69.83 -49.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 1.3600000000000001 110.57 170.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.993 HD22 ' HB1' ' A' ' 319' ' ' ALA . 58.3 tp -47.45 -49.17 26.06 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.959 -1.088 . . . . 1.1499999999999999 110.487 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.768 ' HB2' ' NE2' ' A' ' 338' ' ' GLN . . . -62.82 -37.21 85.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.084 -1.01 . . . . 0.60999999999999999 109.388 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.1 tptm -58.54 -51.79 68.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.777 -1.202 . . . . 1.1599999999999999 110.784 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 13.0 pt20 -65.98 -39.02 90.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.534 -1.354 . . . . 1.8999999999999999 109.773 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.519 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 33.4 mmt180 -68.7 -46.32 69.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 2.6299999999999999 111.421 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 362' ' ' LEU . 62.6 m-85 -116.18 -14.93 11.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.694 -1.254 . . . . 3.3199999999999998 110.582 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 357' ' ' LYS . 20.7 t30 60.19 50.14 6.65 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.84 . . . . 1.8999999999999999 109.883 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.7 mt -106.99 179.68 4.19 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.704 -0.622 . . . . 2.7999999999999998 109.931 -176.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -111.75 154.62 24.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.033 . . . . 4.4000000000000004 110.046 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.882 ' CD ' HG13 ' A' ' 353' ' ' VAL . 69.4 mm-40 -76.38 167.38 21.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 2.2400000000000002 110.006 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.516 ' NH1' ' OD1' ' A' ' 335' ' ' ASP . 70.2 mtt85 -105.71 129.19 53.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 4.1600000000000001 110.569 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.32 117.54 14.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.347 -0.845 . . . . 2.8599999999999999 109.495 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.0 t -70.0 -42.87 79.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 3.04 110.49 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -73.87 -21.0 60.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.024 . . . . 3.6899999999999999 111.071 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 56.0 p -75.07 -26.23 59.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.783 -1.198 . . . . 3.0499999999999998 109.04 171.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.882 HD13 ' CD1' ' A' ' 388' ' ' ILE . 47.0 mt -89.84 1.78 55.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.293 -0.88 . . . . 2.1400000000000001 109.528 170.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 67.0 m80 56.16 28.46 13.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.075 -1.015 . . . . 2.1000000000000001 108.685 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.775 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.26 -165.89 1.42 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.518 0.675 . . . . 1.1200000000000001 110.221 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 49.4 m -137.93 143.6 40.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 2.1099999999999999 110.48 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.8 m-85 -89.62 141.56 28.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.973 -1.079 . . . . 3.0899999999999999 109.563 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 1.008 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.8 t -107.4 110.79 63.17 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.833 -1.167 . . . . 4.0 109.74 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.1 Cg_endo -54.1 151.33 28.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.079 1.568 . . . . 4.6299999999999999 111.207 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.32 122.57 39.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 5.79 109.892 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 28.5 p -112.86 143.42 44.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 5.29 109.856 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.63 44.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 6.1299999999999999 110.693 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.74 -50.67 71.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.989 . . . . 7.7400000000000002 109.936 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 383' ' ' MET . 59.7 p -90.25 -15.01 32.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 3.8199999999999998 109.458 171.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.55 ' HG3' " O4'" ' A' 1001 ' ' ANP . 30.4 ttm180 59.65 61.96 1.84 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.543 -0.723 . . . . 4.25 109.535 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.809 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 89.4 mtp -152.49 147.48 26.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.0899999999999999 110.883 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 38.3 p -146.6 169.19 19.48 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.267 -1.012 . . . . 1.23 108.267 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -173.87 -166.28 31.82 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.939 -1.601 . . . . 1.1299999999999999 110.171 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.99 149.88 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.811 -0.817 . . . . 1.26 109.041 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.568 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.9 144.21 48.54 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.199 -0.938 . . . . 2.04 108.722 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.882 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.4 tt -144.65 164.6 13.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.677 -1.264 . . . . 2.1099999999999999 110.135 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.71 7.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.442 0.904 . . . . 3.8500000000000001 113.442 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.517 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.9 t-20 -144.1 2.44 1.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.159 -1.588 . . . . 2.3300000000000001 111.355 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 93.8 mtt180 -157.54 160.34 38.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.602 -1.311 . . . . 2.6899999999999999 111.098 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.424 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.7 mtp -129.9 140.75 50.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.91 -1.118 . . . . 2.02 109.09 166.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.553 HG13 ' CD1' ' A' ' 339' ' ' LEU . 28.0 mm -130.67 140.46 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.818 -1.177 . . . . 1.6799999999999999 110.008 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 1.008 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.68 143.7 35.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 2.7799999999999998 110.38 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.872 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.3 OUTLIER -144.78 143.66 30.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 1.5700000000000001 109.523 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.648 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.47 -156.1 20.27 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.387 -1.387 . . . . 0.81999999999999995 110.334 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 1.2 p -72.86 160.79 31.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -1.172 . . . . 1.1699999999999999 110.467 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.867 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.9 t -60.32 -48.42 88.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.446 -0.784 . . . . 0.53000000000000003 109.868 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.78 -38.77 82.82 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.01 -1.056 . . . . 1.5900000000000001 108.989 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.809 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.25 -52.3 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 110.722 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.648 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.4 mm -68.94 -37.04 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.749 -1.219 . . . . 0.81000000000000005 111.195 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.2 ttt180 -59.42 -41.95 90.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.848 -1.158 . . . . 2.6200000000000001 110.017 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.6 mtt180 -67.78 -37.77 82.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 2.48 110.948 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.7 t-80 -63.99 -40.2 95.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 2.4300000000000002 110.579 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.638 HG12 ' C ' ' A' ' 410' ' ' GLY . 98.7 t -64.8 -45.56 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.042 . . . . 0.93999999999999995 110.415 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.02 -36.04 80.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.825 -1.172 . . . . 2.1600000000000001 110.776 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.42 -42.06 92.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.05 -1.031 . . . . 1.53 109.738 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.533 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.1 m120 -66.49 -26.63 67.26 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 2.75 109.192 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.78 18.75 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.237 -1.545 . . . . 2.2799999999999998 109.237 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.638 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.15 -170.38 42.67 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 1.72 109.399 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 47.2 p-80 -140.51 151.46 44.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -1.149 . . . . 4.1600000000000001 110.38 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.81 108.73 34.14 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 3.3100000000000001 109.954 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.1 Cg_exo -60.74 143.98 99.48 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.918 1.483 . . . . 1.23 110.929 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -58.86 -43.97 90.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 1.75 110.463 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.82 -41.76 78.4 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.979 -1.076 . . . . 1.8700000000000001 109.97 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 439' ' ' VAL . 49.5 t -66.8 -40.47 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.031 -1.043 . . . . 0.70999999999999996 110.663 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.43 -38.59 90.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 1.8100000000000001 110.058 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 26.6 mt-30 -64.24 -41.77 96.84 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -0.943 . . . . 2.6000000000000001 110.685 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.988 ' O ' HG23 ' A' ' 423' ' ' VAL . 38.2 mttm -62.62 -38.81 91.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.701 -1.249 . . . . 2.4900000000000002 110.784 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.904 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.8 t -66.18 -40.08 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.058 -1.026 . . . . 0.79000000000000004 110.25 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -67.84 -43.44 79.53 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.546 -0.721 . . . . 2.0499999999999998 110.511 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 2.3300000000000001 109.841 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.6 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.121 -0.987 . . . . 1.0 109.703 173.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.2 -49.96 38.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 1.24 110.339 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 56.0 mtp180 -54.29 -21.53 9.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 4.1100000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 85.7 mm-40 -90.13 4.97 48.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 2.9199999999999999 110.509 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.88 71.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 1.1599999999999999 109.709 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.28 157.01 17.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -1.14 . . . . 1.0700000000000001 109.956 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.35 109.25 39.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.21 109.119 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.904 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.5 Cg_exo -75.17 108.5 2.73 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.101 1.58 . . . . 1.2 110.365 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.871 HD21 " C2'" ' A' 1001 ' ' ANP . 77.5 mt -90.25 141.65 28.5 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.896 -1.127 . . . . 1.3999999999999999 108.686 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.7 t -107.61 137.23 39.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.922 -1.111 . . . . 0.52000000000000002 110.022 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.931 HG12 HD21 ' A' ' 440' ' ' LEU . 21.2 t -116.11 135.87 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.611 -0.681 . . . . 1.0800000000000001 109.59 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.18 154.85 41.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 110.543 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.464 ' N ' HD23 ' A' ' 440' ' ' LEU . 4.5 mt-10 -99.74 121.53 41.4 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 173.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.81 -109.7 1.76 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.695 -1.762 . . . . 1.4199999999999999 108.695 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 22.3 p -113.6 12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 1.4199999999999999 111.26 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.6 ptt180 -123.27 139.9 53.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.665 -1.272 . . . . 3.52 110.233 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 HG11 ' A' ' 416' ' ' VAL . 47.1 t -79.2 127.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 1.4099999999999999 111.08 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.931 HD21 HG12 ' A' ' 433' ' ' VAL . 0.5 OUTLIER -91.75 -30.01 16.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.355 -0.84 . . . . 1.79 110.57 178.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.46 -178.36 48.62 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.326 -1.416 . . . . 1.02 110.78 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.904 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.8 t -121.96 155.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.507 -0.996 . . . . 0.56999999999999995 109.793 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.8 mm -124.86 128.12 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 1.05 110.701 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.812 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.85 120.93 40.53 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.295 -0.878 . . . . 0.46000000000000002 110.053 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 5.9 mp -100.16 142.36 31.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.086 -1.009 . . . . 2.1099999999999999 110.404 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -84.75 141.52 30.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.453 -0.78 . . . . 4.4800000000000004 110.022 172.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 36.9 p-10 -95.98 114.5 26.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.836 -0.746 . . . . 3.9100000000000001 110.155 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 0.8 OUTLIER -56.13 -43.7 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 3.6099999999999999 109.646 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 316' ' ' ASN . 47.8 t -98.6 134.49 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.559 -0.713 . . . . 5.0899999999999999 110.153 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -91.97 133.05 36.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 7.5 110.152 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 CA-C-O 118.021 -1.433 . . . . 7.2999999999999998 109.541 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.871 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 40.2 t-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.098 0.475 . . . . 6.0800000000000001 110.163 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 446' ' ' LYS . 65.7 mtt85 -124.19 137.58 54.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 5.8300000000000001 110.515 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.524 ' NE2' HD11 ' A' ' 448' ' ' ILE . 25.5 mt-30 -129.17 143.83 51.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.467 -0.771 . . . . 5.5800000000000001 109.234 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.012 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.12 121.81 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.731 -1.23 . . . . 1.4199999999999999 109.921 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.613 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.12 -39.28 5.32 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.423 -0.911 . . . . 1.6000000000000001 110.523 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -142.47 144.08 32.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.081 -1.012 . . . . 1.8200000000000001 110.972 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 334' ' ' ALA . 29.0 p90 -117.5 147.03 43.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.137 -0.977 . . . . 1.1399999999999999 110.189 172.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.554 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.4 mp -131.24 134.34 25.66 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.868 . . . . 0.53000000000000003 110.504 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.558 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.1 Cg_exo -61.5 158.39 36.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.034 1.544 . . . . 1.4399999999999999 111.445 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -79.79 -164.3 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.492 -0.755 . . . . 1.5800000000000001 109.664 171.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 51.0 tt0 -62.44 104.69 0.53 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.348 -0.845 . . . . 4.0 110.467 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.15 18.72 52.94 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.033 -1.08 . . . . 1.52 110.437 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.6 t -104.8 150.11 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.993 -1.298 . . . . 1.73 110.799 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.98 142.06 28.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.152 -0.967 . . . . 2.02 110.385 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.3 pt-20 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 2.7000000000000002 110.739 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 25.9 tttt -60.75 -44.95 96.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.008 -1.057 . . . . 3.0299999999999998 110.284 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -60.8 -45.88 92.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.90000000000000002 110.307 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 441' ' ' GLY . 16.2 tp -59.66 -45.17 92.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 0.93000000000000005 111.045 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.11 -45.46 90.85 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.87 109.544 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.536 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.1 t0 -61.45 -42.86 99.41 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.981 -1.074 . . . . 1.96 111.665 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.435 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -62.38 -36.71 83.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.76000000000000001 109.897 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.77 79.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.045 . . . . 0.71999999999999997 110.132 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.936 ' OE1' ' HB2' ' A' ' 356' ' ' ALA . 0.9 OUTLIER -65.8 -56.65 10.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 1.72 111.467 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -68.49 -37.39 80.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.612 -1.305 . . . . 1.5800000000000001 110.325 -174.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.95 -14.14 62.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.031 -1.043 . . . . 2.2400000000000002 110.331 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.535 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.7 p -95.98 -15.9 22.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 3.5600000000000001 110.394 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 365' ' ' ARG . 44.7 mt -58.89 -29.66 67.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.063 -1.023 . . . . 4.3600000000000003 110.064 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.95 -3.11 57.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 3.8100000000000001 110.878 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -96.06 137.59 34.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 2.8399999999999999 110.126 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.37 7.4 46.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 2.9900000000000002 110.356 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.785 HG21 ' CD2' ' A' ' 377' ' ' PHE . 24.7 p -74.08 141.02 77.43 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 2.0699999999999998 110.143 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.7 Cg_exo -57.07 -38.87 94.63 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.027 1.541 . . . . 2.3799999999999999 110.246 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.575 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 96.9 mt-10 -63.84 -34.73 78.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 3.25 110.081 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -56.97 -24.08 48.77 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.519 -1.432 . . . . 1.4199999999999999 109.519 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -77.57 -38.38 48.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.328 . . . . 3.6200000000000001 109.904 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 318' ' ' GLN . 52.7 p -56.24 -42.76 77.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 2.3999999999999999 109.524 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 319' ' ' ALA . 62.2 mt -63.59 -50.47 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 1.3899999999999999 111.245 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.535 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 81.7 t -56.68 -35.06 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.785 -1.197 . . . . 1.1799999999999999 110.985 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 68.3 mt -67.85 -44.81 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.703 -1.248 . . . . 1.3600000000000001 110.566 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.012 HD22 ' HB1' ' A' ' 319' ' ' ALA . 62.0 tp -47.3 -48.07 25.18 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.181 -0.949 . . . . 1.1499999999999999 110.733 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.936 ' HB2' ' OE1' ' A' ' 338' ' ' GLN . . . -63.03 -38.27 90.53 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.949 -1.094 . . . . 0.60999999999999999 109.478 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.1 mttt -60.1 -46.88 88.1 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.522 -1.271 . . . . 1.1599999999999999 110.459 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 11.0 pt20 -64.03 -38.65 91.86 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.358 -1.464 . . . . 1.8999999999999999 109.938 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.484 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 40.8 mmt180 -76.76 -44.28 33.63 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 2.6299999999999999 111.518 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.712 ' HB3' HD11 ' A' ' 362' ' ' LEU . 88.3 m-85 -115.73 -13.8 11.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.864 -1.147 . . . . 3.3199999999999998 110.132 -174.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.6 t30 60.55 50.06 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.869 0.842 . . . . 1.8999999999999999 110.285 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.3 mt -115.08 177.93 4.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.858 -0.526 . . . . 2.7999999999999998 109.662 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -122.66 159.48 27.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 4.4000000000000004 110.993 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.4 pt-20 -53.06 154.27 3.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.68 -0.638 . . . . 2.2400000000000002 109.918 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.644 ' H ' HD11 ' A' ' 342' ' ' LEU . 92.6 mtt-85 -99.83 135.76 40.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.065 . . . . 4.1600000000000001 110.028 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.13 113.96 10.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 2.8599999999999999 109.885 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 372' ' ' ALA . 76.9 t -69.65 -44.96 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 3.04 110.382 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -69.76 -22.25 63.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 3.6899999999999999 110.858 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 82.5 p -73.26 -24.08 60.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.795 -1.19 . . . . 3.0499999999999998 109.001 170.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.856 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.6 mt -91.47 1.42 57.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.294 -0.879 . . . . 2.1400000000000001 109.602 170.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 56.83 28.53 14.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.034 -1.041 . . . . 2.1000000000000001 108.921 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.976 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -90.53 -165.06 1.27 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.631 0.729 . . . . 1.1200000000000001 110.5 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.9 m -138.16 143.72 40.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.633 -0.667 . . . . 2.1099999999999999 110.359 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.703 ' CE1' HG21 ' A' ' 367' ' ' VAL . 89.7 m-85 -89.96 139.45 30.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.932 -1.105 . . . . 3.0899999999999999 109.534 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 1.028 HG11 ' NH1' ' A' ' 394' ' ' ARG . 18.2 t -107.22 113.24 62.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.873 -1.142 . . . . 4.0 109.951 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.6 Cg_endo -56.19 154.29 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.006 1.53 . . . . 4.6299999999999999 111.355 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -97.58 122.55 40.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.599 -0.688 . . . . 5.79 109.921 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.6 p -111.63 140.92 45.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 5.29 109.76 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.86 -30.3 61.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.581 -0.7 . . . . 6.1299999999999999 110.489 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.31 -46.58 85.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 7.7400000000000002 110.012 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 48.9 p -92.29 -9.45 41.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 3.8199999999999998 109.794 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 62.1 mtt85 54.87 54.01 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 4.25 109.784 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.583 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 32.4 mtm -152.41 149.49 28.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.954 -1.091 . . . . 2.0899999999999999 111.561 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -147.18 171.32 15.54 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.439 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.22 -161.52 27.71 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.495 -1.812 . . . . 1.1299999999999999 110.548 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' A' ' 393' ' ' ILE . 11.4 tt -148.67 154.28 10.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.72 -0.844 . . . . 1.26 108.72 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.669 HD21 HG21 ' A' ' 375' ' ' VAL . 2.8 m120 -126.28 140.65 52.36 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.031 -1.043 . . . . 2.04 108.527 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.856 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.9 tt -145.16 165.77 11.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.517 -1.364 . . . . 2.1099999999999999 110.483 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.93 7.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.452 0.908 . . . . 3.8500000000000001 113.452 -171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.6 t30 -145.67 3.53 0.98 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.21 -1.556 . . . . 2.3300000000000001 111.325 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 92.1 mtt-85 -157.82 156.97 32.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.626 -1.296 . . . . 2.6899999999999999 110.912 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.8 mtt -129.89 137.96 50.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.919 -1.113 . . . . 2.02 108.993 166.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 386' ' ' ILE . 11.1 mm -128.62 142.0 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 1.6799999999999999 110.368 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 1.028 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.5 mmt180 -142.17 142.55 32.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 2.7799999999999998 110.44 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.844 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.57 144.62 32.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 1.5700000000000001 109.471 177.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.87 -151.96 12.43 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.457 -1.354 . . . . 0.81999999999999995 110.268 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.6 p -73.63 159.27 33.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -1.183 . . . . 1.1699999999999999 110.602 -174.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' A' ' 420' ' ' VAL . 89.6 t -61.61 -49.22 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.53000000000000003 110.031 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.7 m-20 -61.06 -37.53 83.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.988 -1.07 . . . . 1.5900000000000001 108.931 172.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -61.23 -49.83 75.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.534 -0.729 . . . . 0.84999999999999998 110.776 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.574 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.5 mm -67.21 -37.47 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.63 -1.294 . . . . 0.81000000000000005 110.999 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 64.0 ttt180 -59.06 -42.01 89.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 2.6200000000000001 110.092 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 51.9 mtt85 -67.12 -37.38 83.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 2.48 110.821 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 58.2 t-80 -63.53 -40.73 97.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 2.4300000000000002 110.579 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.69 -45.24 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.078 . . . . 0.93999999999999995 110.492 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.32 -35.73 79.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.874 -1.141 . . . . 2.1600000000000001 110.84 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.3 88.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.53 109.659 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.8 m-20 -67.42 -25.47 65.94 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.756 0.788 . . . . 2.75 109.364 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 24.35 14.78 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.467 -1.453 . . . . 2.2799999999999998 109.467 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.632 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.73 -172.37 40.93 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 1.72 109.537 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.1 m80 -138.35 150.96 47.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.176 -1.191 . . . . 4.1600000000000001 110.277 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.792 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.2 t80 -93.03 109.67 41.05 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 3.3100000000000001 110.11 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 21.9 Cg_exo -60.63 142.78 98.77 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.004 1.528 . . . . 1.23 110.954 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -59.03 -43.17 91.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 1.75 110.567 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 414' ' ' THR . 49.2 t0 -53.85 -40.03 66.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 1.8700000000000001 109.975 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 439' ' ' VAL . 75.6 t -70.0 -40.04 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.70999999999999996 110.623 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.2 m-20 -61.1 -38.86 87.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.989 -1.069 . . . . 1.8100000000000001 110.244 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.5 mt-30 -64.78 -42.71 94.86 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.212 -0.93 . . . . 2.6000000000000001 110.738 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -63.79 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.806 -1.183 . . . . 2.4900000000000002 110.924 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.828 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.3 t -65.15 -40.41 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 0.79000000000000004 110.111 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.0 m-20 -70.44 -43.17 70.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.594 -0.691 . . . . 2.0499999999999998 110.78 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -64.53 -31.2 72.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 2.3300000000000001 109.676 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.4 t -61.27 -44.85 99.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.17 -0.956 . . . . 1.0 109.687 172.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -69.13 -45.48 70.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 1.24 110.082 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -58.47 -19.12 34.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 4.1100000000000003 109.634 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -86.09 -1.29 57.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -0.814 . . . . 2.9199999999999999 110.001 176.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.54 77.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.396 -1.482 . . . . 1.1599999999999999 109.396 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 424' ' ' ALA . . . -102.82 156.6 17.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 1.0700000000000001 110.137 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.4 m -93.23 110.17 44.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.948 . . . . 1.21 108.985 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.828 ' HB2' HG13 ' A' ' 420' ' ' VAL . 1.8 Cg_endo -77.76 111.08 3.06 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.021 1.537 . . . . 1.2 110.178 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.723 HD21 " H2'" ' A' 1001 ' ' ANP . 56.6 mt -90.13 145.4 25.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.728 -1.232 . . . . 1.3999999999999999 108.24 166.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -108.45 138.02 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 O-C-N 120.921 -1.112 . . . . 0.52000000000000002 110.109 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.996 HG12 HD21 ' A' ' 440' ' ' LEU . 31.2 t -117.19 137.13 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 1.0800000000000001 109.813 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.728 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -126.67 161.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.667 -0.646 . . . . 0.90000000000000002 110.108 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.688 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.4 mt-10 -115.72 123.53 48.54 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.257 -0.902 . . . . 1.79 108.9 167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.14 -109.76 3.08 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.888 -1.685 . . . . 1.4199999999999999 108.888 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.748 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.4 p -119.72 9.97 11.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 1.4199999999999999 111.044 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt85 -120.34 142.11 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.773 -1.204 . . . . 3.52 110.258 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.053 HG11 HG11 ' A' ' 416' ' ' VAL . 40.2 t -76.69 127.05 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.845 . . . . 1.4099999999999999 110.571 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.996 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.23 -27.3 19.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.157 -0.964 . . . . 1.79 110.435 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 179.25 -178.59 48.79 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.271 -1.442 . . . . 1.02 110.614 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.666 HG11 ' HA ' ' A' ' 420' ' ' VAL . 61.4 t -119.35 154.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -1.023 . . . . 0.56999999999999995 109.922 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 322' ' ' PHE . 27.5 mm -124.19 126.59 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 1.05 110.362 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.916 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.76 121.64 43.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.293 -0.879 . . . . 0.46000000000000002 110.304 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.3 mp -103.86 146.11 29.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 2.1099999999999999 110.196 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 317' ' ' ARG . 75.8 tttt -90.2 141.57 28.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.187 -0.946 . . . . 4.4800000000000004 109.604 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 34.1 p30 -95.88 130.42 42.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.33 -0.856 . . . . 3.9100000000000001 110.492 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.524 HD11 ' NE2' ' A' ' 318' ' ' GLN . 4.3 mm -55.13 -47.83 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.116 -0.99 . . . . 3.6099999999999999 109.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.89 136.09 35.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.258 0.551 . . . . 5.0899999999999999 110.324 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.482 ' HD3' ' OD2' ' A' ' 447' ' ' ASP . 14.4 tptm -144.14 130.21 19.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 7.5 110.122 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 CA-C-O 118.034 -1.425 . . . . 7.2999999999999998 109.54 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.723 " H2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 448' ' ' ILE . 20.7 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.562 . . . . 6.0800000000000001 110.122 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.439 ' NH1' ' O2A' ' A' 1001 ' ' ANP . 98.3 mtt180 -128.43 140.51 51.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 5.8300000000000001 110.36 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.502 ' OE1' HD11 ' A' ' 448' ' ' ILE . 14.3 pt20 -140.58 145.52 36.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.428 -0.795 . . . . 5.5800000000000001 110.149 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -66.56 131.38 45.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 110.023 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -108.24 -34.84 6.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.148 -0.97 . . . . 1.6000000000000001 110.277 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -151.8 141.82 22.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 1.8200000000000001 110.783 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.78 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.5 p90 -117.54 147.24 42.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.912 . . . . 1.1399999999999999 110.134 173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.824 ' C ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -131.83 140.49 38.39 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.53000000000000003 110.663 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 12.6 Cg_exo -64.8 155.55 66.77 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.825 1.434 . . . . 1.4399999999999999 111.102 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.93 -164.59 0.45 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.555 -0.716 . . . . 1.5800000000000001 109.922 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -60.87 104.36 0.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.444 -0.785 . . . . 4.0 110.45 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.66 16.5 58.32 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.962 -1.113 . . . . 1.52 110.358 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 32.5 t -102.92 151.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.349 . . . . 1.73 110.522 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.84 146.63 23.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 2.02 110.022 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 48.3 mt-10 -60.39 -35.58 76.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.215 -0.928 . . . . 2.7000000000000002 111.073 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 42.9 tttp -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.021 -1.049 . . . . 3.0299999999999998 110.51 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 67.5 m -62.16 -47.02 86.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.075 -1.015 . . . . 0.90000000000000002 110.214 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.974 HD13 ' HA3' ' A' ' 441' ' ' GLY . 15.4 tp -54.92 -51.04 67.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.93000000000000005 110.881 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 322' ' ' PHE . . . -62.05 -38.57 89.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.87 110.404 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.595 ' O ' HD23 ' A' ' 339' ' ' LEU . 59.5 t0 -66.25 -46.18 78.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.719 -1.238 . . . . 1.96 111.201 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.641 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.19 -36.1 82.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.042 -1.036 . . . . 0.76000000000000001 110.261 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.63 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -63.33 -35.88 81.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.036 -1.04 . . . . 0.71999999999999997 110.128 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.757 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -73.3 -51.15 18.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 1.72 111.505 -176.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 386' ' ' ILE . 0.9 OUTLIER -72.07 -33.79 68.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.776 -1.202 . . . . 1.5800000000000001 110.346 -177.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -66.01 -14.75 62.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.031 -1.043 . . . . 2.2400000000000002 110.009 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.502 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -98.06 -16.81 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -0.85 . . . . 3.5600000000000001 110.301 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 65.3 mt -56.79 -26.23 57.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.995 -1.065 . . . . 4.3600000000000003 109.743 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -85.57 -23.84 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 3.8100000000000001 110.716 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.502 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -78.47 138.34 38.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.081 . . . . 2.8399999999999999 110.107 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.51 6.66 48.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 2.9900000000000002 110.294 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.523 HG21 ' CD2' ' A' ' 377' ' ' PHE . 25.4 p -76.07 144.2 75.12 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 2.0699999999999998 110.099 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.66 -34.47 96.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.912 1.48 . . . . 2.3799999999999999 110.166 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.17 -35.51 81.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.346 -0.846 . . . . 3.25 110.142 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.68 -28.48 62.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.747 -1.341 . . . . 1.4199999999999999 109.747 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 354' ' ' ILE . 84.7 mtt180 -76.75 -36.32 57.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.947 -1.325 . . . . 3.6200000000000001 109.568 173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 354' ' ' ILE . 32.3 t -54.53 -47.61 72.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.204 -0.935 . . . . 2.3999999999999999 109.763 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.642 HG22 ' OE1' ' A' ' 338' ' ' GLN . 5.5 mt -63.96 -48.7 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 1.3899999999999999 110.849 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.562 HG11 ' OE2' ' A' ' 364' ' ' GLU . 71.1 t -57.72 -30.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 110.423 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 351' ' ' SER . 71.1 mt -68.71 -46.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.26 . . . . 1.3600000000000001 110.3 169.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' A' ' 319' ' ' ALA . 39.5 tp -47.42 -51.64 19.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.127 -0.983 . . . . 1.1499999999999999 110.441 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.757 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.57 -37.27 86.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.60999999999999999 109.58 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 21.3 tptm -54.34 -54.81 35.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.845 -1.159 . . . . 1.1599999999999999 110.677 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.506 ' HG3' ' HG3' ' A' ' 359' ' ' ARG . 19.3 pt20 -67.15 -41.62 85.75 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.525 -1.36 . . . . 1.8999999999999999 110.084 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.624 ' HD2' ' CE2' ' A' ' 322' ' ' PHE . 90.9 mtt-85 -71.05 -39.04 72.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.6299999999999999 111.888 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.672 ' HB3' HD11 ' A' ' 362' ' ' LEU . 57.2 m-85 -115.96 -14.39 11.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.671 -1.268 . . . . 3.3199999999999998 110.409 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.29 50.22 6.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.89 0.852 . . . . 1.8999999999999999 110.213 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 360' ' ' PHE . 24.8 mt -107.02 172.63 6.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.567 -0.531 . . . . 2.7999999999999998 109.567 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -118.92 150.36 40.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.788 -1.195 . . . . 4.4000000000000004 110.273 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.562 ' OE2' HG11 ' A' ' 353' ' ' VAL . 95.7 mt-10 -57.11 148.74 21.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 2.2400000000000002 109.503 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.548 ' CZ ' HD22 ' A' ' 339' ' ' LEU . 10.8 ptp180 -98.76 134.8 41.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.971 -1.081 . . . . 4.1600000000000001 110.317 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.491 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.5 m-20 -72.81 113.17 9.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -0.892 . . . . 2.8599999999999999 109.613 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 372' ' ' ALA . 57.1 t -70.27 -44.47 77.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 3.04 110.514 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.72 -21.66 61.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 3.6899999999999999 111.051 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 64.5 p -74.3 -24.87 59.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.766 -1.209 . . . . 3.0499999999999998 109.04 171.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 388' ' ' ILE . 46.1 mt -91.26 2.65 56.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.577 170.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 65.4 m80 55.84 29.85 14.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 2.1000000000000001 108.892 -172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.895 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.45 -166.86 1.7 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.604 0.716 . . . . 1.1200000000000001 110.301 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 23.4 m -137.42 143.63 41.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.477 -0.764 . . . . 2.1099999999999999 110.502 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.655 ' CE1' HG21 ' A' ' 367' ' ' VAL . 81.6 m-85 -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.012 -1.055 . . . . 3.0899999999999999 109.418 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.521 ' N ' ' HB1' ' A' ' 343' ' ' ALA . 21.5 t -102.91 111.3 64.87 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.801 -1.187 . . . . 4.0 109.684 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.6 151.64 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.096 1.577 . . . . 4.6299999999999999 111.119 -175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.523 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -95.93 122.04 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.468 -0.77 . . . . 5.79 109.875 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 36.2 p -109.72 139.8 44.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 5.29 109.735 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.36 -31.04 60.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.577 -0.702 . . . . 6.1299999999999999 110.528 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -58.42 -44.32 89.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 7.7400000000000002 110.015 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 65.9 p -91.49 -19.6 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 3.8199999999999998 109.852 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 61.1 mtt-85 64.97 53.16 1.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 4.25 109.725 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.606 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.7 mtp -148.75 144.98 27.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.025 . . . . 2.0899999999999999 111.301 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.629 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 43.8 p -144.0 167.01 23.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.088 -1.078 . . . . 1.23 108.088 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.445 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.13 -162.5 27.63 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.893 -1.623 . . . . 1.1299999999999999 110.28 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 339' ' ' LEU . 11.8 tt -151.37 154.12 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 121.832 -0.805 . . . . 1.26 109.1 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 375' ' ' VAL . 3.3 m120 -127.11 140.7 52.08 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.937 -1.102 . . . . 2.04 108.45 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 370' ' ' LEU . 11.7 tt -145.09 165.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.488 -1.383 . . . . 2.1099999999999999 110.285 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.1 7.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.458 0.91 . . . . 3.8500000000000001 113.458 -171.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.523 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 35.1 t30 -145.94 2.94 0.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.152 -1.593 . . . . 2.3300000000000001 111.365 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 66.9 mtp85 -157.67 156.25 31.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.55 -1.344 . . . . 2.6899999999999999 110.779 -173.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.695 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.4 mtm -129.96 140.49 50.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.851 -1.156 . . . . 2.02 109.317 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.846 HG13 HD11 ' A' ' 339' ' ' LEU . 37.0 mm -129.39 140.7 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.723 -1.235 . . . . 1.6799999999999999 109.939 175.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 15.0 tpt180 -140.54 144.83 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 2.7799999999999998 110.069 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 1.021 ' HD3' HD13 ' A' ' 431' ' ' LEU . 0.0 OUTLIER -148.86 148.39 29.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 1.5700000000000001 109.786 -175.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.788 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.37 -147.0 9.58 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.188 -1.482 . . . . 0.81999999999999995 110.435 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.585 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 5.3 p -73.11 158.83 34.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -1.147 . . . . 1.1699999999999999 110.409 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.042 HG21 HG11 ' A' ' 420' ' ' VAL . 58.9 t -58.67 -47.58 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.53000000000000003 109.669 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 89.8 m-20 -61.89 -38.76 89.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.005 -1.06 . . . . 1.5900000000000001 109.18 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -48.85 79.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 110.509 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.788 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.3 mm -67.47 -38.51 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.826 -1.171 . . . . 0.81000000000000005 110.997 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 72.5 ttp85 -58.32 -41.58 84.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.852 -1.155 . . . . 2.6200000000000001 110.134 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.3 mtt180 -66.92 -38.87 87.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 2.48 110.851 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.514 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 55.5 t-80 -64.84 -40.02 94.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.016 -1.053 . . . . 2.4300000000000002 110.722 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.611 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.1 t -65.07 -45.36 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.073 . . . . 0.93999999999999995 110.458 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.4 mt-10 -62.88 -35.53 80.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.153 . . . . 2.1600000000000001 110.744 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.9 88.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.003 -1.061 . . . . 1.53 109.714 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.9 m-20 -67.19 -26.45 66.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.332 -0.855 . . . . 2.75 109.321 172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.31 24.42 14.44 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.294 -1.522 . . . . 2.2799999999999998 109.294 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.611 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.18 -170.02 41.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 1.72 109.407 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -140.89 149.52 42.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -1.18 . . . . 4.1600000000000001 110.413 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.813 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -94.48 109.19 41.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 3.3100000000000001 110.119 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.0 Cg_exo -60.28 142.78 98.98 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.898 1.473 . . . . 1.23 110.922 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 4.5 t -57.62 -43.33 84.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 1.75 110.255 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 418' ' ' GLN . 90.5 m-20 -56.26 -35.9 67.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 1.8700000000000001 110.336 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 439' ' ' VAL . 65.9 t -70.9 -35.74 61.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.393 -1.442 . . . . 0.70999999999999996 110.161 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 98.8 m-20 -62.06 -43.93 97.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 1.8100000000000001 110.529 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 415' ' ' ASP . 9.2 pt20 -68.92 -35.06 76.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.007 -1.058 . . . . 2.6000000000000001 110.502 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.954 ' O ' HG23 ' A' ' 423' ' ' VAL . 18.7 mmtm -61.01 -41.27 96.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.648 -1.282 . . . . 2.4900000000000002 110.583 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.042 HG11 HG21 ' A' ' 398' ' ' VAL . 66.0 t -66.31 -39.45 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.79000000000000004 110.117 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.25 -43.03 74.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.354 -0.841 . . . . 2.0499999999999998 110.773 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.6 mt-30 -65.79 -32.45 73.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 2.3300000000000001 109.696 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.1 t -58.85 -42.74 86.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.228 -0.92 . . . . 1.0 109.673 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.3 66.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.907 . . . . 1.24 109.92 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 93.8 mtt-85 -55.9 -22.18 24.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 4.1100000000000003 109.849 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.5 mt-30 -91.63 6.59 45.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 2.9199999999999999 110.714 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 77.64 37.06 31.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.692 -1.363 . . . . 1.1599999999999999 109.692 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -131.96 160.63 35.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -1.095 . . . . 1.0700000000000001 109.697 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -93.38 109.05 37.96 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 1.21 108.999 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.014 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.9 Cg_endo -79.85 107.32 2.08 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 124.044 1.549 . . . . 1.2 110.213 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 1.021 HD13 ' HD3' ' A' ' 395' ' ' LYS . 0.4 OUTLIER -93.31 161.91 14.21 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.791 -1.193 . . . . 1.3999999999999999 108.534 169.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.813 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.2 t -120.98 139.56 47.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 120.698 -1.251 . . . . 0.52000000000000002 110.472 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.7 HG12 HD21 ' A' ' 440' ' ' LEU . 13.9 t -119.96 136.56 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 1.0800000000000001 109.574 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.5 m -131.4 153.68 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.489 -0.885 . . . . 0.90000000000000002 110.994 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 15.6 mt-10 -97.06 130.15 44.4 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.978 -0.749 . . . . 1.79 108.978 172.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 435' ' ' GLU . . . 50.43 -109.59 0.72 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.481 -1.848 . . . . 1.4199999999999999 108.481 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 8.4 p -114.86 15.4 17.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -1.127 . . . . 1.4199999999999999 111.113 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.524 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.7 ptt85 -125.19 140.48 52.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 3.52 110.318 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 416' ' ' VAL . 41.9 t -78.14 127.93 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.814 . . . . 1.4099999999999999 111.232 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.879 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.18 -32.76 19.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 1.79 110.273 175.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.974 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . 177.57 -177.35 48.32 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.081 -1.533 . . . . 1.02 110.819 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.755 ' CG1' HG22 ' A' ' 420' ' ' VAL . 49.1 t -120.14 154.74 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.515 -0.991 . . . . 0.56999999999999995 109.596 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 322' ' ' PHE . 14.9 mm -122.35 127.06 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.743 -1.223 . . . . 1.05 110.761 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.33 121.4 40.21 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.136 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.9 mp -103.58 136.44 43.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 2.1099999999999999 110.655 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -89.01 144.17 26.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.427 -0.796 . . . . 4.4800000000000004 109.382 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -95.86 137.29 35.14 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.08 -1.013 . . . . 3.9100000000000001 110.284 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.502 HD11 ' OE1' ' A' ' 318' ' ' GLN . 5.5 mm -57.99 -50.09 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 3.6099999999999999 109.679 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.68 134.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.187 0.518 . . . . 5.0899999999999999 110.274 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -144.89 130.44 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 7.5 110.135 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 7.2999999999999998 109.526 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.632 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.472 ' O ' HD13 ' A' ' 448' ' ' ILE . 16.0 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.332 0.587 . . . . 6.0800000000000001 110.294 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -41.95 141.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 5.8300000000000001 110.417 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 35.7 tt0 -148.56 140.39 23.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.521 -0.737 . . . . 5.5800000000000001 110.384 -176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.79 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -62.2 134.86 57.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.934 -1.104 . . . . 1.4199999999999999 110.11 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.21 -40.06 4.55 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.279 -0.968 . . . . 1.6000000000000001 110.53 174.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.411 ' OE2' HD11 ' A' ' 323' ' ' ILE . 85.2 tt0 -143.52 144.0 31.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.124 -0.985 . . . . 1.8200000000000001 110.994 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.033 ' CD1' HD21 ' A' ' 355' ' ' LEU . 23.7 p90 -117.61 146.94 43.29 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.266 -0.897 . . . . 1.1399999999999999 110.406 173.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.4 mm -130.79 138.56 33.27 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.53000000000000003 110.433 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.546 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 12.4 Cg_exo -62.22 156.8 48.45 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.199 1.631 . . . . 1.4399999999999999 111.21 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.802 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.86 -164.82 0.64 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 1.5800000000000001 109.664 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.9 tt0 -63.32 104.7 0.64 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.301 -0.874 . . . . 4.0 110.415 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.26 17.85 51.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.394 -1.082 . . . . 1.52 110.394 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.909 HG11 ' O ' ' A' ' 440' ' ' LEU . 61.8 t -104.64 149.76 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.956 -1.32 . . . . 1.73 110.804 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.99 142.19 28.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 2.02 110.332 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.546 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -64.68 -41.94 95.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 2.7000000000000002 110.763 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.578 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 39.2 mttp -60.7 -42.01 96.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.048 -1.032 . . . . 3.0299999999999998 110.202 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 90.1 m -60.11 -45.99 91.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.90000000000000002 110.27 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 443' ' ' ILE . 12.3 tp -60.29 -45.78 92.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.93000000000000005 111.101 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.804 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.23 -39.09 88.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.061 -1.024 . . . . 0.87 109.785 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -65.45 -45.28 84.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.088 -1.008 . . . . 1.96 111.36 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.31 -36.8 85.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.074 . . . . 0.76000000000000001 110.384 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.86 76.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 0.71999999999999997 110.099 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.656 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.74 -52.55 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 1.72 111.388 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.787 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.16 -36.27 74.59 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.7 -1.25 . . . . 1.5800000000000001 110.43 -176.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.614 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.43 -13.39 61.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 2.2400000000000002 110.332 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 89.0 p -97.37 -15.99 20.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.237 -0.915 . . . . 3.5600000000000001 110.286 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.606 HD11 ' H ' ' A' ' 365' ' ' ARG . 53.0 mt -59.06 -28.47 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 4.3600000000000003 110.153 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.04 -20.74 25.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 3.8100000000000001 110.929 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -77.47 137.87 38.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 2.8399999999999999 110.007 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.34 6.72 48.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 2.9900000000000002 110.291 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.805 HG21 ' CD2' ' A' ' 377' ' ' PHE . 43.7 p -76.69 142.66 70.45 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.876 . . . . 2.0699999999999998 110.055 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.447 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 10.8 Cg_endo -59.23 -35.23 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.98 1.516 . . . . 2.3799999999999999 110.134 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.574 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -63.98 -35.96 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 3.25 110.136 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -57.81 -28.53 60.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.533 -1.427 . . . . 1.4199999999999999 109.533 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 59.9 mtm180 -75.12 -36.3 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.32 . . . . 3.6200000000000001 109.444 171.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.762 ' HA ' HD12 ' A' ' 354' ' ' ILE . 16.3 m -54.47 -44.68 72.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.289 -0.882 . . . . 2.3999999999999999 109.82 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.613 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.6 mt -67.46 -46.81 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 1.3899999999999999 111.04 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.8 t -54.4 -31.82 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.618 -1.301 . . . . 1.1799999999999999 110.048 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.4 mt -68.0 -45.5 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.905 -1.122 . . . . 1.3600000000000001 110.33 169.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 322' ' ' PHE . 8.7 tt -47.21 -53.04 14.2 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.16 -0.962 . . . . 1.1499999999999999 110.509 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 1.033 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -65.32 -36.68 84.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.935 -1.103 . . . . 0.60999999999999999 109.634 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 46.1 tptt -58.57 -49.09 78.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.92 -1.112 . . . . 1.1599999999999999 110.805 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 359' ' ' ARG . 12.2 pt20 -65.15 -39.45 92.99 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.455 -1.403 . . . . 1.8999999999999999 109.696 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -73.79 -46.26 46.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 2.6299999999999999 111.522 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.807 ' HB2' HD23 ' A' ' 362' ' ' LEU . 72.9 m-85 -116.15 -15.0 11.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.638 -1.289 . . . . 3.3199999999999998 110.454 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.5 t-20 58.39 41.23 23.3 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.543 -0.723 . . . . 1.8999999999999999 109.952 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 1.033 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.51 -176.6 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.681 -0.637 . . . . 2.7999999999999998 109.787 175.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -124.36 151.89 43.82 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.124 -0.985 . . . . 4.4000000000000004 109.886 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.71 148.87 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 2.2400000000000002 109.394 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.606 ' H ' HD11 ' A' ' 342' ' ' LEU . 25.3 ttm180 -96.79 142.09 29.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.004 -1.06 . . . . 4.1600000000000001 109.997 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 369' ' ' SER . 92.0 m-20 -82.71 110.95 18.21 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.604 -0.685 . . . . 2.8599999999999999 109.871 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.731 HG21 ' CE1' ' A' ' 374' ' ' PHE . 73.9 t -70.02 -47.65 67.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.461 -0.774 . . . . 3.04 110.291 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.74 -19.25 60.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.103 -0.998 . . . . 3.6899999999999999 110.999 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 366' ' ' ASP . 41.7 t -72.69 -28.91 62.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.774 -1.204 . . . . 3.0499999999999998 109.224 170.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 388' ' ' ILE . 26.4 mt -90.59 3.86 52.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 2.1400000000000001 109.835 172.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.5 m-70 58.62 27.3 15.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.089 -1.007 . . . . 2.1000000000000001 108.755 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.98 -166.81 1.69 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.504 0.669 . . . . 1.1200000000000001 110.254 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 37.3 m -139.26 143.68 38.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 2.1099999999999999 110.581 -177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.731 ' CE1' HG21 ' A' ' 367' ' ' VAL . 75.7 m-85 -88.88 143.0 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.062 -1.024 . . . . 3.0899999999999999 109.616 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.654 HG23 ' HA ' ' A' ' 386' ' ' ILE . 6.4 t -110.06 112.67 57.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.929 -1.107 . . . . 4.0 109.906 175.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.1 Cg_endo -54.82 151.77 31.36 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 124.088 1.572 . . . . 4.6299999999999999 111.331 -175.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -98.9 122.49 42.22 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.561 -0.712 . . . . 5.79 109.947 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 30.4 p -111.82 140.16 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 5.29 109.749 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.73 60.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.546 -0.721 . . . . 6.1299999999999999 110.543 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -58.32 -46.12 86.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 7.7400000000000002 109.921 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 383' ' ' MET . 47.3 p -91.5 -12.84 33.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 3.8199999999999998 109.676 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.0 mtt180 58.16 53.08 6.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.77 . . . . 4.25 109.827 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.575 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.4 mtm -152.46 149.73 28.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.005 -1.059 . . . . 2.0899999999999999 111.464 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.1 p -147.44 174.58 11.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.717 -1.216 . . . . 1.23 107.717 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.436 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . 179.26 -163.96 31.81 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 118.492 -1.813 . . . . 1.1299999999999999 110.388 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.787 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.4 149.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.914 -0.772 . . . . 1.26 108.914 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.606 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -121.69 144.15 48.94 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.17 -0.956 . . . . 2.04 108.624 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.891 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.0 tt -144.87 164.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.639 -1.288 . . . . 2.1099999999999999 110.189 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.56 7.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.454 0.909 . . . . 3.8500000000000001 113.454 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -143.74 1.78 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.174 -1.579 . . . . 2.3300000000000001 111.385 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 94.7 mtt180 -157.48 160.28 38.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.618 -1.301 . . . . 2.6899999999999999 111.072 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.1 mtm -129.96 140.55 50.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 2.02 109.105 166.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.706 HD13 ' HG2' ' A' ' 435' ' ' GLU . 14.6 mm -131.51 140.26 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 1.6799999999999999 110.11 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.454 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 12.5 tpt180 -142.27 144.46 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 2.7799999999999998 110.419 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.37 147.01 30.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 1.5700000000000001 109.594 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.67 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.01 -150.97 11.11 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.29 -1.433 . . . . 0.81999999999999995 110.453 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -69.87 153.2 43.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -1.091 . . . . 1.1699999999999999 110.571 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.845 HG21 ' CG1' ' A' ' 420' ' ' VAL . 66.4 t -60.14 -49.37 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.53000000000000003 110.131 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.9 m-20 -59.71 -37.71 79.63 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.135 . . . . 1.5900000000000001 109.041 172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -60.89 -50.74 72.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.84999999999999998 110.631 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.67 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -64.69 -39.07 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.24 . . . . 0.81000000000000005 111.142 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 58.5 ttp180 -58.48 -42.33 87.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.776 -1.202 . . . . 2.6200000000000001 110.108 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.2 mtt180 -66.46 -36.76 83.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.079 -1.013 . . . . 2.48 110.783 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.454 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 85.7 t60 -63.71 -40.45 96.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 2.4300000000000002 110.58 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 437' ' ' SER . 87.0 t -64.5 -45.49 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.895 -1.128 . . . . 0.93999999999999995 110.414 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 96.9 mt-10 -61.93 -36.33 81.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 2.1600000000000001 110.785 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.21 -41.43 90.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.043 . . . . 1.53 109.649 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.7 m120 -66.22 -26.51 67.41 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 2.75 109.148 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.25 22.87 18.43 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 109.292 -1.523 . . . . 2.2799999999999998 109.292 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.61 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.94 -172.83 40.75 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.532 -1.427 . . . . 1.72 109.532 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.9 m80 -138.13 149.4 45.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -1.171 . . . . 4.1600000000000001 110.253 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.828 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.5 t80 -90.33 112.46 52.9 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 3.3100000000000001 110.111 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.43 143.38 97.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.443 . . . . 1.23 110.604 -178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.6 t -60.39 -44.46 95.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 1.75 110.417 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.539 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -57.04 -35.7 69.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 1.8700000000000001 110.348 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 439' ' ' VAL . 71.0 t -70.7 -36.71 66.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.606 -1.309 . . . . 0.70999999999999996 110.19 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -63.71 -44.16 94.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 1.8100000000000001 110.369 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.8 pt20 -66.63 -36.55 82.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.869 -1.145 . . . . 2.6000000000000001 110.35 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.1 OUTLIER -61.89 -39.4 91.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.755 -1.215 . . . . 2.4900000000000002 110.478 177.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 398' ' ' VAL . 39.5 t -64.36 -41.2 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.143 -0.973 . . . . 0.79000000000000004 110.45 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -70.17 -43.15 71.42 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.634 -0.666 . . . . 2.0499999999999998 110.912 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.53 -30.79 71.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 2.3300000000000001 109.753 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 419' ' ' LYS . 76.8 t -59.93 -43.57 92.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.041 -1.037 . . . . 1.0 109.671 171.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.83 -49.62 44.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 1.24 110.25 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 92.7 mtt-85 -53.98 -21.8 8.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 4.1100000000000003 109.824 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.6 mt-30 -89.44 4.75 48.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 2.9199999999999999 110.609 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.27 10.6 70.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.777 -1.329 . . . . 1.1599999999999999 109.777 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.15 157.37 17.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.107 . . . . 1.0700000000000001 109.948 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.18 109.22 38.49 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 1.21 108.936 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.669 ' HA ' HG11 ' A' ' 423' ' ' VAL . 6.1 Cg_exo -75.96 114.43 3.92 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 123.915 1.482 . . . . 1.2 110.228 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.823 HD21 " O2'" ' A' 1001 ' ' ANP . 70.1 mt -90.05 161.69 15.71 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.82 -1.175 . . . . 1.3999999999999999 108.348 165.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.766 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.0 t -125.26 138.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.72 -1.238 . . . . 0.52000000000000002 110.212 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.123 HG12 HD21 ' A' ' 440' ' ' LEU . 33.9 t -117.26 138.98 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.71 -0.619 . . . . 1.0800000000000001 109.648 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.743 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.08 162.24 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.90000000000000002 110.074 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.706 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.0 mt-10 -116.73 124.37 49.48 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.127 -0.983 . . . . 1.79 108.881 166.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.3 -109.8 3.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.906 -1.677 . . . . 1.4199999999999999 108.906 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 405' ' ' VAL . 27.6 p -119.61 9.88 11.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -1.149 . . . . 1.4199999999999999 110.989 -177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.1 ptt180 -120.7 142.71 49.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 3.52 110.304 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.008 HG11 HG11 ' A' ' 416' ' ' VAL . 42.8 t -76.58 127.47 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 1.4099999999999999 110.699 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.123 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.61 -25.67 21.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 1.79 110.564 178.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.661 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.78 178.18 48.47 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.222 -1.466 . . . . 1.02 110.909 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.817 ' O ' HD13 ' A' ' 443' ' ' ILE . 57.5 t -121.67 150.24 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.476 -1.014 . . . . 0.56999999999999995 109.806 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 442' ' ' VAL . 12.0 mm -121.48 128.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 1.05 110.828 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.773 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -98.82 121.11 40.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.46000000000000002 110.19 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.7 mp -101.01 137.06 39.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 2.1099999999999999 110.272 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -86.71 139.44 30.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.091 -1.006 . . . . 4.4800000000000004 109.162 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -95.93 129.65 43.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.15 -0.969 . . . . 3.9100000000000001 110.532 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -59.08 -49.12 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 3.6099999999999999 109.536 175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.3 t -101.69 134.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 5.0899999999999999 110.234 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -93.15 145.26 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 7.5 110.202 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.003 -1.443 . . . . 7.2999999999999998 109.507 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.823 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 84.5 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.154 0.502 . . . . 6.0800000000000001 110.187 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -127.9 137.71 52.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.97 . . . . 5.8300000000000001 110.449 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.525 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 22.5 pt20 -136.45 144.42 44.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.434 -0.791 . . . . 5.5800000000000001 109.837 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.965 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -65.33 125.35 24.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 1.4199999999999999 110.098 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -109.69 -37.07 5.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.242 -0.911 . . . . 1.6000000000000001 110.564 175.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.508 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.5 tt0 -142.67 149.18 38.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.073 -1.017 . . . . 1.8200000000000001 110.854 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.864 ' CD2' ' HB2' ' A' ' 334' ' ' ALA . 4.3 p90 -117.33 142.99 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 1.1399999999999999 110.243 173.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.838 ' O ' HD22 ' A' ' 333' ' ' LEU . 12.4 mm -127.36 130.03 23.79 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.53000000000000003 110.299 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 14.1 Cg_exo -60.78 158.31 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.746 1.393 . . . . 1.4399999999999999 111.534 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.808 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.44 -166.52 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.359 -0.838 . . . . 1.5800000000000001 109.325 169.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 57.7 tt0 -64.51 105.79 1.02 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.195 -0.941 . . . . 4.0 110.379 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.4 19.14 46.56 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.416 -1.073 . . . . 1.52 110.416 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 440' ' ' LEU . 50.8 t -107.2 152.26 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.257 . . . . 1.73 110.897 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 89.0 m-20 -84.71 143.67 29.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.225 -0.922 . . . . 2.02 110.218 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -66.72 -41.61 87.65 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.032 . . . . 2.7000000000000002 110.662 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 6.3 mtpm? -59.95 -37.32 79.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.029 -1.044 . . . . 3.0299999999999998 109.673 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 86.4 m -58.84 -45.52 89.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.90000000000000002 110.372 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.852 HD21 ' O ' ' A' ' 442' ' ' VAL . 39.9 tp -61.74 -43.28 99.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.93000000000000005 111.075 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.864 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -59.77 -37.65 79.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.87 109.996 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -66.25 -50.82 62.44 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.308 -0.87 . . . . 1.96 111.521 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.34 -39.86 92.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.122 -0.986 . . . . 0.76000000000000001 110.714 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.701 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -66.0 -42.12 90.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.71999999999999997 110.606 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.701 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.3 mp0 -77.47 -33.67 54.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.086 -1.009 . . . . 1.72 111.808 -173.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -74.88 -37.77 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.505 -1.372 . . . . 1.5800000000000001 109.991 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -71.34 -4.37 25.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 2.2400000000000002 110.641 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.501 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -97.58 -15.46 20.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.165 -0.96 . . . . 3.5600000000000001 110.065 179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 364' ' ' GLU . 55.1 mt -55.99 -22.56 27.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.251 -0.905 . . . . 4.3600000000000003 110.058 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -82.32 -36.66 26.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 3.8100000000000001 110.673 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.501 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.6 p30 -71.68 138.02 48.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 2.8399999999999999 110.309 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.66 6.97 47.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 2.9900000000000002 110.193 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 377' ' ' PHE . 40.0 p -73.81 142.56 80.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 2.0699999999999998 110.161 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 25.8 Cg_exo -57.81 -36.81 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 2.3799999999999999 110.26 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 351' ' ' SER . 97.1 mt-10 -64.26 -36.87 85.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 3.25 110.143 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -60.92 -27.65 67.28 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.635 -1.386 . . . . 1.4199999999999999 109.635 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.9 mtt180 -75.66 -35.14 60.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.854 -1.38 . . . . 3.6200000000000001 109.439 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.763 ' HA ' HD12 ' A' ' 354' ' ' ILE . 14.6 t -54.43 -50.25 68.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.257 -0.902 . . . . 2.3999999999999999 109.818 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 319' ' ' ALA . 28.1 mt -61.23 -50.1 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 1.3899999999999999 110.922 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.969 HG13 ' CG ' ' A' ' 364' ' ' GLU . 44.3 t -56.59 -30.13 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.831 -1.168 . . . . 1.1799999999999999 110.621 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 351' ' ' SER . 63.6 mt -66.0 -45.58 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.681 -1.262 . . . . 1.3600000000000001 110.116 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.965 HD22 ' HB1' ' A' ' 319' ' ' ALA . 50.7 tp -47.28 -48.05 24.92 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.254 -0.903 . . . . 1.1499999999999999 110.263 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.556 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -67.93 -39.12 83.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.961 -1.087 . . . . 0.60999999999999999 109.561 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.723 ' HE3' HG12 ' A' ' 353' ' ' VAL . 69.5 mttt -61.14 -46.24 91.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.759 -1.213 . . . . 1.1599999999999999 110.926 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -66.63 -38.4 86.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.218 -1.551 . . . . 1.8999999999999999 109.549 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.498 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 41.8 mmt180 -73.9 -41.49 62.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.228 -0.92 . . . . 2.6299999999999999 111.745 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 362' ' ' LEU . 62.9 m-85 -101.12 -15.0 17.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.797 -1.19 . . . . 3.3199999999999998 109.609 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.892 ' O ' HD23 ' A' ' 362' ' ' LEU . 44.0 t30 60.73 47.83 7.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.688 0.756 . . . . 1.8999999999999999 110.431 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.892 HD23 ' O ' ' A' ' 361' ' ' ASN . 19.6 mt -142.72 -159.57 0.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.723 -0.611 . . . . 2.7999999999999998 109.652 175.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -119.94 158.42 26.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 4.4000000000000004 110.189 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 1.0 ' HB3' HD11 ' A' ' 342' ' ' LEU . 67.7 mm-40 -65.54 -170.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.793 . . . . 2.2400000000000002 109.882 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 342' ' ' LEU . 82.6 mtp180 -105.03 134.75 47.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 4.1600000000000001 110.171 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.9 t0 -78.6 126.28 30.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 2.8599999999999999 109.687 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 372' ' ' ALA . 79.9 t -71.13 -41.24 75.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.262 0.553 . . . . 3.04 110.314 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -72.17 -19.14 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 3.6899999999999999 110.543 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 60.1 p -74.46 -27.23 60.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.861 -1.15 . . . . 3.0499999999999998 109.135 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 371' ' ' HIS . 66.8 mt -92.28 0.53 57.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.281 -0.887 . . . . 2.1400000000000001 109.779 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 29.7 m170 56.25 28.31 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 2.1000000000000001 108.919 -171.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.806 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -89.69 -162.74 0.91 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.687 0.756 . . . . 1.1200000000000001 110.539 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 19.6 m -128.98 143.6 50.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.541 -0.725 . . . . 2.1099999999999999 111.211 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.642 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 55.7 m-85 -91.19 149.11 21.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.16 -0.962 . . . . 3.0899999999999999 109.535 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.595 HG23 ' HA ' ' A' ' 386' ' ' ILE . 12.2 t -110.51 111.53 57.24 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.673 -1.267 . . . . 4.0 109.763 171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.0 Cg_endo -54.24 150.35 33.09 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.051 1.553 . . . . 4.6299999999999999 111.162 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.588 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -98.24 122.21 41.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 5.79 109.818 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 46.4 p -111.87 141.29 45.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 5.29 109.825 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.76 -29.26 58.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.503 -0.748 . . . . 6.1299999999999999 110.376 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -56.32 -46.22 79.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 7.7400000000000002 109.919 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 70.8 m -91.61 -19.76 22.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 3.8199999999999998 109.748 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 381' ' ' SER . 37.2 mtt85 65.26 53.13 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.642 -0.661 . . . . 4.25 109.494 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 86.7 mtp -148.38 143.68 26.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 2.0899999999999999 111.274 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.588 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 49.1 p -146.2 168.29 21.39 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.175 -1.046 . . . . 1.23 108.175 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.679 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.18 -162.08 27.37 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.741 -1.695 . . . . 1.1299999999999999 110.392 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.855 HG22 ' HB ' ' A' ' 393' ' ' ILE . 12.7 tt -145.43 153.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.848 -0.795 . . . . 1.26 108.975 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.414 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 7.9 m120 -126.96 105.17 8.43 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 120.897 -1.127 . . . . 2.04 108.992 172.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.056 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.58 155.38 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 O-C-N 120.833 -1.167 . . . . 2.1099999999999999 108.916 -169.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 1.056 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.4 m-20 -63.08 7.73 0.08 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.837 -1.164 . . . . 3.8500000000000001 113.584 -167.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.8 t30 -139.99 1.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.109 -1.62 . . . . 2.3300000000000001 111.111 172.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 388' ' ' ILE . 35.8 mtm105 -157.82 163.34 38.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.696 -1.252 . . . . 2.6899999999999999 110.773 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.838 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.0 mtp -129.66 139.87 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.854 -1.154 . . . . 2.02 109.42 168.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.855 ' HB ' HG22 ' A' ' 386' ' ' ILE . 35.2 mm -129.77 139.89 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.03 -1.044 . . . . 1.6799999999999999 110.098 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 404' ' ' HIS . 29.7 mmm180 -138.31 142.06 39.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 2.7799999999999998 110.155 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -142.4 144.14 32.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.5700000000000001 109.44 178.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.722 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.59 -155.8 17.43 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.332 -1.414 . . . . 0.81999999999999995 110.388 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 3.7 p -72.71 160.23 32.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -1.086 . . . . 1.1699999999999999 110.391 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.937 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.2 t -60.01 -48.26 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.1 -1.0 . . . . 0.53000000000000003 109.853 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.9 -38.43 85.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.055 -1.028 . . . . 1.5900000000000001 109.016 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.84 -50.68 72.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.576 -0.702 . . . . 0.84999999999999998 110.707 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.722 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.2 mm -68.8 -37.23 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.767 -1.208 . . . . 0.81000000000000005 111.075 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -59.23 -42.2 90.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.817 -1.177 . . . . 2.6200000000000001 110.142 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.56 -38.01 83.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.118 -0.989 . . . . 2.48 110.828 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.569 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 57.7 t-80 -64.09 -40.08 95.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.064 . . . . 2.4300000000000002 110.569 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.609 HG12 ' C ' ' A' ' 410' ' ' GLY . 86.4 t -65.11 -46.08 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.998 -1.064 . . . . 0.93999999999999995 110.475 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.69 -35.14 78.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.889 -1.132 . . . . 2.1600000000000001 110.835 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.16 -41.91 89.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 1.53 109.682 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 98.0 m-20 -66.85 -26.02 66.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.399 -0.813 . . . . 2.75 109.298 171.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.24 22.66 19.06 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.364 -1.494 . . . . 2.2799999999999998 109.364 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.609 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.13 -170.89 41.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 1.72 109.383 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 99.0 m-70 -139.78 153.84 47.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -1.222 . . . . 4.1600000000000001 110.417 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 1.9 t80 -95.19 108.97 42.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 3.3100000000000001 110.129 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.3 Cg_exo -60.51 142.23 97.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.913 1.48 . . . . 1.23 110.815 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.6 t -58.59 -41.96 86.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 1.75 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.506 ' N ' ' CG2' ' A' ' 414' ' ' THR . 50.8 t0 -54.4 -40.24 68.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.038 -1.039 . . . . 1.8700000000000001 110.098 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 74.0 t -71.0 -39.36 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.70999999999999996 110.673 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.578 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 83.3 m-20 -61.13 -39.42 89.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 1.8100000000000001 110.25 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.63 -43.09 94.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.119 -0.988 . . . . 2.6000000000000001 110.81 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.942 ' O ' HG23 ' A' ' 423' ' ' VAL . 23.3 mttm -62.87 -38.82 92.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.215 . . . . 2.4900000000000002 110.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.9 t -65.41 -40.24 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.03 -1.044 . . . . 0.79000000000000004 110.222 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.4 m-20 -69.29 -42.91 74.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.693 -0.63 . . . . 2.0499999999999998 110.723 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 426' ' ' GLN . 91.8 mt-30 -64.62 -32.63 74.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.342 -0.849 . . . . 2.3300000000000001 109.555 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.0 t -62.65 -42.27 95.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.153 -0.967 . . . . 1.0 109.936 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.92 -53.26 11.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 1.24 110.527 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.537 ' HB3' ' NH1' ' A' ' 425' ' ' ARG . 24.5 mtm105 -56.36 -21.12 22.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 4.1100000000000003 109.856 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 422' ' ' GLN . 87.1 mm-40 -90.14 6.61 41.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.347 -0.845 . . . . 2.9199999999999999 110.523 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.84 9.41 68.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.862 -1.295 . . . . 1.1599999999999999 109.862 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.86 154.52 19.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 1.0700000000000001 109.954 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.7 m -93.29 109.29 39.24 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 1.21 109.146 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.018 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.5 Cg_exo -78.52 107.0 2.21 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.028 1.541 . . . . 1.2 110.253 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.904 HD21 " O2'" ' A' 1001 ' ' ANP . 84.3 mt -90.28 146.77 23.97 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.8 -1.188 . . . . 1.3999999999999999 108.796 166.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.9 t -110.84 137.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 120.881 -1.137 . . . . 0.52000000000000002 110.143 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.889 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.4 t -117.93 136.29 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.568 -0.708 . . . . 1.0800000000000001 109.725 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.803 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.9 m -131.89 154.59 40.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.334 -0.854 . . . . 0.90000000000000002 110.7 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.9 mt-10 -98.71 121.55 40.8 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.006 -0.738 . . . . 1.79 109.006 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.17 -109.69 1.63 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 108.566 -1.813 . . . . 1.4199999999999999 108.566 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 408' ' ' ASN . 6.5 p -113.75 14.01 18.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -1.134 . . . . 1.4199999999999999 111.191 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt180 -123.68 140.23 53.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.634 -1.291 . . . . 3.52 110.226 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.5 t -80.56 126.43 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 1.4099999999999999 111.09 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.915 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.69 -31.95 19.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 1.79 110.272 175.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.66 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 174.48 -175.49 46.79 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.316 -1.421 . . . . 1.02 110.843 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.852 ' O ' HD21 ' A' ' 333' ' ' LEU . 46.8 t -121.0 158.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.603 -0.939 . . . . 0.56999999999999995 109.829 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 442' ' ' VAL . 13.9 mm -122.27 130.0 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.093 -1.005 . . . . 1.05 110.812 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.582 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -102.48 118.42 36.82 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.513 -0.742 . . . . 0.46000000000000002 110.279 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.9 mp -103.99 137.59 41.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.1099999999999999 110.076 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.89 145.27 27.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.212 -0.93 . . . . 4.4800000000000004 109.772 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 35.5 p30 -95.89 133.54 39.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 3.9100000000000001 110.329 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 316' ' ' ASN . 4.5 mm -55.07 -48.89 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 3.6099999999999999 109.359 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.97 135.0 40.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.154 0.502 . . . . 5.0899999999999999 110.264 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -91.02 132.55 35.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 7.5 110.154 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.491 -1.444 . . . . 7.2999999999999998 109.491 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.904 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.49 ' C ' HD13 ' A' ' 448' ' ' ILE . 29.7 p-10 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.334 0.587 . . . . 6.0800000000000001 110.482 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 348' ' ' GLU . 32.3 ptt180 -37.43 134.99 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.598 0.713 . . . . 5.8300000000000001 110.961 -173.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 14.1 pt20 -147.9 155.65 41.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.492 -0.755 . . . . 5.5800000000000001 109.544 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.03 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -69.39 126.53 30.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.788 -1.195 . . . . 1.4199999999999999 109.754 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.73 -38.68 5.08 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.231 -0.987 . . . . 1.6000000000000001 110.511 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -139.96 144.94 37.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 1.8200000000000001 110.739 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.93 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 6.1 p90 -117.43 146.78 43.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 1.1399999999999999 110.274 173.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.6 mm -129.18 133.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.53000000000000003 110.351 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 11.9 Cg_exo -62.09 158.57 38.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.076 1.566 . . . . 1.4399999999999999 111.243 -176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.731 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -78.72 -166.38 0.87 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.438 -0.789 . . . . 1.5800000000000001 109.583 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.6 tt0 -62.69 102.81 0.37 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.33 -0.857 . . . . 4.0 110.36 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.7 16.76 44.18 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.062 -1.066 . . . . 1.52 110.451 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 60.4 t -105.27 151.74 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.911 -1.346 . . . . 1.73 110.857 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -87.65 143.76 27.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.21 -0.931 . . . . 2.02 110.437 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 12.5 pt-20 -66.49 -41.7 88.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.109 -0.994 . . . . 2.7000000000000002 110.825 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 45.7 tttm -61.67 -42.73 99.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.019 -1.051 . . . . 3.0299999999999998 110.189 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.0 m -58.65 -45.73 88.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.90000000000000002 110.255 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' HA3' ' A' ' 441' ' ' GLY . 13.2 tp -59.48 -45.95 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.93000000000000005 111.004 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.93 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -61.18 -36.94 81.22 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.142 -0.974 . . . . 0.87 109.829 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.54 -46.0 84.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.979 -1.076 . . . . 1.96 111.263 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.64 -38.5 89.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.001 . . . . 0.76000000000000001 110.328 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.208 -0.997 . . . . 0.71999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.726 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.15 -51.32 32.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -0.874 . . . . 1.72 111.304 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.912 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -71.75 -36.66 70.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.702 -1.248 . . . . 1.5800000000000001 110.582 -177.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.38 -12.87 61.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.069 . . . . 2.2400000000000002 110.234 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 81.5 p -97.12 -17.51 19.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 3.5600000000000001 110.163 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 364' ' ' GLU . 46.0 mt -58.32 -26.84 63.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 4.3600000000000003 109.928 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -88.86 -9.36 51.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 3.8100000000000001 110.835 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.76 139.65 30.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 2.8399999999999999 110.12 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.56 6.73 48.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 2.9900000000000002 110.291 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 36.4 p -77.91 142.6 65.13 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 2.0699999999999998 110.137 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.7 Cg_exo -57.52 -33.42 96.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.987 1.519 . . . . 2.3799999999999999 110.268 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.79 -36.54 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 3.25 110.067 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.454 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.23 -27.65 63.15 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 1.4199999999999999 109.625 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 56.7 mtm180 -77.04 -36.35 56.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.275 . . . . 3.6200000000000001 109.653 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.9 m -54.46 -45.4 73.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.184 -0.947 . . . . 2.3999999999999999 109.583 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.726 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.2 mt -65.72 -50.13 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 111.183 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.636 HG13 ' CD ' ' A' ' 364' ' ' GLU . 60.0 t -53.87 -32.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.691 -1.256 . . . . 1.1799999999999999 110.401 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.8 mt -68.56 -46.14 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.824 -1.172 . . . . 1.3600000000000001 110.491 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.3 tt -47.21 -51.76 17.7 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.218 -0.926 . . . . 1.1499999999999999 110.284 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.682 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.54 -38.12 89.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.825 -1.172 . . . . 0.60999999999999999 109.606 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 361' ' ' ASN . 42.2 tptt -58.66 -52.82 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.763 -1.211 . . . . 1.1599999999999999 111.05 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -65.74 -39.0 90.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.511 -1.368 . . . . 1.8999999999999999 109.865 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.9 mmt180 -71.6 -44.87 63.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 2.6299999999999999 111.35 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.667 ' HB3' HD21 ' A' ' 362' ' ' LEU . 33.6 m-85 -116.24 -14.93 11.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.69 -1.256 . . . . 3.3199999999999998 110.726 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.27 50.07 6.57 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.292 -0.88 . . . . 1.8999999999999999 109.925 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 360' ' ' PHE . 21.5 mt -99.54 -178.42 3.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.764 -0.585 . . . . 2.7999999999999998 109.914 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -106.89 159.51 16.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 4.4000000000000004 110.732 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.755 ' OE1' HD21 ' A' ' 342' ' ' LEU . 73.1 mm-40 -77.56 166.97 22.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.602 -0.686 . . . . 2.2400000000000002 109.85 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.843 ' CD ' HD22 ' A' ' 339' ' ' LEU . 58.5 mtp85 -101.57 132.64 47.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 4.1600000000000001 110.563 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 366' ' ' ASP . 39.0 p-10 -85.63 110.11 19.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.639 0.733 . . . . 2.8599999999999999 109.936 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.767 HG21 ' CE1' ' A' ' 374' ' ' PHE . 74.0 t -70.72 -48.05 60.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.451 -0.78 . . . . 3.04 110.505 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -75.16 -23.1 57.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.886 -1.134 . . . . 3.6899999999999999 111.459 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.446 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 42.2 t -73.33 -28.88 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.739 -1.226 . . . . 3.0499999999999998 109.202 170.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.6 mt -86.63 -2.2 58.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 2.1400000000000001 109.678 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.62 28.67 17.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 108.699 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -85.54 -167.83 1.99 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 110.114 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 22.8 m -136.67 143.68 43.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 2.1099999999999999 110.577 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.9 m-85 -90.01 139.45 30.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.069 -1.019 . . . . 3.0899999999999999 109.553 173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 386' ' ' ILE . 13.2 t -106.2 111.42 64.3 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.852 -1.155 . . . . 4.0 109.851 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.54 151.37 31.11 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.104 1.581 . . . . 4.6299999999999999 111.27 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.546 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.28 122.39 39.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.659 -0.651 . . . . 5.79 109.776 177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.4 p -112.1 141.1 46.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 5.29 109.841 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.77 -30.42 59.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.577 -0.702 . . . . 6.1299999999999999 110.472 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.67 -43.65 85.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 7.7400000000000002 109.822 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 383' ' ' MET . 0.6 OUTLIER -92.64 -17.65 24.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 3.8199999999999998 109.639 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 381' ' ' SER . 86.1 mtt180 61.03 51.94 4.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 4.25 109.542 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.662 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.3 mtm -150.7 149.63 30.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.091 -1.006 . . . . 2.0899999999999999 111.233 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 28.1 p -146.85 169.71 18.54 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.843 -1.169 . . . . 1.23 107.843 172.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.61 -165.35 32.05 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 118.641 -1.742 . . . . 1.1299999999999999 110.289 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.912 HG21 HD12 ' A' ' 339' ' ' LEU . 3.2 tt -150.97 149.8 13.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 O-C-N 121.852 -0.793 . . . . 1.26 108.979 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.2 m120 -122.48 142.8 50.19 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.117 -0.989 . . . . 2.04 108.661 176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 370' ' ' LEU . 7.1 tt -144.53 163.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.666 -1.271 . . . . 2.1099999999999999 110.112 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.6 7.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.452 0.908 . . . . 3.8500000000000001 113.452 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.0 t30 -141.93 -0.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.103 -1.623 . . . . 2.3300000000000001 111.398 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 67.1 mtm180 -157.41 160.69 38.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.602 -1.312 . . . . 2.6899999999999999 111.023 -173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.8 mtp -129.91 140.65 50.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 2.02 109.118 167.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.683 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.0 mm -131.6 139.83 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.854 -1.154 . . . . 1.6799999999999999 110.134 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.5 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 12.3 tpt180 -142.23 144.66 33.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.151 -0.968 . . . . 2.7799999999999998 110.393 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.887 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.9 147.11 30.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 1.5700000000000001 109.694 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.704 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.11 -151.0 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.246 -1.454 . . . . 0.81999999999999995 110.628 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.8 m -70.9 155.39 40.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -1.087 . . . . 1.1699999999999999 110.71 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 420' ' ' VAL . 88.1 t -60.65 -49.41 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.53000000000000003 110.17 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.7 t0 -58.84 -37.66 76.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.911 -1.118 . . . . 1.5900000000000001 108.878 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.662 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.26 -51.62 68.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.459 -0.775 . . . . 0.84999999999999998 110.751 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.7 mm -66.55 -37.78 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.81000000000000005 111.156 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -59.26 -42.38 91.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 2.6200000000000001 110.058 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 72.8 mtt180 -67.35 -37.66 83.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 2.48 110.904 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.5 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.7 t60 -64.3 -39.39 93.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.987 -1.07 . . . . 2.4300000000000002 110.56 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 437' ' ' SER . 97.5 t -64.91 -46.18 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.929 -1.107 . . . . 0.93999999999999995 110.482 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.79 -35.88 81.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.865 -1.147 . . . . 2.1600000000000001 110.856 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.65 88.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 1.53 109.67 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -66.94 -25.79 66.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 2.75 109.26 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.34 17.2 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.517 -1.433 . . . . 2.2799999999999998 109.517 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.94 -171.59 38.76 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.427 -1.469 . . . . 1.72 109.427 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.411 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.1 m-70 -139.06 154.55 48.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.195 -1.18 . . . . 4.1600000000000001 110.335 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -95.18 110.52 50.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.924 . . . . 3.3100000000000001 110.078 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.6 141.58 97.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.935 1.492 . . . . 1.23 110.846 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.47 -43.57 93.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 1.75 110.529 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 414' ' ' THR . 92.0 m-20 -56.22 -40.65 74.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.099 -1.001 . . . . 1.8700000000000001 110.048 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 439' ' ' VAL . 53.2 t -67.31 -41.28 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 0.70999999999999996 110.709 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.3 -38.17 88.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.018 . . . . 1.8100000000000001 109.914 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 94.8 mm-40 -64.68 -41.51 96.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.208 -0.932 . . . . 2.6000000000000001 110.925 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.969 ' O ' HG23 ' A' ' 423' ' ' VAL . 27.5 mttt -62.87 -39.37 94.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.68 -1.262 . . . . 2.4900000000000002 110.831 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 430' ' ' PRO . 78.6 t -66.27 -39.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 0.79000000000000004 110.356 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -68.5 -43.32 77.12 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.606 -0.684 . . . . 2.0499999999999998 110.703 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.498 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 25.5 mt-30 -65.15 -31.44 72.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 2.3300000000000001 109.842 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.8 t -61.63 -43.93 97.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.098 -1.001 . . . . 1.0 109.806 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.28 -50.69 30.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 1.24 110.294 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 97.2 mtt180 -54.56 -21.88 11.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.347 -0.846 . . . . 4.1100000000000003 109.884 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.9 mm-40 -90.37 3.93 52.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.865 . . . . 2.9199999999999999 110.523 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.11 10.45 66.24 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.772 -1.331 . . . . 1.1599999999999999 109.772 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.56 156.44 17.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -1.102 . . . . 1.0700000000000001 109.886 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.8 m -93.37 109.01 37.65 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 1.21 109.299 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.041 ' HB2' HG13 ' A' ' 420' ' ' VAL . 2.7 Cg_endo -78.95 108.49 2.41 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.07 1.563 . . . . 1.2 110.47 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.738 HD21 " O2'" ' A' 1001 ' ' ANP . 81.1 mt -90.25 147.72 23.35 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.189 . . . . 1.3999999999999999 108.837 166.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.786 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 59.3 t -111.44 138.58 39.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.783 -1.198 . . . . 0.52000000000000002 110.215 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.031 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.31 138.4 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 1.0800000000000001 109.952 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.756 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -127.35 161.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.505 -0.747 . . . . 0.90000000000000002 110.23 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.683 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.9 mt-10 -115.91 125.86 53.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.114 -0.991 . . . . 1.79 108.845 166.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.15 -109.75 3.07 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.821 -1.712 . . . . 1.4199999999999999 108.821 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.857 ' O ' HG13 ' A' ' 405' ' ' VAL . 19.0 p -120.28 10.4 11.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -1.176 . . . . 1.4199999999999999 110.931 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 435' ' ' GLU . 32.7 ptt-85 -121.61 143.77 49.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.914 -1.116 . . . . 3.52 110.229 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 416' ' ' VAL . 40.6 t -77.13 126.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 1.4099999999999999 110.594 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.031 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.15 -27.08 20.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 1.79 110.223 178.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.4 -178.36 48.6 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.448 -1.358 . . . . 1.02 110.51 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.897 ' O ' HD13 ' A' ' 443' ' ' ILE . 43.3 t -124.21 158.25 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -1.075 . . . . 0.56999999999999995 109.742 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.1 mm -124.95 127.17 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.083 -1.011 . . . . 1.05 110.722 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.678 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.78 122.46 42.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.429 -0.794 . . . . 0.46000000000000002 110.119 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.1 mp -99.95 139.35 35.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.002 -1.061 . . . . 2.1099999999999999 110.311 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -84.74 136.65 33.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 4.4800000000000004 109.89 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -96.19 141.76 29.17 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.445 -0.784 . . . . 3.9100000000000001 110.204 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.2 mp -57.53 -42.98 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 3.6099999999999999 108.915 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.89 135.83 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.751 -0.593 . . . . 5.0899999999999999 110.199 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -144.26 130.58 19.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 7.5 110.124 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.947 -1.474 . . . . 7.2999999999999998 109.511 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.738 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 448' ' ' ILE . 83.8 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.228 0.537 . . . . 6.0800000000000001 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.512 ' NH1' ' OD2' ' A' ' 447' ' ' ASP . 91.1 mtt-85 -121.83 130.46 53.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -0.96 . . . . 5.8300000000000001 110.107 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 58.7 mm-40 -123.6 142.61 50.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 5.5800000000000001 109.881 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.067 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -70.85 124.1 23.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.72 -1.238 . . . . 1.4199999999999999 109.825 173.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 12.6 m -108.21 -36.19 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.152 -0.967 . . . . 1.6000000000000001 110.543 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -145.49 146.54 31.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 1.8200000000000001 110.641 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.916 ' O ' HD13 ' A' ' 323' ' ' ILE . 5.7 p90 -117.43 146.91 43.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 1.1399999999999999 110.595 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.3 mm -131.41 135.04 26.38 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.53000000000000003 110.397 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 12.8 Cg_exo -62.48 156.97 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 1.4399999999999999 111.269 -176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.79 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.58 -167.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.882 . . . . 1.5800000000000001 109.317 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 61.1 tt0 -64.0 107.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 4.0 110.37 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.02 16.53 54.02 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.31 -1.116 . . . . 1.52 110.31 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.936 HG11 ' O ' ' A' ' 440' ' ' LEU . 47.4 t -105.41 150.38 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.897 -1.355 . . . . 1.73 110.814 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.457 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.3 m-20 -86.12 143.13 28.2 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -0.979 . . . . 2.02 110.026 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.3 -38.3 90.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.067 -1.021 . . . . 2.7000000000000002 110.306 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.592 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 58.4 mttt -59.55 -38.76 81.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.02 . . . . 3.0299999999999998 109.724 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 91.8 m -59.74 -46.59 88.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.892 . . . . 0.90000000000000002 110.454 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 443' ' ' ILE . 21.0 tp -62.1 -44.7 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.93000000000000005 111.096 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.515 ' O ' ' NE2' ' A' ' 338' ' ' GLN . . . -60.28 -38.34 83.29 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.123 -0.985 . . . . 0.87 109.745 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 57.9 t0 -66.11 -48.42 70.92 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.041 -1.037 . . . . 1.96 111.347 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.2 -37.11 84.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.76000000000000001 110.533 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.55 75.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.961 -1.087 . . . . 0.71999999999999997 110.087 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -69.65 -51.85 31.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 1.72 111.348 -178.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.53 -36.8 73.93 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.639 -1.288 . . . . 1.5800000000000001 110.481 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.89 -13.03 61.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 2.2400000000000002 110.271 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.528 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 78.9 p -96.69 -15.7 21.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.92 . . . . 3.5600000000000001 110.161 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.525 HD11 ' H ' ' A' ' 365' ' ' ARG . 55.3 mt -59.34 -27.83 66.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 4.3600000000000003 110.157 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.85 -15.51 36.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 3.8100000000000001 110.825 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -85.49 138.15 32.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.969 -1.082 . . . . 2.8399999999999999 110.062 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.42 6.86 47.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 2.9900000000000002 110.262 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.2 p -73.18 143.56 83.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 2.0699999999999998 110.087 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.405 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 11.0 Cg_endo -59.84 -36.52 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.949 1.499 . . . . 2.3799999999999999 110.035 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.574 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.89 -36.07 82.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 3.25 110.117 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.28 62.5 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.454 -1.458 . . . . 1.4199999999999999 109.454 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 58.4 mtm180 -75.67 -35.44 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.323 . . . . 3.6200000000000001 109.498 172.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 t -54.52 -46.8 73.6 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.342 -0.943 . . . . 2.3999999999999999 109.654 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.72 HG22 ' OE1' ' A' ' 338' ' ' GLN . 16.4 mt -64.65 -48.99 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 1.3899999999999999 111.055 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.528 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 64.4 t -55.01 -31.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.746 -1.221 . . . . 1.1799999999999999 110.252 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.9 mt -68.6 -46.16 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.79 -1.194 . . . . 1.3600000000000001 110.342 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.067 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.2 -53.83 12.22 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.107 -0.996 . . . . 1.1499999999999999 110.688 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.705 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.82 -37.91 89.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.959 -1.088 . . . . 0.60999999999999999 109.663 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.651 ' HZ3' ' HA ' ' A' ' 363' ' ' ARG . 0.5 OUTLIER -59.35 -51.49 69.71 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.777 -1.202 . . . . 1.1599999999999999 110.827 -175.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 21.3 pt20 -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.514 -1.366 . . . . 1.8999999999999999 109.841 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.477 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.1 mmm180 -71.51 -44.34 64.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 2.6299999999999999 111.487 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.592 ' CE1' ' HG2' ' A' ' 331' ' ' LYS . 38.2 m-85 -116.12 -14.69 11.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.818 -1.176 . . . . 3.3199999999999998 110.372 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 357' ' ' LYS . 13.4 t-20 60.38 50.17 6.29 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.937 0.875 . . . . 1.8999999999999999 110.006 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 360' ' ' PHE . 21.7 mt -95.57 -178.61 4.46 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.62 -0.511 . . . . 2.7999999999999998 109.62 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.651 ' HA ' ' HZ3' ' A' ' 357' ' ' LYS . 63.6 mtp180 -117.86 149.77 40.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 4.4000000000000004 110.92 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.77 149.12 22.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.561 -0.712 . . . . 2.2400000000000002 109.555 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.525 ' H ' HD11 ' A' ' 342' ' ' LEU . 88.5 mtt180 -98.32 123.79 42.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.859 -1.151 . . . . 4.1600000000000001 110.233 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.484 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.1 m-20 -71.33 113.61 8.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.85 . . . . 2.8599999999999999 109.508 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.9 t -70.51 -44.28 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 3.04 110.546 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -75.45 -19.28 59.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.024 -1.047 . . . . 3.6899999999999999 111.096 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.1 p -74.88 -24.79 58.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.751 -1.218 . . . . 3.0499999999999998 109.049 171.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.2 mt -91.36 3.56 54.6 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.408 -0.808 . . . . 2.1400000000000001 109.642 171.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 6.2 m80 57.74 27.55 14.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 2.1000000000000001 108.64 -171.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -87.74 -166.72 1.66 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.489 0.661 . . . . 1.1200000000000001 110.185 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.47 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 31.2 m -138.95 143.71 38.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.556 -0.715 . . . . 2.1099999999999999 110.466 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.659 ' CE1' HG21 ' A' ' 367' ' ' VAL . 69.9 m-85 -88.6 144.96 25.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.016 -1.053 . . . . 3.0899999999999999 109.586 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.615 HG11 ' NH1' ' A' ' 394' ' ' ARG . 9.8 t -113.07 109.27 52.31 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.93 -1.106 . . . . 4.0 109.788 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.6 Cg_endo -54.81 152.3 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.07 1.563 . . . . 4.6299999999999999 111.172 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.48 122.43 37.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 5.79 109.858 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.2 p -112.76 142.01 45.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 5.29 109.829 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.6 57.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 6.1299999999999999 110.592 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -57.21 -47.15 82.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 7.7400000000000002 109.982 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 383' ' ' MET . 3.6 m -93.12 -14.87 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 3.8199999999999998 109.686 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 381' ' ' SER . 85.0 mtt180 61.64 55.23 2.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 4.25 109.783 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.686 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.8 mtm -152.46 151.4 30.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.992 -1.067 . . . . 2.0899999999999999 111.471 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -146.56 170.2 17.4 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.835 -1.172 . . . . 1.23 107.835 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.44 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.83 -165.43 32.29 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.611 -1.757 . . . . 1.1299999999999999 110.344 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 339' ' ' LEU . 3.0 tt -151.42 149.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.923 -0.769 . . . . 1.26 108.923 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.592 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.4 m120 -121.54 144.03 48.95 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.199 -0.938 . . . . 2.04 108.737 176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.868 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.45 164.23 13.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 120.676 -1.265 . . . . 2.1099999999999999 110.135 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.14 7.83 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.571 0.952 . . . . 3.8500000000000001 113.571 -171.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 391' ' ' ARG . 37.4 t-20 -145.48 2.29 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.015 -1.678 . . . . 2.3300000000000001 111.481 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 28.7 mmt180 -154.8 159.77 40.82 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.704 -1.248 . . . . 2.6899999999999999 110.757 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 64.3 mtt -129.96 140.61 50.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.126 . . . . 2.02 109.136 167.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 435' ' ' GLU . 14.9 mm -132.22 140.67 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.74 -1.225 . . . . 1.6799999999999999 110.224 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.638 ' HB3' HG22 ' A' ' 434' ' ' VAL . 20.1 tpt180 -142.32 145.9 34.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 110.438 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.879 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -147.42 146.3 29.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 1.5700000000000001 109.846 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.665 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.71 -151.62 14.59 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.389 -1.386 . . . . 0.81999999999999995 110.416 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 17.1 m -71.27 156.81 39.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -1.049 . . . . 1.1699999999999999 110.807 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.803 HG21 HG11 ' A' ' 420' ' ' VAL . 96.1 t -60.53 -49.68 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.53000000000000003 110.204 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -59.51 -37.85 79.41 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.846 -1.159 . . . . 1.5900000000000001 109.065 172.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.686 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.76 -51.83 68.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.489 -0.757 . . . . 0.84999999999999998 110.712 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.753 HG23 ' CG1' ' A' ' 434' ' ' VAL . 20.3 mm -66.7 -38.5 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.745 -1.222 . . . . 0.81000000000000005 111.21 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 73.1 ttt180 -58.83 -42.18 88.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.813 -1.18 . . . . 2.6200000000000001 110.105 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.2 mtt-85 -67.0 -37.7 84.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 2.48 110.813 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.417 ' CD2' ' HG2' ' A' ' 394' ' ' ARG . 84.7 t60 -64.31 -40.13 95.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.944 -1.097 . . . . 2.4300000000000002 110.611 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 437' ' ' SER . 88.8 t -64.94 -45.65 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.938 -1.101 . . . . 0.93999999999999995 110.426 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.0 -36.33 81.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.844 -1.16 . . . . 2.1600000000000001 110.738 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.52 88.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.055 -1.028 . . . . 1.53 109.735 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -66.19 -26.0 67.2 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.435 -0.79 . . . . 2.75 109.218 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.28 23.13 17.65 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.263 -1.535 . . . . 2.2799999999999998 109.263 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.621 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.93 -171.84 38.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.545 -1.422 . . . . 1.72 109.545 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.5 t60 -139.02 150.75 46.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 4.1600000000000001 110.19 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.6 t80 -90.67 110.63 42.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 3.3100000000000001 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.8 Cg_exo -59.42 142.37 98.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.889 1.468 . . . . 1.23 110.672 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.6 t -59.75 -43.9 94.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 1.75 110.348 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 47.9 t0 -55.99 -35.74 67.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.993 . . . . 1.8700000000000001 110.214 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.035 ' CG1' HG11 ' A' ' 439' ' ' VAL . 66.7 t -71.75 -36.24 58.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.486 -1.384 . . . . 0.70999999999999996 110.27 177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.2 -42.5 99.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 1.8100000000000001 110.336 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.18 -37.75 81.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.003 -1.061 . . . . 2.6000000000000001 110.699 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.956 ' O ' HG23 ' A' ' 423' ' ' VAL . 54.5 mttm -63.14 -39.51 94.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.422 -1.424 . . . . 2.4900000000000002 110.798 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 430' ' ' PRO . 69.6 t -65.89 -39.85 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.054 -1.029 . . . . 0.79000000000000004 110.341 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.2 m-20 -68.64 -43.55 76.07 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.599 -0.688 . . . . 2.0499999999999998 110.759 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.8 mm-40 -65.0 -31.74 73.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 2.3300000000000001 109.76 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.0 t -61.59 -43.59 97.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.169 -0.957 . . . . 1.0 109.813 173.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.52 -51.02 25.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 1.24 110.389 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 90.7 mtt-85 -54.58 -21.95 11.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 4.1100000000000003 109.915 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -91.62 6.07 47.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 2.9199999999999999 110.675 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.94 69.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.718 -1.353 . . . . 1.1599999999999999 109.718 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.46 155.7 18.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 1.0700000000000001 109.918 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.27 109.94 43.31 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.184 -0.947 . . . . 1.21 108.827 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.998 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.6 Cg_exo -77.53 112.98 3.44 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 124.045 1.55 . . . . 1.2 110.08 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.925 HD21 " O2'" ' A' 1001 ' ' ANP . 61.0 mt -90.03 161.84 15.65 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.882 -1.137 . . . . 1.3999999999999999 108.312 166.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.834 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.9 t -125.51 140.01 49.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 120.755 -1.216 . . . . 0.52000000000000002 110.151 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.044 HG12 HD21 ' A' ' 440' ' ' LEU . 21.4 t -120.15 137.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.607 -0.683 . . . . 1.0800000000000001 109.732 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.875 ' C ' HD23 ' A' ' 440' ' ' LEU . 1.7 m -115.63 162.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.571 -0.706 . . . . 0.90000000000000002 109.719 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.653 ' HG3' HD22 ' A' ' 440' ' ' LEU . 11.7 mt-10 -123.19 124.91 44.1 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.093 -1.004 . . . . 1.79 108.704 165.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 64.94 -109.63 2.99 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.588 -1.805 . . . . 1.4199999999999999 108.588 -169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.896 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.5 p -123.71 17.52 9.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -1.104 . . . . 1.4199999999999999 110.89 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -128.14 166.04 19.24 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.831 -1.168 . . . . 3.52 109.751 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.035 HG11 ' CG1' ' A' ' 416' ' ' VAL . 32.8 t -89.79 124.56 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.19 -0.944 . . . . 1.4099999999999999 111.018 -175.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.044 HD21 HG12 ' A' ' 433' ' ' VAL . 0.9 OUTLIER -84.97 -30.15 24.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.354 -0.841 . . . . 1.79 110.186 174.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.95 -177.32 47.65 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.952 -1.594 . . . . 1.02 111.088 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.859 ' O ' HD13 ' A' ' 443' ' ' ILE . 55.1 t -123.88 155.78 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.577 -0.955 . . . . 0.56999999999999995 109.808 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.903 HD11 HD11 ' A' ' 333' ' ' LEU . 13.8 mm -123.2 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.918 -1.114 . . . . 1.05 111.097 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.644 ' C ' HD12 ' A' ' 445' ' ' LEU . . . -101.94 119.98 39.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.46000000000000002 110.247 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.1 mp -107.08 148.14 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 110.377 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' LYS . 31.7 pttt -94.22 128.12 40.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 4.4800000000000004 109.279 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.512 ' OD2' ' NH1' ' A' ' 317' ' ' ARG . 77.4 m-20 -88.1 133.39 34.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.964 -1.085 . . . . 3.9100000000000001 109.897 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 316' ' ' ASN . 4.7 mm -55.0 -49.82 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 3.6099999999999999 109.23 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.84 133.82 44.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.3 0.571 . . . . 5.0899999999999999 110.108 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -91.58 132.96 35.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 7.5 110.184 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.969 -1.461 . . . . 7.2999999999999998 109.482 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.925 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 448' ' ' ILE . 15.2 m120 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.326 0.584 . . . . 6.0800000000000001 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.637 ' NH2' " H3'" ' A' 1001 ' ' ANP . 57.3 ttp180 -42.6 137.51 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 5.8300000000000001 110.382 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 351' ' ' SER . 36.7 tt0 -150.44 151.78 33.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 5.5800000000000001 110.314 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.01 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.08 131.94 49.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.023 -1.048 . . . . 1.4199999999999999 109.856 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -110.75 -37.88 5.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 110.413 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.528 ' HA ' ' NH1' ' A' ' 359' ' ' ARG . 84.3 tt0 -145.75 143.32 29.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.058 -1.026 . . . . 1.8200000000000001 111.002 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.923 ' O ' HD13 ' A' ' 323' ' ' ILE . 41.8 p90 -117.52 146.78 43.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.275 -0.891 . . . . 1.1399999999999999 110.092 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 322' ' ' PHE . 12.5 mm -131.55 124.82 20.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.076 -1.015 . . . . 0.53000000000000003 111.173 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.548 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 2.9 Cg_endo -52.18 158.61 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.017 1.536 . . . . 1.4399999999999999 110.986 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.63 -164.01 0.45 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.514 -0.741 . . . . 1.5800000000000001 109.992 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.5 tt0 -61.73 101.35 0.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 4.0 110.4 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.34 17.12 51.38 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.002 -1.094 . . . . 1.52 110.459 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 440' ' ' LEU . 75.7 t -101.88 147.64 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.309 . . . . 1.73 110.523 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.47 142.96 31.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.994 . . . . 2.02 110.151 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -63.97 -38.39 90.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 2.7000000000000002 110.942 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 17.7 mtmt -59.26 -39.41 82.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.077 -1.015 . . . . 3.0299999999999998 109.645 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 64.5 m -61.7 -47.71 84.04 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 110.452 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 443' ' ' ILE . 27.0 tp -64.04 -46.55 83.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.93000000000000005 111.104 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -59.03 -40.39 84.88 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.03 -1.044 . . . . 0.87 109.753 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 339' ' ' LEU . 83.7 m-20 -66.93 -44.94 79.38 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.913 -1.117 . . . . 1.96 111.5 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.29 -36.69 84.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.76000000000000001 110.291 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.43 77.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.71999999999999997 109.987 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.665 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.85 -52.55 23.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.351 -0.843 . . . . 1.72 111.433 -178.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.894 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.99 -37.81 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.667 -1.271 . . . . 1.5800000000000001 110.414 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.49 -11.29 59.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.979 -1.076 . . . . 2.2400000000000002 110.112 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.523 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 90.2 p -96.5 -16.65 21.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 3.5600000000000001 110.216 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.595 HD11 ' H ' ' A' ' 365' ' ' ARG . 40.5 mt -60.36 -25.14 65.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 4.3600000000000003 110.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -95.44 4.25 53.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 3.8100000000000001 111.396 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.565 ' OD2' ' N6 ' ' A' 1001 ' ' ANP . 8.2 p-10 -107.47 149.96 27.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.733 -1.229 . . . . 2.8399999999999999 110.287 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -99.65 8.5 44.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 2.9900000000000002 110.171 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 45.7 p -80.15 141.25 53.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.335 -0.853 . . . . 2.0699999999999998 110.111 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.3 Cg_exo -57.58 -31.48 91.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.93 1.49 . . . . 2.3799999999999999 110.239 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 317' ' ' ARG . 75.3 mm-40 -63.89 -37.14 86.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 3.25 110.104 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.478 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.83 -27.3 61.66 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.564 -1.414 . . . . 1.4199999999999999 109.564 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 354' ' ' ILE . 79.0 mtt180 -77.29 -37.2 53.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.276 . . . . 3.6200000000000001 109.66 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 p -55.72 -42.47 75.37 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.116 -0.99 . . . . 2.3999999999999999 109.703 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.599 HG22 ' OE1' ' A' ' 338' ' ' GLN . 11.3 mt -69.43 -47.78 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.3899999999999999 111.004 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 60.5 t -54.31 -31.16 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.739 -1.225 . . . . 1.1799999999999999 110.211 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 351' ' ' SER . 65.8 mt -68.56 -46.59 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 1.3600000000000001 110.383 170.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.01 HD22 ' HB1' ' A' ' 319' ' ' ALA . 66.4 tp -47.3 -53.07 14.51 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.111 -0.993 . . . . 1.1499999999999999 110.493 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.665 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.07 -36.44 84.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.857 -1.152 . . . . 0.60999999999999999 109.565 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 361' ' ' ASN . 40.9 tptt -54.82 -54.64 39.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.886 -1.134 . . . . 1.1599999999999999 110.775 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.5 pt20 -66.52 -43.03 86.33 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.509 -1.369 . . . . 1.8999999999999999 109.858 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 322' ' ' PHE . 39.9 mtp180 -69.67 -40.13 76.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 2.6299999999999999 111.697 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.774 ' HB3' HD11 ' A' ' 362' ' ' LEU . 76.6 m-85 -116.09 -14.73 11.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.735 -1.228 . . . . 3.3199999999999998 110.604 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.1 t30 60.29 50.11 6.51 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.809 . . . . 1.8999999999999999 109.925 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.7 mt -107.2 175.44 5.5 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.788 -0.57 . . . . 2.7999999999999998 109.829 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -117.6 154.98 30.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.865 -1.147 . . . . 4.4000000000000004 110.271 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 152.5 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 2.2400000000000002 109.589 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.595 ' H ' HD11 ' A' ' 342' ' ' LEU . 73.8 mmt-85 -94.68 144.36 25.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 4.1600000000000001 110.52 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 366' ' ' ASP . 34.6 p30 -86.88 107.92 18.55 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.668 0.747 . . . . 2.8599999999999999 110.226 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 374' ' ' PHE . 78.8 t -71.15 -48.81 52.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.514 -0.741 . . . . 3.04 110.452 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -73.99 -22.14 59.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.985 -1.072 . . . . 3.6899999999999999 111.282 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.445 ' HB3' ' CG ' ' A' ' 366' ' ' ASP . 41.2 t -72.96 -28.55 62.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.664 -1.273 . . . . 3.0499999999999998 109.248 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.919 HD13 ' CD1' ' A' ' 388' ' ' ILE . 31.0 mt -86.8 0.89 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.873 . . . . 2.1400000000000001 109.697 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 76.6 t60 58.35 26.12 13.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.095 -1.003 . . . . 2.1000000000000001 108.739 -172.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -85.15 -166.81 1.61 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.469 0.652 . . . . 1.1200000000000001 110.121 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 23.3 m -139.32 143.69 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 110.674 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 367' ' ' VAL . 79.8 m-85 -89.34 140.48 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.105 -0.997 . . . . 3.0899999999999999 109.529 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 1.012 HG11 ' NH1' ' A' ' 394' ' ' ARG . 10.6 t -109.06 113.53 59.05 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.884 -1.135 . . . . 4.0 110.059 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -55.8 153.28 31.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.06 1.558 . . . . 4.6299999999999999 111.371 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -97.86 122.72 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 5.79 109.905 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 25.7 p -111.83 140.44 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 5.29 109.781 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.87 61.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 6.1299999999999999 110.543 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -58.44 -45.9 87.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.053 -1.03 . . . . 7.7400000000000002 109.967 -176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 383' ' ' MET . 48.8 p -91.68 -12.31 34.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 3.8199999999999998 109.665 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.452 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 94.1 mtt180 57.31 53.11 7.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 4.25 109.772 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.516 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 44.5 mtm -153.07 150.39 29.1 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.068 -1.053 . . . . 2.0899999999999999 111.418 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 22.8 p -145.75 172.32 13.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 1.23 107.563 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -178.85 -164.54 31.81 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.33 -1.891 . . . . 1.1299999999999999 110.548 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.894 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -150.33 149.86 14.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.926 -0.768 . . . . 1.26 108.926 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.7 m120 -121.4 143.53 49.17 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.101 -0.999 . . . . 2.04 108.837 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.919 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.9 tt -143.9 163.67 15.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.668 -1.27 . . . . 2.1099999999999999 110.09 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.38 7.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.403 0.89 . . . . 3.8500000000000001 113.403 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 55.9 t30 -141.94 -0.44 1.32 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.088 -1.633 . . . . 2.3300000000000001 111.352 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 68.9 mtt85 -157.36 160.81 38.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.522 -1.361 . . . . 2.6899999999999999 110.987 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.3 mtp -129.96 140.64 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.903 -1.123 . . . . 2.02 109.236 167.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.667 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 32.1 mm -130.12 139.62 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.816 -1.177 . . . . 1.6799999999999999 110.257 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 1.012 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.0 mmt180 -140.85 143.73 34.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.376 -0.827 . . . . 2.7799999999999998 110.336 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.15 145.63 31.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 1.5700000000000001 109.588 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.578 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 174.36 -149.55 10.74 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.289 -1.434 . . . . 0.81999999999999995 110.478 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.8 m -70.33 153.39 43.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.996 . . . . 1.1699999999999999 110.801 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.703 HG21 HG11 ' A' ' 420' ' ' VAL . 97.9 t -60.51 -49.83 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.28 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.76 -36.41 76.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.95 -1.094 . . . . 1.5900000000000001 109.014 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -63.53 -47.79 80.21 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.597 -0.689 . . . . 0.84999999999999998 110.834 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.587 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.4 mm -67.15 -34.61 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.293 -1.504 . . . . 0.81000000000000005 110.694 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.9 ttt180 -62.13 -43.13 99.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.971 -1.081 . . . . 2.6200000000000001 109.926 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.28 -32.18 72.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.48 110.357 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.6 t60 -66.08 -41.45 90.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.786 -1.196 . . . . 2.4300000000000002 110.529 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.637 HG12 ' C ' ' A' ' 410' ' ' GLY . 84.0 t -64.42 -44.81 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.93999999999999995 110.38 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.33 -35.68 79.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.877 -1.139 . . . . 2.1600000000000001 110.749 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.94 88.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 1.53 109.744 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.3 m-20 -67.64 -25.97 66.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.341 -0.85 . . . . 2.75 109.286 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.94 13.4 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.383 -1.487 . . . . 2.2799999999999998 109.383 -176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.07 -170.83 39.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 48.7 p-80 -139.74 146.5 39.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -1.19 . . . . 4.1600000000000001 110.314 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.1 t80 -89.82 110.5 40.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 3.3100000000000001 110.093 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.6 Cg_exo -59.71 141.46 97.01 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.855 1.45 . . . . 1.23 110.856 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.559 HG23 ' N ' ' A' ' 415' ' ' ASP . 6.0 t -59.14 -43.51 92.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.364 -0.835 . . . . 1.75 110.57 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 414' ' ' THR . 49.7 t0 -54.28 -40.23 67.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 1.8700000000000001 110.14 -178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 439' ' ' VAL . 75.3 t -70.15 -40.12 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.08 . . . . 0.70999999999999996 110.56 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.577 ' OD1' ' CD1' ' A' ' 412' ' ' PHE . 79.9 m-20 -60.82 -38.72 86.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.054 . . . . 1.8100000000000001 110.185 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.8 mt-30 -64.92 -42.92 94.31 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.21 -0.931 . . . . 2.6000000000000001 110.791 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 63.2 mttm -62.63 -38.62 90.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.713 -1.242 . . . . 2.4900000000000002 110.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 72.1 t -66.51 -39.31 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.079 -1.013 . . . . 0.79000000000000004 110.34 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.0 m-20 -68.54 -43.69 76.15 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.448 -0.782 . . . . 2.0499999999999998 110.56 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 426' ' ' GLN . 99.4 mm-40 -65.36 -31.13 72.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.829 . . . . 2.3300000000000001 109.87 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 71.5 t -60.99 -43.66 96.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.034 -1.041 . . . . 1.0 109.687 172.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.24 39.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.24 110.287 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp85 -54.65 -21.73 11.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 4.1100000000000003 109.905 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.8 mm-40 -91.41 3.75 54.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.273 -0.892 . . . . 2.9199999999999999 110.637 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.08 67.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.8 -1.32 . . . . 1.1599999999999999 109.8 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.07 156.5 17.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -1.136 . . . . 1.0700000000000001 109.796 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.34 39.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 1.21 109.101 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -76.71 111.78 3.32 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.97 1.511 . . . . 1.2 110.243 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.909 HD21 " O2'" ' A' 1001 ' ' ANP . 70.4 mt -90.05 161.85 15.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.861 -1.149 . . . . 1.3999999999999999 108.32 165.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.9 t -125.25 139.74 50.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.77 -1.172 . . . . 0.52000000000000002 110.325 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.07 HG12 HD21 ' A' ' 440' ' ' LEU . 18.8 t -119.02 137.58 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.628 . . . . 1.0800000000000001 109.405 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.639 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -130.7 154.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.267 -0.896 . . . . 0.90000000000000002 110.705 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.7 mt-10 -99.12 121.28 40.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.977 -0.749 . . . . 1.79 108.977 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 55.83 -109.69 1.56 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.608 -1.797 . . . . 1.4199999999999999 108.608 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 405' ' ' VAL . 20.8 p -113.21 13.61 19.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -1.138 . . . . 1.4199999999999999 111.182 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 22.3 ptt180 -122.98 140.89 52.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.74 -1.225 . . . . 3.52 110.284 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.019 HG11 HG11 ' A' ' 416' ' ' VAL . 24.5 t -79.14 127.51 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.4099999999999999 111.024 -174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.07 HD21 HG12 ' A' ' 433' ' ' VAL . 0.8 OUTLIER -91.43 -28.65 17.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 1.79 110.488 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 175.55 -179.06 46.97 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.317 -1.42 . . . . 1.02 110.908 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 443' ' ' ILE . 58.9 t -122.62 155.71 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.52 -0.988 . . . . 0.56999999999999995 109.802 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.893 HD13 ' O ' ' A' ' 442' ' ' VAL . 14.5 mm -125.23 128.13 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.997 -1.064 . . . . 1.05 111.098 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.765 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.66 121.78 42.2 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.38 -0.825 . . . . 0.46000000000000002 110.222 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.502 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.9 mp -100.35 138.0 38.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 2.1099999999999999 110.256 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -88.37 145.68 25.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.432 -0.792 . . . . 4.4800000000000004 109.717 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 34.3 p30 -95.79 117.36 30.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 3.9100000000000001 110.611 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -54.59 -47.18 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 3.6099999999999999 109.468 176.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.32 134.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.588 -0.695 . . . . 5.0899999999999999 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -93.0 144.94 24.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 7.5 110.214 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.035 -1.425 . . . . 7.2999999999999998 109.576 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.909 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.543 ' O ' HD13 ' A' ' 448' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 6.0800000000000001 110.384 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' HB2' ' OE2' ' A' ' 348' ' ' GLU . 97.9 mtt180 -45.56 143.62 1.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 5.8300000000000001 110.252 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 39.1 tt0 -156.28 141.95 17.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.49 -0.756 . . . . 5.5800000000000001 110.438 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -61.81 133.46 55.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.923 -1.111 . . . . 1.4199999999999999 109.854 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -111.92 -40.47 4.24 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.288 -0.965 . . . . 1.6000000000000001 110.615 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -137.4 142.02 41.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.08 -1.013 . . . . 1.8200000000000001 110.955 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.09 ' CD1' HD21 ' A' ' 355' ' ' LEU . 19.5 p90 -117.68 147.05 43.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.301 -0.874 . . . . 1.1399999999999999 110.218 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 323' ' ' ILE . 2.8 mp -133.6 136.86 27.59 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.53000000000000003 110.415 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.7 Cg_exo -61.56 157.53 41.27 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.107 1.583 . . . . 1.4399999999999999 111.243 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.744 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -77.63 -165.88 0.68 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.392 -0.817 . . . . 1.5800000000000001 109.578 170.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.9 tt0 -64.17 104.56 0.75 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.274 -0.891 . . . . 4.0 110.428 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.73 16.93 50.55 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.415 -1.074 . . . . 1.52 110.415 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.896 HG11 ' O ' ' A' ' 440' ' ' LEU . 55.3 t -104.9 150.03 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.346 . . . . 1.73 110.785 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -86.27 142.05 28.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.264 -0.897 . . . . 2.02 110.328 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -64.77 -41.79 95.61 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 2.7000000000000002 110.799 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 43.4 mtpt -60.7 -41.45 95.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.035 -1.041 . . . . 3.0299999999999998 110.227 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.4 m -59.41 -45.87 90.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.90000000000000002 110.286 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.71 HD22 ' HA3' ' A' ' 441' ' ' GLY . 18.5 tp -61.39 -44.63 96.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.93000000000000005 111.239 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.67 -38.39 84.75 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.034 -1.042 . . . . 0.87 109.614 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.582 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.2 m-20 -65.31 -45.3 84.86 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.026 . . . . 1.96 111.475 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.974 -1.079 . . . . 0.76000000000000001 110.361 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.52 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.71999999999999997 109.967 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.627 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.12 -52.97 19.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 1.72 111.336 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.924 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -70.33 -36.72 74.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.718 -1.239 . . . . 1.5800000000000001 110.408 -176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.49 -12.44 60.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.214 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.604 ' OG ' HG23 ' A' ' 353' ' ' VAL . 92.9 p -97.01 -17.77 19.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 3.5600000000000001 110.294 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.911 HD21 ' OE1' ' A' ' 364' ' ' GLU . 46.1 mt -59.48 -27.48 66.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 4.3600000000000003 110.144 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.16 -24.49 24.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 3.8100000000000001 110.938 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.3 p30 -74.11 139.1 44.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 2.8399999999999999 110.151 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.55 7.25 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 2.9900000000000002 110.186 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.752 HG21 ' CD2' ' A' ' 377' ' ' PHE . 67.3 p -78.43 144.45 65.99 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 2.0699999999999998 110.102 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.62 -32.62 96.24 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.943 1.496 . . . . 2.3799999999999999 110.125 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.463 ' OE2' ' HB2' ' A' ' 317' ' ' ARG . 77.1 mm-40 -64.16 -36.0 82.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 3.25 110.217 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 344' ' ' ASP . . . -58.99 -28.32 63.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 1.4199999999999999 109.768 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -76.34 -36.54 58.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.963 -1.316 . . . . 3.6200000000000001 109.548 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.733 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.9 m -54.49 -44.95 73.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.439 -0.904 . . . . 2.3999999999999999 109.808 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.623 HG22 ' OE1' ' A' ' 338' ' ' GLN . 13.4 mt -67.74 -46.88 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 1.3899999999999999 111.127 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 1.027 HG13 ' OE2' ' A' ' 364' ' ' GLU . 39.4 t -52.54 -33.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.539 -1.35 . . . . 1.1799999999999999 110.242 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 351' ' ' SER . 44.4 mt -66.71 -44.85 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.771 -1.206 . . . . 1.3600000000000001 110.258 169.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.09 HD21 ' CD1' ' A' ' 322' ' ' PHE . 9.2 tt -47.15 -51.8 17.2 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.215 -0.928 . . . . 1.1499999999999999 110.875 -173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -67.28 -39.49 86.05 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.9 -1.125 . . . . 0.60999999999999999 109.864 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 361' ' ' ASN . 6.2 mtmt -66.26 -46.02 78.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 1.1599999999999999 111.273 -175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.2 pt20 -63.55 -37.49 87.52 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.205 -1.559 . . . . 1.8999999999999999 109.491 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.479 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 27.7 mmm180 -77.01 -47.49 20.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.199 -0.938 . . . . 2.6299999999999999 111.474 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.762 ' HB2' HD23 ' A' ' 362' ' ' LEU . 22.7 m-85 -115.92 -14.72 11.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.766 -1.209 . . . . 3.3199999999999998 110.344 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 357' ' ' LYS . 23.1 t30 60.16 39.86 18.92 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.462 -0.773 . . . . 1.8999999999999999 110.111 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.69 -171.89 2.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.575 -0.703 . . . . 2.7999999999999998 109.575 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -123.24 151.87 41.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.19 -0.944 . . . . 4.4000000000000004 110.503 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 1.027 ' OE2' HG13 ' A' ' 353' ' ' VAL . 65.1 mm-40 -64.48 158.12 24.79 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.462 -0.774 . . . . 2.2400000000000002 110.064 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.538 ' H ' HD11 ' A' ' 342' ' ' LEU . 97.2 mtt180 -102.96 131.74 49.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 4.1600000000000001 110.515 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.489 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.6 m-20 -76.63 115.35 16.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 2.8599999999999999 109.668 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HB3' ' A' ' 372' ' ' ALA . 54.3 t -70.42 -43.53 78.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.345 -0.847 . . . . 3.04 110.66 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -75.62 -19.32 59.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.015 . . . . 3.6899999999999999 111.066 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.3 p -75.0 -24.77 58.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.762 -1.211 . . . . 3.0499999999999998 109.016 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 388' ' ' ILE . 33.3 mt -91.77 3.18 55.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.388 -0.82 . . . . 2.1400000000000001 109.621 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 370' ' ' LEU . 77.2 t60 57.78 27.54 14.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 2.1000000000000001 108.708 -172.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.66 -165.22 1.28 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.518 0.675 . . . . 1.1200000000000001 110.375 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.452 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 43.2 m -139.07 143.74 38.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 2.1099999999999999 110.625 -177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 367' ' ' VAL . 70.2 m-85 -88.95 144.0 26.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.884 -1.135 . . . . 3.0899999999999999 109.62 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 1.015 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.1 t -111.16 113.48 54.38 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.874 -1.141 . . . . 4.0 109.975 174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.9 Cg_endo -55.38 153.31 28.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.973 1.512 . . . . 4.6299999999999999 111.332 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.752 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -98.23 122.51 41.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.637 -0.664 . . . . 5.79 109.862 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 29.6 p -110.61 140.03 45.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 5.29 109.83 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.498 ' CB ' ' O3G' ' A' 1001 ' ' ANP . . . -74.96 -31.28 61.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.714 . . . . 6.1299999999999999 110.458 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.53 -46.14 87.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 7.7400000000000002 110.027 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 383' ' ' MET . 32.3 p -91.93 -10.72 38.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.99 . . . . 3.8199999999999998 109.663 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 91.1 mtt180 56.05 53.59 8.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.815 . . . . 4.25 109.869 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.531 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 41.3 mtm -151.72 148.95 28.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.969 -1.082 . . . . 2.0899999999999999 111.469 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.4 p -145.71 171.1 15.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.62 -1.252 . . . . 1.23 107.62 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.446 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -177.78 -164.19 30.74 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 118.505 -1.807 . . . . 1.1299999999999999 110.427 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.924 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.66 13.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.879 -0.777 . . . . 1.26 109.057 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.59 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.57 144.26 48.18 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.125 -0.984 . . . . 2.04 108.551 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.903 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.1 tt -144.49 164.2 13.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.756 -1.215 . . . . 2.1099999999999999 110.191 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -63.2 7.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.501 0.926 . . . . 3.8500000000000001 113.501 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 21.8 t-20 -145.7 3.16 0.96 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.104 -1.622 . . . . 2.3300000000000001 111.381 174.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 87.7 mtt180 -157.45 160.16 38.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.509 -1.369 . . . . 2.6899999999999999 110.945 -173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.7 mtm -129.96 140.63 50.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.882 -1.136 . . . . 2.02 109.174 167.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.653 HG13 HD11 ' A' ' 339' ' ' LEU . 30.6 mm -130.52 140.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.774 -1.203 . . . . 1.6799999999999999 110.311 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 1.015 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.8 mmt180 -141.3 143.54 34.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 2.7799999999999998 110.451 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.889 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.31 145.65 31.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 1.5700000000000001 109.64 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.657 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.39 -149.87 10.52 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.377 -1.392 . . . . 0.81999999999999995 110.338 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 400' ' ' ALA . 1.4 p -73.92 159.69 32.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -1.128 . . . . 1.1699999999999999 110.757 -174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.653 ' CG2' HG11 ' A' ' 420' ' ' VAL . 79.5 t -61.19 -50.61 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.53000000000000003 110.12 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.82 -36.08 78.17 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.055 -1.028 . . . . 1.5900000000000001 108.847 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.59 ' HB2' ' OG ' ' A' ' 397' ' ' SER . . . -64.19 -46.45 83.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.682 -0.636 . . . . 0.84999999999999998 110.888 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.657 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.1 mm -69.86 -34.64 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.26 -1.525 . . . . 0.81000000000000005 110.759 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -61.87 -43.35 99.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.985 -1.072 . . . . 2.6200000000000001 109.865 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.44 -32.58 72.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 2.48 110.391 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.535 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.2 t60 -65.78 -41.51 91.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.835 -1.165 . . . . 2.4300000000000002 110.495 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.687 HG12 ' C ' ' A' ' 410' ' ' GLY . 93.8 t -64.69 -45.35 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.032 . . . . 0.93999999999999995 110.358 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -62.65 -36.05 81.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.852 -1.155 . . . . 2.1600000000000001 110.833 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.64 91.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.981 -1.075 . . . . 1.53 109.721 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.68 -26.19 66.92 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.326 -0.859 . . . . 2.75 109.221 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.19 22.47 19.74 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.307 -1.517 . . . . 2.2799999999999998 109.307 -175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.687 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.44 -169.81 40.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 1.72 109.448 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.5 m80 -140.19 152.1 45.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -1.184 . . . . 4.1600000000000001 110.442 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.808 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.11 109.78 39.81 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 3.3100000000000001 109.938 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 26.0 Cg_exo -58.0 141.77 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.881 1.464 . . . . 1.23 110.802 -176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -59.04 -43.86 91.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.348 -0.845 . . . . 1.75 110.372 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.5 m-20 -56.62 -40.59 75.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.056 -1.027 . . . . 1.8700000000000001 110.11 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 439' ' ' VAL . 49.6 t -68.56 -41.05 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.982 -1.074 . . . . 0.70999999999999996 110.773 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -62.35 -37.64 86.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.947 -1.095 . . . . 1.8100000000000001 109.917 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 95.6 mt-30 -64.34 -42.89 96.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.195 -0.941 . . . . 2.6000000000000001 110.647 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.983 ' O ' HG23 ' A' ' 423' ' ' VAL . 69.2 mttm -62.85 -38.18 89.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.762 -1.211 . . . . 2.4900000000000002 110.893 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 430' ' ' PRO . 75.4 t -66.38 -39.49 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.79000000000000004 110.341 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.4 m-20 -68.86 -43.54 75.19 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.497 -0.752 . . . . 2.0499999999999998 110.65 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.4 mm-40 -65.3 -30.99 71.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 2.3300000000000001 109.875 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 419' ' ' LYS . 70.6 t -60.62 -43.5 94.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.076 -1.015 . . . . 1.0 109.649 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.42 -49.99 43.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 1.24 110.27 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 60.4 mtp180 -54.51 -21.65 10.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 4.1100000000000003 109.969 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 86.6 mm-40 -91.02 3.58 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 2.9199999999999999 110.63 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.75 10.16 67.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.771 -1.332 . . . . 1.1599999999999999 109.771 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.34 156.84 17.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.162 . . . . 1.0700000000000001 109.911 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.2 m -93.25 109.34 39.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.21 108.968 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.963 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.7 Cg_exo -75.37 112.23 3.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.012 1.532 . . . . 1.2 110.237 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.653 HD21 " C2'" ' A' 1001 ' ' ANP . 61.8 mt -89.95 161.81 15.71 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.891 -1.131 . . . . 1.3999999999999999 108.273 165.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.808 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 57.3 t -125.99 139.39 51.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.756 -1.215 . . . . 0.52000000000000002 110.278 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.966 HG12 HD21 ' A' ' 440' ' ' LEU . 20.2 t -118.56 136.36 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.639 -0.663 . . . . 1.0800000000000001 109.357 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.652 ' CA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.47 154.71 40.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.643 -0.823 . . . . 0.90000000000000002 110.642 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -99.61 121.35 41.09 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.029 -0.73 . . . . 1.79 109.029 172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.7 -109.72 1.75 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.676 -1.769 . . . . 1.4199999999999999 108.676 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 405' ' ' VAL . 22.2 p -113.39 13.03 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -1.147 . . . . 1.4199999999999999 111.234 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 28.6 ptt180 -123.1 139.9 53.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.694 -1.254 . . . . 3.52 110.24 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.032 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.24 127.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.787 . . . . 1.4099999999999999 111.06 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.966 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -92.27 -29.26 16.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 1.79 110.722 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.71 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.77 179.01 48.89 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.122 -1.513 . . . . 1.02 110.867 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 443' ' ' ILE . 65.1 t -123.99 153.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.463 -1.021 . . . . 0.56999999999999995 109.805 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.2 mm -124.49 127.79 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.962 -1.086 . . . . 1.05 111.188 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.02 121.22 40.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.852 . . . . 0.46000000000000002 110.216 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.0 mp -99.32 139.24 35.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.003 . . . . 2.1099999999999999 110.158 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -85.51 140.03 31.0 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.284 -0.885 . . . . 4.4800000000000004 109.635 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 34.9 p30 -96.0 115.81 28.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 3.9100000000000001 110.602 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.594 HD12 ' N ' ' A' ' 448' ' ' ILE . 1.5 mp -56.77 -46.4 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 3.6099999999999999 109.417 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.93 136.42 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.635 -0.665 . . . . 5.0899999999999999 110.254 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -89.95 132.69 35.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 7.5 110.149 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.959 -1.467 . . . . 7.2999999999999998 109.531 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.653 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 35.4 t30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.174 0.511 . . . . 6.0800000000000001 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -125.36 137.87 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 5.8300000000000001 110.304 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.504 ' NE2' HD11 ' A' ' 448' ' ' ILE . 14.9 mt-30 -135.77 149.52 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 5.5800000000000001 109.436 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 355' ' ' LEU . . . -68.94 121.78 17.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.67 -1.269 . . . . 1.4199999999999999 109.65 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -108.14 -41.52 4.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.119 -1.032 . . . . 1.6000000000000001 110.648 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.466 ' OE2' HD11 ' A' ' 323' ' ' ILE . 84.3 tt0 -138.41 143.8 39.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.056 -1.027 . . . . 1.8200000000000001 110.967 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.816 ' O ' HD13 ' A' ' 323' ' ' ILE . 23.8 p90 -117.58 146.81 43.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.18 -0.95 . . . . 1.1399999999999999 110.305 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 322' ' ' PHE . 11.7 mm -129.64 132.56 24.28 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.257 -0.902 . . . . 0.53000000000000003 110.588 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 17.0 Cg_exo -59.74 159.25 25.24 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.103 1.58 . . . . 1.4399999999999999 111.377 -175.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.746 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -75.5 -167.96 0.75 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.298 -0.876 . . . . 1.5800000000000001 109.409 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.5 tt0 -63.55 104.88 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.228 -0.92 . . . . 4.0 110.476 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.45 16.05 50.98 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.023 -1.084 . . . . 1.52 110.498 174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.9 t -105.1 151.63 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.944 -1.327 . . . . 1.73 110.835 -176.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -84.87 142.61 29.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.34 -0.85 . . . . 2.02 110.299 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.567 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -64.78 -39.33 93.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 2.7000000000000002 110.54 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 330' ' ' GLU . 18.6 mttp -62.12 -41.18 97.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 3.0299999999999998 110.232 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.6 m -59.14 -45.28 91.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.90000000000000002 110.194 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 440' ' ' LEU . 18.4 tp -61.08 -45.08 96.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.93000000000000005 111.244 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.51 -38.26 83.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.87 109.811 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.96 -50.12 65.47 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.274 -0.891 . . . . 1.96 111.358 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.664 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.05 -39.63 90.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.76000000000000001 110.7 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.721 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -65.96 -41.93 90.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.71999999999999997 110.126 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.721 ' OE1' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mp0 -77.25 -33.94 55.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 1.72 111.581 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 340' ' ' ALA . 4.7 pp -75.13 -37.58 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.596 -1.315 . . . . 1.5800000000000001 110.168 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.946 ' N ' HD12 ' A' ' 339' ' ' LEU . . . -70.12 -7.71 43.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 2.2400000000000002 110.299 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.522 ' CA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -94.89 -13.72 25.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 3.5600000000000001 109.925 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 364' ' ' GLU . 50.6 mt -55.54 -26.53 43.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 4.3600000000000003 109.894 174.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -86.31 -21.43 27.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 3.8100000000000001 110.786 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.522 ' OD2' ' CA ' ' A' ' 341' ' ' SER . 1.2 p30 -82.51 136.87 34.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 2.8399999999999999 110.155 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.92 6.85 47.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 2.9900000000000002 110.265 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 35.3 p -77.06 146.26 74.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 2.0699999999999998 110.255 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.58 -35.35 90.37 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.966 1.508 . . . . 2.3799999999999999 110.281 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.3 mt-10 -64.1 -37.34 87.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 3.25 110.114 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.75 -25.44 61.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.465 -1.454 . . . . 1.4199999999999999 109.465 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 354' ' ' ILE . 78.9 mtt180 -76.79 -37.06 56.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.054 -1.262 . . . . 3.6200000000000001 109.701 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.6 m -54.51 -45.6 73.33 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.126 -0.984 . . . . 2.3999999999999999 109.649 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.677 HG12 ' HB2' ' A' ' 319' ' ' ALA . 27.3 mt -64.96 -50.57 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 1.3899999999999999 111.161 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.704 HG13 ' CG ' ' A' ' 364' ' ' GLU . 33.9 t -56.98 -30.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.79 -1.194 . . . . 1.1799999999999999 110.605 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 351' ' ' SER . 73.9 mt -65.61 -46.25 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.658 -1.276 . . . . 1.3600000000000001 110.027 168.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.946 HD12 ' HB1' ' A' ' 319' ' ' ALA . 4.6 tt -47.26 -50.07 22.11 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.175 -0.953 . . . . 1.1499999999999999 110.162 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.566 ' CB ' ' HG2' ' A' ' 338' ' ' GLN . . . -64.84 -37.26 87.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.60999999999999999 109.357 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 361' ' ' ASN . 31.7 tptt -58.22 -53.01 63.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.776 -1.202 . . . . 1.1599999999999999 111.031 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.1 pt20 -68.53 -41.3 80.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.452 -1.405 . . . . 1.8999999999999999 110.165 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 30.7 mmt180 -67.65 -38.96 84.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 2.6299999999999999 111.318 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.536 ' HB3' ' CD1' ' A' ' 362' ' ' LEU . 97.1 m-85 -115.79 -14.9 11.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.125 . . . . 3.3199999999999998 110.22 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.597 ' O ' HD23 ' A' ' 362' ' ' LEU . 11.4 t-20 60.52 50.03 6.18 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.749 0.785 . . . . 1.8999999999999999 109.931 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 361' ' ' ASN . 29.0 mt -130.7 -179.14 5.12 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.675 -0.641 . . . . 2.7999999999999998 109.875 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -106.53 153.71 21.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.001 -1.062 . . . . 4.4000000000000004 109.921 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.812 ' HB3' HD11 ' A' ' 342' ' ' LEU . 77.6 mm-40 -67.88 -174.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 2.2400000000000002 109.777 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.803 HH21 HD13 ' A' ' 339' ' ' LEU . 58.8 mtm180 -104.2 135.12 46.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.09 -1.006 . . . . 4.1600000000000001 110.362 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 369' ' ' SER . 54.5 t0 -80.56 125.68 30.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.223 -0.923 . . . . 2.8599999999999999 109.753 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 372' ' ' ALA . 51.0 t -71.15 -42.28 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 121.807 -0.558 . . . . 3.04 110.404 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -75.62 -19.51 59.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 3.6899999999999999 111.058 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 366' ' ' ASP . 63.8 p -74.75 -26.32 59.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 3.0499999999999998 109.018 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.88 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.9 mt -94.55 1.29 55.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.853 . . . . 2.1400000000000001 109.667 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 88.4 m-70 55.82 32.99 20.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.076 -1.015 . . . . 2.1000000000000001 108.934 -173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.759 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.99 -164.63 1.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.584 0.707 . . . . 1.1200000000000001 110.543 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 45.2 m -136.24 143.71 44.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.721 -0.612 . . . . 2.1099999999999999 110.505 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.723 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.8 m-85 -91.35 142.44 27.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.972 -1.08 . . . . 3.0899999999999999 109.702 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 387' ' ' ASN . 21.5 t -106.81 110.82 63.88 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.861 -1.149 . . . . 4.0 109.764 173.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.42 151.85 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.119 1.589 . . . . 4.6299999999999999 111.181 -175.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.575 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -96.69 122.2 39.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 5.79 109.863 178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.5 p -110.92 140.37 45.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 5.29 109.799 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.85 -30.78 59.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.475 -0.765 . . . . 6.1299999999999999 110.482 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -58.09 -44.6 87.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.993 . . . . 7.7400000000000002 109.966 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 383' ' ' MET . 58.2 m -90.42 -20.46 22.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 3.8199999999999998 109.668 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 62.6 mtt180 64.53 53.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.561 -0.712 . . . . 4.25 109.589 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.619 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.4 mtp -149.36 144.58 26.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.042 -1.036 . . . . 2.0899999999999999 111.205 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.575 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 48.8 p -145.85 166.19 26.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.1 -1.074 . . . . 1.23 108.1 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.633 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -178.84 -161.05 25.87 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.759 -1.686 . . . . 1.1299999999999999 110.247 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.871 HG22 ' HB ' ' A' ' 393' ' ' ILE . 13.0 tt -148.81 154.36 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.723 -0.869 . . . . 1.26 109.249 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.667 HD21 HG21 ' A' ' 375' ' ' VAL . 2.9 m120 -126.55 140.06 52.73 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 120.946 -1.096 . . . . 2.04 108.291 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.88 ' CD1' HD13 ' A' ' 370' ' ' LEU . 15.2 tt -145.74 166.4 9.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.497 -1.377 . . . . 2.1099999999999999 110.623 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.4 7.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.474 0.916 . . . . 3.8500000000000001 113.474 -171.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 29.7 t30 -147.74 4.63 0.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.087 -1.633 . . . . 2.3300000000000001 111.444 174.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 390' ' ' ASN . 71.8 mtt85 -157.79 156.99 32.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.559 -1.338 . . . . 2.6899999999999999 110.82 -173.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.615 ' O ' HD13 ' A' ' 393' ' ' ILE . 86.4 mtp -129.93 138.77 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.852 -1.155 . . . . 2.02 109.163 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.871 ' HB ' HG22 ' A' ' 386' ' ' ILE . 33.0 mm -128.28 138.86 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.878 -1.139 . . . . 1.6799999999999999 110.123 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.578 ' NH1' ' CE1' ' A' ' 404' ' ' HIS . 28.3 mmt85 -138.32 142.92 39.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 2.7799999999999998 110.15 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.886 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -144.25 144.03 31.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 1.5700000000000001 109.282 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.746 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 176.6 -153.37 14.0 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.106 -1.521 . . . . 0.81999999999999995 110.712 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 19.4 m -71.61 157.32 38.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -1.101 . . . . 1.1699999999999999 110.63 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.953 ' CG2' HG11 ' A' ' 420' ' ' VAL . 92.3 t -59.67 -48.38 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.53000000000000003 109.995 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.38 -37.15 79.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.92 -1.112 . . . . 1.5900000000000001 108.949 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.619 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -64.44 -48.98 73.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.656 -0.652 . . . . 0.84999999999999998 110.779 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.746 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.3 mm -68.67 -33.58 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.344 -1.472 . . . . 0.81000000000000005 110.652 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 48.1 ttp180 -62.17 -43.51 98.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 2.6200000000000001 109.842 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -33.02 73.28 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.212 -0.93 . . . . 2.48 110.392 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.578 ' CE1' ' NH1' ' A' ' 394' ' ' ARG . 84.8 t60 -65.83 -41.57 91.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.805 -1.184 . . . . 2.4300000000000002 110.437 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.663 HG12 ' C ' ' A' ' 410' ' ' GLY . 95.2 t -64.45 -45.3 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.042 -1.036 . . . . 0.93999999999999995 110.566 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.2 mt-10 -62.62 -36.24 82.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.864 -1.148 . . . . 2.1600000000000001 110.811 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.64 92.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 1.53 109.673 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 18.3 m120 -66.95 -27.06 67.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.428 -0.795 . . . . 2.75 109.217 172.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.32 23.84 15.83 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.184 -1.567 . . . . 2.2799999999999998 109.184 -175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.663 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.22 -168.32 40.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 1.72 109.395 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 83.6 t60 -142.23 149.37 39.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.134 -1.216 . . . . 4.1600000000000001 110.567 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.821 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -92.46 109.57 39.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 3.3100000000000001 110.042 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 22.6 Cg_exo -60.11 140.52 92.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.852 1.448 . . . . 1.23 110.864 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.1 t -58.86 -42.34 89.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.903 . . . . 1.75 110.384 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.9 m-20 -56.24 -41.06 75.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.013 -1.055 . . . . 1.8700000000000001 109.942 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 439' ' ' VAL . 50.7 t -67.74 -41.08 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.061 -1.024 . . . . 0.70999999999999996 110.814 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.33 -37.76 86.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.958 -1.089 . . . . 1.8100000000000001 109.996 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.2 mt-30 -64.49 -41.87 96.19 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 2.6000000000000001 110.771 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.971 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.5 mttm -63.25 -39.28 94.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.729 -1.232 . . . . 2.4900000000000002 110.807 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.016 HG13 ' HB2' ' A' ' 430' ' ' PRO . 79.1 t -65.88 -40.01 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.969 -1.082 . . . . 0.79000000000000004 110.326 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -68.0 -43.07 79.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.547 -0.721 . . . . 2.0499999999999998 110.553 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.2 mt-30 -66.03 -31.65 72.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 2.3300000000000001 109.736 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 419' ' ' LYS . 79.7 t -61.91 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 1.0 109.638 172.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.56 -53.2 12.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 1.24 110.559 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -55.44 -20.34 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 4.1100000000000003 109.816 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 95.8 mt-30 -91.39 6.76 44.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.447 -0.783 . . . . 2.9199999999999999 110.616 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.23 69.42 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.794 -1.323 . . . . 1.1599999999999999 109.794 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -103.89 154.56 19.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 1.0700000000000001 109.901 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.5 m -93.35 109.44 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 1.21 109.133 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.016 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 Cg_exo -78.87 107.32 2.23 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.018 1.536 . . . . 1.2 110.222 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.854 HD21 " C2'" ' A' 1001 ' ' ANP . 92.4 mt -90.2 144.47 25.83 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.739 -1.226 . . . . 1.3999999999999999 108.695 166.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.821 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 55.7 t -109.19 137.89 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.895 -1.128 . . . . 0.52000000000000002 110.163 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.886 HG22 ' CG ' ' A' ' 395' ' ' LYS . 18.0 t -117.45 135.86 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.555 -0.716 . . . . 1.0800000000000001 109.723 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.807 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -131.7 154.39 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.322 -0.861 . . . . 0.90000000000000002 110.703 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 438' ' ' ARG . 4.6 mt-10 -98.87 121.42 40.8 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.962 -0.755 . . . . 1.79 108.962 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.14 -109.66 1.61 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.622 -1.791 . . . . 1.4199999999999999 108.622 -172.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 22.1 p -113.54 13.88 18.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -1.13 . . . . 1.4199999999999999 111.216 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.527 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.3 ptt180 -124.25 140.88 52.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.756 -1.215 . . . . 3.52 110.203 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.051 HG11 HG11 ' A' ' 416' ' ' VAL . 44.4 t -81.36 125.81 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.453 -0.779 . . . . 1.4099999999999999 111.11 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.881 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.9 -29.96 20.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 1.79 110.374 175.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.65 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 173.17 -175.39 46.05 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.098 -1.525 . . . . 1.02 110.792 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 443' ' ' ILE . 39.0 t -121.44 159.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -1.008 . . . . 0.56999999999999995 109.945 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 442' ' ' VAL . 18.3 mm -126.01 129.22 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 1.05 110.921 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.697 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.15 121.1 41.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.42 -0.8 . . . . 0.46000000000000002 110.31 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.5 mp -102.67 145.72 29.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.989 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -96.5 143.03 27.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.203 -0.936 . . . . 4.4800000000000004 109.869 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 33.2 p30 -95.94 129.45 43.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.422 -0.799 . . . . 3.9100000000000001 110.35 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 448' ' ' ILE . 4.5 mm -54.0 -48.79 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 3.6099999999999999 109.324 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.17 136.05 37.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.225 0.536 . . . . 5.0899999999999999 110.304 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -89.7 132.49 35.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 7.5 110.142 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 118.013 -1.437 . . . . 7.2999999999999998 109.522 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.854 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.487 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 7.1 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.321 0.581 . . . . 6.0800000000000001 110.394 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.474 ' NH2' ' OG1' ' A' ' 429' ' ' THR . 53.1 mtp180 -42.48 139.61 1.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.49 -0.756 . . . . 5.8300000000000001 110.435 -176.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 351' ' ' SER . 36.1 tt0 -153.9 146.28 23.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.528 -0.732 . . . . 5.5800000000000001 110.279 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.951 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -62.15 137.68 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.002 -1.061 . . . . 1.4199999999999999 110.126 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -113.65 -34.81 5.4 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.555 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -153.63 146.31 24.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 1.8200000000000001 110.984 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 443' ' ' ILE . 2.4 p90 -117.44 147.12 42.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.072 -1.018 . . . . 1.1399999999999999 110.258 172.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.616 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.03 135.06 25.95 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.114 -0.991 . . . . 0.53000000000000003 110.842 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 16.4 Cg_exo -64.31 158.32 49.48 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.742 1.39 . . . . 1.4399999999999999 111.569 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -76.35 -167.52 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.499 -0.751 . . . . 1.5800000000000001 109.723 173.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.7 tt0 -62.55 104.69 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.29 -0.881 . . . . 4.0 110.306 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.09 58.0 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.031 -1.08 . . . . 1.52 110.415 175.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.0 t -102.04 155.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.335 . . . . 1.73 110.411 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 332' ' ' THR . 48.0 p30 -100.43 153.77 19.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 2.02 109.951 176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.564 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 59.5 mt-10 -64.61 -33.27 75.52 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.992 -1.067 . . . . 2.7000000000000002 110.841 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.589 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 27.3 mttt -62.49 -46.1 89.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.986 . . . . 3.0299999999999998 110.706 -178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 329' ' ' ASP . 61.8 m -63.55 -47.58 81.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.085 . . . . 0.90000000000000002 110.203 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.992 ' HA ' HD12 ' A' ' 440' ' ' LEU . 26.2 tp -59.4 -48.16 82.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.078 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.502 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.94 -39.98 87.4 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.098 -1.001 . . . . 0.87 109.784 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 339' ' ' LEU . 22.2 t70 -67.04 -44.92 78.98 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 120.607 -1.308 . . . . 1.96 111.633 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 440' ' ' LEU . . . -65.37 -37.85 88.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.915 -1.115 . . . . 0.76000000000000001 110.142 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.49 -30.06 70.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.037 . . . . 0.71999999999999997 109.443 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 338' ' ' GLN . 0.2 OUTLIER -73.0 -52.61 13.78 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.445 -0.785 . . . . 1.72 110.486 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 386' ' ' ILE . 0.3 OUTLIER -68.82 -36.62 78.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 1.5800000000000001 110.167 -178.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.68 ' HB1' ' HA2' ' A' ' 385' ' ' GLY . . . -68.22 -14.46 63.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 2.2400000000000002 110.417 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 30.5 p -95.76 -15.95 22.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 3.5600000000000001 110.114 177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.564 HD11 ' H ' ' A' ' 365' ' ' ARG . 46.6 mt -58.33 -27.42 64.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.015 -1.053 . . . . 4.3600000000000003 109.988 176.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.09 -22.45 25.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.408 -0.807 . . . . 3.8100000000000001 110.792 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -77.62 136.7 38.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.899 -1.126 . . . . 2.8399999999999999 110.007 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.44 6.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 2.9900000000000002 110.256 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.635 HG21 ' CD2' ' A' ' 377' ' ' PHE . 44.7 p -74.69 139.5 74.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 2.0699999999999998 110.043 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 29.4 Cg_exo -56.42 -35.86 96.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.012 1.533 . . . . 2.3799999999999999 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.01 -35.92 82.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 3.25 110.122 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.65 -28.85 63.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.668 -1.373 . . . . 1.4199999999999999 109.668 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -77.73 -35.6 51.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.026 -1.279 . . . . 3.6200000000000001 109.498 174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.3 m -54.38 -44.28 72.12 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.329 -0.948 . . . . 2.3999999999999999 109.439 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.9 mt -63.19 -56.91 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.08 -1.012 . . . . 1.3899999999999999 111.036 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.517 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 76.9 t -51.26 -30.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 110.77 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 351' ' ' SER . 53.5 mt -68.56 -49.63 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.625 -1.297 . . . . 1.3600000000000001 110.481 170.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.951 HD22 ' HB1' ' A' ' 319' ' ' ALA . 53.5 tp -47.6 -49.84 25.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.149 -0.969 . . . . 1.1499999999999999 110.973 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.804 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -64.09 -36.91 85.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.015 . . . . 0.60999999999999999 109.369 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 361' ' ' ASN . 8.0 tptm -59.94 -51.49 69.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.905 -1.122 . . . . 1.1599999999999999 111.028 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 15.2 pt20 -65.46 -39.49 92.05 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.321 -1.487 . . . . 1.8999999999999999 109.869 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.643 ' HE ' HD11 ' A' ' 355' ' ' LEU . 86.5 mtt-85 -73.25 -44.15 59.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 2.6299999999999999 111.699 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.681 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 21.2 m-85 -116.05 -15.04 11.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.704 -1.247 . . . . 3.3199999999999998 110.81 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.2 t-20 59.79 43.09 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 1.8999999999999999 110.061 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -79.75 -177.32 5.84 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.554 -0.716 . . . . 2.7999999999999998 109.622 173.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -123.75 152.55 42.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.031 -1.043 . . . . 4.4000000000000004 110.618 176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.56 145.14 29.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.795 -0.762 . . . . 2.2400000000000002 109.472 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.564 ' H ' HD11 ' A' ' 342' ' ' LEU . 95.3 mtt-85 -100.87 126.93 47.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.028 -1.045 . . . . 4.1600000000000001 110.195 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -73.6 112.28 9.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 2.8599999999999999 109.651 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 374' ' ' PHE . 55.5 t -70.9 -44.96 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 3.04 110.551 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.02 -19.15 60.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.035 . . . . 3.6899999999999999 111.193 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.7 p -74.87 -24.74 58.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.711 -1.243 . . . . 3.0499999999999998 109.125 171.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.872 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.1 mt -91.11 3.0 55.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.33 -0.856 . . . . 2.1400000000000001 109.578 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 0.4 OUTLIER 59.73 26.85 16.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -0.999 . . . . 2.1000000000000001 108.685 -171.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.667 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.18 -166.97 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.501 0.667 . . . . 1.1200000000000001 110.233 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.49 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 29.1 m -138.94 143.65 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 2.1099999999999999 110.556 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.668 ' CE1' HG21 ' A' ' 367' ' ' VAL . 68.0 m-85 -88.37 143.83 26.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.036 -1.04 . . . . 3.0899999999999999 109.484 172.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 386' ' ' ILE . 10.5 t -111.95 110.18 54.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.85 -1.156 . . . . 4.0 109.912 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.1 Cg_endo -55.55 153.04 30.75 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.028 1.541 . . . . 4.6299999999999999 111.121 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -92.95 122.28 35.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.727 . . . . 5.79 109.885 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 21.5 p -112.83 142.4 45.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 5.29 109.842 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -28.55 58.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.726 . . . . 6.1299999999999999 110.581 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -57.65 -47.46 82.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.015 -1.053 . . . . 7.7400000000000002 110.03 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.548 ' HB2' ' HE2' ' A' ' 383' ' ' MET . 53.3 p -91.94 -13.75 30.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 3.8199999999999998 109.691 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 381' ' ' SER . 41.5 mtp180 60.42 54.09 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.441 -0.787 . . . . 4.25 109.686 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.656 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 40.3 mtm -152.99 151.72 30.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 2.0899999999999999 111.414 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.1 p -144.96 168.01 21.28 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.715 -1.217 . . . . 1.23 107.715 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.68 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -176.38 -163.5 28.94 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 118.521 -1.799 . . . . 1.1299999999999999 110.399 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 339' ' ' LEU . 3.3 tt -151.14 150.62 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.945 -0.761 . . . . 1.26 108.945 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.8 m120 -122.16 144.26 49.06 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.082 -1.012 . . . . 2.04 108.716 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.3 tt -144.69 164.3 13.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 O-C-N 120.634 -1.291 . . . . 2.1099999999999999 110.239 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.24 7.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.566 0.95 . . . . 3.8500000000000001 113.566 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 49.4 t30 -145.19 2.86 1.01 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.1 -1.625 . . . . 2.3300000000000001 111.342 174.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 78.1 mtm180 -157.61 159.27 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.58 -1.325 . . . . 2.6899999999999999 110.968 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.514 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.9 140.68 50.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.84 -1.163 . . . . 2.02 109.111 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 339' ' ' LEU . 30.3 mm -130.63 139.69 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.777 -1.202 . . . . 1.6799999999999999 110.111 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.57 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 56.2 mmm-85 -140.42 146.45 38.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.225 -0.922 . . . . 2.7799999999999998 110.582 175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.613 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -144.93 146.89 32.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 1.5700000000000001 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.55 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 169.6 -149.33 13.12 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.4 -1.381 . . . . 0.81999999999999995 110.479 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 73.7 m -72.35 156.71 38.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -1.153 . . . . 1.1699999999999999 110.864 -175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 420' ' ' VAL . 85.1 t -61.16 -48.21 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.139 -0.976 . . . . 0.53000000000000003 110.053 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 55.9 t0 -59.52 -37.91 79.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.922 -1.112 . . . . 1.5900000000000001 108.969 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.656 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -59.92 -52.97 63.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.462 -0.774 . . . . 0.84999999999999998 110.665 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.8 mm -67.07 -38.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.81000000000000005 111.242 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 40.3 ttm180 -59.53 -41.54 90.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 2.6200000000000001 109.997 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 32.0 mtm105 -66.96 -37.59 84.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.005 . . . . 2.48 110.902 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 56.1 t-80 -63.77 -40.58 97.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.077 . . . . 2.4300000000000002 110.68 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.9 t -64.92 -45.19 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.088 . . . . 0.93999999999999995 110.462 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.26 -35.55 79.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.836 -1.165 . . . . 2.1600000000000001 110.754 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.6 89.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 1.53 109.682 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 97.7 m-20 -66.67 -26.39 67.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.291 -0.881 . . . . 2.75 109.26 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.26 23.01 18.0 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.32 -1.512 . . . . 2.2799999999999998 109.32 -175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.625 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.72 -170.4 41.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.375 -1.49 . . . . 1.72 109.375 177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 12.9 p80 -140.57 151.14 44.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.209 -1.171 . . . . 4.1600000000000001 110.369 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -93.46 109.48 40.86 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 3.3100000000000001 110.044 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 23.3 Cg_exo -59.82 141.47 96.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.957 1.504 . . . . 1.23 110.743 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.9 t -58.72 -43.1 90.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.378 -0.826 . . . . 1.75 110.377 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.542 ' N ' HG23 ' A' ' 414' ' ' THR . 52.5 t0 -54.75 -41.76 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.129 -0.982 . . . . 1.8700000000000001 110.066 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 439' ' ' VAL . 51.9 t -68.51 -39.91 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.70999999999999996 110.888 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.5 -38.85 91.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.018 -1.052 . . . . 1.8100000000000001 110.006 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.9 mm-40 -64.55 -41.43 96.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 2.6000000000000001 110.845 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 423' ' ' VAL . 39.5 mttm -62.38 -39.91 94.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.691 -1.256 . . . . 2.4900000000000002 110.789 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 430' ' ' PRO . 74.3 t -66.74 -39.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.041 -1.037 . . . . 0.79000000000000004 110.494 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.3 m-20 -67.32 -43.64 81.13 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.508 -0.745 . . . . 2.0499999999999998 110.396 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.27 -32.47 74.15 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 109.774 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 419' ' ' LYS . 77.8 t -61.43 -42.78 95.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.051 -1.031 . . . . 1.0 109.66 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.41 -50.7 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 1.24 110.383 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 96.7 mtt180 -54.87 -21.75 12.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 109.938 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.2 mt-30 -89.98 5.57 45.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.363 -0.835 . . . . 2.9199999999999999 110.589 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.14 9.84 69.76 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.867 -1.293 . . . . 1.1599999999999999 109.867 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 154.98 19.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 1.0700000000000001 109.933 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.474 ' OG1' ' NH2' ' A' ' 317' ' ' ARG . 3.3 m -93.32 108.14 31.1 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.21 108.916 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 1.029 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.7 Cg_exo -76.39 111.03 3.18 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.926 1.488 . . . . 1.2 110.095 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.941 HD21 " O2'" ' A' 1001 ' ' ANP . 88.7 mt -90.21 142.11 28.04 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.837 -1.164 . . . . 1.3999999999999999 108.902 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.794 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 62.0 t -107.07 138.49 32.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 O-C-N 120.92 -1.112 . . . . 0.52000000000000002 110.006 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 134.82 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.651 -0.656 . . . . 1.0800000000000001 109.537 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.811 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -130.26 154.28 40.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.528 -0.869 . . . . 0.90000000000000002 110.791 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.55 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.4 mt-10 -98.93 121.84 41.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.0 -0.741 . . . . 1.79 109.0 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.06 -109.74 1.63 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.498 -1.841 . . . . 1.4199999999999999 108.498 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 405' ' ' VAL . 6.7 p -114.07 14.21 18.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 1.4199999999999999 111.211 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 29.4 ptt180 -123.38 140.91 52.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.788 -1.195 . . . . 3.52 110.247 -177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.082 HG11 HG11 ' A' ' 416' ' ' VAL . 42.6 t -81.55 126.7 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.376 -0.827 . . . . 1.4099999999999999 111.073 -175.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.992 HD12 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -88.67 -31.89 18.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 1.79 110.307 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.773 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 177.23 -176.81 48.21 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.107 -1.52 . . . . 1.02 110.855 177.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.019 ' O ' HD13 ' A' ' 443' ' ' ILE . 45.0 t -117.95 159.61 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.446 -1.032 . . . . 0.56999999999999995 109.781 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 1.019 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.2 mm -129.01 123.65 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.056 -1.027 . . . . 1.05 110.426 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.98 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -99.84 123.15 43.79 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.133 -0.98 . . . . 0.46000000000000002 110.399 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.2 mp -101.28 139.46 36.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.04 -1.037 . . . . 2.1099999999999999 110.226 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 81.2 tttt -85.89 141.45 29.57 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.265 -0.897 . . . . 4.4800000000000004 109.689 172.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 447' ' ' ASP . 33.6 p30 -95.86 120.06 35.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 3.9100000000000001 110.66 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.592 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.2 mp -55.32 -48.22 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 3.6099999999999999 109.353 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.96 135.09 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 5.0899999999999999 110.214 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -92.63 145.22 24.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 7.5 110.22 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.984 -1.453 . . . . 7.2999999999999998 109.556 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.941 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 448' ' ' ILE . 11.4 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.578 . . . . 6.0800000000000001 110.422 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' ASN . 66.1 mtt85 -41.07 142.98 0.44 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.556 -0.715 . . . . 5.8300000000000001 110.516 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 25.2 pt20 -148.12 156.05 42.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 5.5800000000000001 110.269 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.879 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -71.02 134.13 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 1.4199999999999999 110.138 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.22 -37.18 5.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.191 -0.943 . . . . 1.6000000000000001 110.604 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.49 145.98 29.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.002 -1.061 . . . . 1.8200000000000001 110.88 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.674 ' CB ' HD12 ' A' ' 443' ' ' ILE . 36.3 p90 -117.49 146.98 43.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.907 . . . . 1.1399999999999999 110.063 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.57 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.3 mp -133.88 132.7 21.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.53000000000000003 110.781 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.642 ' HB3' HG12 ' A' ' 328' ' ' VAL . 14.0 Cg_exo -62.37 158.13 42.15 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.967 1.509 . . . . 1.4399999999999999 111.522 -175.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.56 -163.12 0.53 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.457 0.646 . . . . 1.5800000000000001 109.959 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 56.0 tt0 -62.82 102.68 0.37 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.38 -0.825 . . . . 4.0 110.303 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.91 15.76 53.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.296 -1.121 . . . . 1.52 110.296 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 440' ' ' LEU . 98.8 t -102.83 151.47 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.28 . . . . 1.73 110.631 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.449 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.0 m-20 -93.85 147.9 22.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.182 -0.949 . . . . 2.02 110.295 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 24.7 mt-10 -63.7 -40.35 96.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.126 -0.984 . . . . 2.7000000000000002 111.198 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 22.1 tttm -60.45 -42.8 96.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 3.0299999999999998 110.042 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 77.2 m -60.02 -46.95 87.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.139 -0.976 . . . . 0.90000000000000002 110.366 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 443' ' ' ILE . 22.4 tp -62.77 -46.55 87.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.93000000000000005 111.164 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.67 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -60.11 -39.03 84.8 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.022 -1.049 . . . . 0.87 109.726 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 339' ' ' LEU . 84.8 m-20 -65.54 -45.24 84.17 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.95 -1.094 . . . . 1.96 111.351 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.15 -37.81 88.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.76000000000000001 110.404 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.79 76.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.015 -1.053 . . . . 0.71999999999999997 109.969 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.704 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.17 -53.16 21.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 1.72 111.284 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 386' ' ' ILE . 0.5 OUTLIER -69.44 -34.54 74.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.704 -1.248 . . . . 1.5800000000000001 110.62 -175.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -65.94 -16.38 63.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 2.2400000000000002 110.211 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 344' ' ' ASP . 34.3 p -99.38 -11.87 20.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.147 -0.971 . . . . 3.5600000000000001 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.58 HD11 ' H ' ' A' ' 365' ' ' ARG . 73.9 mt -59.28 -21.76 60.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.985 -1.072 . . . . 4.3600000000000003 110.077 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -83.65 -34.36 25.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.351 -0.843 . . . . 3.8100000000000001 110.688 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 341' ' ' SER . 44.1 p30 -104.19 127.51 51.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.825 -1.172 . . . . 2.8399999999999999 110.447 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.91 18.59 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.148 -0.97 . . . . 2.9900000000000002 110.501 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 80.1 p -58.72 160.45 10.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 2.0699999999999998 110.04 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.546 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 35.2 Cg_exo -51.67 -54.5 5.23 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.95 1.5 . . . . 2.3799999999999999 110.167 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.557 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 94.1 mt-10 -66.13 -35.52 80.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 3.25 110.148 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.471 ' HA2' ' N6 ' ' A' 1001 ' ' ANP . . . -61.61 -40.42 98.72 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.967 -1.253 . . . . 1.4199999999999999 109.967 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.546 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 35.3 ptt180 -78.64 -26.58 45.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.858 -1.378 . . . . 3.6200000000000001 110.238 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.609 ' HA ' HD12 ' A' ' 354' ' ' ILE . 42.5 m -57.4 -44.85 84.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.748 -1.22 . . . . 2.3999999999999999 109.67 173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 338' ' ' GLN . 3.8 mt -63.85 -51.53 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 1.3899999999999999 110.941 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.649 HG11 ' OE2' ' A' ' 364' ' ' GLU . 82.4 t -56.24 -30.66 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.707 -1.246 . . . . 1.1799999999999999 110.355 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 351' ' ' SER . 64.3 mt -68.29 -46.47 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.797 -1.189 . . . . 1.3600000000000001 110.338 169.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.879 HD22 ' HB1' ' A' ' 319' ' ' ALA . 52.5 tp -47.33 -53.48 13.56 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 110.359 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.704 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.74 -36.91 84.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.60999999999999999 109.784 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 361' ' ' ASN . 20.6 tptp -53.5 -55.23 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.824 -1.172 . . . . 1.1599999999999999 110.447 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 20.4 pt20 -66.64 -39.65 88.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.737 -1.227 . . . . 1.8999999999999999 109.949 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 19.6 mmm180 -69.56 -40.5 76.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.314 -0.866 . . . . 2.6299999999999999 111.491 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 362' ' ' LEU . 98.4 m-85 -116.02 -14.72 11.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 3.3199999999999998 110.088 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.54 ' N ' ' O ' ' A' ' 357' ' ' LYS . 22.6 t30 60.31 50.14 6.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.765 0.793 . . . . 1.8999999999999999 110.125 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.796 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.4 mt -109.98 178.6 4.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.666 -0.647 . . . . 2.7999999999999998 109.791 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -118.88 151.78 37.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.078 . . . . 4.4000000000000004 110.161 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.649 ' OE2' HG11 ' A' ' 353' ' ' VAL . 95.7 mt-10 -55.81 149.62 14.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 2.2400000000000002 109.677 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.672 ' NH2' HD13 ' A' ' 339' ' ' LEU . 56.3 mtm180 -97.59 132.17 43.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.99 -1.069 . . . . 4.1600000000000001 110.05 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.4 m-20 -72.2 117.94 14.46 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 2.8599999999999999 109.909 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 53.2 t -68.51 -45.32 82.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.418 -0.801 . . . . 3.04 110.313 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -74.94 -19.09 60.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 3.6899999999999999 111.128 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 46.2 t -72.9 -28.72 62.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.773 -1.204 . . . . 3.0499999999999998 109.336 170.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.912 HD13 ' CD1' ' A' ' 388' ' ' ILE . 25.4 mt -89.4 4.79 47.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.377 -0.827 . . . . 2.1400000000000001 109.729 172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 85.9 m-70 57.87 26.05 12.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 2.1000000000000001 108.761 -171.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -88.28 -165.96 1.46 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.515 0.674 . . . . 1.1200000000000001 110.258 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.525 ' C ' HG11 ' A' ' 367' ' ' VAL . 50.0 m -138.3 143.68 40.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.614 -0.679 . . . . 2.1099999999999999 110.48 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 66.7 m-85 -87.31 146.03 26.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.03 -1.044 . . . . 3.0899999999999999 109.584 172.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.656 HG11 ' NH1' ' A' ' 394' ' ' ARG . 17.0 t -112.42 108.47 54.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 4.0 109.668 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.04 150.29 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.022 1.538 . . . . 4.6299999999999999 110.959 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.612 ' CE2' ' C5 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -93.18 122.64 35.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.562 -0.712 . . . . 5.79 109.803 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.3 p -111.97 143.98 42.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 5.29 109.975 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.87 -28.29 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.672 . . . . 6.1299999999999999 110.59 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -57.9 -46.3 85.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -0.991 . . . . 7.7400000000000002 110.06 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 383' ' ' MET . 68.0 m -92.13 -19.49 22.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 3.8199999999999998 109.796 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 381' ' ' SER . 52.1 mtt85 65.49 54.65 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.672 -0.643 . . . . 4.25 109.65 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.755 ' CE ' HD13 ' A' ' 401' ' ' ILE . 83.2 mtp -151.81 149.2 28.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 2.0899999999999999 111.351 -175.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 9.8 p -143.21 170.9 14.87 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.296 -1.002 . . . . 1.23 108.296 170.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -174.17 -167.81 34.2 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.055 -1.545 . . . . 1.1299999999999999 110.093 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 339' ' ' LEU . 2.8 tt -151.44 149.83 13.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.783 -0.834 . . . . 1.26 109.053 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.9 m120 -120.38 144.25 47.99 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.193 -0.942 . . . . 2.04 108.698 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.912 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.6 tt -145.19 163.9 12.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.571 -1.331 . . . . 2.1099999999999999 110.231 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.53 7.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.444 0.905 . . . . 3.8500000000000001 113.444 -172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 34.1 t30 -143.83 1.82 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.077 -1.64 . . . . 2.3300000000000001 111.369 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 89.3 mtt180 -157.28 160.76 38.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.508 -1.37 . . . . 2.6899999999999999 110.999 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.576 ' HE3' ' ND2' ' A' ' 387' ' ' ASN . 90.8 mmm -129.92 140.6 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 2.02 109.038 166.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 435' ' ' GLU . 16.6 mm -130.19 139.14 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.776 -1.203 . . . . 1.6799999999999999 110.063 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.656 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.6 mmt180 -139.49 145.67 39.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 2.7799999999999998 110.3 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.884 ' CE ' HD13 ' A' ' 431' ' ' LEU . 2.8 tmtt? -150.86 144.81 25.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.773 . . . . 1.5700000000000001 109.513 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 1.008 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 172.78 -155.87 23.83 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.116 -1.516 . . . . 0.81999999999999995 110.756 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 27.0 m -70.94 156.4 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -1.016 . . . . 1.1699999999999999 110.574 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.752 ' CG2' HG11 ' A' ' 420' ' ' VAL . 93.5 t -58.55 -48.52 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.948 . . . . 0.53000000000000003 110.185 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.99 -37.45 79.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.893 -1.129 . . . . 1.5900000000000001 108.954 172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -65.05 -49.13 71.31 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 111.059 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 1.008 HD11 ' N ' ' A' ' 396' ' ' GLY . 42.1 mm -69.84 -33.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.313 -1.492 . . . . 0.81000000000000005 110.495 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 76.5 ttt180 -62.47 -43.66 98.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.029 -1.044 . . . . 2.6200000000000001 109.94 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 400' ' ' ALA . 0.8 OUTLIER -68.25 -33.25 74.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -0.883 . . . . 2.48 110.249 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 394' ' ' ARG . 48.1 t-80 -65.46 -40.59 93.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.869 -1.144 . . . . 2.4300000000000002 110.382 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 437' ' ' SER . 88.7 t -63.89 -45.13 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.062 -1.024 . . . . 0.93999999999999995 110.358 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -61.37 -36.7 80.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.866 -1.146 . . . . 2.1600000000000001 110.696 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.1 92.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 1.53 109.693 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 20.0 m120 -65.63 -26.65 67.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.385 -0.822 . . . . 2.75 109.094 171.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 21.79 21.49 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.291 -1.523 . . . . 2.2799999999999998 109.291 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.589 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.14 -172.92 42.01 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.486 -1.445 . . . . 1.72 109.486 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.8 m-70 -138.16 148.14 44.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -1.19 . . . . 4.1600000000000001 110.241 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.829 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.6 t80 -87.42 111.64 42.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 3.3100000000000001 110.082 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.1 Cg_exo -58.35 143.37 97.58 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.786 1.414 . . . . 1.23 110.771 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.4 t -60.21 -44.69 94.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 1.75 110.403 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.7 m-20 -57.31 -36.01 70.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 1.8700000000000001 110.175 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 439' ' ' VAL . 73.3 t -70.13 -36.63 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.423 -1.423 . . . . 0.70999999999999996 110.233 176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.21 -43.13 99.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.926 -1.109 . . . . 1.8100000000000001 110.313 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.5 pt20 -68.05 -37.6 81.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.986 -1.071 . . . . 2.6000000000000001 110.605 178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.981 ' O ' HG23 ' A' ' 423' ' ' VAL . 55.4 mttm -63.62 -37.63 88.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.417 -1.427 . . . . 2.4900000000000002 110.526 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.847 HG13 ' HB2' ' A' ' 430' ' ' PRO . 94.8 t -66.18 -40.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.978 -1.077 . . . . 0.79000000000000004 110.113 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 93.3 m-20 -69.77 -43.03 73.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.518 -0.739 . . . . 2.0499999999999998 110.884 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 25.7 mt-30 -65.26 -30.4 71.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 2.3300000000000001 109.925 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 419' ' ' LYS . 80.6 t -59.6 -43.41 91.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.006 -1.059 . . . . 1.0 109.594 171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.27 -49.42 50.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 1.24 110.325 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.6 mtt180 -53.66 -22.26 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 4.1100000000000003 109.821 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -90.12 4.66 49.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.82 . . . . 2.9199999999999999 110.56 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 87.53 10.75 69.93 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.686 -1.365 . . . . 1.1599999999999999 109.686 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.66 158.64 16.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.31 -1.112 . . . . 1.0700000000000001 109.997 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -93.35 109.86 43.0 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.21 109.055 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.847 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.9 Cg_exo -74.97 109.48 2.94 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.091 1.574 . . . . 1.2 110.243 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.884 HD13 ' CE ' ' A' ' 395' ' ' LYS . 41.1 mt -89.98 161.99 15.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.933 -1.104 . . . . 1.3999999999999999 108.503 165.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 48.2 t -125.61 140.62 47.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 O-C-N 120.798 -1.189 . . . . 0.52000000000000002 110.299 177.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 440' ' ' LEU . 35.7 t -119.9 138.07 51.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.659 -0.651 . . . . 1.0800000000000001 109.729 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.725 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 m -126.34 162.77 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.717 . . . . 0.90000000000000002 109.922 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.726 ' HG2' HD13 ' A' ' 393' ' ' ILE . 8.3 mt-10 -117.48 124.74 49.5 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.037 -1.04 . . . . 1.79 108.939 166.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.65 -109.73 3.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.846 -1.702 . . . . 1.4199999999999999 108.846 -171.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.821 ' O ' HG13 ' A' ' 405' ' ' VAL . 23.9 p -120.09 11.28 11.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -1.11 . . . . 1.4199999999999999 110.866 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 34.9 ptt180 -120.91 143.64 48.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.918 -1.114 . . . . 3.52 110.291 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.044 HG11 HG11 ' A' ' 416' ' ' VAL . 41.3 t -78.75 126.58 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 1.4099999999999999 110.729 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -87.82 -27.9 21.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 1.79 110.647 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 178.3 -177.47 48.41 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.067 -1.54 . . . . 1.02 111.045 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.84 ' O ' HD13 ' A' ' 443' ' ' ILE . 76.5 t -121.03 153.85 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.502 -0.999 . . . . 0.56999999999999995 109.985 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.8 mm -122.86 129.43 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 1.05 110.916 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.776 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 121.58 41.76 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.46000000000000002 109.949 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.8 mp -101.11 137.84 38.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.04 -1.038 . . . . 2.1099999999999999 110.536 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 13.7 tttp -84.93 137.85 32.86 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.266 -0.896 . . . . 4.4800000000000004 109.307 170.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -95.97 132.2 41.54 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.154 -0.967 . . . . 3.9100000000000001 110.446 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.591 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.2 mp -58.94 -49.41 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 3.6099999999999999 109.498 175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.44 HG23 HG22 ' A' ' 448' ' ' ILE . 45.7 t -102.42 134.7 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.717 . . . . 5.0899999999999999 110.181 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -92.85 144.25 25.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 7.5 110.235 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.463 -1.455 . . . . 7.2999999999999998 109.463 -179.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.612 ' C5 ' ' CE2' ' A' ' 377' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.514 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 85.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.214 0.53 . . . . 6.0800000000000001 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.644 ' NH2' H5'1 ' A' 1001 ' ' ANP . 80.9 mtm180 -128.81 143.45 50.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 5.8300000000000001 110.459 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 351' ' ' SER . 21.4 pt20 -144.26 154.55 43.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 5.5800000000000001 109.941 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -69.76 132.51 46.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.077 . . . . 1.4199999999999999 110.065 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -109.03 -37.01 5.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 1.6000000000000001 110.372 174.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -147.98 144.21 27.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 1.8200000000000001 110.687 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.699 ' CB ' HD12 ' A' ' 443' ' ' ILE . 39.3 p90 -117.51 146.87 43.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.057 173.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.549 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.2 mp -134.72 133.11 20.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.935 . . . . 0.53000000000000003 110.836 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.654 ' HB3' HG12 ' A' ' 328' ' ' VAL . 15.8 Cg_exo -61.52 158.58 35.84 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.096 1.577 . . . . 1.4399999999999999 111.399 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.716 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.79 -164.97 0.56 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.609 -0.682 . . . . 1.5800000000000001 109.806 174.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 415' ' ' ASP . 50.1 tt0 -62.49 103.12 0.38 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 4.0 110.328 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.24 53.87 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.044 -1.074 . . . . 1.52 110.425 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 440' ' ' LEU . 93.9 t -102.88 151.56 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.293 . . . . 1.73 110.646 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.462 ' C ' ' HG3' ' A' ' 324' ' ' PRO . 88.2 m-20 -92.46 146.3 23.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.263 -0.898 . . . . 2.02 110.235 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 28.7 mt-10 -62.2 -39.18 91.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.133 -0.979 . . . . 2.7000000000000002 111.134 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 85.3 tttt -60.75 -43.25 98.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.894 -1.128 . . . . 3.0299999999999998 110.137 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 83.5 m -60.0 -46.77 88.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.90000000000000002 110.395 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 443' ' ' ILE . 16.8 tp -63.21 -46.44 87.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.93000000000000005 111.103 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.69 -38.56 81.89 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.001 -1.062 . . . . 0.87 109.619 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.569 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.8 t0 -65.95 -46.89 76.53 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.88 -1.137 . . . . 1.96 111.461 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -66.46 -37.73 85.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.76000000000000001 110.491 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.417 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.18 -33.75 76.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.71999999999999997 110.046 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.749 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -70.73 -52.22 22.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 1.72 111.386 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.927 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.56 -35.55 73.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.782 -1.199 . . . . 1.5800000000000001 110.564 -175.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -68.25 -9.95 51.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.115 . . . . 2.2400000000000002 110.218 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.495 ' HA ' ' OD2' ' A' ' 344' ' ' ASP . 0.7 OUTLIER -100.72 -15.12 17.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 3.5600000000000001 110.169 179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 339' ' ' LEU . 62.2 mt -59.52 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.856 . . . . 4.3600000000000003 110.227 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.425 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -83.57 -12.55 55.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 3.8100000000000001 110.545 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.6 p30 -100.75 138.52 37.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.046 -1.034 . . . . 2.8399999999999999 110.486 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.63 18.94 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 2.9900000000000002 110.317 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 65.6 p -86.93 154.38 55.28 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 2.0699999999999998 110.297 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.535 ' HA ' ' NE ' ' A' ' 350' ' ' ARG . 11.5 Cg_endo -60.32 -40.27 60.08 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.98 1.516 . . . . 2.3799999999999999 110.216 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.573 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -66.26 -38.95 89.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 3.25 110.123 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -65.76 -35.71 91.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.155 -1.178 . . . . 1.4199999999999999 110.155 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 347' ' ' PRO . 27.0 ptt180 -77.36 -26.49 52.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.788 -1.419 . . . . 3.6200000000000001 109.998 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 354' ' ' ILE . 19.8 m -57.82 -46.84 84.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.712 -1.242 . . . . 2.3999999999999999 109.79 172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.749 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -62.66 -50.66 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.143 -0.973 . . . . 1.3899999999999999 110.96 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.455 ' HA ' ' OE1' ' A' ' 338' ' ' GLN . 74.3 t -54.82 -31.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 110.351 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 351' ' ' SER . 55.8 mt -67.91 -46.32 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.726 -1.234 . . . . 1.3600000000000001 110.423 169.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 319' ' ' ALA . 57.2 tp -47.31 -51.63 18.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.211 -0.931 . . . . 1.1499999999999999 110.527 -173.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.703 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -64.75 -37.01 86.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.916 -1.115 . . . . 0.60999999999999999 109.559 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 361' ' ' ASN . 19.4 tptt -55.67 -54.32 45.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.878 -1.139 . . . . 1.1599999999999999 110.794 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.8 pt20 -66.41 -39.56 89.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.525 -1.359 . . . . 1.8999999999999999 109.952 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.459 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.5 mmt180 -69.77 -41.37 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 2.6299999999999999 111.5 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.705 ' HB3' HD11 ' A' ' 362' ' ' LEU . 52.6 m-85 -116.0 -14.75 11.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.725 -1.234 . . . . 3.3199999999999998 110.441 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 357' ' ' LYS . 25.8 t30 60.53 50.16 6.05 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.793 0.806 . . . . 1.8999999999999999 110.251 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.705 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.1 mt -109.86 179.72 4.04 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.814 -0.554 . . . . 2.7999999999999998 109.773 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -114.99 150.15 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 4.4000000000000004 110.882 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.3 pt-20 -61.58 155.57 21.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 2.2400000000000002 109.732 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.9 mtt180 -97.07 123.09 40.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 4.1600000000000001 109.883 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 369' ' ' SER . 92.1 m-20 -72.41 118.26 15.1 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 2.8599999999999999 109.85 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 374' ' ' PHE . 69.5 t -68.63 -44.51 82.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.387 -0.821 . . . . 3.04 110.246 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -74.25 -19.12 60.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 3.6899999999999999 110.877 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 366' ' ' ASP . 25.5 m -72.75 -32.79 65.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.827 -1.17 . . . . 3.0499999999999998 109.338 170.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 366' ' ' ASP . 65.2 mt -86.7 -0.18 55.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 2.1400000000000001 109.751 171.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.5 25.9 14.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.01 -1.057 . . . . 2.1000000000000001 108.83 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.35 -163.3 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.539 0.685 . . . . 1.1200000000000001 110.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.576 ' C ' HG11 ' A' ' 367' ' ' VAL . 19.9 m -128.63 142.46 51.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.635 -0.666 . . . . 2.1099999999999999 111.32 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.637 ' CD1' HG21 ' A' ' 367' ' ' VAL . 31.7 m-85 -91.69 148.8 21.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.194 -0.941 . . . . 3.0899999999999999 109.578 171.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 386' ' ' ILE . 14.9 t -114.7 110.06 47.21 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.675 -1.265 . . . . 4.0 109.786 172.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.6 Cg_endo -53.99 150.8 29.55 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.043 1.549 . . . . 4.6299999999999999 111.118 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 384' ' ' SER . 1.0 OUTLIER -97.82 122.17 40.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.624 -0.673 . . . . 5.79 109.812 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 20.5 p -112.35 141.5 45.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 5.29 109.752 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.52 55.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.762 . . . . 6.1299999999999999 110.614 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -57.67 -47.51 82.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.001 -1.062 . . . . 7.7400000000000002 109.891 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 383' ' ' MET . 73.7 m -89.43 -17.6 28.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.144 -0.973 . . . . 3.8199999999999998 109.576 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.568 ' NH2' " O2'" ' A' 1001 ' ' ANP . 18.7 ttt180 60.94 56.98 2.7 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.991 -0.684 . . . . 4.25 109.417 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.804 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 90.5 mtp -149.68 145.36 26.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 2.0899999999999999 111.095 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.604 ' OG ' ' N1 ' ' A' 1001 ' ' ANP . 50.7 p -146.16 168.36 21.2 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . -177.86 -162.67 28.26 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.809 -1.662 . . . . 1.1299999999999999 110.256 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.927 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.45 150.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.852 -0.796 . . . . 1.26 108.852 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.43 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 8.6 m120 -124.33 105.27 9.32 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.04 -1.038 . . . . 2.04 109.139 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.066 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -111.04 153.32 12.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 2.1099999999999999 108.893 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 1.066 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.7 m-20 -62.06 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.369 0.604 . . . . 3.8500000000000001 111.822 -173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 388' ' ' ILE . 42.8 t30 178.48 -30.14 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.667 -0.646 . . . . 2.3300000000000001 109.735 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.604 ' O ' HG22 ' A' ' 388' ' ' ILE . 78.9 mtm180 -155.38 147.35 23.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.064 -1.023 . . . . 2.6899999999999999 111.816 -173.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.491 ' O ' HD13 ' A' ' 393' ' ' ILE . 64.5 mtt -101.35 140.58 35.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 2.02 109.603 173.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.723 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -129.99 138.47 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.852 -1.155 . . . . 1.6799999999999999 109.796 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.564 ' NH1' ' NE2' ' A' ' 404' ' ' HIS . 57.3 mmm-85 -140.53 142.83 35.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 2.7799999999999998 110.391 175.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.873 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.69 144.03 31.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.423 -0.798 . . . . 1.5700000000000001 109.444 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.548 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 178.67 -154.26 14.08 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.469 -1.348 . . . . 0.81999999999999995 110.154 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 2.1 p -72.53 159.79 33.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -1.105 . . . . 1.1699999999999999 110.431 -176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.902 ' CG2' HG11 ' A' ' 420' ' ' VAL . 69.8 t -59.68 -47.25 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.308 -0.87 . . . . 0.53000000000000003 109.796 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 56.0 t0 -59.95 -38.0 81.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.102 -0.999 . . . . 1.5900000000000001 109.072 172.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.31 -51.1 70.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.468 -0.77 . . . . 0.84999999999999998 110.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.3 mm -68.42 -36.31 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 111.05 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.503 ' HD2' ' HB2' ' A' ' 412' ' ' PHE . 41.6 tpt85 -58.26 -44.0 88.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 2.6200000000000001 110.057 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 74.9 mtt180 -68.19 -37.2 80.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 2.48 110.87 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.564 ' NE2' ' NH1' ' A' ' 394' ' ' ARG . 58.0 t-80 -63.77 -39.41 94.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.923 -1.111 . . . . 2.4300000000000002 110.436 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 410' ' ' GLY . 99.5 t -64.62 -47.22 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.962 -1.086 . . . . 0.93999999999999995 110.374 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.24 -36.15 81.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.851 -1.156 . . . . 2.1600000000000001 110.846 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.78 87.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 1.53 109.758 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.4 m120 -66.26 -27.51 68.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.354 -0.841 . . . . 2.75 109.11 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.17 25.18 13.03 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.183 -1.567 . . . . 2.2799999999999998 109.183 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -94.36 -172.37 38.32 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 1.72 109.566 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -137.71 146.17 43.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -1.159 . . . . 4.1600000000000001 110.254 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.83 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.3 t80 -87.89 112.26 47.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 3.3100000000000001 110.048 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.85 141.77 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.857 1.451 . . . . 1.23 110.595 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.0 t -60.65 -44.04 96.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 1.75 110.39 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.541 ' O ' ' CG ' ' A' ' 418' ' ' GLN . 49.4 t0 -56.24 -37.07 69.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.05 -1.031 . . . . 1.8700000000000001 110.182 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 439' ' ' VAL . 72.3 t -70.07 -36.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.516 -1.365 . . . . 0.70999999999999996 110.237 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -63.31 -42.99 99.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 1.8100000000000001 110.428 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.541 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.0 pt20 -68.08 -37.27 81.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.953 -1.092 . . . . 2.6000000000000001 110.657 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.963 ' O ' HG23 ' A' ' 423' ' ' VAL . 31.6 mttm -62.88 -38.83 92.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 2.4900000000000002 110.792 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.978 HG13 ' HB2' ' A' ' 430' ' ' PRO . 71.0 t -66.1 -39.99 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.993 -1.067 . . . . 0.79000000000000004 110.314 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.8 m-20 -69.01 -43.12 75.43 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.673 -0.642 . . . . 2.0499999999999998 110.675 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.6 mm-40 -65.36 -31.56 72.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 2.3300000000000001 109.753 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 419' ' ' LYS . 74.8 t -61.13 -43.16 95.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 109.79 172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -71.57 -51.24 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.24 110.447 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 71.8 mtp180 -55.13 -21.42 13.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 4.1100000000000003 109.965 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.3 mt-30 -91.36 5.52 48.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 2.9199999999999999 110.731 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.71 67.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.807 -1.317 . . . . 1.1599999999999999 109.807 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.17 155.5 18.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -1.127 . . . . 1.0700000000000001 109.873 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.29 109.67 41.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.87 . . . . 1.21 109.122 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.978 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.1 Cg_exo -77.09 112.07 3.34 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.032 1.543 . . . . 1.2 110.177 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.717 HD21 " C2'" ' A' 1001 ' ' ANP . 82.7 mt -90.03 161.27 15.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.744 -1.222 . . . . 1.3999999999999999 108.358 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.83 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 66.6 t -125.77 138.87 53.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.723 -1.235 . . . . 0.52000000000000002 110.164 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.13 HG12 HD21 ' A' ' 440' ' ' LEU . 21.9 t -118.63 138.34 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.692 -0.63 . . . . 1.0800000000000001 109.586 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 439' ' ' VAL . 2.7 m -130.86 154.75 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.656 -0.818 . . . . 0.90000000000000002 110.733 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 5.7 mt-10 -103.07 123.85 47.42 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.953 -0.758 . . . . 1.79 108.953 172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.96 -109.75 2.43 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.647 -1.781 . . . . 1.4199999999999999 108.647 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.553 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 18.5 p -116.53 10.32 14.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -1.172 . . . . 1.4199999999999999 111.307 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 32.2 ptt180 -122.91 140.09 53.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.697 -1.252 . . . . 3.52 110.414 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.059 HG11 HG11 ' A' ' 416' ' ' VAL . 43.4 t -74.67 129.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 1.4099999999999999 110.979 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.13 HD21 HG12 ' A' ' 433' ' ' VAL . 0.6 OUTLIER -89.57 -29.6 18.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 1.79 110.489 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.542 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 177.39 -177.94 48.31 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.218 -1.467 . . . . 1.02 110.965 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.862 ' O ' HD13 ' A' ' 443' ' ' ILE . 59.3 t -122.13 152.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.488 -1.007 . . . . 0.56999999999999995 109.992 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.4 mm -123.85 130.15 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 1.05 111.051 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -102.24 121.88 43.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.402 -0.811 . . . . 0.46000000000000002 110.081 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 6.4 mp -102.76 138.75 39.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.077 -1.015 . . . . 2.1099999999999999 110.586 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 15.0 tttt -84.96 147.01 26.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.538 -0.726 . . . . 4.4800000000000004 109.662 173.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 33.2 p30 -95.42 121.43 37.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 3.9100000000000001 110.488 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.2 mp -54.21 -47.47 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 3.6099999999999999 109.379 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.2 135.67 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.555 -0.716 . . . . 5.0899999999999999 110.241 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -92.49 144.61 25.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 7.5 110.184 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.987 -1.452 . . . . 7.2999999999999998 109.536 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.717 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 448' ' ' ILE . 84.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.239 0.543 . . . . 6.0800000000000001 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -131.79 139.58 48.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 5.8300000000000001 110.444 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.469 ' OE1' HD11 ' A' ' 448' ' ' ILE . 14.4 pt20 -145.0 150.93 37.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 5.5800000000000001 110.173 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.125 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.38 136.09 52.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.948 -1.095 . . . . 1.4199999999999999 110.161 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 446' ' ' LYS . 1.8 m -108.93 -40.41 5.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.323 -0.951 . . . . 1.6000000000000001 110.44 173.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -147.36 146.75 29.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.134 -0.978 . . . . 1.8200000000000001 110.854 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.036 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 10.9 p90 -117.42 146.88 43.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 1.1399999999999999 110.296 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' PHE . 9.1 mm -127.95 136.25 28.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.302 -0.874 . . . . 0.53000000000000003 110.648 177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.557 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.9 Cg_exo -64.61 155.76 64.89 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.914 1.481 . . . . 1.4399999999999999 111.288 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -74.93 -166.84 0.51 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.484 -0.76 . . . . 1.5800000000000001 109.614 173.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 51.2 tt0 -62.69 105.89 0.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.235 -0.916 . . . . 4.0 110.359 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.3 56.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.332 -1.107 . . . . 1.52 110.332 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.91 HG11 ' O ' ' A' ' 440' ' ' LEU . 58.0 t -103.82 152.53 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.902 -1.351 . . . . 1.73 110.677 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -93.27 146.69 23.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 2.02 110.077 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 27.0 mt-10 -62.99 -40.08 96.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.124 -0.985 . . . . 2.7000000000000002 111.117 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 78.6 tttt -62.84 -45.21 93.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.036 -1.04 . . . . 3.0299999999999998 110.277 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 86.1 m -61.12 -47.1 87.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.087 -1.008 . . . . 0.90000000000000002 110.253 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 440' ' ' LEU . 29.3 tp -59.72 -48.01 83.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.93000000000000005 111.061 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 1.036 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -60.4 -39.76 88.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.121 -0.987 . . . . 0.87 109.936 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 59.3 t0 -62.16 -44.27 96.99 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.91 -1.119 . . . . 1.96 111.324 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -63.11 -36.43 83.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.887 -1.133 . . . . 0.76000000000000001 110.043 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.64 -35.55 80.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.171 -0.956 . . . . 0.71999999999999997 110.412 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.799 ' NE2' ' HB2' ' A' ' 356' ' ' ALA . 4.9 mm-40 -70.11 -55.17 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 1.72 110.794 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -64.99 -37.74 88.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.741 -1.224 . . . . 1.5800000000000001 110.198 -175.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.606 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -67.35 -15.38 63.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.012 -1.055 . . . . 2.2400000000000002 110.201 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.564 ' OG ' HG23 ' A' ' 353' ' ' VAL . 84.0 p -94.82 -18.04 21.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 3.5600000000000001 110.051 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 339' ' ' LEU . 45.4 mt -58.16 -28.03 64.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 4.3600000000000003 109.915 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 375' ' ' VAL . . . -91.27 3.18 55.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.83 . . . . 3.8100000000000001 110.972 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 3.3 p30 -101.49 147.2 26.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.96 -1.087 . . . . 2.8399999999999999 110.232 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.89 6.33 47.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 2.9900000000000002 110.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 1.8 p -85.37 140.84 36.45 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 2.0699999999999998 110.193 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.25 -30.82 88.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.001 1.527 . . . . 2.3799999999999999 110.23 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.565 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.6 mt-10 -63.9 -38.14 90.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 3.25 110.137 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.487 ' HA3' ' OD2' ' A' ' 344' ' ' ASP . . . -58.93 -28.76 63.94 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.488 -1.445 . . . . 1.4199999999999999 109.488 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -75.67 -35.79 60.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.31 . . . . 3.6200000000000001 109.405 172.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.0 m -54.4 -43.82 71.8 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.391 -0.923 . . . . 2.3999999999999999 109.617 177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.682 HG22 ' OE1' ' A' ' 338' ' ' GLN . 12.8 mt -68.23 -47.59 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 1.3899999999999999 111.309 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.564 HG23 ' OG ' ' A' ' 341' ' ' SER . 74.7 t -53.57 -32.84 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.528 -1.357 . . . . 1.1799999999999999 110.358 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 58.8 mt -70.3 -50.02 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.683 -1.261 . . . . 1.3600000000000001 110.677 171.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.125 HD12 ' CB ' ' A' ' 319' ' ' ALA . 0.4 OUTLIER -47.47 -46.87 27.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.02 -1.05 . . . . 1.1499999999999999 110.211 -175.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -61.39 -37.99 85.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.045 -1.034 . . . . 0.60999999999999999 109.246 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.4 tptm -61.32 -46.05 91.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 1.1599999999999999 111.092 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 355' ' ' LEU . 9.2 pt20 -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.46 -1.4 . . . . 1.8999999999999999 109.892 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.47 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 38.6 mmt180 -79.16 -47.33 16.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 2.6299999999999999 111.423 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.821 ' HB2' HD23 ' A' ' 362' ' ' LEU . 78.9 m-85 -116.29 -14.95 11.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.814 -1.179 . . . . 3.3199999999999998 110.509 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 24.0 t30 59.62 38.14 22.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.407 -0.808 . . . . 1.8999999999999999 110.086 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.8 OUTLIER -76.83 -178.6 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.565 -0.709 . . . . 2.7999999999999998 109.572 172.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -128.33 154.49 45.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.96 -1.087 . . . . 4.4000000000000004 110.76 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 13.6 pt-20 -54.69 145.49 19.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 2.2400000000000002 109.523 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.578 ' CZ ' HD13 ' A' ' 339' ' ' LEU . 28.4 ptt180 -101.38 134.69 44.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 4.1600000000000001 110.277 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 93.2 m-20 -69.39 118.39 12.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 2.8599999999999999 110.21 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' A' ' 372' ' ' ALA . 62.2 t -68.61 -44.96 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 3.04 110.309 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -74.9 -18.86 60.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -0.891 . . . . 3.6899999999999999 111.231 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 40.1 t -67.79 -32.74 73.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.451 -1.405 . . . . 3.0499999999999998 108.934 165.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.937 HD13 ' CD1' ' A' ' 388' ' ' ILE . 27.3 mt -93.81 -2.22 53.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 2.1400000000000001 109.965 172.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 367' ' ' VAL . 64.6 m80 56.65 32.33 20.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 2.1000000000000001 108.97 -172.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.956 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -83.83 -164.96 1.0 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 1.1200000000000001 110.128 176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 32.9 m -135.85 143.73 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.534 -0.729 . . . . 2.1099999999999999 110.454 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 367' ' ' VAL . 91.5 m-85 -90.52 138.48 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 3.0899999999999999 109.581 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.955 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.5 t -106.97 111.96 63.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.875 -1.14 . . . . 4.0 109.995 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.5 Cg_endo -55.12 153.62 25.72 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.064 1.56 . . . . 4.6299999999999999 111.216 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -94.69 122.62 37.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.582 -0.699 . . . . 5.79 109.872 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 24.0 p -112.37 140.58 46.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.92 . . . . 5.29 109.846 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.27 -30.61 60.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 6.1299999999999999 110.489 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -58.38 -46.05 87.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.151 -0.968 . . . . 7.7400000000000002 109.984 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.0 m -91.36 -12.46 34.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 3.8199999999999998 109.649 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.47 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 86.6 mtt-85 57.31 52.68 8.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.389 -0.82 . . . . 4.25 109.658 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.505 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 44.1 mtm -151.53 149.59 29.38 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 2.0899999999999999 111.309 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.3 p -143.91 164.8 29.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.605 -1.258 . . . . 1.23 107.605 170.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' A' ' 394' ' ' ARG . . . -172.81 -166.29 31.11 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 118.645 -1.74 . . . . 1.1299999999999999 110.193 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.799 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.09 149.89 13.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 O-C-N 121.9 -0.765 . . . . 1.26 108.97 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.632 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 2.6 m120 -121.07 144.21 48.66 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.167 -0.958 . . . . 2.04 108.66 177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.937 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.2 tt -145.31 164.99 11.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 120.662 -1.274 . . . . 2.1099999999999999 110.354 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -63.67 7.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.56 0.948 . . . . 3.8500000000000001 113.56 -171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 39.7 t-20 -146.06 3.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.086 -1.634 . . . . 2.3300000000000001 111.485 174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.55 ' NH2' ' NH1' ' A' ' 365' ' ' ARG . 71.7 mtm180 -157.55 159.95 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.493 -1.38 . . . . 2.6899999999999999 111.033 -173.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 393' ' ' ILE . 63.8 mtt -129.89 140.64 50.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.068 . . . . 2.02 109.165 167.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.606 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 34.4 mm -129.95 140.29 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.851 -1.156 . . . . 1.6799999999999999 110.181 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.955 ' NH1' HG11 ' A' ' 375' ' ' VAL . 17.1 mmm180 -141.9 143.27 33.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 2.7799999999999998 110.467 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.883 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -145.76 145.46 30.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.485 -0.76 . . . . 1.5700000000000001 109.583 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.608 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 173.18 -147.81 9.9 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.267 -1.444 . . . . 0.81999999999999995 110.475 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 59.7 m -71.89 156.15 39.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -1.033 . . . . 1.1699999999999999 110.921 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.722 ' CG2' HG11 ' A' ' 420' ' ' VAL . 91.7 t -61.12 -49.69 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.858 . . . . 0.53000000000000003 110.213 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.5 -36.23 77.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 1.5900000000000001 108.889 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 397' ' ' SER . . . -63.87 -47.46 80.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.634 -0.666 . . . . 0.84999999999999998 110.936 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.608 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.7 mm -69.01 -35.36 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.262 -1.524 . . . . 0.81000000000000005 110.709 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.2 ttt180 -61.42 -43.08 99.49 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.003 -1.061 . . . . 2.6200000000000001 109.848 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 404' ' ' HIS . 0.0 OUTLIER -68.66 -31.66 70.95 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -0.917 . . . . 2.48 110.382 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.559 ' N ' ' HG3' ' A' ' 403' ' ' ARG . 86.8 t60 -65.78 -41.77 91.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.733 -1.229 . . . . 2.4300000000000002 110.413 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.66 HG12 ' C ' ' A' ' 410' ' ' GLY . 90.4 t -64.49 -45.0 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.012 . . . . 0.93999999999999995 110.414 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.1 mt-10 -62.46 -36.0 81.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.838 -1.164 . . . . 2.1600000000000001 110.774 -177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.09 -1.006 . . . . 1.53 109.696 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.5 m120 -66.78 -26.73 67.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.306 -0.871 . . . . 2.75 109.233 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.0 15.76 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.287 -1.525 . . . . 2.2799999999999998 109.287 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.66 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.99 -170.13 39.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.362 -1.495 . . . . 1.72 109.362 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -139.77 148.61 42.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -1.217 . . . . 4.1600000000000001 110.42 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.822 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.3 t80 -89.99 110.86 43.04 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 3.3100000000000001 109.985 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.4 Cg_exo -58.9 141.39 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.871 1.459 . . . . 1.23 110.728 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.2 t -59.36 -43.85 92.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -0.858 . . . . 1.75 110.41 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.0 m-20 -56.55 -41.88 77.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 1.8700000000000001 110.106 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 51.4 t -67.66 -40.66 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.70999999999999996 110.722 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -62.37 -38.03 87.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.992 -1.068 . . . . 1.8100000000000001 110.022 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.4 mt-30 -64.58 -41.92 95.95 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.222 -0.924 . . . . 2.6000000000000001 110.756 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.979 ' O ' HG23 ' A' ' 423' ' ' VAL . 67.1 mttm -63.27 -38.92 93.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.723 -1.235 . . . . 2.4900000000000002 110.756 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 430' ' ' PRO . 90.0 t -66.48 -39.9 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.058 . . . . 0.79000000000000004 110.395 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -68.68 -43.35 76.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.506 -0.746 . . . . 2.0499999999999998 110.714 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 92.2 mt-30 -65.1 -31.29 72.42 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.312 -0.867 . . . . 2.3300000000000001 109.782 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.979 HG23 ' O ' ' A' ' 419' ' ' LYS . 73.1 t -61.16 -43.64 96.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.165 -0.959 . . . . 1.0 109.723 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 1.24 110.276 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 81.8 mtp180 -54.63 -22.11 12.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 4.1100000000000003 109.905 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.8 mt-30 -91.22 4.47 52.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.372 -0.83 . . . . 2.9199999999999999 110.681 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.68 66.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.89 -1.284 . . . . 1.1599999999999999 109.89 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -102.95 156.04 17.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -1.173 . . . . 1.0700000000000001 109.84 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.4 m -93.3 109.19 38.61 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 1.21 109.034 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.97 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.0 Cg_exo -77.36 113.4 3.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.991 1.522 . . . . 1.2 110.161 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.76 HD21 " C2'" ' A' 1001 ' ' ANP . 73.1 mt -89.98 161.22 15.98 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.829 -1.169 . . . . 1.3999999999999999 108.19 165.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.822 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 60.8 t -124.62 139.37 51.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.744 -1.223 . . . . 0.52000000000000002 110.098 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.883 HG22 ' CG ' ' A' ' 395' ' ' LYS . 20.2 t -118.55 134.9 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.688 -0.633 . . . . 1.0800000000000001 109.367 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -131.48 154.63 40.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.561 -0.856 . . . . 0.90000000000000002 110.769 176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 438' ' ' ARG . 4.8 mt-10 -100.81 121.67 42.1 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 173.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 57.92 -109.66 1.97 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.659 -1.776 . . . . 1.4199999999999999 108.659 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 405' ' ' VAL . 16.1 p -115.13 13.4 16.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -1.151 . . . . 1.4199999999999999 111.188 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 33.1 ptt85 -123.43 140.77 52.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.766 -1.209 . . . . 3.52 110.194 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 43.3 t -81.78 126.64 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.436 -0.79 . . . . 1.4099999999999999 111.11 -174.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.91 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -90.03 -28.29 19.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 1.79 110.574 177.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.709 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -179.64 -179.63 48.78 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.073 -1.537 . . . . 1.02 111.076 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.898 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.1 t -123.7 156.04 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.982 . . . . 0.56999999999999995 109.709 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -124.26 127.43 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.858 -1.151 . . . . 1.05 111.138 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.694 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -97.5 121.98 40.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.46000000000000002 110.067 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 319' ' ' ALA . 6.1 mp -102.2 140.99 35.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 110.467 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.436 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 68.3 tttt -84.9 142.9 29.37 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.396 -0.815 . . . . 4.4800000000000004 109.71 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 35.1 p30 -95.94 117.29 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 3.9100000000000001 110.379 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -53.55 -47.03 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 3.6099999999999999 109.334 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.62 134.62 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.53 -0.731 . . . . 5.0899999999999999 110.197 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -90.93 133.5 35.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 7.5 110.229 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.967 -1.463 . . . . 7.2999999999999998 109.581 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.76 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 81.6 m-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.07 0.462 . . . . 6.0800000000000001 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.506 HH22 HNB1 ' A' 1001 ' ' ANP . 73.9 mtt85 -124.7 136.21 53.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 5.8300000000000001 110.332 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' LEU . 46.0 mm-40 -127.2 142.75 51.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.798 . . . . 5.5800000000000001 109.472 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.844 ' HB2' HG13 ' A' ' 352' ' ' ILE . . . -64.44 121.59 14.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.835 -1.165 . . . . 1.4199999999999999 110.28 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -119.76 -40.87 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 1.6000000000000001 110.862 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -126.15 129.58 49.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.065 . . . . 1.8200000000000001 110.719 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.037 ' O ' HD13 ' A' ' 323' ' ' ILE . 14.8 p90 -118.46 141.39 48.6 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.623 -0.673 . . . . 1.1399999999999999 110.208 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 1.037 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.23 138.29 22.6 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 120.923 -1.11 . . . . 0.53000000000000003 111.201 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HG3' ' CA ' ' A' ' 330' ' ' GLU . 14.4 Cg_exo -61.16 159.02 32.04 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.088 1.573 . . . . 1.4399999999999999 111.254 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.891 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.29 -166.86 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.322 -0.861 . . . . 1.5800000000000001 109.461 170.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 58.3 tt0 -63.55 104.72 0.68 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.213 -0.929 . . . . 4.0 110.3 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 89.76 18.9 50.05 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.305 -1.118 . . . . 1.52 110.305 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.918 HG11 ' O ' ' A' ' 440' ' ' LEU . 48.2 t -104.66 147.59 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.991 -1.299 . . . . 1.73 110.738 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -82.99 139.48 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 2.02 110.277 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CA ' ' HG3' ' A' ' 324' ' ' PRO . 21.1 pt-20 -63.25 -43.47 97.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.255 -0.903 . . . . 2.7000000000000002 110.796 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.528 ' N ' ' HG3' ' A' ' 330' ' ' GLU . 96.6 mttt -59.48 -42.11 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.86 -1.15 . . . . 3.0299999999999998 110.347 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 88.0 m -60.43 -45.48 93.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.958 -1.089 . . . . 0.90000000000000002 110.114 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 323' ' ' ILE . 18.6 tp -57.46 -47.57 81.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.93000000000000005 111.06 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.962 ' HB1' ' NH2' ' A' ' 359' ' ' ARG . . . -61.45 -40.73 95.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.136 -0.978 . . . . 0.87 109.762 -176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 61.1 t0 -66.78 -47.11 73.15 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.401 -0.812 . . . . 1.96 111.48 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 339' ' ' LEU . . . -63.47 -33.92 76.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.047 -1.033 . . . . 0.76000000000000001 110.346 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -62.09 -36.22 81.05 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.71999999999999997 109.884 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.644 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 1.2 mm-40 -68.41 -57.57 5.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.72 110.868 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.1 OUTLIER -57.49 -40.27 78.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.646 -1.284 . . . . 1.5800000000000001 109.866 -176.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.785 ' HB2' HG22 ' A' ' 393' ' ' ILE . . . -67.45 -12.35 60.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.009 . . . . 2.2400000000000002 110.212 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.895 ' OG ' HG22 ' A' ' 353' ' ' VAL . 39.2 p -98.47 -14.99 19.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 3.5600000000000001 110.148 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 364' ' ' GLU . 67.8 mt -60.06 -31.17 69.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 4.3600000000000003 110.076 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.482 ' HB2' ' HD1' ' A' ' 374' ' ' PHE . . . -91.14 -15.06 30.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 3.8100000000000001 110.953 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -76.37 136.03 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.858 -1.151 . . . . 2.8399999999999999 110.078 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -96.25 7.49 46.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 2.9900000000000002 110.359 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.734 HG21 ' CE2' ' A' ' 377' ' ' PHE . 15.9 p -78.0 145.6 70.02 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 2.0699999999999998 110.206 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.6 -37.46 79.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 2.3799999999999999 110.175 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.568 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.0 mt-10 -63.66 -34.74 78.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 3.25 109.978 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.879 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -57.93 -25.7 56.84 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.599 -1.4 . . . . 1.4199999999999999 109.599 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -75.75 -37.45 59.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.904 -1.351 . . . . 3.6200000000000001 109.535 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 354' ' ' ILE . 18.3 t -54.47 -44.82 72.93 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.211 -0.93 . . . . 2.3999999999999999 109.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 319' ' ' ALA . 4.2 mt -65.59 -48.59 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 1.3899999999999999 110.867 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.895 HG22 ' OG ' ' A' ' 341' ' ' SER . 13.0 t -56.89 -30.48 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.766 -1.209 . . . . 1.1799999999999999 110.166 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 351' ' ' SER . 72.1 mt -70.25 -49.94 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.806 -1.184 . . . . 1.3600000000000001 110.555 171.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 319' ' ' ALA . 37.8 tp -47.51 -47.85 27.59 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.1499999999999999 110.1 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.644 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -63.62 -37.21 86.46 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.566 -1.334 . . . . 0.60999999999999999 109.477 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 361' ' ' ASN . 12.0 ttpt -58.19 -49.9 75.42 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.777 -1.202 . . . . 1.1599999999999999 110.621 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -66.1 -44.92 82.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.2 -1.562 . . . . 1.8999999999999999 110.187 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.962 ' NH2' ' HB1' ' A' ' 334' ' ' ALA . 25.0 mtm180 -62.13 -44.82 95.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.917 -1.114 . . . . 2.6299999999999999 111.757 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.626 ' HB3' HD11 ' A' ' 362' ' ' LEU . 97.8 m-85 -115.75 -14.5 11.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.175 . . . . 3.3199999999999998 109.942 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 357' ' ' LYS . 30.4 t-20 60.65 50.21 5.82 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.895 0.855 . . . . 1.8999999999999999 110.336 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 360' ' ' PHE . 26.1 mt -118.21 172.35 7.49 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.535 . . . . 2.7999999999999998 109.687 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -119.22 167.32 11.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 4.4000000000000004 110.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.887 ' HG3' HD22 ' A' ' 342' ' ' LEU . 5.0 tt0 -57.94 148.68 25.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.518 -0.739 . . . . 2.2400000000000002 109.418 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.454 ' H ' HD11 ' A' ' 342' ' ' LEU . 59.5 mtm180 -100.92 140.04 35.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 4.1600000000000001 110.068 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' A' ' 369' ' ' SER . 92.5 m-20 -73.53 116.38 14.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.327 -0.858 . . . . 2.8599999999999999 109.99 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.661 HG21 ' CE1' ' A' ' 374' ' ' PHE . 41.7 t -70.03 -44.97 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.517 -0.74 . . . . 3.04 110.467 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.17 -19.18 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 3.6899999999999999 110.776 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 366' ' ' ASP . 44.9 t -72.72 -28.93 62.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.819 -1.176 . . . . 3.0499999999999998 109.359 170.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.892 HD13 ' CD1' ' A' ' 388' ' ' ILE . 39.3 mt -88.48 3.77 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 2.1400000000000001 109.672 171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 389' ' ' ASP . 1.4 t-80 60.16 25.03 14.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.958 -1.089 . . . . 2.1000000000000001 108.716 -171.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 387' ' ' ASN . . . -90.42 -165.3 1.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.462 0.649 . . . . 1.1200000000000001 110.331 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.519 ' C ' HG11 ' A' ' 367' ' ' VAL . 53.3 m -139.44 143.59 37.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.545 -0.722 . . . . 2.1099999999999999 110.56 -178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 367' ' ' VAL . 53.0 m-85 -88.3 144.26 26.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 3.0899999999999999 109.695 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 394' ' ' ARG . 21.7 t -113.15 110.22 51.28 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.14 . . . . 4.0 109.824 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.8 Cg_endo -54.73 152.8 26.66 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.01 1.532 . . . . 4.6299999999999999 111.166 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.734 ' CE2' HG21 ' A' ' 346' ' ' THR . 1.1 t80 -94.53 122.03 36.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.66 -0.65 . . . . 5.79 109.855 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.36 139.74 46.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 5.29 109.751 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.9 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.635 -0.666 . . . . 6.1299999999999999 110.45 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -58.18 -46.17 86.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 7.7400000000000002 109.936 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 383' ' ' MET . 54.3 p -91.2 -13.2 33.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 3.8199999999999998 109.691 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 381' ' ' SER . 92.1 mtt180 58.48 53.0 6.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 4.25 109.833 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.617 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 45.7 mtm -151.97 149.9 29.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.013 -1.054 . . . . 2.0899999999999999 111.363 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 24.2 p -144.33 166.16 25.86 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.734 -1.209 . . . . 1.23 107.734 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -173.69 -166.81 32.49 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 118.659 -1.734 . . . . 1.1299999999999999 110.381 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.0 tt -151.48 149.32 14.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.881 -0.776 . . . . 1.26 108.964 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.666 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -119.42 144.53 46.88 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.43 -0.952 . . . . 2.04 108.43 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.892 ' CD1' HD13 ' A' ' 370' ' ' LEU . 4.4 tt -145.1 163.82 12.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.684 -1.26 . . . . 2.1099999999999999 110.179 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 371' ' ' HIS . 93.1 m-20 -63.45 7.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.376 0.88 . . . . 3.8500000000000001 113.376 -172.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 40.1 t-20 -143.47 1.28 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.091 -1.63 . . . . 2.3300000000000001 111.408 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.39 161.49 39.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.478 -1.389 . . . . 2.6899999999999999 111.125 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.409 ' C ' HG12 ' A' ' 393' ' ' ILE . 86.2 mtp -129.8 140.38 51.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 2.02 108.932 166.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 340' ' ' ALA . 8.6 mm -131.81 141.52 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.746 -1.221 . . . . 1.6799999999999999 110.257 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.7 mmt180 -142.4 142.46 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.287 -0.883 . . . . 2.7799999999999998 110.946 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.839 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.64 144.44 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.823 . . . . 1.5700000000000001 109.388 176.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.545 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 175.43 -154.17 17.12 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.23 -1.462 . . . . 0.81999999999999995 110.472 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.4 m -69.61 154.03 42.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.559 -0.965 . . . . 1.1699999999999999 110.687 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.844 HG21 ' CG1' ' A' ' 420' ' ' VAL . 71.2 t -61.35 -49.94 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.53000000000000003 110.326 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 400' ' ' ALA . 25.1 p-10 -60.26 -34.67 74.05 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.917 -1.115 . . . . 1.5900000000000001 108.939 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.79 -51.32 68.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.707 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.58 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 22.3 mm -65.11 -38.97 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.234 . . . . 0.81000000000000005 110.824 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 77.3 ttt180 -57.69 -40.35 79.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 2.6200000000000001 110.124 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 16.2 mmm180 -66.77 -39.97 88.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 2.48 110.637 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.526 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 85.6 t60 -65.58 -38.71 90.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 2.4300000000000002 110.737 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 437' ' ' SER . 74.2 t -64.53 -44.81 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.93999999999999995 110.339 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.5 mt-10 -62.36 -36.65 82.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.779 -1.201 . . . . 2.1600000000000001 110.732 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.9 92.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 1.53 109.749 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 18.0 m120 -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.358 -0.839 . . . . 2.75 109.182 171.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.68 19.11 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.365 -1.494 . . . . 2.2799999999999998 109.365 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.602 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -91.63 -172.55 42.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.446 -1.462 . . . . 1.72 109.446 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.429 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 98.5 m-70 -138.49 152.69 48.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -1.187 . . . . 4.1600000000000001 110.344 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.801 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.5 t80 -94.45 109.73 44.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 3.3100000000000001 110.073 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.5 Cg_exo -58.86 143.1 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.968 1.509 . . . . 1.23 110.865 -176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 415' ' ' ASP . 5.4 t -59.82 -43.9 94.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.386 -0.821 . . . . 1.75 110.64 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 414' ' ' THR . 92.8 m-20 -56.46 -40.15 74.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.092 -1.005 . . . . 1.8700000000000001 110.086 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 439' ' ' VAL . 54.0 t -69.61 -39.71 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.132 -0.98 . . . . 0.70999999999999996 110.779 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.919 -1.113 . . . . 1.8100000000000001 110.006 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 422' ' ' GLN . 94.3 mm-40 -65.23 -43.59 90.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.962 . . . . 2.6000000000000001 110.928 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.985 ' O ' HG23 ' A' ' 423' ' ' VAL . 70.8 mttt -63.16 -35.13 79.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.713 -1.242 . . . . 2.4900000000000002 110.507 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.844 ' CG1' HG21 ' A' ' 398' ' ' VAL . 41.8 t -66.04 -40.83 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.79000000000000004 110.303 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.5 m-20 -70.33 -42.67 71.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.481 -0.762 . . . . 2.0499999999999998 110.695 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 418' ' ' GLN . 99.1 mm-40 -65.38 -29.37 70.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -0.839 . . . . 2.3300000000000001 109.942 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 419' ' ' LYS . 72.9 t -59.53 -44.22 92.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.07 . . . . 1.0 109.724 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 430' ' ' PRO . . . -70.89 -50.01 39.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 1.24 110.34 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 88.6 mtt180 -53.78 -21.86 8.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.374 -0.829 . . . . 4.1100000000000003 109.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.7 mt-30 -91.3 3.71 54.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 2.9199999999999999 110.716 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 88.61 10.17 67.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.839 -1.304 . . . . 1.1599999999999999 109.839 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -103.23 158.26 16.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -1.132 . . . . 1.0700000000000001 109.907 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 317' ' ' ARG . 3.1 m -93.28 109.21 38.73 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 1.21 108.992 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.2 Cg_exo -73.55 111.67 3.35 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 124.25 1.658 . . . . 1.2 110.339 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.69 HD21 " C2'" ' A' 1001 ' ' ANP . 49.7 mt -90.28 161.6 15.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.658 -1.276 . . . . 1.3999999999999999 108.733 165.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.801 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.0 t -126.84 140.08 50.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 120.752 -1.217 . . . . 0.52000000000000002 110.185 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.99 HG12 HD21 ' A' ' 440' ' ' LEU . 37.9 t -119.25 140.01 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.766 -0.584 . . . . 1.0800000000000001 109.846 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.4 m -126.28 164.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.663 -0.648 . . . . 0.90000000000000002 109.929 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.719 ' HG2' HD13 ' A' ' 393' ' ' ILE . 12.5 mt-10 -120.39 125.2 47.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.0 -1.063 . . . . 1.79 108.869 164.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.87 -109.71 3.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.985 -1.646 . . . . 1.4199999999999999 108.985 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 405' ' ' VAL . 37.7 p -119.84 10.08 11.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 1.4199999999999999 110.898 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 35.7 ptt85 -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 3.52 110.396 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.067 HG11 HG11 ' A' ' 416' ' ' VAL . 44.3 t -76.14 127.75 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.384 -0.823 . . . . 1.4099999999999999 110.562 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.99 HD21 HG12 ' A' ' 433' ' ' VAL . 1.0 OUTLIER -88.99 -28.11 20.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 1.79 110.505 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.776 ' HA3' HD13 ' A' ' 333' ' ' LEU . . . -179.93 -179.37 48.8 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.187 -1.482 . . . . 1.02 110.644 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.831 ' O ' HD13 ' A' ' 443' ' ' ILE . 48.2 t -120.29 152.72 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.485 -1.009 . . . . 0.56999999999999995 109.954 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.64 154.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.384 -0.823 . . . . 1.05 109.643 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.962 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -135.17 125.77 26.95 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.786 -0.766 . . . . 0.46000000000000002 110.2 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 444' ' ' ALA . 6.5 mp -103.83 144.64 31.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.1099999999999999 110.036 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 317' ' ' ARG . 38.3 tttp -86.2 140.22 30.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.237 -0.914 . . . . 4.4800000000000004 109.645 174.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 36.6 p30 -95.86 130.24 42.87 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.289 -0.882 . . . . 3.9100000000000001 110.647 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 448' ' ' ILE . 4.4 mm -55.52 -48.65 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.066 -1.021 . . . . 3.6099999999999999 109.417 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.55 135.68 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.205 0.526 . . . . 5.0899999999999999 110.27 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -92.4 145.71 24.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 7.5 110.225 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 7.2999999999999998 109.515 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.69 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.474 ' N ' ' HB ' ' A' ' 448' ' ' ILE . 80.8 m-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.273 0.558 . . . . 6.0800000000000001 110.213 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 447' ' ' ASP . 25.8 mmt85 -123.45 139.91 53.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 5.8300000000000001 110.327 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.511 ' CB ' ' OG ' ' A' ' 351' ' ' SER . 23.9 pt20 -140.93 141.82 34.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.449 -0.782 . . . . 5.5800000000000001 110.231 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.091 ' CB ' HD12 ' A' ' 355' ' ' LEU . . . -68.03 134.15 50.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.4199999999999999 110.439 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.514 ' O ' ' NH2' ' A' ' 359' ' ' ARG . 1.8 m -113.9 -39.88 3.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.287 -0.883 . . . . 1.6000000000000001 110.653 175.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -141.73 147.06 36.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.007 -1.058 . . . . 1.8200000000000001 111.167 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 360' ' ' PHE . 3.7 p90 -117.43 146.97 43.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.226 -0.921 . . . . 1.1399999999999999 110.264 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.8 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.8 mp -134.34 133.21 21.46 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.333 -0.855 . . . . 0.53000000000000003 110.819 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.6 Cg_exo -60.12 157.46 34.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.85 1.447 . . . . 1.4399999999999999 111.803 -175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -81.95 -163.02 0.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.43 -0.794 . . . . 1.5800000000000001 109.558 169.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 55.7 tt0 -63.99 106.8 1.1 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.346 -0.846 . . . . 4.0 110.424 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.63 21.09 52.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.329 -1.108 . . . . 1.52 110.329 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 440' ' ' LEU . 56.8 t -106.81 148.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.268 . . . . 1.73 110.815 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.5 m-20 -84.55 142.25 30.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 2.02 110.205 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.563 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.4 pt-20 -65.39 -40.56 93.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 2.7000000000000002 110.428 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 360' ' ' PHE . 23.2 tttp -59.69 -40.41 87.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.047 . . . . 3.0299999999999998 109.796 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 89.5 m -59.03 -46.51 88.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.90000000000000002 110.477 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 323' ' ' ILE . 43.1 tp -61.59 -45.16 95.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 0.93000000000000005 110.934 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.506 ' O ' ' OE1' ' A' ' 338' ' ' GLN . . . -59.62 -39.09 83.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.176 -0.952 . . . . 0.87 109.648 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 339' ' ' LEU . 86.1 m-20 -69.84 -45.67 67.3 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 120.664 -1.273 . . . . 1.96 111.58 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.93 -38.22 88.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.76000000000000001 110.238 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.432 ' HB3' ' OE1' ' A' ' 338' ' ' GLN . . . -62.3 -30.44 71.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.97 -1.082 . . . . 0.71999999999999997 109.486 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.618 ' OE1' ' N ' ' A' ' 338' ' ' GLN . 0.0 OUTLIER -71.21 -53.32 14.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.365 -0.835 . . . . 1.72 110.256 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 335' ' ' ASP . 0.3 OUTLIER -67.84 -36.31 80.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.984 -1.072 . . . . 1.5800000000000001 110.368 -178.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -68.07 -12.24 60.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.069 . . . . 2.2400000000000002 110.402 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.537 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 99.9 p -96.67 -16.02 21.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 3.5600000000000001 110.075 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.56 HD11 ' H ' ' A' ' 365' ' ' ARG . 53.8 mt -59.26 -27.22 65.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.015 . . . . 4.3600000000000003 110.139 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -89.75 -8.7 51.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 3.8100000000000001 110.991 -175.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 1.3 p30 -92.21 138.28 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.121 . . . . 2.8399999999999999 110.053 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.58 6.71 48.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.108 -0.995 . . . . 2.9900000000000002 110.246 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 32.0 p -76.1 141.47 70.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 2.0699999999999998 110.08 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.9 Cg_exo -56.8 -34.2 96.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.848 1.446 . . . . 2.3799999999999999 110.204 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -37.14 86.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 3.25 110.25 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -61.04 -28.89 69.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.744 -1.342 . . . . 1.4199999999999999 109.744 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -77.32 -34.91 55.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.324 . . . . 3.6200000000000001 109.387 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.741 ' HA ' HD12 ' A' ' 354' ' ' ILE . 8.8 t -54.36 -47.57 72.44 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.352 -0.939 . . . . 2.3999999999999999 109.472 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.619 HG12 ' HB2' ' A' ' 319' ' ' ALA . 23.6 mt -59.97 -55.76 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.3899999999999999 110.922 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.537 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 58.0 t -51.16 -30.23 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.877 -1.14 . . . . 1.1799999999999999 110.569 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 351' ' ' SER . 45.3 mt -66.91 -47.4 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.675 -1.266 . . . . 1.3600000000000001 110.353 168.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.091 HD12 ' CB ' ' A' ' 319' ' ' ALA . 1.6 tt -47.29 -52.11 17.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 1.1499999999999999 110.709 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 362' ' ' LEU . . . -68.52 -39.04 81.36 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.983 -1.073 . . . . 0.60999999999999999 109.998 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 361' ' ' ASN . 27.3 mttt -65.55 -42.99 91.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.673 -1.267 . . . . 1.1599999999999999 110.739 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 13.4 pt20 -62.73 -39.34 93.76 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.096 -1.627 . . . . 1.8999999999999999 109.722 176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 320' ' ' SER . 26.3 mmt85 -75.89 -47.49 25.18 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.122 -0.987 . . . . 2.6299999999999999 111.579 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 322' ' ' PHE . 27.8 m-85 -115.87 -14.58 11.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.776 -1.203 . . . . 3.3199999999999998 110.272 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 357' ' ' LYS . 26.8 t30 60.13 42.92 14.82 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.542 -0.724 . . . . 1.8999999999999999 110.385 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 356' ' ' ALA . 0.7 OUTLIER -77.36 -173.2 2.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.447 -0.783 . . . . 2.7999999999999998 109.626 171.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -129.07 153.45 47.63 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 4.4000000000000004 109.929 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.33 146.23 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 2.2400000000000002 109.523 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.56 ' H ' HD11 ' A' ' 342' ' ' LEU . 57.7 mtp180 -97.17 128.19 43.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 4.1600000000000001 109.975 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.495 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.4 m-20 -73.4 111.76 8.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 2.8599999999999999 109.821 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.75 HG21 ' CE1' ' A' ' 374' ' ' PHE . 60.0 t -71.0 -45.62 71.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.394 -0.816 . . . . 3.04 110.498 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -74.39 -19.24 60.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.112 -0.992 . . . . 3.6899999999999999 111.088 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.495 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 59.5 p -74.84 -24.97 58.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.763 -1.21 . . . . 3.0499999999999998 109.1 171.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.1 mt -91.94 3.22 55.69 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.296 -0.877 . . . . 2.1400000000000001 109.684 170.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.0 m-70 58.31 28.6 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 2.1000000000000001 108.742 -171.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.728 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -88.04 -167.52 1.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.473 0.654 . . . . 1.1200000000000001 110.258 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 36.3 m -139.84 143.69 36.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.72 . . . . 2.1099999999999999 110.567 -176.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.75 ' CE1' HG21 ' A' ' 367' ' ' VAL . 78.4 m-85 -90.18 140.28 29.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 3.0899999999999999 109.649 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.963 HG11 ' NH1' ' A' ' 394' ' ' ARG . 24.3 t -106.69 112.41 63.57 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.839 -1.163 . . . . 4.0 109.822 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.4 Cg_endo -54.25 151.75 27.82 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.125 1.592 . . . . 4.6299999999999999 111.244 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.53 ' CZ ' ' C4 ' ' A' 1001 ' ' ANP . 1.0 OUTLIER -96.72 122.48 39.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.692 . . . . 5.79 109.884 178.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 23.3 p -111.58 141.02 45.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 5.29 109.796 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -75.75 -30.48 59.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 6.1299999999999999 110.502 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -58.23 -45.01 88.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 7.7400000000000002 110.011 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.9 m -89.92 -20.77 22.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.146 -0.971 . . . . 3.8199999999999998 109.648 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 379' ' ' ALA . 52.3 mtm-85 64.68 53.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.633 -0.667 . . . . 4.25 109.471 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.738 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.1 mtp -150.64 146.56 26.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 2.0899999999999999 111.115 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.2 p -144.23 165.96 26.4 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.875 -1.157 . . . . 1.23 107.875 171.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 394' ' ' ARG . . . -170.25 -167.52 30.8 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.728 -1.701 . . . . 1.1299999999999999 110.294 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.622 HG22 ' HA ' ' A' ' 340' ' ' ALA . 3.2 tt -151.13 149.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.835 -0.803 . . . . 1.26 109.003 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.589 HD21 HG21 ' A' ' 375' ' ' VAL . 2.9 m120 -121.94 144.3 48.95 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.268 -0.895 . . . . 2.04 108.666 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.94 165.17 12.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 120.68 -1.262 . . . . 2.1099999999999999 110.221 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.81 7.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.468 0.914 . . . . 3.8500000000000001 113.468 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 22.9 t-20 -145.13 3.42 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.171 -1.581 . . . . 2.3300000000000001 111.354 174.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.31 159.74 37.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.536 -1.353 . . . . 2.6899999999999999 110.99 -173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 69.0 mtm -129.84 140.65 50.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.903 -1.123 . . . . 2.02 109.004 167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.705 HD13 ' HG2' ' A' ' 435' ' ' GLU . 13.9 mm -130.75 142.6 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.79 -1.194 . . . . 1.6799999999999999 110.198 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.963 ' NH1' HG11 ' A' ' 375' ' ' VAL . 29.1 mmt180 -141.32 142.43 33.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 110.691 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.825 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -141.31 142.57 33.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.5700000000000001 109.094 176.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.65 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 179.55 -160.28 25.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.075 -1.536 . . . . 0.81999999999999995 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.587 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 43.0 m -70.22 158.64 35.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -1.066 . . . . 1.1699999999999999 110.489 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.764 ' CG2' HG11 ' A' ' 420' ' ' VAL . 98.9 t -60.9 -49.0 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.53000000000000003 110.134 -175.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 91.2 m-20 -59.6 -38.01 80.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.891 -1.131 . . . . 1.5900000000000001 108.891 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.738 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -60.4 -51.84 67.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.523 -0.736 . . . . 0.84999999999999998 110.703 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.65 HD11 ' N ' ' A' ' 396' ' ' GLY . 20.8 mm -67.48 -37.93 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.592 -1.317 . . . . 0.81000000000000005 111.199 -176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 70.3 ttt180 -59.07 -42.03 89.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.813 -1.18 . . . . 2.6200000000000001 110.11 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 71.3 mtt180 -67.05 -37.05 83.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.995 . . . . 2.48 110.808 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.528 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.4 t60 -63.54 -40.48 97.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.066 . . . . 2.4300000000000002 110.697 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 437' ' ' SER . 98.1 t -64.6 -45.3 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.973 -1.08 . . . . 0.93999999999999995 110.44 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.32 -35.87 80.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.884 -1.135 . . . . 2.1600000000000001 110.712 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.05 -41.88 90.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 1.53 109.798 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 19.3 m120 -66.43 -26.46 67.24 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.341 -0.85 . . . . 2.75 109.183 171.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.27 23.2 17.52 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.293 -1.523 . . . . 2.2799999999999998 109.293 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.637 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.72 -172.05 40.85 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 1.72 109.509 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.3 m80 -138.49 150.85 46.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -1.162 . . . . 4.1600000000000001 110.252 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.8 ' CE1' HG12 ' A' ' 416' ' ' VAL . 3.0 t80 -90.99 110.21 40.49 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 3.3100000000000001 109.943 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.8 Cg_exo -58.13 143.8 96.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.835 1.44 . . . . 1.23 110.659 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 2.5 t -59.72 -44.67 93.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 1.75 110.4 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 414' ' ' THR . 91.6 m-20 -57.47 -35.92 70.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.8700000000000001 110.308 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 439' ' ' VAL . 72.2 t -70.34 -36.05 65.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.532 -1.355 . . . . 0.70999999999999996 110.233 176.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.4 -43.5 97.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.097 . . . . 1.8100000000000001 110.347 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 11.1 pt20 -68.15 -37.37 80.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 2.6000000000000001 110.639 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.975 ' O ' HG23 ' A' ' 423' ' ' VAL . 68.7 mttm -63.54 -38.31 90.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.586 -1.321 . . . . 2.4900000000000002 110.731 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.764 HG11 ' CG2' ' A' ' 398' ' ' VAL . 86.1 t -65.58 -40.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 0.79000000000000004 110.208 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.42 -42.66 74.71 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.589 -0.694 . . . . 2.0499999999999998 110.689 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.535 ' HA ' ' CD ' ' A' ' 425' ' ' ARG . 92.3 mt-30 -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.318 -0.864 . . . . 2.3300000000000001 109.734 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.976 HG13 ' CB ' ' A' ' 444' ' ' ALA . 93.9 t -60.75 -40.55 85.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.93 -1.107 . . . . 1.0 109.463 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 428' ' ' ALA . . . -72.44 -53.64 11.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 1.24 110.596 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.535 ' CD ' ' HA ' ' A' ' 422' ' ' GLN . 11.6 ptm180 -57.42 -18.22 16.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 4.1100000000000003 109.945 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.5 mt-30 -90.12 11.03 22.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.428 -0.795 . . . . 2.9199999999999999 110.634 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 79.76 32.28 37.5 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.769 -1.332 . . . . 1.1599999999999999 109.769 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 423' ' ' VAL . . . -130.37 155.61 46.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 1.0700000000000001 109.815 177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 3.5 m -93.31 109.0 37.45 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.21 109.275 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.764 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.8 Cg_exo -76.42 109.35 2.85 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.944 1.497 . . . . 1.2 110.307 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.919 HD21 " C2'" ' A' 1001 ' ' ANP . 99.1 mt -90.16 144.41 25.89 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.697 -1.252 . . . . 1.3999999999999999 108.69 166.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 58.3 t -108.97 138.18 37.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 120.74 -1.225 . . . . 0.52000000000000002 110.133 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.915 HG12 HD21 ' A' ' 440' ' ' LEU . 39.0 t -116.08 136.74 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.656 -0.653 . . . . 1.0800000000000001 109.839 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -129.22 162.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.621 -0.674 . . . . 0.90000000000000002 110.131 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.705 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.7 mt-10 -115.99 124.97 51.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.164 -0.96 . . . . 1.79 108.872 166.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 66.02 -109.77 3.09 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.945 -1.662 . . . . 1.4199999999999999 108.945 -172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.1 p -120.66 10.51 11.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -1.11 . . . . 1.4199999999999999 110.958 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 36.5 ptt85 -120.27 141.23 50.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.897 -1.127 . . . . 3.52 110.198 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.977 HG11 HG11 ' A' ' 416' ' ' VAL . 41.0 t -79.6 127.74 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 1.4099999999999999 110.67 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 433' ' ' VAL . 0.4 OUTLIER -89.57 -26.57 20.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 1.79 110.513 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . -179.84 -178.74 48.64 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.083 -1.532 . . . . 1.02 110.818 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 420' ' ' VAL . 41.5 t -119.89 155.85 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.481 -1.011 . . . . 0.56999999999999995 109.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 322' ' ' PHE . 22.4 mm -124.3 125.63 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.111 -0.993 . . . . 1.05 110.167 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.976 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.39 122.48 43.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.311 -0.868 . . . . 0.46000000000000002 110.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 4.9 mp -100.38 139.31 36.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 2.1099999999999999 110.154 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.8 146.84 27.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.268 -0.895 . . . . 4.4800000000000004 109.52 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 35.0 p30 -91.93 122.0 34.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 3.9100000000000001 110.617 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -53.57 -47.69 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 3.6099999999999999 109.545 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.62 135.53 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.505 -0.747 . . . . 5.0899999999999999 110.252 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -90.51 132.9 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 7.5 110.143 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 7.2999999999999998 109.533 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.919 " C2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.473 ' HB2' HG12 ' A' ' 448' ' ' ILE . 97.4 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.229 0.538 . . . . 6.0800000000000001 110.247 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 348' ' ' GLU . 98.1 mtt180 -136.64 144.14 43.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.244 -0.91 . . . . 5.8300000000000001 110.467 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 448' ' ' ILE . 16.6 mt-30 -135.47 148.6 49.3 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.82 . . . . 5.5800000000000001 109.659 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 355' ' ' LEU . . . -66.33 122.66 17.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.82 -1.175 . . . . 1.4199999999999999 109.837 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.8 m -114.78 -37.9 4.1 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.369 -0.933 . . . . 1.6000000000000001 110.758 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.525 ' HG2' HD11 ' A' ' 323' ' ' ILE . 86.1 tt0 -131.68 134.41 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 1.8200000000000001 110.719 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.048 ' O ' HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.61 141.18 48.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.954 0.883 . . . . 1.1399999999999999 111.624 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 322' ' ' PHE . 4.9 mm -138.51 140.03 26.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.752 -1.217 . . . . 0.53000000000000003 110.516 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.556 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 7.1 Cg_exo -67.99 159.26 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.759 1.399 . . . . 1.4399999999999999 111.31 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' A' ' 328' ' ' VAL . . . -79.99 -163.48 0.55 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 1.5800000000000001 109.676 171.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 60.4 tt0 -63.4 105.86 0.82 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.323 -0.861 . . . . 4.0 110.494 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.54 19.39 56.76 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.327 -1.109 . . . . 1.52 110.327 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 440' ' ' LEU . 44.3 t -104.58 151.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 1.73 110.568 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.481 ' HB2' ' OG1' ' A' ' 332' ' ' THR . 88.9 m-20 -85.46 144.61 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 2.02 109.831 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CE2' ' A' ' 322' ' ' PHE . 21.9 pt-20 -63.21 -40.87 98.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.126 -0.984 . . . . 2.7000000000000002 110.412 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 360' ' ' PHE . 18.9 tttt -58.21 -38.0 75.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 3.0299999999999998 109.992 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 329' ' ' ASP . 90.2 m -58.87 -47.05 86.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.90000000000000002 110.271 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.985 HD22 ' O ' ' A' ' 323' ' ' ILE . 34.2 tp -59.3 -47.85 83.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.93000000000000005 110.903 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 322' ' ' PHE . . . -64.15 -35.48 80.9 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.119 -0.988 . . . . 0.87 110.295 -177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.618 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.9 t0 -64.44 -48.23 76.08 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.72 -1.238 . . . . 1.96 110.948 -177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.457 ' HB3' HD13 ' A' ' 440' ' ' LEU . . . -66.95 -38.1 85.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.76000000000000001 110.607 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 341' ' ' SER . . . -64.6 -33.32 75.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.93 -1.106 . . . . 0.71999999999999997 110.176 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.677 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -70.26 -51.22 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 1.72 111.351 -178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.95 HD11 HG13 ' A' ' 393' ' ' ILE . 0.8 OUTLIER -74.72 -37.52 62.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.699 -1.251 . . . . 1.5800000000000001 110.346 -176.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 393' ' ' ILE . . . -69.38 -8.9 50.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 2.2400000000000002 110.233 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 83.8 p -98.95 -14.16 19.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.393 -0.817 . . . . 3.5600000000000001 110.172 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 364' ' ' GLU . 54.8 mt -63.36 -22.21 66.74 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.199 -0.938 . . . . 4.3600000000000003 110.468 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.05 -13.44 44.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 3.8100000000000001 110.944 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.49 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 2.5 p30 -93.9 138.86 31.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.884 -1.135 . . . . 2.8399999999999999 110.228 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.46 7.0 47.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 2.9900000000000002 110.296 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 347' ' ' PRO . 22.0 p -71.48 141.0 85.0 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.254 -0.904 . . . . 2.0699999999999998 110.05 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.6 Cg_exo -57.03 -36.74 99.41 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.909 1.479 . . . . 2.3799999999999999 110.25 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.587 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 95.6 mt-10 -64.52 -36.37 83.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 3.25 110.11 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -59.47 -27.04 62.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.582 -1.407 . . . . 1.4199999999999999 109.582 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 354' ' ' ILE . 47.0 mtp85 -76.6 -36.56 57.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.278 . . . . 3.6200000000000001 109.663 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.744 ' HA ' HD12 ' A' ' 354' ' ' ILE . 21.5 m -54.51 -43.15 71.61 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.187 -0.946 . . . . 2.3999999999999999 109.656 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.64 HG22 ' OE1' ' A' ' 338' ' ' GLN . 19.9 mt -66.75 -51.01 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 1.3899999999999999 111.087 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.681 HG12 ' HE2' ' A' ' 357' ' ' LYS . 64.2 t -52.86 -31.41 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.673 -1.267 . . . . 1.1799999999999999 110.328 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 351' ' ' SER . 67.2 mt -68.64 -46.0 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.799 -1.188 . . . . 1.3600000000000001 110.687 171.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 319' ' ' ALA . 10.1 tt -47.03 -50.92 18.59 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.085 -1.009 . . . . 1.1499999999999999 110.525 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.677 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -66.86 -38.52 86.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 109.841 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.681 ' HE2' HG12 ' A' ' 353' ' ' VAL . 52.6 mtmt -62.89 -47.6 82.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.753 -1.217 . . . . 1.1599999999999999 111.379 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.7 pt20 -64.73 -40.03 94.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.146 -1.596 . . . . 1.8999999999999999 109.535 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.497 ' HG3' ' HG3' ' A' ' 358' ' ' GLN . 63.8 mtp85 -75.7 -41.57 53.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 2.6299999999999999 111.476 -177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.704 ' HB3' HD11 ' A' ' 362' ' ' LEU . 94.4 m-85 -115.72 -13.63 11.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.938 -1.102 . . . . 3.3199999999999998 110.311 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 357' ' ' LYS . 31.6 t-20 60.56 50.04 6.11 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.949 0.88 . . . . 1.8999999999999999 110.169 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.0 mt -108.26 177.74 4.71 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.534 -0.543 . . . . 2.7999999999999998 109.534 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -119.91 151.15 39.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.93 -1.107 . . . . 4.4000000000000004 110.068 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 12.3 pt-20 -54.75 149.02 11.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 2.2400000000000002 109.517 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 342' ' ' LEU . 92.6 mtt-85 -95.53 123.99 39.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.009 -1.057 . . . . 4.1600000000000001 109.788 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.492 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.0 m-20 -72.08 117.03 13.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.237 -0.914 . . . . 2.8599999999999999 109.918 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 374' ' ' PHE . 56.2 t -68.4 -43.24 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.473 -0.767 . . . . 3.04 110.288 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -72.99 -19.09 61.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 3.6899999999999999 110.914 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 54.0 p -74.64 -28.34 60.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.865 -1.147 . . . . 3.0499999999999998 109.372 172.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 388' ' ' ILE . 70.9 mt -90.05 1.3 56.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 2.1400000000000001 109.588 170.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 30.6 m80 58.56 27.03 15.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 2.1000000000000001 108.774 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.795 ' HB1' ' HA ' ' A' ' 388' ' ' ILE . . . -86.5 -163.03 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.595 0.712 . . . . 1.1200000000000001 110.263 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.599 ' C ' HG11 ' A' ' 367' ' ' VAL . 17.0 m -129.53 143.04 50.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.579 -0.7 . . . . 2.1099999999999999 111.198 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.643 ' CD1' HG21 ' A' ' 367' ' ' VAL . 42.4 m-85 -90.06 151.4 21.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.187 -0.945 . . . . 3.0899999999999999 109.373 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.84 HG11 ' NH1' ' A' ' 394' ' ' ARG . 14.0 t -117.37 110.19 41.3 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.834 -1.166 . . . . 4.0 109.875 173.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 10.0 Cg_endo -56.03 152.86 34.82 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.033 1.544 . . . . 4.6299999999999999 110.999 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 384' ' ' SER . 1.1 t80 -96.51 122.35 39.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.484 -0.76 . . . . 5.79 109.978 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 26.4 p -112.61 141.16 46.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 5.29 109.78 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.31 59.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.608 -0.683 . . . . 6.1299999999999999 110.537 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -58.39 -46.94 85.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 7.7400000000000002 109.975 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 383' ' ' MET . 51.8 p -90.86 -12.19 37.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 3.8199999999999998 109.555 173.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.494 ' O ' ' HA3' ' A' ' 396' ' ' GLY . 86.7 mtt-85 56.43 54.07 7.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 4.25 109.773 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.515 ' HG3' ' HB1' ' A' ' 400' ' ' ALA . 43.8 mtm -153.91 151.08 29.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 2.0899999999999999 111.497 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 25.7 p -149.3 174.45 12.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 340' ' ' ALA . . . 169.89 -150.43 14.85 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 118.554 -1.784 . . . . 1.1299999999999999 110.458 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 339' ' ' LEU . 10.2 tt -151.42 153.27 10.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.917 -0.771 . . . . 1.26 108.917 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 386' ' ' ILE . 8.6 m120 -127.09 105.33 8.51 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 120.989 -1.069 . . . . 2.04 109.06 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.059 HD13 ' N ' ' A' ' 389' ' ' ASP . 0.0 OUTLIER -112.28 155.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.873 -1.142 . . . . 2.1099999999999999 109.019 -168.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 1.059 ' N ' HD13 ' A' ' 388' ' ' ILE . 92.1 m-20 -63.44 7.84 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.88 -1.137 . . . . 3.8500000000000001 113.55 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.518 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 38.6 t-20 -139.78 1.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.038 -1.664 . . . . 2.3300000000000001 111.07 172.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 388' ' ' ILE . 79.8 mtm180 -158.04 162.69 38.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.636 -1.29 . . . . 2.6899999999999999 110.802 -173.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 393' ' ' ILE . 85.9 mtp -129.77 139.92 51.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.816 -1.177 . . . . 2.02 109.453 168.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.95 HG13 HD11 ' A' ' 339' ' ' LEU . 39.6 mm -131.07 138.02 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.108 . . . . 1.6799999999999999 110.063 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.84 ' NH1' HG11 ' A' ' 375' ' ' VAL . 11.5 tpt180 -139.34 143.52 37.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 2.7799999999999998 109.932 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.929 ' HG3' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -146.89 148.1 31.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.392 -0.817 . . . . 1.5700000000000001 109.904 -178.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.698 ' N ' HD11 ' A' ' 401' ' ' ILE . . . 171.98 -147.28 9.93 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.409 -1.377 . . . . 0.81999999999999995 110.254 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 3.5 m -69.71 151.96 45.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 1.1699999999999999 110.656 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.892 HG21 ' CG1' ' A' ' 420' ' ' VAL . 85.9 t -60.17 -48.1 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.53000000000000003 110.01 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.3 m-20 -60.1 -38.48 83.07 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.014 -1.054 . . . . 1.5900000000000001 109.004 172.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 397' ' ' SER . . . -61.57 -49.95 74.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.462 -0.773 . . . . 0.84999999999999998 110.708 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.698 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.0 mm -63.63 -40.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.734 -1.229 . . . . 0.81000000000000005 110.933 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 406' ' ' GLU . 42.0 ttm180 -58.15 -40.05 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.913 -1.117 . . . . 2.6200000000000001 110.03 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 75.0 mmt-85 -65.69 -39.15 90.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.091 -1.005 . . . . 2.48 110.571 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.11 -40.19 94.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.003 -1.061 . . . . 2.4300000000000002 110.717 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.641 HG12 ' C ' ' A' ' 410' ' ' GLY . 83.3 t -64.83 -44.51 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.93999999999999995 110.404 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 402' ' ' ARG . 75.8 mm-40 -62.45 -36.37 82.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.843 -1.16 . . . . 2.1600000000000001 110.719 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.22 91.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.53 109.691 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.6 m120 -66.34 -26.39 67.27 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.842 . . . . 2.75 109.187 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.34 22.04 20.56 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.253 -1.539 . . . . 2.2799999999999998 109.253 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.641 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.66 -171.57 40.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.438 -1.465 . . . . 1.72 109.438 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 97.0 m-70 -139.39 154.75 47.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -1.202 . . . . 4.1600000000000001 110.34 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.811 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.7 t80 -95.07 109.29 43.72 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 3.3100000000000001 110.041 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 25.4 Cg_exo -58.24 143.89 96.44 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.917 1.483 . . . . 1.23 110.702 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.1 t -59.69 -44.25 93.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 1.75 110.427 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 90.8 m-20 -57.18 -35.46 69.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 1.8700000000000001 110.373 -176.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 439' ' ' VAL . 66.2 t -71.48 -35.87 58.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.528 -1.357 . . . . 0.70999999999999996 110.109 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.23 -42.89 99.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 1.8100000000000001 110.443 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.2 pt20 -68.35 -37.41 80.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.921 -1.112 . . . . 2.6000000000000001 110.648 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 423' ' ' VAL . 60.8 mttp -63.41 -38.2 90.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.486 -1.384 . . . . 2.4900000000000002 110.644 176.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.892 ' CG1' HG21 ' A' ' 398' ' ' VAL . 37.4 t -64.76 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.79000000000000004 110.383 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 92.7 m-20 -70.1 -42.75 72.28 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.551 -0.718 . . . . 2.0499999999999998 110.817 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 94.2 mt-30 -65.3 -31.2 72.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 2.3300000000000001 109.793 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 419' ' ' LYS . 78.5 t -59.82 -43.48 91.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.073 -1.017 . . . . 1.0 109.708 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.91 -49.25 53.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 1.24 110.229 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 98.1 mtt180 -54.7 -21.64 11.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 4.1100000000000003 109.897 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 97.2 mt-30 -89.88 4.06 51.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.878 . . . . 2.9199999999999999 110.58 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.03 11.64 72.75 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.65 -1.38 . . . . 1.1599999999999999 109.65 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.05 157.42 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -1.08 . . . . 1.0700000000000001 109.884 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.24 109.05 37.6 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 1.21 108.922 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.661 ' HA ' HG11 ' A' ' 423' ' ' VAL . 5.6 Cg_exo -76.37 113.29 3.65 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.011 1.532 . . . . 1.2 110.163 -176.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.939 HD21 " O2'" ' A' 1001 ' ' ANP . 69.1 mt -89.98 154.03 20.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.844 -1.16 . . . . 1.3999999999999999 108.539 165.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 61.3 t -119.27 139.23 47.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.794 -1.191 . . . . 0.52000000000000002 110.034 176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.929 HG22 ' HG3' ' A' ' 395' ' ' LYS . 14.3 t -121.03 134.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.678 -0.639 . . . . 1.0800000000000001 109.384 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 440' ' ' LEU . 2.6 m -130.33 154.34 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.527 -0.869 . . . . 0.90000000000000002 110.703 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 4.0 mt-10 -99.18 121.95 41.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.911 -0.774 . . . . 1.79 108.911 173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.97 -109.7 1.79 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.678 -1.769 . . . . 1.4199999999999999 108.678 -173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 405' ' ' VAL . 12.2 p -114.63 13.81 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 1.4199999999999999 111.21 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 31.3 ptt85 -123.65 140.52 52.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.792 -1.192 . . . . 3.52 110.203 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 416' ' ' VAL . 42.9 t -79.53 127.49 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.343 -0.848 . . . . 1.4099999999999999 111.174 -174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.923 ' O ' HG11 ' A' ' 328' ' ' VAL . 0.3 OUTLIER -87.95 -31.85 19.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.872 . . . . 1.79 110.408 176.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.799 ' CA ' HD13 ' A' ' 333' ' ' LEU . . . 178.76 -178.73 48.81 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.054 -1.546 . . . . 1.02 111.155 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.889 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.8 t -121.39 153.12 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.754 -0.851 . . . . 0.56999999999999995 109.643 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.964 ' CD1' HD21 ' A' ' 333' ' ' LEU . 13.4 mm -124.53 127.17 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.081 -1.012 . . . . 1.05 110.734 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.804 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.38 121.38 41.43 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.314 -0.867 . . . . 0.46000000000000002 110.243 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 445' ' ' LEU . 8.3 mp -102.72 145.46 29.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.035 . . . . 2.1099999999999999 110.295 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -88.11 142.52 27.7 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.191 -0.943 . . . . 4.4800000000000004 109.291 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 447' ' ' ASP . 36.5 p30 -95.74 118.53 32.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.195 -0.941 . . . . 3.9100000000000001 110.727 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 0.9 OUTLIER -52.89 -46.97 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 3.6099999999999999 109.563 177.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 45.1 t -101.04 134.36 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 5.0899999999999999 110.124 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -91.26 132.75 35.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 7.5 110.181 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.003 -1.443 . . . . 7.2999999999999998 109.565 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.939 " O2'" HD21 ' A' ' 431' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 447' ' ' ASP . 18.7 t-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.157 0.503 . . . . 6.0800000000000001 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' A' ' 348' ' ' GLU . 87.6 mtm-85 -121.99 140.25 52.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.081 . . . . 5.8300000000000001 110.519 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.568 ' NE2' HD11 ' A' ' 448' ' ' ILE . 15.5 mt-30 -135.62 150.55 49.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 5.5800000000000001 109.403 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -68.24 122.82 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.891 -1.131 . . . . 1.4199999999999999 109.731 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.594 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -109.95 -39.75 4.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.193 -0.942 . . . . 1.6000000000000001 110.613 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -136.82 145.46 44.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.097 -1.002 . . . . 1.8200000000000001 110.807 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.652 ' CE2' ' HB2' ' A' ' 334' ' ' ALA . 7.4 p90 -117.51 146.86 43.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 110.228 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HD22 ' A' ' 333' ' ' LEU . 2.1 mp -132.9 133.04 22.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.53000000000000003 110.424 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 15.4 Cg_exo -62.1 158.16 40.69 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.933 1.491 . . . . 1.4399999999999999 111.66 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.698 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -80.01 -164.94 0.74 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.527 -0.733 . . . . 1.5800000000000001 109.813 172.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 50.4 tt0 -62.33 106.73 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.315 -0.866 . . . . 4.0 110.415 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.55 58.98 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.324 -1.11 . . . . 1.52 110.324 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 440' ' ' LEU . 62.9 t -103.28 152.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.902 -1.352 . . . . 1.73 110.517 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 332' ' ' THR . 30.4 p-10 -96.1 151.21 19.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.105 -0.997 . . . . 2.02 110.147 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 20.9 pt-20 -70.56 -36.04 73.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.985 -1.072 . . . . 2.7000000000000002 111.077 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.453 ' HG2' ' CE1' ' A' ' 360' ' ' PHE . 2.8 mtpt -61.35 -41.76 97.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.983 -1.073 . . . . 3.0299999999999998 110.203 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 329' ' ' ASP . 90.3 m -61.0 -45.98 92.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.90000000000000002 110.35 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 443' ' ' ILE . 21.5 tp -59.18 -44.72 92.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.93000000000000005 110.869 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -59.59 -40.37 87.19 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.065 -1.022 . . . . 0.87 109.798 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 339' ' ' LEU . 58.3 t0 -65.91 -45.44 81.94 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.06 -1.025 . . . . 1.96 111.384 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.01 -36.94 86.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.067 -1.021 . . . . 0.76000000000000001 110.238 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.11 75.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.042 -1.036 . . . . 0.71999999999999997 110.006 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.669 ' OE1' HG22 ' A' ' 352' ' ' ILE . 0.0 OUTLIER -68.66 -53.55 21.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 1.72 111.245 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 386' ' ' ILE . 0.4 OUTLIER -70.84 -36.69 73.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.664 -1.273 . . . . 1.5800000000000001 110.377 -176.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.611 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.53 -12.34 60.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 2.2400000000000002 110.147 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.516 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 91.1 p -97.57 -18.08 19.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 3.5600000000000001 110.192 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.662 HD11 ' H ' ' A' ' 365' ' ' ARG . 46.1 mt -58.16 -29.15 65.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.977 -1.077 . . . . 4.3600000000000003 109.961 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -90.05 -3.15 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 3.8100000000000001 110.759 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.1 p30 -97.02 138.27 34.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.116 . . . . 2.8399999999999999 110.186 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.97 7.13 47.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 2.9900000000000002 110.244 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.873 HG21 ' CD2' ' A' ' 377' ' ' PHE . 82.6 p -75.32 141.12 73.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 2.0699999999999998 110.194 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 26.7 Cg_exo -57.4 -37.58 97.04 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.962 1.506 . . . . 2.3799999999999999 110.174 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.562 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 96.9 mt-10 -63.93 -35.28 80.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 3.25 110.102 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.17 -25.98 57.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.49 -1.444 . . . . 1.4199999999999999 109.49 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -76.19 -35.78 58.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.946 -1.326 . . . . 3.6200000000000001 109.572 172.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.589 ' HA ' HD12 ' A' ' 354' ' ' ILE . 20.1 m -54.74 -45.73 74.18 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.17 -0.956 . . . . 2.3999999999999999 109.708 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 319' ' ' ALA . 53.0 mt -64.93 -49.66 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 1.3899999999999999 111.345 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 75.1 t -55.23 -32.95 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.686 -1.259 . . . . 1.1799999999999999 110.418 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 351' ' ' SER . 69.6 mt -66.85 -45.83 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.699 -1.251 . . . . 1.3600000000000001 110.27 169.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' A' ' 319' ' ' ALA . 60.4 tp -47.28 -51.18 19.78 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.182 -0.949 . . . . 1.1499999999999999 110.816 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.61 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -66.15 -37.63 86.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.94 -1.1 . . . . 0.60999999999999999 109.726 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 361' ' ' ASN . 39.1 mtmt -62.55 -47.87 81.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.697 -1.252 . . . . 1.1599999999999999 111.026 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 359' ' ' ARG . 21.0 pt20 -64.85 -40.62 95.45 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.32 -1.487 . . . . 1.8999999999999999 109.707 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.508 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 56.9 mmm-85 -73.18 -44.86 59.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.119 -0.988 . . . . 2.6299999999999999 111.604 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.699 ' HB3' HD11 ' A' ' 362' ' ' LEU . 76.2 m-85 -115.73 -13.61 11.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 3.3199999999999998 110.368 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER 60.62 50.1 5.94 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.885 0.85 . . . . 1.8999999999999999 110.192 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 360' ' ' PHE . 22.5 mt -110.68 -178.81 3.58 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.588 -0.523 . . . . 2.7999999999999998 109.588 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt85 -123.09 152.12 41.35 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.818 -1.176 . . . . 4.4000000000000004 110.225 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.53 ' HB2' ' CD2' ' A' ' 342' ' ' LEU . 21.2 pt-20 -52.01 153.25 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 2.2400000000000002 109.738 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.662 ' H ' HD11 ' A' ' 342' ' ' LEU . 73.1 mtp180 -98.81 136.11 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.03 -1.044 . . . . 4.1600000000000001 110.245 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 366' ' ' ASP . 36.8 p-10 -78.63 113.17 16.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.527 -0.733 . . . . 2.8599999999999999 110.021 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.927 HG13 ' HB3' ' A' ' 372' ' ' ALA . 71.4 t -70.83 -42.94 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 3.04 110.775 -177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.04 -19.15 61.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.082 . . . . 3.6899999999999999 111.542 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.434 ' OG ' ' CG ' ' A' ' 366' ' ' ASP . 27.8 p -75.14 -24.89 58.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.65 -1.281 . . . . 3.0499999999999998 109.081 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.883 HD13 ' CD1' ' A' ' 388' ' ' ILE . 32.3 mt -90.25 1.95 55.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.378 -0.827 . . . . 2.1400000000000001 109.675 171.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 82.7 m-70 57.73 28.68 16.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.154 -0.966 . . . . 2.1000000000000001 108.836 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.927 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -86.71 -166.34 1.53 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.453 0.644 . . . . 1.1200000000000001 110.178 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 33.6 m -138.67 143.69 39.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.596 -0.69 . . . . 2.1099999999999999 110.517 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 367' ' ' VAL . 83.1 m-85 -89.55 138.8 31.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.929 -1.107 . . . . 3.0899999999999999 109.438 172.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.608 HG21 HD21 ' A' ' 387' ' ' ASN . 13.1 t -105.52 112.18 64.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.837 -1.165 . . . . 4.0 109.898 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 9.7 Cg_endo -54.87 151.6 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.091 1.574 . . . . 4.6299999999999999 111.354 -175.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.873 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -98.51 122.44 41.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.605 -0.684 . . . . 5.79 109.825 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 32.0 p -113.27 141.91 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 5.29 109.817 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 382' ' ' ARG . . . -73.79 -30.68 62.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.526 -0.734 . . . . 6.1299999999999999 110.396 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -49.58 -53.55 23.25 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.139 -0.976 . . . . 7.7400000000000002 109.98 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 383' ' ' MET . 60.1 p -91.47 -14.4 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 3.8199999999999998 109.783 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 397' ' ' SER . 49.7 mtm180 64.13 55.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.566 -0.709 . . . . 4.25 109.704 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.62 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 88.3 mtp -150.64 146.29 26.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 2.0899999999999999 111.339 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 35.2 p -146.44 170.41 16.89 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.976 -1.12 . . . . 1.23 107.976 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 375' ' ' VAL . . . -176.88 -166.62 34.17 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.667 -1.73 . . . . 1.1299999999999999 110.372 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -149.05 149.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 O-C-N 121.916 -0.756 . . . . 1.26 108.977 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.608 HD21 HG21 ' A' ' 375' ' ' VAL . 3.0 m120 -122.27 143.84 49.36 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.233 -0.917 . . . . 2.04 108.745 177.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.883 ' CD1' HD13 ' A' ' 370' ' ' LEU . 6.0 tt -144.74 164.88 12.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.637 -1.289 . . . . 2.1099999999999999 110.215 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.88 7.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.461 0.912 . . . . 3.8500000000000001 113.461 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 32.2 t30 -144.82 3.07 1.07 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.157 -1.589 . . . . 2.3300000000000001 111.4 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 95.0 mtt180 -157.44 159.58 37.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.596 -1.315 . . . . 2.6899999999999999 110.917 -173.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 393' ' ' ILE . 69.6 mtm -129.97 140.64 50.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.823 -1.173 . . . . 2.02 109.069 167.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 340' ' ' ALA . 20.3 mm -131.46 138.69 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.798 -1.189 . . . . 1.6799999999999999 110.006 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.431 ' NH1' ' CD2' ' A' ' 404' ' ' HIS . 13.7 tpt180 -142.28 144.02 33.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.7799999999999998 110.393 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.881 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.14 144.45 32.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.504 -0.747 . . . . 1.5700000000000001 109.306 178.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.733 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -178.86 -156.7 17.82 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.361 -1.4 . . . . 0.81999999999999995 110.204 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 400' ' ' ALA . 17.5 m -68.94 156.55 38.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -1.07 . . . . 1.1699999999999999 110.366 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.748 ' CG2' HG11 ' A' ' 420' ' ' VAL . 97.3 t -60.02 -48.69 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.964 . . . . 0.53000000000000003 110.04 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 403' ' ' ARG . 90.7 m-20 -60.68 -37.78 82.77 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.965 -1.085 . . . . 1.5900000000000001 109.046 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.62 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.41 -48.67 80.15 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.55 -0.719 . . . . 0.84999999999999998 110.714 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.733 HD11 ' N ' ' A' ' 396' ' ' GLY . 19.5 mm -65.58 -39.19 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.723 -1.235 . . . . 0.81000000000000005 110.896 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 406' ' ' GLU . 62.1 ttt180 -57.93 -40.42 80.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.849 -1.157 . . . . 2.6200000000000001 110.057 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 399' ' ' ASP . 41.9 mmt180 -66.01 -39.08 89.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.151 -0.968 . . . . 2.48 110.6 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.431 ' CD2' ' NH1' ' A' ' 394' ' ' ARG . 56.0 t-80 -64.88 -39.72 93.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 2.4300000000000002 110.723 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.583 HG12 ' C ' ' A' ' 410' ' ' GLY . 75.2 t -64.51 -45.22 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.93999999999999995 110.401 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' ARG . 97.0 mt-10 -62.55 -36.45 82.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.842 -1.161 . . . . 2.1600000000000001 110.688 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.53 93.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.031 -1.043 . . . . 1.53 109.744 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.548 ' CB ' ' HB2' ' A' ' 437' ' ' SER . 19.2 m120 -66.11 -27.11 67.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.367 -0.833 . . . . 2.75 109.143 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.2 22.64 19.21 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.208 -1.557 . . . . 2.2799999999999998 109.208 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.583 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -93.04 -171.09 40.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 1.72 109.498 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 77.4 m80 -138.68 152.3 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -1.12 . . . . 4.1600000000000001 110.283 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.772 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 2.8 t80 -92.77 110.09 43.2 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 3.3100000000000001 110.043 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.8 Cg_exo -58.46 142.09 97.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.877 1.462 . . . . 1.23 110.616 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 3.4 t -59.46 -43.34 93.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 1.75 110.343 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 419' ' ' LYS . 92.3 m-20 -56.45 -36.66 69.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 1.8700000000000001 110.222 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 439' ' ' VAL . 64.8 t -69.8 -36.86 71.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.53 -1.356 . . . . 0.70999999999999996 110.233 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.24 -43.11 98.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.923 -1.111 . . . . 1.8100000000000001 110.265 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.538 ' CG ' ' O ' ' A' ' 415' ' ' ASP . 16.4 pt20 -68.45 -36.78 79.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.968 -1.083 . . . . 2.6000000000000001 110.628 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.995 ' O ' HG23 ' A' ' 423' ' ' VAL . 29.6 mttp -64.8 -36.93 85.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.479 -1.388 . . . . 2.4900000000000002 110.562 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 430' ' ' PRO . 99.2 t -65.63 -41.45 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.79000000000000004 110.148 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 424' ' ' ALA . 92.3 m-20 -69.78 -45.0 68.95 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.371 -0.831 . . . . 2.0499999999999998 110.871 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.513 ' HA ' ' CG ' ' A' ' 425' ' ' ARG . 92.4 mt-30 -62.82 -31.07 71.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 2.3300000000000001 110.343 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 1.01 HG13 ' CB ' ' A' ' 444' ' ' ALA . 96.6 t -57.42 -41.78 79.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.745 -1.222 . . . . 1.0 108.727 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 421' ' ' ASP . . . -66.71 -44.6 81.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.437 -0.789 . . . . 1.24 110.054 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.513 ' CG ' ' HA ' ' A' ' 422' ' ' GLN . 12.8 mmm180 -53.9 -23.03 11.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.1100000000000003 109.165 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 94.8 mt-30 -91.41 3.22 55.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.542 -0.724 . . . . 2.9199999999999999 110.566 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 82.08 13.97 78.05 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.546 -1.422 . . . . 1.1599999999999999 109.546 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.85 160.93 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -1.035 . . . . 1.0700000000000001 109.961 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 3.3 m -93.26 109.51 40.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.344 -0.847 . . . . 1.21 109.109 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.816 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.3 Cg_exo -75.71 111.5 3.31 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.14 1.6 . . . . 1.2 110.231 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.584 ' CD2' " O2'" ' A' 1001 ' ' ANP . 44.0 mt -90.01 161.89 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.791 -1.193 . . . . 1.3999999999999999 108.155 165.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 91.1 t -124.63 139.58 50.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.789 -1.195 . . . . 0.52000000000000002 110.338 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 440' ' ' LEU . 21.3 t -119.36 137.85 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.736 -0.603 . . . . 1.0800000000000001 109.415 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 439' ' ' VAL . 2.8 m -129.77 154.65 40.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 119.649 -0.82 . . . . 0.90000000000000002 110.714 176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.546 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 6.5 mt-10 -103.16 124.72 49.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.941 -0.763 . . . . 1.79 108.941 172.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 59.54 -109.79 2.38 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.69 -1.764 . . . . 1.4199999999999999 108.69 -172.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 408' ' ' ASN . 19.6 p -117.21 11.64 14.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -1.178 . . . . 1.4199999999999999 111.173 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.531 ' NH2' ' HB3' ' A' ' 435' ' ' GLU . 32.4 ptt-85 -123.75 141.39 52.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.763 -1.21 . . . . 3.52 110.343 -177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.017 HG11 HG11 ' A' ' 416' ' ' VAL . 41.8 t -76.37 128.51 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.529 -0.732 . . . . 1.4099999999999999 111.065 -174.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -90.95 -29.83 17.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 1.79 110.517 178.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.588 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 178.06 -177.81 48.43 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.118 -1.515 . . . . 1.02 110.828 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.837 ' O ' HD13 ' A' ' 443' ' ' ILE . 61.4 t -120.26 154.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.56999999999999995 109.93 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.837 HD13 ' O ' ' A' ' 442' ' ' VAL . 15.6 mm -122.82 129.19 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.048 -1.033 . . . . 1.05 110.967 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 1.01 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -103.94 122.11 44.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.46000000000000002 110.183 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 444' ' ' ALA . 7.0 mp -102.82 145.71 29.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.013 -1.054 . . . . 2.1099999999999999 110.224 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -95.39 144.08 26.21 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.211 -0.93 . . . . 4.4800000000000004 109.679 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 316' ' ' ASN . 40.6 t0 -95.86 137.45 34.91 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.197 -0.939 . . . . 3.9100000000000001 110.173 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.568 HD11 ' NE2' ' A' ' 318' ' ' GLN . 4.1 mm -54.23 -44.29 64.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.124 0.964 . . . . 3.6099999999999999 108.947 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 44.4 t -97.83 134.56 35.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.805 -0.634 . . . . 5.0899999999999999 110.114 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -90.99 132.76 35.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 7.5 110.133 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 117.962 -1.465 . . . . 7.2999999999999998 109.549 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.611 ' N1 ' ' HE3' ' A' ' 395' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_